Voya Financial (VOYA) 10-K 21 Feb 25 2024 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($) $ in Billions	12 Months Ended
	Dec. 31, 2024	Feb. 14, 2025	Jun. 28, 2024
Document Information [Line Items]
Document Type	10-K
Document Period End Date	Dec. 31, 2024
Current Fiscal Year End Date	--12-31
Document Annual Report	true
Document Transition Report	false
Entity File Number	001-35897
Entity Registrant Name	Voya Financial, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	52-1222820
Entity Address, Address Line One	230 Park Avenue,
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10169
City Area Code	212
Local Phone Number	309-8200
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
ICFR Auditor Attestation Flag	true
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Document Financial Statement Error Correction [Flag]	false
Entity Shell Company	false
Entity Public Float			$ 7
Entity Common Stock, Shares Outstanding		95,526,278
Documents Incorporated by Reference	Portions of Voya Financial, Inc.'s Proxy Statement for its 2025 Annual Meeting of Shareholders are incorporated by reference in the Annual Report on Form 10-K in response to Part III, Items 10, 11, 12, 13 and 14.
Amendment Flag	false
Entity Central Index Key	0001535929
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	FY
Common Stock
Document Information [Line Items]
Title of 12(b) Security	Common Stock, $.01 Par Value
Trading Symbol	VOYA
Security Exchange Name	NYSE
Depositary Shares
Document Information [Line Items]
Title of 12(b) Security	Depositary Shares, each representing a 1/40th
Trading Symbol	VOYAPrB
Security Exchange Name	NYSE

Audit Information

Audit Information	12 Months Ended
	Dec. 31, 2024
Audit Information [Abstract]
Auditor Location	San Antonio, Texas
Auditor Name	Ernst & Young LLP
Auditor Firm ID	42

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Investments:
Short-term investments under securities loan agreements, including collateral delivered	$ 1,042	$ 1,015
Accrued investment income	396	411
Premium receivable and reinsurance recoverable (net of allowance for credit losses of $16 and $28 as of 2024 and 2023, respectively)	11,284	11,982
Deferred policy acquisition costs and Value of business acquired	2,148	2,250
Deferred income taxes	2,134	2,160
Goodwill	748	748
Other intangibles, net	832	857
Assets held in separate accounts	101,676	93,133
Total assets	163,889	157,085
Liabilities:
Future policy benefits	9,332	9,560
Contract owner account balances	37,104	39,174
Payables under securities loan and repurchase agreements, including collateral held	1,309	1,121
Short-term debt	399	1
Long-term debt	2,103	2,097
Derivatives	332	371
Liabilities related to separate accounts	101,676	93,133
Total liabilities	157,882	151,032
Commitments and Contingencies (Note 20)
Redeemable noncontrolling interest	219	175
Shareholders' equity:
Preferred stock ($0.01 par value per share; $625 aggregate liquidation preference as of 2024 and 2023)	0	0
Common stock ($0.01 par value per share; 900,000,000 shares authorized; 105,592,281 and 103,584,699 shares issued as of 2024 and 2023, respectively; 95,497,265 and 102,854,569 shares outstanding as of 2024 and 2023, respectively)	1	1
Treasury stock (at cost; 10,095,016 and 730,130 shares as of 2024 and 2023, respectively)	(754)	(56)
Additional paid-in capital	6,266	6,143
Accumulated other comprehensive income (loss)	(2,462)	(2,400)
Retained earnings:
Unappropriated	954	505
Total Voya Financial, Inc. shareholders' equity	4,005	4,193
Noncontrolling interest	1,783	1,685
Total shareholders' equity	5,788	5,878
Total liabilities and shareholder's equity	163,889	157,085
Excluding consolidated VIEs
Investments:
Fixed maturities, available-for-sale	24,089	25,375
Fixed maturities, at fair value using the fair value option	1,849	2,076
Equity securities, at fair value	246	236
Short-term investments	94	213
Mortgage loans on real estate/ Corporate loans	4,675	5,192
Policy loans	342	352
Limited partnerships/corporations	1,836	1,621
Derivatives	303	311
Other investments	67	64
Securities pledged (amortized cost of $1,665 and $1,232 as of 2024 and 2023, respectively)	1,523	1,160
Total investments	35,024	36,600
Cash and cash equivalents	1,399	937
Other assets	2,312	2,372
Liabilities:
Other liabilities	2,886	2,956
VIEs
Investments:
Mortgage loans on real estate/ Corporate loans	1,434	1,404
Limited partnerships/corporations	3,067	2,861
Cash and cash equivalents	115	181
Other assets	278	174
Liabilities:
Other liabilities	1,640	1,287
Collateralized loan obligations notes, at fair value using the fair value option	$ 1,101	$ 1,332

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Statement of Financial Position [Abstract]
Fixed maturities, amortized cost	$ 26,536	$ 27,690
Fixed maturities, allowance for credit loss	38	17	$ 12	$ 58
Allowance for losses for commercial mortgage loans	24	26
Securities pledged, amortized costs	1,665	1,232
Allowance for credit losses on premium receivable reinsurance recoverable	16	28	32	24
Allowance for credit losses on other assets	$ 1	$ 1	$ 1	$ 0
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, aggregate liquidation preference	$ 625	$ 625
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	900,000,000	900,000,000
Common stock, shares issued	105,592,281	103,584,699
Common stock, shares outstanding	95,497,265	102,854,569	97,200,000	107,800,000
Treasury Stock, shares	10,095,016	730,130

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Revenues:
Net investment income	$ 2,074	$ 2,159	$ 2,281
Fee income	2,113	1,916	1,742
Premiums	3,176	2,717	2,423
Net gains (losses)	(27)	(72)	(686)
Other Income	423	327	148
Net investment income	291	301	22
Total revenues	8,050	7,348	5,930
Benefits and expenses:
Policyholder benefits	2,627	1,960	1,566
Interest credited to contract owner account balances	992	1,076	962
Operating expenses	3,082	3,096	2,542
Net amortization of Deferred policy acquisition costs and Value of business acquired	223	230	240
Interest expense	124	132	134
Operating expenses related to CIEs:, Interest expense	175	166	49
Other corporate	28	10	9
Total benefits and expenses	7,251	6,670	5,502
Income before income taxes	799	678	428
Income tax expense (benefit)	57	(51)	(5)
Net income (loss)	742	729	433
Income (loss) attributable to noncontrolling interests	75	104	(77)
Net income available to Voya Financial, Inc.	667	625	510
Less: Preferred stock dividends	41	36	36
Net income available to Voya Financial, Inc.'s common shareholders	$ 626	$ 589	$ 474
Net income available to Voya Financial, Inc.'s common shareholders per common share:
Basic	$ 6.31	$ 5.74	$ 4.70
Diluted	$ 6.17	$ 5.42	$ 4.30

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ 742	$ 729	$ 433
Other comprehensive income (loss), before tax:
Change in current discount rate	103	(33)	290
Unrealized gains (losses) on securities	(180)	863	(6,445)
Pension and other postretirement benefits liability	(1)	(1)	0
Other comprehensive income (loss), before tax	(78)	829	(6,155)
Income tax expense (benefit) related to items of other comprehensive income (loss)	(16)	174	(1,293)
Other comprehensive income (loss), after tax	(62)	655	(4,862)
Comprehensive income (loss)	680	1,384	(4,429)
Less: Comprehensive income (loss) attributable to noncontrolling interest and redeemable noncontrolling interest	75	104	(77)
Comprehensive income (loss) attributable to Voya Financial, Inc.	$ 605	$ 1,280	$ (4,352)

Consolidated Statements of Chan

Consolidated Statements of Changes in Shareholder's Equity - USD ($) $ in Millions	Total	Common Stock	Treasury stock	Additional Paid-In Capital	Additional Paid-In Capital Preferred Stock	Additional Paid-In Capital Common Stock	Accumulated Other Comprehensive Income (Loss)	Retained Earnings (Deficit), Unappropriated	Total Voya Financial, Inc. Shareholders' Equity	Noncontrolling Interest
Beginning balance at Dec. 31, 2021	$ 9,668	$ 1	$ (80)	$ 7,542			$ 1,807	$ (1,170)	$ 8,100	$ 1,568
Increase (Decrease) in Stockholders' Equity
Net income (loss)	433							510	510
Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest	419									(91)
Interest in VIM Holdings LLC	412								412
Other comprehensive income (loss), after tax	(4,862)						(4,862)		(4,862)
Other comprehensive income (loss), after tax	(4,862)
Comprehensive income (loss)	(4,429)								(4,352)
Less: Comprehensive income (loss) attributable to noncontrolling interest and redeemable noncontrolling interest	(77)									(91)
Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Nonredeemable Noncontrolling Interest	(4,443)
Net consolidations (deconsolidations) of CIEs	(3)									(3)
Common stock issuance	7			7					7
Common stock acquired - Share repurchase	(750)		(750)					0	(750)
Treasury stock retirement	(458)		838	(1,297)				459
Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings					$ 36	$ 80
Dividends, Preferred Stock, Cash	(36)								(36)
Dividends on common stock	(80)								(80)
Share-based compensation	48		(47)	95					48
Contributions from (Distributions to) noncontrolling interest, net	2									2
Ending balance at Dec. 31, 2022	4,831	1	(39)	6,643			(3,055)	(201)	3,349	1,482
Increase (Decrease) in Temporary Equity [Roll Forward]
Temporary Equity, Interest in VIM Holdings LLC	148
Net income (loss)	14
Total comprehensive income (loss)	14
Contributions from (Distributions to) noncontrolling interest, net	4
Ending balance at Dec. 31, 2022	166
Increase (Decrease) in Stockholders' Equity
Net income (loss)	729
Interest in VIM Holdings LLC				412
Net income (loss)	695							625	625	70
Other comprehensive income (loss), after tax	655						655		655
Comprehensive income (loss)	1,384								1,280
Less: Comprehensive income (loss) attributable to noncontrolling interest and redeemable noncontrolling interest	104									70
Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Nonredeemable Noncontrolling Interest	1,350
Net consolidations (deconsolidations) of CIEs	(7)									7
Common stock acquired - Share repurchase	(374)		(374)						(374)
Treasury stock retirement	(186)		412	(598)				186
Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings					$ 18	$ 41
Dividends, Preferred Stock, Cash	(36)							(18)	(36)
Dividends on common stock	(125)							(84)	(125)
Share-based compensation	99		(55)	157				(3)	99
Contributions from (Distributions to) noncontrolling interest, net	140									140
Ending balance at Dec. 31, 2023	5,878	1	(56)	6,143			(2,400)	505	4,193	1,685
Increase (Decrease) in Temporary Equity [Roll Forward]
Net income (loss)	34
Total comprehensive income (loss)	34
Net consolidations (deconsolidations) of CIEs, Mezzanine Equity	(2)
Contributions from (Distributions to) noncontrolling interest, net	(23)
Ending balance at Dec. 31, 2023	175
Increase (Decrease) in Stockholders' Equity
Net income (loss)	742
Net income (loss)	694							667	667	27
Other comprehensive income (loss), after tax	(62)						(62)		(62)
Comprehensive income (loss)	680								605
Less: Comprehensive income (loss) attributable to noncontrolling interest and redeemable noncontrolling interest	75									27
Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Nonredeemable Noncontrolling Interest	632
Net consolidations (deconsolidations) of CIEs	(2)									(2)
Common stock issuance	6			6					6
Common stock acquired - Share repurchase	(640)		(640)						(640)
Treasury stock retirement	0
Dividends, Preferred Stock, Cash	(41)							(41)	(41)
Dividends on common stock	(168)							(168)	(168)
Share-based compensation	54		(58)	117				(5)	54
Contributions from (Distributions to) noncontrolling interest, net	69							(4)	(4)	73
Ending balance at Dec. 31, 2024	5,788	$ 1	$ (754)	$ 6,266			$ (2,462)	$ 954	$ 4,005	$ 1,783
Increase (Decrease) in Temporary Equity [Roll Forward]
Net income (loss)	48
Total comprehensive income (loss)	48
Net consolidations (deconsolidations) of CIEs, Mezzanine Equity	0
Contributions from (Distributions to) noncontrolling interest, net	(4)
Ending balance at Dec. 31, 2024	$ 219

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Cash Flows from Operating Activities:
Net income (loss)	$ 742	$ 729	$ 433
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Deferred income tax expense (benefit)	42	(62)	3
Net (gains) losses	27	72	686
Share-based compensation	96	126	90
(Gains) losses on CIEs	(196)	(230)	76
(Gains) losses on limited partnerships/corporations	0	33	27
Changes in operating assets and liabilities:
Deferred policy acquisition costs, value of business acquired and sales inducements, net	102	113	124
Premium receivable and reinsurance recoverable	649	538	278
Other receivables and asset accruals	(153)	31	(211)
Contract owner accounts, future policy benefits and claims, net	465	272	337
Other payables and accruals	(70)	(95)	(279)
(Increase) decrease in cash held by CIEs	(511)	(98)	(355)
Other, net	152	209	143
Net cash (used in) provided by operating activities	1,345	1,638	1,352
Proceeds from the sale, maturity, disposal or redemption of:
Fixed maturities	6,239	6,980	7,900
Equity securities	36	139	5
Mortgage loans on real estate	784	600	854
Limited partnerships/corporations	292	470	256
Acquisition of:
Fixed maturities	(5,511)	(4,439)	(8,518)
Equity securities	(59)	(28)	(76)
Mortgage loans on real estate	(301)	(408)	(669)
Limited partnerships/corporations	(464)	(307)	(353)
Short-term investments, net	119	144	(260)
Derivatives, net	206	81	291
Sales from CIEs	1,496	962	849
Purchases within CIEs	(2,608)	(1,225)	(2,338)
Collateral received (delivered), net	167	(19)	54
Receipts on deposit asset contracts	217	253	126
Payments for business acquisitions, net of cash acquired	0	(584)	(2)
Other, net	(132)	(87)	(65)
Net cash provided by (used in) investing activities	481	2,532	(1,946)
Cash Flows from Financing Activities:
Deposits received for investment contracts	2,945	2,501	5,818
Maturities and withdrawals from investment contracts	(5,569)	(6,355)	(6,354)
Proceeds from issuance of long-term debt	397	388	0
Repayments of long-term debt, including current maturities	(1)	(541)	(366)
Borrowings of CIEs	1,186	487	1,628
Repayments of borrowings of CIEs	(1,081)	(687)	(932)
Contributions from (distributions to) participants in CIEs, net	1,634	772	1,166
Proceeds from issuance of common stock, net	6	0	7
Common stock acquired - Share repurchase	(640)	(369)	(750)
Dividends paid on preferred stock	(41)	(36)	(36)
Dividends paid on common stock	(171)	(127)	(83)
Other, net	(95)	(92)	(70)
Net cash provided by (used in) financing activities	(1,430)	(4,059)	28
Net increase (decrease) in cash and cash equivalents, including cash in CIEs	396	111	(566)
Cash and cash equivalents, including cash in CIEs, beginning of period	1,118	1,007	1,573
Cash and cash equivalents, including cash in CIEs, end of period	1,514	1,118	1,007
Supplemental cash flow information:
Income taxes paid	9	11	14
Interest paid	103	113	131
Non-cash investing and financing activities:
Treasury stock retirement	0	186	$ 458
Reconciliation of cash and cash equivalents, including cash in CIEs:
Total cash and cash equivalents, including cash in CIEs	1,514	1,118
Excluding consolidated VIEs
Reconciliation of cash and cash equivalents, including cash in CIEs:
Cash and cash equivalents	1,399	937
VIEs
Reconciliation of cash and cash equivalents, including cash in CIEs:
Cash and cash equivalents	$ 115	$ 181

Consolidated Statements of Ca_2

Consolidated Statements of Cash Flows (Parenthetical) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Statement of Cash Flows [Abstract]
Dividends paid on common stock	$ 3	$ 2	$ 3

Business, Basis of Presentation

Business, Basis of Presentation and Significant Accounting Policies	12 Months Ended
	Dec. 31, 2024
Accounting Policies [Abstract]
Business, Basis of Presentation and Significant Accounting Policies	Business, Basis of Presentation and Significant Accounting Policies Business Voya Financial, Inc., together with its subsidiaries (collectively the "Company"), is a financial services organization that offers a broad range of retirement services, group insurance and supplemental health products, investment management services and mutual funds primarily in the United States. Products and services are provided by the Company through three segments: Wealth Solutions, Health Solutions and Investment Management. Activities not directly related to the Company's segments and certain run-off activities that are not meaningful to the Company's business strategy are included within Corporate. See the Segments Note to these Consolidated Financial Statements. On September 11, 2024, the Company announced a definitive agreement to acquire the full-service retirement plan business of OneAmerica Financial. This acquisition was accomplished through the purchase of legal entities and an indemnity reinsurance agreement. The acquisition adds scale and a broader set of capabilities to the Company's full-service business in Wealth Solutions, including incremental assets in emerging and mid-market segments, employee stock ownership plan capabilities and opportunities for distribution partnerships. The transaction closed on January 2, 2025. The purchase consideration includes approximately $50 in cash paid at closing and contingent consideration of up to $160 based on plan persistency and transition incentives. On August 1, 2023, the Company acquired all remaining equity interest in VFI SLK Global Services Private Limited previously held by SLK and renamed the entity as Voya India. Voya India was a private limited company in India formed pursuant to a joint venture agreement between the Company and SLK on August 1, 2019, with the Company and SLK holding 49% and 51% of ownership shares, respectively. The purpose of Voya India is to provide technology and business operation services to the Company. As a result of the acquisition, Voya India has become a wholly owned subsidiary of the Company and provides the Company with improved strategic and operational flexibility. As part of the purchase consideration, an upfront payment of $53 was made at closing. The Company recorded a gain of $45 in relation to the revaluation of the existing investment in Voya India which was recorded in Net gains (losses) in the Consolidated Statements of Operations for the year ended December 31, 2023. Net assets acquired as part of this transaction included goodwill of $102. On January 24, 2023, the Company acquired all outstanding shares of Benefitfocus, pursuant to an agreement and plan of merger entered into on November 1, 2022. The acquisition has expanded the Company’s capacity to meet the growing demand for comprehensive benefits and savings solutions and increases its ability to deliver innovative solutions for employers and health plans. The total purchase consideration for the acquisition was $595, of which $583 was paid in cash ($558 paid by the Company and $25 of the cash acquired was used to fund the transaction). Net assets acquired as part of this transaction included cash of $49, goodwill of $319, intangible assets of $275, deferred tax assets of $45 and assumed lease liabilities of $91. Intangible assets primarily included customer relationships of $190 with a useful life of 15 years, and software of $70 with a useful life of 5 years. Basis of Presentation The accompanying Consolidated Financial Statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States ("U.S. GAAP"). The Consolidated Financial Statements include the accounts of Voya Financial, Inc. and its subsidiaries, as well as other voting interest entities ("VOEs") and variable interest entities ("VIEs") in which the Company has a controlling financial interest. See the Consolidated and Nonconsolidated Investment Entities Note to these Consolidated Financial Statements. Intercompany transactions and balances have been eliminated. Certain reclassifications have been made to prior-period amounts to conform to current-period reporting classifications. These reclassifications had no impact on Net income (loss) or Total shareholders’ equity. Significant Accounting Policies Estimates and Assumptions The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. Those estimates are inherently subject to change and actual results could differ from those estimates, and the differences may be material to the Consolidated Financial Statements. The Company has identified the following accounts and policies as the most significant in that they involve a higher degree of judgment, are subject to a significant degree of variability and/or contain significant accounting estimates: • Reserves for future policy benefits; • Valuation of investments and derivatives; • Investment impairments; • Goodwill and other intangible assets; • Income taxes; • Contingencies; and • Employee benefit plans. Fair Value Measurement The Company measures the fair value of its financial assets and liabilities based on assumptions used by market participants in pricing the asset or liability, which may include inherent risk, restrictions on the sale or use of an asset, or nonperformance risk, including the Company's own credit risk. The estimate of fair value is the price that would be received to sell an asset or transfer a liability ("exit price") in an orderly transaction between market participants in the principal market, or the most advantageous market in the absence of a principal market, for that asset or liability. The Company uses a number of valuation sources to determine the fair values of its financial assets and liabilities, including quoted market prices, third-party commercial pricing services, third-party brokers, industry-standard, vendor-provided software that models the value based on market observable inputs, and other internal modeling techniques based on projected cash flows. Investments The accounting policies for the Company's principal investments are as follows: Fixed Maturities and Equity Securities : The Company measures its equity securities at fair value and recognizes any changes in fair value in net income. The Company's fixed maturities are generally designated as available-for-sale. In addition, the Company has fixed maturities accounted for using the fair value option ("FVO"). Available-for-sale securities are reported at fair value and unrealized capital gains (losses) on these securities are recorded directly in Accumulated other comprehensive income ("AOCI") and presented net of Deferred income taxes. Trading securities are valued at fair value, with the changes in fair value recorded in Net gains (losses) and interest income recorded in Net investment income in the Consolidated Statements of Operations. In addition, certain fixed maturities have embedded derivatives, which are reported with the host contract on the Consolidated Balance Sheets. In connection with funds withheld reinsurance treaties, the Company has elected the FVO for certain of its fixed maturities to better match the measurement of those assets and related embedded derivative liabilities in the Consolidated Statements of Operations. Certain collateralized mortgage obligations ("CMOs"), primarily interest-only and principal-only strips, are accounted for as hybrid instruments and valued at fair value with changes in the fair value recorded in Net gains (losses). Changes in fair value associated with derivatives purchased to hedge CMOs are also recorded in Net gains (losses). Purchases and sales of fixed maturities and equity securities, excluding private placements, are recorded on the trade date. Purchases and sales of private placements and mortgage loans are recorded on the closing date. Investment gains and losses on sales of securities are generally determined on a first-in-first-out ("FIFO") basis. Interest income on fixed maturities is recorded when earned using an effective yield method, giving effect to amortization of premiums and accretion of discounts. Dividends on equity securities are recorded when declared. Such dividends and interest income are recorded in Net investment income. Included within fixed maturities are loan-backed securities, including residential mortgage-backed securities ("RMBS"), commercial mortgage-backed securities ("CMBS") and asset-backed securities ("ABS"). Amortization of the premium or discount from the purchase of these securities considers the estimated timing and amount of prepayments of the underlying loans. Actual prepayment experience is periodically reviewed and effective yields are recalculated when differences arise between the prepayments originally anticipated and the actual prepayments received and currently anticipated. Prepayment assumptions for single-class and multi-class mortgage-backed securities ("MBS") and ABS are estimated by management using inputs obtained from third-party specialists, including broker-dealers, and based on management's knowledge of the current market. For prepayment-sensitive securities such as interest-only and principal-only strips, inverse floaters and credit-sensitive MBS and ABS securities, which represent beneficial interests in securitized financial assets that are not of high credit quality or that have been credit impaired, the effective yield is recalculated on a prospective basis. For all other MBS and ABS, the effective yield is recalculated on a retrospective basis. Short-term Investments : Short-term investments include investments with remaining maturities of one year or less, but greater than three months, at the time of purchase. These investments are stated at fair value. Mortgage Loans on Real Estate : The Company's mortgage loans on real estate are all commercial mortgage loans, which are reported at amortized cost, net of allowance for credit losses. Amortized cost is the principal balance outstanding, net of deferred loan fees and costs. Accrued interest receivable is reported in Accrued investment income on the Consolidated Balance Sheets. Mortgage loans are evaluated by the Company's investment professionals, including an appraisal of loan-specific credit quality, property characteristics and market trends. Loan performance is continuously monitored on a loan-specific basis throughout the year. The Company's review includes submitted appraisals, operating statements, rent revenues and annual inspection reports, among other items. This review evaluates whether the properties are performing at a consistent and acceptable level to secure the debt. Management estimates the credit loss allowance balance using a factor-based method of probability of default and loss given default which incorporates relevant available information, from internal and external sources, relating to past events, current conditions, and reasonable and supportable forecasts. Included in the factor-based method are the consideration of debt type, capital market factors and market vacancy rates, and loan-specific risk characteristics such as debt service coverage ratios (“DSC”), loan-to-value (“LTV”), collateral size, seniority of the loan, segmentation and property types. The allowance for credit losses is a valuation account that is deducted from the loans’ amortized cost basis to present the net amount expected to be collected on the loans. The change in the allowance for credit losses is recorded in Net gains (losses). Loans are written off against the allowance when management believes the uncollectability of a loan balance is confirmed. Expected recoveries do not exceed the aggregate of amounts previously written-off and expected to be written-off. Mortgages are rated for the purpose of quantifying the level of risk. Those loans with higher risk are placed on a watch list and are closely monitored for collateral deficiency or other credit events that may lead to a potential loss of principal or interest. The Company defines delinquent mortgage loans consistent with industry practice as 60 days past due. Commercial mortgage loans are placed on non-accrual status when 90 days in arrears if the Company has concerns regarding the collectability of future payments, or if a loan has matured without being paid off or extended. Factors considered may include conversations with the borrower, loss of major tenant, bankruptcy of borrower or major tenant, decreased property cash flow, number of days past due, or various other circumstances. Based on an assessment as to the collectability of the principal, a determination is made either to apply against the book value or apply according to the contractual terms of the loan. Funds recovered in excess of book value would then be applied to recover expenses, impairments, and then interest. Accrual of interest resumes after factors resulting in doubts about collectability have improved. For those mortgages that are determined to require foreclosure, expected credit losses are based on the fair value of the underlying collateral, net of estimated costs to obtain and sell at the point of foreclosure. Property obtained from foreclosed mortgage loans is recorded in Other investments on the Consolidated Balance Sheets. Policy Loans : Policy loans are carried at an amount equal to the unpaid balance. Interest income on such loans is recorded as earned in Net investment income using the contractually agreed upon interest rate. Generally, interest is capitalized on the policy's anniversary date. Valuation allowances are not established for policy loans, as these loans are collateralized by the cash surrender value of the associated insurance contracts. Any unpaid principal or interest on the loan is deducted from the account value or the death benefit prior to settlement of the policy. Limited Partnerships/Corporations : The Company uses the equity method of accounting for investments in limited partnership interests that are not consolidated, which primarily consist of investments in private equity funds, hedge funds and other VIEs for which the Company is not the primary beneficiary. Generally, the Company records its share of earnings using a lag methodology, relying on the most recent financial information available, typically not to exceed three months. The Company's earnings from limited partnership interests accounted for under the equity method are recorded in Net investment income. Other Investments : Other investments are comprised primarily of Federal Home Loan Bank ("FHLB") stock and property obtained from foreclosed mortgage loans, as well as other miscellaneous investments. The Company is a member of the FHLB system and is required to own a certain amount of FHLB stock based on the level of borrowings and other factors. FHLB stock is carried at cost, classified as a restricted security and periodically evaluated for impairment based on ultimate recovery of par value. Securities Pledged : The Company engages in securities lending whereby certain securities from its portfolio are loaned to other institutions, through a lending agent, for short periods of time. The Company has the right to approve any institution with whom the lending agent transacts on its behalf. Initial collateral, primarily cash, is required at an agreed-upon percentage of the market value of the loaned securities. The lending agent retains the collateral and invests it in short-term liquid assets on behalf of the Company. The market value of the loaned securities is monitored on a daily basis with additional collateral obtained or refunded as the market value of the loaned securities fluctuates. The lending agent indemnifies the Company against losses resulting from the failure of a counterparty to return securities pledged where collateral is insufficient to cover the loss. See also Repurchase Agreements below. Investment Impairments The Company evaluates its available-for-sale investments quarterly to determine whether a decline in fair value below the amortized cost basis has resulted from credit loss or other factors. This evaluation process entails considerable judgment and estimation. Factors considered in this analysis include, but are not limited to, the extent to which the fair value has been less than amortized cost, the issuer's financial condition and near-term prospects, future economic conditions and market forecasts, interest rate changes and changes in ratings of the security. A severe unrealized loss position on a fixed maturity may not have any impact on (a) the ability of the issuer to service all scheduled interest and principal payments and (b) the evaluation of recoverability of all contractual cash flows or the ability to recover an amount at least equal to its amortized cost based on the present value of the expected future cash flows to be collected. When assessing the Company's intent to sell a security, or if it is more likely than not it will be required to sell a security before recovery of its amortized cost basis, management evaluates facts and circumstances such as, but not limited to, decisions to rebalance the investment portfolio and sales of investments to meet cash flow or capital needs. When the Company has determined it has the intent to sell, or if it is more likely than not that the Company will be required to sell a security before recovery of its amortized cost basis, and the fair value has declined below amortized cost ("intent impairment"), the individual security is written down from amortized cost to fair value, and a corresponding charge is recorded in Net gains (losses) as impairments in the Consolidated Statements of Operations. For available-for-sale securities that do not meet the intent impairment criteria but the Company has determined that a credit loss exists, the present value of cash flows expected to be collected from the security are compared to the amortized cost basis of the security. If the present value of cash flows expected to be collected is less than the amortized cost basis, a credit loss allowance is recorded for the credit loss, limited by the amount that the fair value is less than the amortized cost basis. The Company uses the following methodology and significant inputs in determining whether a credit loss exists: • When determining collectability and the period over which the value is expected to recover for U.S. and foreign corporate securities, foreign government securities and state and political subdivision securities, the Company applies the same considerations utilized in its overall impairment evaluation process, which incorporates information regarding the specific security, the industry and geographic area in which the issuer operates and overall macroeconomic conditions. Projected future cash flows are estimated using assumptions derived from the Company's best estimates of likely scenario-based outcomes, after giving consideration to a variety of variables that includes, but is not limited to: general payment terms of the security; the likelihood that the issuer can service the scheduled interest and principal payments; the quality and amount of any credit enhancements; the security's position within the capital structure of the issuer; possible corporate restructurings or asset sales by the issuer; and changes to the rating of the security or the issuer by rating agencies. • Additional considerations are made when assessing the unique features that apply to certain structured securities, such as subprime, Alt-A, non-agency RMBS, CMBS and ABS. These additional factors for structured securities include, but are not limited to: the quality of underlying collateral; expected prepayment speeds; loan-to-value ratios; debt service coverage ratios; current and forecasted loss severity; consideration of the payment terms of the underlying assets backing a particular security; and the payment priority within the tranche structure of the security. • When determining the amount of the credit loss for U.S. and foreign corporate securities, foreign government securities and state and political subdivision securities, the Company considers the estimated fair value as the recovery value when available information does not indicate that another value is more appropriate. When information is identified that indicates a recovery value other than estimated fair value, the Company considers in the determination of recovery value the same considerations utilized in its overall impairment evaluation process, which incorporates available information and the Company's best estimate of scenario-based outcomes regarding the specific security and issuer; possible corporate restructurings or asset sales by the issuer; the quality and amount of any credit enhancements; the security's position within the capital structure of the issuer; fundamentals of the industry and geographic area in which the security issuer operates; and the overall macroeconomic conditions. • The Company performs a discounted cash flow analysis comparing the current amortized cost of a security to the present value of future cash flows expected to be received, including estimated defaults and prepayments. The discount rate is generally the effective interest rate of the fixed maturity prior to impairment. Changes in the allowance for credit losses are recorded in Net gains (losses) as impairments. Losses are charged against the allowance when the Company believes the uncollectability of an available-for-sale security is confirmed or when either of the criteria regarding intent or requirement to sell is met. Accrued interest receivable on available-for-sale securities is excluded from the estimate of credit losses. The Company evaluates the collectability of accrued interest receivable as part of its quarterly impairment evaluation of available-for-sale investments. Losses are recorded in Net investment income when the Company believes the uncollectability of the accrued interest receivable is confirmed. Derivatives The Company's use of derivatives is limited mainly to economic hedging to reduce the Company's exposure to cash flow variability of assets and liabilities, interest rate risk, credit risk, exchange rate risk and market risk. It is the Company's policy not to offset amounts recognized for derivative instruments and amounts recognized for the right to reclaim cash collateral or the obligation to return cash collateral arising from derivative instruments executed with the same counterparty under a master netting arrangement, which provides the Company with the legal right of offset. However, in accordance with the Chicago Mercantile Exchange ("CME") rules related to the variation margin payments, the Company is required to adjust the derivative balances with the variation margin payments related to its cleared derivatives executed through CME. The Company enters into interest rate, equity market, credit default and currency contracts, including swaps, futures, forwards, caps, floors and options, to reduce and manage various risks associated with changes in value, yield, price, cash flow or exchange rates of assets or liabilities held or intended to be held, or to assume or reduce credit exposure associated with a referenced asset, index or pool. The Company also utilizes options and futures on equity indices to reduce and manage risks associated with its universal life-type ("UL-type") and annuity products. Derivative contracts are reported as Derivatives assets or liabilities on the Consolidated Balance Sheets at fair value. Changes in the fair value of derivatives are recorded in Net gains (losses) in the Consolidated Statements of Operations. Gains (losses) and net investment income related to derivatives are reflected as adjustments to reconcile Net cash flows from operating activities, and the net cash activity from derivatives is reflected in Net cash flows from investing activities, in the Consolidated Statements of Cash Flows. Any noncash activity, to the extent it is material, is excluded and reflected in a noncash supplementary schedule related to investing and financing activities. To qualify for hedge accounting, at the inception of the hedging relationship, the Company formally documents its risk management objective and strategy for undertaking the hedging transaction, as well as its designation of the hedge as either (a) a hedge of the exposure to changes in the estimated fair value of a recognized asset or liability or an identified portion thereof that is attributable to a particular risk ("fair value hedge") or (b) a hedge of a forecasted transaction or of the variability of cash flows that is attributable to interest rate risk to be received or paid related to a recognized asset or liability ("cash flow hedge"). In this documentation, the Company sets forth how the hedging instrument is expected to hedge the designated risks related to the hedged item and sets forth the method that will be used to retrospectively and prospectively assess the hedging instrument's effectiveness and the method that will be used to measure ineffectiveness. A derivative designated as a hedging instrument must be assessed as being highly effective in offsetting the designated risk of the hedged item. Hedge effectiveness is formally assessed at inception and periodically throughout the life of the designated hedging relationship. • Fair Value Hedge : For derivative instruments that are designated and qualify as a fair value hedge, the entire change in the fair value of the hedging instrument included in the assessment of hedge effectiveness is recorded in the same line item in the Consolidated Statements of Operations as impacted by the hedged item. • Cash Flow Hedge : For derivative instruments that are designated and qualify as a cash flow hedge, the entire change in the fair value of the hedging instrument included in the assessment of hedge effectiveness is reported as a component of AOCI. Those amounts are subsequently reclassified to earnings when the hedged item affects earnings, and are reported in the same line item in the Consolidated Statements of Operations as impacted by the hedged item. Even if a derivative qualifies for hedge accounting treatment, there may be an element of ineffectiveness of the hedge. The ineffective portion of a hedging relationship subject to hedge accounting is recognized in Net gains (losses). When hedge accounting is discontinued because it is determined that the derivative is no longer expected to be highly effective in offsetting changes in the estimated fair value or cash flows of a hedged item, the derivative continues to be carried on the Consolidated Balance Sheets at its estimated fair value, with subsequent changes in estimated fair value recognized currently in Net gains (losses). The carrying value of the hedged asset or liability under a fair value hedge is no longer adjusted for changes in its estimated fair value due to the hedged risk, and the cumulative adjustment to its carrying value is amortized into income over the remaining life of the hedged item. Provided the hedged forecasted transaction is still probable of occurrence, the changes in estimated fair value of derivatives recorded in Other comprehensive income (loss) related to discontinued cash flow hedges are released into the Consolidated Statements of Operations when the Company's earnings are affected by the variability in cash flows of the hedged item. When hedge accounting is discontinued because it is no longer probable that the forecasted transactions will occur on the anticipated date, or within two months of that date, the derivative continues to be carried on the Consolidated Balance Sheets at its estimated fair value, with changes in estimated fair value recognized currently in Net gains (losses). Derivative gains and losses recorded in Other comprehensive income (loss) pursuant to the discontinued cash flow hedge of a forecasted transaction that is no longer probable are recognized immediately in Net gains (losses). The Company also has investments in certain fixed maturities and has issued certain UL-type and annuity products that contain embedded derivatives for which fair value is at least partially determined by levels of or changes in domestic and/or foreign interest rates (short-term or long-term), exchange rates, prepayment rates, equity markets or credit ratings/spreads. Embedded derivatives within fixed maturities are included with the host contract on the Consolidated Balance Sheets, and changes in the fair value of the embedded derivatives are recorded in Net gains (losses). Embedded derivatives within certain UL-type and annuity products are included in Future policy benefits on the Consolidated Balance Sheets, and changes in the fair value of the embedded derivatives are recorded in Net gains (losses). In addition, the Company has entered into coinsurance with funds withheld and modified coinsurance reinsurance arrangements that contain embedded derivatives, the fair value of which is based on the change in the fair value of the underlying assets held in trust. These embedded derivatives are reported with the host contract in Other liabilities and Premium receivables and reinsurance recoverable, respectively, on the Consolidated Balance Sheets. Changes in the fair value of embedded derivatives are recorded in Policyholder benefits in the Consolidated Statements of Operations. Cash and Cash Equivalents Cash and cash equivalents include cash on hand, amounts due from banks and other highly liquid investments, such as money market instruments and debt instruments with maturities of three months or less at the time of purchase. Cash and cash equivalents are stated at fair value. Cash and cash equivalents of VIEs and VOEs are not available for general use by the Company. Deferred Policy Acquisition Costs and Value of Business Acquired Deferred policy acquisition costs ("DAC") represent policy acquisition costs that have been capitalized and are subject to amortization. Capitalized costs are incremental, direct costs of contract acquisition and certain other costs related directly to successful acquisition activities. Such costs consist principally of commissions, underwriting, sales and contract issuance and processing expenses directly related to the successful acquisition of new and renewal business. Indirect or unsuccessful acquisition costs, maintenance, product development and overhead expenses are charged to expense as incurred. Value of business acquired ("VOBA") represents the outstanding value of in-force business acquired and is subject to amortization. The value is based on the present value of estimated net cash flows embedded in the insurance contracts at the time of the acquisition and increased for subsequent deferrable expenses on purchased policies. DAC/VOBA amortization is recorded in Net amortization of Deferred policy acquisition costs and Value of business acquired in the Consolidated Statements of Operations. Amortization Methodologies The Company amortizes DAC/VOBA related to certain traditional life insurance contracts, certain accident and health insurance contracts and deferred annuity contracts on a constant level basis over the expected term of the related contracts. Contracts are grouped for amortization purposes by product or market type and issue year cohort on a basis consistent with those used in estimating the associated liability or other related balance, where applicable. The principal assumption deemed critical to the DAC/VOBA amortization is the estimated contract term, which incorporates mortality and persistency, and represents management’s best estimate of future outcome. The Company periodically reviews this assumption against actual experience and, based on additional information that becomes available, updates the assumption. Changes in contract term estimates are reflected prospectively in amortization expense as of the beginning of the reporting period in which the change is made. VOBA is subject to recoverability testing; DAC is not. The Company performs testing to assess the recoverability of VOBA on an annual basis, or more frequently if circumstances indicate a potential loss recognition issue exists. If VOBA is not deemed recoverable, charges will be applied against the VOBA bal

Investments (excluding Consolid

Investments (excluding Consolidated Investment Entities)	12 Months Ended
	Dec. 31, 2024
Investments, Debt and Equity Securities [Abstract]
Investments (excluding Consolidated Investment Entities)	Investments (excluding Consolidated Investment Entities) Fixed Maturities Available-for-sale and FVO fixed maturities were as follows as of December 31, 2024: Amortized Cost Gross Unrealized Capital Gains Gross Unrealized Capital Losses Embedded Derivatives (2) Allowance for credit losses Fair Value Fixed maturities: U.S. Treasuries $ 524 $ — $ 52 $ — $ — $ 472 U.S. Government agencies and authorities 29 1 — — — 30 State, municipalities and political subdivisions 697 — 117 — — 580 U.S. corporate public securities 7,938 124 1,054 — — 7,008 U.S. corporate private securities 5,275 43 329 — 6 4,983 Foreign corporate public securities and foreign governments (1) 2,729 32 287 — 2 2,472 Foreign corporate private securities (1) 2,693 22 169 — 9 2,537 Residential mortgage-backed securities 3,709 27 261 (4) — 3,471 Commercial mortgage-backed securities 3,677 4 532 — 17 3,132 Other asset-backed securities 2,779 39 45 — 4 2,769 Total fixed maturities, including securities pledged 30,050 292 2,846 (4) 38 27,454 Less: Securities pledged 1,665 — 149 — — 1,516 Total fixed maturities $ 28,385 $ 292 $ 2,697 $ (4) $ 38 $ 25,938 (1) Primarily U.S. dollar denominated. (2) Embedded derivatives within fixed maturity securities are reported with the host investment. The changes in fair value of embedded derivatives are reported in Net gains (losses) in the Consolidated Statements of Operations. Available-for-sale and FVO fixed maturities were as follows as of December 31, 2023: Amortized Cost Gross Unrealized Capital Gains Gross Unrealized Capital Losses Embedded Derivatives (2) Allowance for credit losses Fair Value Fixed maturities: U.S. Treasuries $ 417 $ 7 $ 21 $ — $ — $ 403 U.S. Government agencies and authorities 54 3 1 — — 56 State, municipalities and political subdivisions 871 1 101 — — 771 U.S. corporate public securities 8,402 168 904 — — 7,666 U.S. corporate private securities 5,040 44 324 — — 4,760 Foreign corporate public securities and foreign governments (1) 2,928 47 270 — 3 2,702 Foreign corporate private securities (1) 2,916 27 129 — 2 2,812 Residential mortgage-backed securities 3,695 36 257 2 — 3,476 Commercial mortgage-backed securities 4,147 1 644 — 9 3,495 Other asset-backed securities 2,528 16 71 — 3 2,470 Total fixed maturities, including securities pledged 30,998 350 2,722 2 17 28,611 Less: Securities pledged 1,232 — 72 — — 1,160 Total fixed maturities $ 29,766 $ 350 $ 2,650 $ 2 $ 17 $ 27,451 (1) Primarily U.S. dollar denominated. (2) Embedded derivatives within fixed maturity securities are reported with the host investment. The changes in fair value of embedded derivatives are reported in Net gains (losses) in the Consolidated Statements of Operations. The amortized cost and fair value of fixed maturities, including securities pledged, as of December 31, 2024, are shown below by contractual maturity. Actual maturities may differ from contractual maturities as securities may be restructured, called or prepaid. MBS and Other ABS are shown separately because they are not due at a single maturity date. Amortized Fair Due to mature: One year or less $ 607 $ 581 After one year through five years 3,946 3,819 After five years through ten years 3,723 3,590 After ten years 11,609 10,092 Mortgage-backed securities 7,386 6,603 Other asset-backed securities 2,779 2,769 Fixed maturities, including securities pledged $ 30,050 $ 27,454 As of December 31, 2024 and 2023, the Company did not have any investments in a single issuer, other than obligations of the U.S. Government and government agencies, with a carrying value in excess of 10% of the Company's Total shareholders' equity. Repurchase Agreements and Securities Pledged As of December 31, 2024 and 2023, the Company did not have any securities pledged in dollar rolls or reverse repurchase agreements. As of December 31, 2024, Securities pledged included fixed maturity securities and other investments of $1,516 and $7, respectively. As of December 31, 2023, Securities pledged included fixed maturities of $1,160. The Company engages in securities lending whereby the initial collateral is required at a rate of at least 102% of the market value of the loaned securities. The lending agent retains the collateral and invests it in high quality liquid assets on behalf of the Company. The market value of the loaned securities is monitored on a daily basis with additional collateral obtained or refunded as the market value of the loaned securities fluctuates. The lending agent indemnifies the Company against losses resulting from the failure of a counterparty to return securities pledged where collateral is insufficient to cover the loss. In the normal course of business, the Company receives cash collateral and non-cash collateral in the form of securities. If cash is received as collateral, the lending agent retains the cash collateral and invests it in short-term liquid assets on behalf of the Company. Securities retained as collateral by the lending agent may not be sold or re-pledged, except in the event of default, and are not reflected on the Company’s Consolidated Balance Sheets. This collateral generally consists of U.S. Treasury, U.S. Government agency securities and MBS pools. The following table presents Securities pledged as of the dates indicated: December 31, 2024 December 31, 2023 Securities pledged/obligations under repurchase agreements (1) $ 281 $ 117 Securities loaned to lending agent (2) 1,083 842 Securities pledged as collateral (2)(3) 159 201 Total $ 1,523 $ 1,160 (1) Comprised of other asset-backed securities and included in Securities pledged and Payables under securities loan and repurchase agreements, including collateral held on the Consolidated Balance Sheets. (2) Included in Securities pledged on the Consolidated Balance Sheets. (3) See Collateral within the Derivative Financial Instruments Note to these Consolidated Financial Statements for more information. The following table presents collateral held by asset class that the Company pledged under securities lending as of the dates indicated: December 31, 2024 December 31, 2023 U.S. Treasuries $ 22 $ 14 U.S. corporate public securities 601 568 Short-term investments 241 55 Foreign corporate public securities and foreign governments 258 238 Total (1) $ 1,122 $ 875 (1) As of December 31, 2024 and 2023, liabilities to return cash collateral were $736 and $660, respectively, and included in Payables under securities loan and repurchase agreements, including collateral held on the Consolidated Balance Sheets. The Company's securities lending activities are conducted on an overnight basis, and all securities loaned can be recalled at any time. The Company does not offset assets and liabilities associated with its securities lending program. Allowance for credit losses The following table presents a rollforward of the allowance for credit losses on available-for-sale fixed maturity securities for the period presented: Year Ended December 31, 2024 U.S. corporate private securities Commercial mortgage-backed securities Foreign corporate public securities and foreign governments Foreign corporate private securities Other asset-backed securities Total Balance as of January 1 $ — $ 9 $ 3 $ 2 $ 3 $ 17 Credit losses on securities for which credit losses were not previously recorded 6 9 — 8 1 24 Reductions for securities sold during the period — — (1) — — (1) Increase (decrease) on securities with allowance recorded in previous period — (1) — (1) — (2) Balance as of December 31 $ 6 $ 17 $ 2 $ 9 $ 4 $ 38 Year Ended December 31, 2023 U.S. corporate private securities Commercial mortgage-backed securities Foreign corporate public securities and foreign governments Foreign corporate private securities Other asset-backed securities Total Balance as of January 1 $ — $ — $ 9 $ 2 $ 1 $ 12 Credit losses on securities for which credit losses were not previously recorded — 9 — — 2 11 Reductions for securities sold during the period — — (5) — — (5) Increase (decrease) on securities with allowance recorded in previous period — — (1) — — (1) Balance as of December 31 $ — $ 9 $ 3 $ 2 $ 3 $ 17 For additional information about the Company’s methodology and significant inputs used in determining whether a credit loss exists, see the Business, Basis of Presentation and Significant Accounting Policies Note to these Consolidated Financial Statements. Unrealized Capital Losses The following tables present available-for-sale fixed maturities, including securities pledged, for which an allowance for credit losses has not been recorded by investment category and duration as of the dates indicated: As of December 31, 2024 Twelve Months or Less More Than Twelve Months Below Amortized Cost Total Fair Value Unrealized Capital Losses Fair Value Unrealized Capital Losses Fair Value Unrealized Capital Losses U.S. Treasuries $ 304 $ 20 $ 133 $ 32 $ 437 $ 52 U.S. Government agencies and authorities 14 — — — 14 — State, municipalities and political subdivisions 7 — 562 117 569 117 U.S. corporate public securities 818 35 4,215 1,019 5,033 1,054 U.S. corporate private securities 546 13 2,845 316 3,391 329 Foreign corporate public securities and foreign governments 450 17 1,285 270 1,735 287 Foreign corporate private securities 490 12 1,468 157 1,958 169 Residential mortgage-backed 311 8 1,210 253 1,521 261 Commercial mortgage-backed 24 — 2,751 532 2,775 532 Other asset-backed 93 2 315 43 408 45 Total $ 3,057 $ 107 $ 14,784 $ 2,739 $ 17,841 $ 2,846 As of December 31, 2023 Twelve Months or Less More Than Twelve Months Below Amortized Cost Total Fair Value Unrealized Capital Losses Fair Value Unrealized Capital Losses Fair Value Unrealized Capital Losses U.S. Treasuries $ 99 $ 3 $ 109 $ 18 $ 208 $ 21 U.S. Government agencies and authorities — — 3 1 3 1 State, municipalities and political subdivisions 20 — 731 101 751 101 U.S. corporate public securities 321 17 5,101 887 5,422 904 U.S. corporate private securities 176 7 3,365 317 3,541 324 Foreign corporate public securities and foreign governments 82 2 1,749 268 1,831 270 Foreign corporate private securities 189 5 2,101 124 2,290 129 Residential mortgage-backed 114 3 1,354 254 1,468 257 Commercial mortgage-backed 84 2 3,269 642 3,353 644 Other asset-backed 136 3 1,156 68 1,292 71 Total $ 1,221 $ 42 $ 18,938 $ 2,680 $ 20,159 $ 2,722 As of December 31, 2024, the average duration of the Company's fixed maturities portfolio, including securities pledged, is between 6 and 6.5 years. As of December 31, 2024 and 2023, the Company concluded that an allowance for credit losses was not warranted for the securities above because the unrealized losses are interest rate related. The Company does not intend to sell the investments and it is not more likely than not that the Company will be required to sell the investments before recovery of their amortized cost bases. Evaluating Securities for Impairments The Company performs a regular evaluation, on a security-by-security basis, of its available-for-sale securities holdings, including fixed maturity securities, in accordance with its impairment policy in order to evaluate whether such investments are impaired. For the years ended December 31, 2024, 2023 and 2022, intent impairments were $13, $27 and $23, respectively. The Company may sell securities during the period in which fair value has declined below amortized cost for fixed maturities. In certain situations, new factors, including changes in the business environment, can change the Company’s previous intent to continue holding a security. Accordingly, these factors may lead the Company to record additional intent related capital losses. Debt Modifications The Company evaluates all debt modifications to determine whether a modification results in a new loan or a continuation of an existing loan. Disclosures are required for loan modifications with borrowers experiencing financial difficulty. For the years ended December 31, 2024 and 2023, the Company had no material debt modifications that require such disclosure. Mortgage Loans on Real Estate The Company diversifies its commercial mortgage loan portfolio by geographic region and property type to reduce concentration risk. The Company manages risk when originating commercial mortgage loans by generally lending only up to 75% of the estimated fair value of the underlying real estate. Subsequently, the Company continuously evaluates mortgage loans based on relevant current information including a review of loan-specific performance, property characteristics and market trends. Loan performance is monitored on a loan specific basis through the review of submitted appraisals, operating statements, rent revenues and annual inspection reports, among other items. This review ensures properties are performing at a consistent and acceptable level to secure the debt. The components to evaluate debt service coverage are received and reviewed at least annually to determine the level of risk. LTV and DSC ratios are measures commonly used to assess the risk and quality of mortgage loans. The LTV ratio is expressed as a percentage of the amount of the loan relative to the value of the underlying property at origination. An LTV ratio in excess of 100% indicates the unpaid loan amount exceeds the underlying collateral. The DSC ratio, based upon the most recently received financial statements, is expressed as a percentage of the amount of a property’s net income to its debt service payments. A DSC ratio of less than 1.0 indicates that a property’s operations do not generate sufficient income to cover debt payments. These ratios are utilized as part of the review process described above. The following tables present commercial mortgage loans by year of origination and LTV ratio as of the dates indicated. The information is updated as of December 31, 2024 and 2023, respectively. As of December 31, 2024 Year of Origination Loan-to-Value Ratios 0% - 50% >50% - 60% >60% - 70% >70% - 80% >80% and above Total 2024 $ 138 $ 131 $ 15 $ — $ — $ 284 2023 96 221 40 — — 357 2022 239 282 95 — — 616 2021 240 184 95 — — 519 2020 184 71 — — — 255 Prior 2,500 148 2 — 18 2,668 Total $ 3,397 $ 1,037 $ 247 $ — $ 18 $ 4,699 As of December 31, 2023 Year of Origination Loan-to-Value Ratios 0% - 50% >50% - 60% >60% - 70% >70% - 80% >80% and above Total 2023 $ 150 $ 222 $ — $ — $ — $ 372 2022 252 326 73 — — 651 2021 244 214 209 — — 667 2020 168 112 — 10 16 306 2019 238 68 28 — — 334 Prior 2,586 280 4 — 18 2,888 Total $ 3,638 $ 1,222 $ 314 $ 10 $ 34 $ 5,218 The following tables present commercial mortgage loans by year of origination and DSC ratio as of the dates indicated. The information is updated as of December 31, 2024 and 2023, respectively. As of December 31, 2024 Debt Service Coverage Ratios Year of Origination >1.5x >1.25x - 1.5x >1.0x - 1.25x <1.0x Total (1) 2024 $ 161 $ 93 $ 28 $ 2 $ 284 2023 118 180 48 11 357 2022 295 101 76 144 616 2021 258 16 97 148 519 2020 207 20 20 8 255 Prior 2,018 219 346 85 2,668 Total $ 3,057 $ 629 $ 615 $ 398 $ 4,699 (1) No commercial mortgage loans were secured by land or construction loans As of December 31, 2023 Debt Service Coverage Ratios Year of Origination >1.5x >1.25x - 1.5x >1.0x - 1.25x <1.0x Total (1) 2023 $ 189 $ 116 $ 67 $ — $ 372 2022 204 68 192 187 651 2021 260 14 64 329 667 2020 211 24 21 50 306 2019 203 26 84 21 334 Prior 2,216 264 255 153 2,888 Total $ 3,283 $ 512 $ 683 $ 740 $ 5,218 (1) No commercial mortgage loans were secured by land or construction loans The following tables present the commercial mortgage loans by year of origination and U.S. region as of the dates indicated. The information is updated as of December 31, 2024 and 2023, respectively. As of December 31, 2024 Year of Origination U.S. Region Pacific South Atlantic Middle Atlantic West South Central Mountain East North Central New England West North Central East South Central Total 2024 $ 58 $ 80 $ 41 $ 57 $ 20 $ 9 $ 7 $ 3 $ 9 $ 284 2023 49 85 12 101 39 39 3 26 3 357 2022 140 122 49 98 89 92 5 1 20 616 2021 95 51 113 93 96 47 9 15 — 519 2020 61 118 17 10 12 15 — 7 15 255 Prior 707 632 619 176 211 134 51 109 29 2,668 Total $ 1,110 $ 1,088 $ 851 $ 535 $ 467 $ 336 $ 75 $ 161 $ 76 $ 4,699 As of December 31, 2023 Year of Origination U.S. Region Pacific South Atlantic Middle Atlantic West South Central Mountain East North Central New England West North Central East South Central Total 2023 $ 69 $ 77 $ 12 $ 101 $ 39 $ 42 $ 3 $ 26 $ 3 $ 372 2022 140 132 47 100 113 93 5 1 20 651 2021 96 63 124 148 111 75 9 40 1 667 2020 63 155 17 10 12 26 — 7 16 306 2019 53 100 10 74 45 4 14 13 21 334 Prior 734 605 765 189 214 171 47 144 19 2,888 Total $ 1,155 $ 1,132 $ 975 $ 622 $ 534 $ 411 $ 78 $ 231 $ 80 $ 5,218 The following tables present the commercial mortgage loans by year of origination and property type as of the dates indicated. The information is updated as of December 31, 2024 and 2023, respectively. As of December 31, 2024 Year of Origination Property Type Retail Industrial Apartments Office Hotel/Motel Other Mixed Use Total 2024 $ 58 $ 154 $ 57 $ 15 $ — $ — $ — $ 284 2023 124 172 13 16 32 — — 357 2022 79 261 222 35 10 9 — 616 2021 35 128 218 111 — 18 9 519 2020 55 48 56 96 — — — 255 Prior 610 713 640 437 67 155 46 2,668 Total $ 961 $ 1,476 $ 1,206 $ 710 $ 109 $ 182 $ 55 $ 4,699 As of December 31, 2023 Year of Origination Property Type Retail Industrial Apartments Office Hotel/Motel Other Mixed Use Total 2023 $ 125 $ 164 $ 33 $ 18 $ 32 $ — $ — $ 372 2022 79 263 255 34 10 10 — 651 2021 36 145 335 123 — 18 10 667 2020 57 49 72 128 — — — 306 2019 45 82 160 36 11 — — 334 Prior 780 755 618 463 60 163 49 2,888 Total $ 1,122 $ 1,458 $ 1,473 $ 802 $ 113 $ 191 $ 59 $ 5,218 The following table summarizes activity in the allowance for losses for commercial mortgage loans for the periods indicated: December 31, 2024 December 31, 2023 Allowance for credit losses, beginning of period $ 26 $ 18 Credit losses on mortgage loans for which credit losses were not previously recorded 1 2 Increase (decrease) on mortgage loans with an allowance recorded in previous period — 9 Provision for expected credit losses 27 29 Write-offs (3) (3) Allowance for credit losses, end of period $ 24 $ 26 The following table presents the payment status of commercial mortgage loans as of the dates indicated: December 31, 2024 December 31, 2023 Current $ 4,673 $ 5,202 30-59 days past due — — 60-89 days past due — — Greater than 90 days past due 26 16 Total $ 4,699 $ 5,218 Commercial mortgage loans are placed on non-accrual status when 90 days in arrears, when the Company has concerns regarding the collectability of future payments, or when a loan has matured without being paid off or extended. As of December 31, 2024 and 2023, the Company had $26 and $16, respectively, of commercial mortgage loans in non-accrual status. The amount of interest income recognized on loans in non-accrual status for the years ended December 31, 2024 and 2023 was immaterial. Net Investment Income The following table summarizes Net investment income by investment type for the periods indicated: Year Ended December 31, 2024 2023 2022 Fixed maturities $ 1,678 $ 1,766 $ 1,940 Equity securities 19 21 12 Mortgage loans on real estate 234 249 237 Policy loans 20 20 21 Short-term investments and cash equivalents 40 39 13 Limited partnerships and other 159 135 118 Gross investment income 2,150 2,230 2,341 Less: Investment expenses 76 71 60 Net investment income $ 2,074 $ 2,159 $ 2,281 For the years ended December 31, 2024 and 2023, the Company had $18 and $10, respectively, of investments in fixed maturities that did not produce net investment income. Fixed maturities are moved to a non-accrual status when the investment defaults. Net Gains (Losses) Net gains (losses) comprise the difference between the amortized cost of investments and proceeds from sale and redemption, as well as losses incurred due to the credit-related and intent-related impairment of investments. Net gains (losses) are also primarily generated from changes in fair value of embedded derivatives within products and fixed maturities, changes in fair value of fixed maturities recorded at FVO and changes in fair value including accruals on derivative instruments, except for effective cash flow hedges. Net gains (losses) also include changes in fair value of trading debt securities and changes in fair value of equity securities. The cost of the investments on disposal is generally determined based on FIFO methodology. Net gains (losses) were as follows for the periods indicated: Year Ended December 31, 2024 2023 2022 Fixed maturities, available-for-sale, including securities pledged $ (48) $ (31) $ (30) Fixed maturities, at fair value option (167) (100) (920) Equity securities, at fair value 6 3 (39) Derivatives 193 29 305 Embedded derivatives - fixed maturities (6) (1) (9) Other derivatives 2 — — Standalone derivatives (1) — (12) Managed custody guarantees 4 (2) (5) Stabilizer (14) (1) 19 Mortgage loans (1) (12) — Other investments 5 43 5 Net gains (losses) $ (27) $ (72) $ (686) Proceeds from the sale of fixed maturities, available-for-sale, and equity securities and the related gross realized gains and losses, before tax, were as follows for the periods indicated: Year Ended December 31, 2024 2023 2022 Proceeds on sales $ 3,510 $ 5,393 $ 5,448 Gross gains 50 69 100 Gross losses (62) 78 109

Derivative Financial Instrument

Derivative Financial Instruments	12 Months Ended
	Dec. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	Derivative Financial Instruments The Company primarily enters into the following types of derivatives: Interest rate swaps : The Company uses interest rate swaps primarily to reduce market risks from changes in interest rates and to alter interest rate exposure arising from mismatches between assets and/or liabilities. Interest rate swaps are also used to hedge the interest rate risk associated with the value of assets it owns or in an anticipation of acquiring them. Using interest rate swaps, the Company agrees with another party to exchange, at specified intervals, the difference between fixed rate and floating rate interest payments, calculated by reference to an agreed upon notional principal amount. These transactions are entered into pursuant to master agreements that provide for a single net payment to be made to/from the counterparty at each due date. The Company utilizes these contracts in qualifying hedging relationships as well as non-qualifying hedging relationships. Foreign exchange swaps : The Company uses foreign exchange or currency swaps to reduce the risk of change in the value, yield or cash flows associated with certain foreign denominated invested assets. Foreign exchange swaps represent contracts that require the exchange of foreign currency cash flows against U.S. dollar cash flows at regular periods, typically quarterly or semi-annually. The Company utilizes these contracts in qualifying hedging relationships as well as non-qualifying hedging relationships. Total return swaps : The Company uses total return swaps as a hedge of interest related risks within various Legacy Annuity and Retirement products. Total return swaps are also used as a hedge of other corporate liabilities. Using total return swaps, the Company agrees with another party to exchange, at specified intervals, the difference between the economic performance of assets or a market index and a fixed or variable funding multiplied by reference to an agreed upon notional amount. No cash is exchanged at the onset of the contracts. Cash is paid and received over the life of the contract based upon the terms of the swaps. The Company utilizes these contracts in non-qualifying hedging relationships. Futures: Futures contracts are used to hedge against a decrease in certain equity indices. Such decreases may correlate to a decrease in variable annuity account values which would increase the possibility of the Company incurring an expense for guaranteed benefits in excess of account values. The Company also uses interest rate futures contracts to hedge its exposure to market risks due to changes in interest rates. The Company enters into exchange traded futures with regulated futures commissions that are members of the exchange. The Company also posts initial and variation margins, with the exchange, on a daily basis. The Company utilizes exchange-traded futures in non-qualifying hedging relationships. The Company may also use futures contracts as a hedge against an increase in certain equity indices. Embedded derivatives : The Company also invests in certain fixed maturity instruments and has issued certain products that contain embedded derivatives for which market value is at least partially determined by, among other things, levels of or changes in domestic and/or foreign interest rates (short-term or long-term), exchange rates, prepayment rates, equity rates or credit ratings/spreads. In addition, the Company has entered into coinsurance with funds withheld arrangements, which contain embedded derivatives. The Company utilizes derivative contracts mainly to hedge exposure to variability in cash flows, interest rate risk, credit risk, foreign exchange risk and equity market risk. The majority of derivatives used by the Company are designated as product hedges, which hedge the exposure arising from insurance liabilities or guarantees embedded in the contracts the Company offers through various product lines. The Company also uses derivatives contracts to hedge its exposure to various risks associated with the investment portfolio. The Company also uses credit default swaps coupled with other investments in order to produce the investment characteristics of otherwise permissible investments. Based on the notional amounts, a substantial portion of the Company's derivative positions was not designated or did not qualify for hedge accounting as part of a hedging relationship as outlined in ASC Topic 815 as of December 31, 2024 and 2023. The notional amounts and fair values of derivatives were as follows as of the dates indicated: December 31, 2024 December 31, 2023 Notional Asset Fair Value Liability Fair Value Notional Asset Fair Value Liability Fair Value Derivatives: Qualifying for hedge accounting (1) Fair value hedges (2) : Interest rate contracts (3) $ — $ — $ — $ — $ — $ — Foreign exchange contracts 106 6 — 98 — 4 Cash flow hedges: Interest rate contracts 11 — — 12 — — Foreign exchange contracts 623 46 2 718 33 7 Derivatives: Non-qualifying for hedge accounting (1) Interest rate contracts 14,633 246 313 16,773 270 354 Foreign exchange contracts 203 3 6 183 4 2 Equity contracts 286 2 9 255 4 2 Credit contracts 97 — 2 137 — 2 Embedded derivatives and MCGs: Within fixed maturity investments (4) N/A — 4 N/A 2 — Within reinsurance agreements (5) N/A 55 41 N/A 61 49 MCGs (6) N/A — 4 N/A — 8 Stabilizer (6) N/A — 15 N/A — 1 Total $ 358 $ 396 $ 374 $ 429 (1) Open derivative contracts are reported as Derivatives assets or liabilities at fair value on the Consolidated Balance Sheets. (2) Total carrying amount of hedged assets and liabilities was $307 and $106 as of December 31, 2024 and 2023, respectively. (3) Cumulative amount of fair value hedging adjustments included in the carrying amount of hedged assets and liabilities was $(8) and $(6) as of December 31, 2024 and 2023, respectively, of which includes $2 and $0, respectively, of hedging adjustments on discontinued hedging relationships. (4) Included in Fixed maturities, available-for-sale, at fair value on the Consolidated Balance Sheets. (5) Included in Other liabilities, Other assets, and Premium receivable and reinsurance recoverable on the Consolidated Balance Sheets. (6) Included in Contract owner account balances on the Consolidated Balance Sheets. N/A - Not applicable See the Fair Value Measurements (excluding Consolidated Investment Entities) Note to these Consolidated Financial Statements for additional information on derivative asset and liability fair values. The Company does not offset any derivative assets and liabilities in the Consolidated Balance Sheets. The disclosures set out in the table below include the fair values of Over-The-Counter (“OTC”) and cleared derivatives excluding exchange traded contracts subject to master netting agreements or similar agreements as of the dates indicated: Gross Amount Recognized (1) Counterparty Netting (2) Cash Collateral Netting (2) Securities Collateral Netting (2) Net receivables/ payables December 31, 2024 Derivative assets $ 303 $ (261) $ (34) $ (3) $ 5 Derivative liabilities 332 (261) (58) (6) 7 December 31, 2023 Derivative assets 311 (216) (76) (8) 11 Derivative liabilities 370 (216) (150) (3) 1 (1) As of December 31, 2024, gross amounts exclude asset and liability exchange traded contracts of $0 and $0, respectively. As of December 31, 2023, gross amounts exclude asset and liability exchange traded contracts of $0 and $1, respectively. (2) Represents the netting of receivable with payable balances, net of collateral, for the same counterparty under eligible netting agreements. Collateral Under the terms of the OTC Derivative International Swaps and Derivatives Association, Inc. ("ISDA") agreements, the Company may receive from, or deliver to, counterparties collateral to assure that terms of the ISDA agreements will be met with regard to the Credit Support Annex ("CSA"). The terms of the CSA call for the Company to pay interest on any cash received equal to the Federal Funds rate. To the extent cash collateral is received and delivered, it is included in Payables under securities loan and repurchase agreements, including collateral held and Short-term investments under securities loan agreements, including collateral delivered, respectively, on the Consolidated Balance Sheets and is reinvested in short-term investments. Collateral held is used in accordance with the CSA to satisfy any obligations. Investment grade bonds owned by the Company are the source of noncash collateral posted, which is reported in Securities pledged on the Consolidated Balance Sheets. As of December 31, 2024, the Company held $33 and pledged $56 of net cash collateral related to OTC derivative contracts and cleared derivative contracts, respectively. As of December 31, 2023, the Company held $84 and $147 of net cash collateral related to OTC derivative contracts and cleared derivative contracts, respectively. In addition, as of December 31, 2024, the Company delivered $159 of securities and held $4 of securities as collateral. As of December 31, 2023, the Company delivered $201 of securities and held $11 securities as collateral. The location and effect of derivatives qualifying for hedge accounting on the Consolidated Statements of Operations and Consolidated Statements of Comprehensive Income are as follows for the periods indicated: Year Ended December 31, 2024 2023 2022 Interest Rate Contracts Foreign Exchange Contracts Interest Rate Contracts Foreign Exchange Contracts Interest Rate Contracts Foreign Exchange Contracts Location of Gain (Loss) Reclassified from AOCI into Income Net investment income Net investment income and Net gains (losses) Net investment income Net investment income and Net gains (losses) Net investment income Net investment income and Net gains (losses) Amount of Gain (Loss) Recognized in Other Comprehensive Income (1) $ — $ 18 $ — $ (43) $ (2) $ 70 Amount of Gain (Loss) Reclassified from AOCI — 16 — 10 — 11 (1) See the Accumulated Other Comprehensive Income (Loss) Note to these Consolidated Financial Statements for additional information. The location and amount of gain (loss) recognized in the Consolidated Statements of Operations for derivatives qualifying for hedge accounting are as follows for the periods indicated: Year Ended December 31, 2024 2023 2022 Net investment Income Net gains (losses) Net investment Income Net gains (losses) Net investment Income Net gains (losses) Total amounts of line items presented in the statements of operations in which the effects of fair value or cash flow hedges are recorded $ 2,074 $ (27) $ 2,159 $ (72) $ 2,281 $ (686) Fair value hedges: Interest rate contracts: Hedged items — 2 — — — — Derivatives designated as hedging instruments (1) — (2) — — — — Foreign exchange contracts: Hedged items — (6) — 3 — (6) Derivatives designated as hedging instruments (1) — 8 — (1) — 7 Cash flow hedges: Foreign exchange contracts: Gain (loss) reclassified from AOCI into income (2) 10 6 10 — 11 — (1) For the years ended December 31, 2024, 2023, and 2022 $2, $2 and $1, respectively, of the change in derivative instruments designated and qualifying as fair value hedges were excluded from the assessment of hedge effectiveness and recognized currently in earnings. (2) See the Accumulated Other Comprehensive Income (Loss) Note to these Consolidated Financial Statements for additional information. The location and effect of derivatives not designated as hedging instruments on the Consolidated Statements of Operations are as follows for the periods indicated: Location of Gain (Loss) Recognized on Derivative Year Ended December 31, 2024 2023 2022 Derivatives: Non-qualifying for hedge accounting Interest rate contracts Net gains (losses) $ 170 $ 15 $ 334 Foreign exchange contracts Net gains (losses) (8) — (1) Equity contracts Net gains (losses) 18 14 (32) Credit contracts Net gains (losses) 1 1 (3) Embedded derivatives and MCGs: Within fixed maturity investments Net gains (losses) (6) (1) (9) Within reinsurance agreements (1) Policyholder benefits (3) (37) 217 MCGs Net gains (losses) 4 (2) (5) Stabilizer Net gains (losses) (14) (1) 19 Total $ 162 $ (11) $ 520 (1) For the years ended December 31, 2024, 2023, and 2022, the amount excludes gains (losses) from standalone derivatives of $(1), $0, and $(12), respectively, recognized in Net gains (losses).

Fair Value Measurements (exclud

Fair Value Measurements (excluding Consolidated Investment Entities)	12 Months Ended
	Dec. 31, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurements (excluding Consolidated Investment Entities)	Fair Value Measurements (excluding Consolidated Investment Entities) Fair Value Measurement The following table presents the Company's hierarchy for its assets and liabilities measured at fair value on a recurring basis as of December 31, 2024: Level 1 Level 2 Level 3 Total Assets: Fixed maturities, including securities pledged: U.S. Treasuries $ 402 $ 70 $ — $ 472 U.S. Government agencies and authorities — 30 — 30 State, municipalities and political subdivisions — 580 — 580 U.S. corporate public securities — 6,949 59 7,008 U.S. corporate private securities — 3,486 1,497 4,983 Foreign corporate public securities and foreign governments (1) — 2,412 60 2,472 Foreign corporate private securities (1) — 2,116 421 2,537 Residential mortgage-backed securities — 3,404 67 3,471 Commercial mortgage-backed securities — 3,132 — 3,132 Other asset-backed securities — 2,746 23 2,769 Total fixed maturities, including securities pledged 402 24,925 2,127 27,454 Equity securities 148 — 98 246 Derivatives: Interest rate contracts — 246 — 246 Foreign exchange contracts — 55 — 55 Equity contracts — 2 — 2 Embedded derivative on reinsurance — 55 — 55 Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements 2,511 1 23 2,535 Assets held in separate accounts 95,946 5,390 340 101,676 Total assets $ 99,007 $ 30,674 $ 2,588 $ 132,269 Liabilities: Contingent consideration $ — $ — $ 2 $ 2 Stabilizer and MCGs — — 19 19 Derivatives: Interest rate contracts 11 302 — 313 Foreign exchange contracts — 8 — 8 Equity contracts — 9 — 9 Credit contracts — 2 — 2 Embedded derivative on reinsurance — (12) (2) 53 41 Total liabilities $ 11 $ 309 $ 74 $ 394 (1) Primarily U.S. dollar denominated. (2) The Company classifies the embedded derivative within liabilities given the underlying nature of the balance and the right-of-offset. The following table presents the Company's hierarchy for its assets and liabilities measured at fair value on a recurring basis as of December 31, 2023: Level 1 Level 2 Level 3 Total Assets: Fixed maturities, including securities pledged: U.S. Treasuries $ 346 $ 57 $ — $ 403 U.S. Government agencies and authorities — 55 1 56 State, municipalities and political subdivisions — 771 — 771 U.S. corporate public securities — 7,648 18 7,666 U.S. corporate private securities — 3,234 1,526 4,760 Foreign corporate public securities and foreign governments (1) — 2,702 — 2,702 Foreign corporate private securities (1) — 2,376 436 2,812 Residential mortgage-backed securities — 3,419 57 3,476 Commercial mortgage-backed securities — 3,495 — 3,495 Other asset-backed securities — 2,418 52 2,470 Total fixed maturities, including securities pledged 346 26,175 2,090 28,611 Equity securities 140 — 96 236 Derivatives: Interest rate contracts 7 263 — 270 Foreign exchange contracts — 37 — 37 Equity contracts — 4 — 4 Embedded derivative on reinsurance — 61 — 61 Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements 2,148 17 — 2,165 Assets held in separate accounts 87,180 5,605 348 93,133 Total assets $ 89,821 $ 32,162 $ 2,534 $ 124,517 Liabilities: Contingent consideration $ — $ — $ 51 $ 51 Stabilizer and MCGs — — 9 9 Derivatives: Interest rate contracts — 354 — 354 Foreign exchange contracts — 13 — 13 Equity contracts — 2 — 2 Credit contracts — 2 — 2 Embedded derivative on reinsurance — (9) (2) 58 49 Total liabilities $ — $ 362 $ 118 $ 480 (1) Primarily U.S. dollar denominated. (2) The Company classifies the embedded derivative within liabilities given the underlying nature of the balance and the right-of-offset. Valuation of Financial Assets and Liabilities at Fair Value Certain assets and liabilities are measured at estimated fair value on the Company's Consolidated Balance Sheets. The Company defines fair value as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The exit price and the transaction (or entry) price will be the same at initial recognition in many circumstances. However, in certain cases, the transaction price may not represent fair value. The fair value of a liability is based on the amount that would be paid to transfer a liability to a third-party with an equal credit standing. Fair value is required to be a market-based measurement that is determined based on a hypothetical transaction at the measurement date, from a market participant's perspective. The Company considers three broad valuation approaches when a quoted price is unavailable: (i) the market approach, (ii) the income approach and (iii) the cost approach. The Company determines the most appropriate valuation technique to use, given the instrument being measured and the availability of sufficient inputs. The Company prioritizes the inputs to fair valuation approaches and allows for the use of unobservable inputs to the extent that observable inputs are not available. The Company utilizes a number of valuation methodologies to determine the fair values of its financial assets and liabilities in conformity with the concepts of exit price and the fair value hierarchy as prescribed in ASC Topic 820. Valuations are obtained from third-party commercial pricing services, brokers and industry-standard, vendor-provided software that models the value based on market observable inputs. The valuations obtained from third-party commercial pricing services are non-binding. The Company reviews the assumptions and inputs used by third-party commercial pricing services for each reporting period in order to determine an appropriate fair value hierarchy level. The documentation and analysis obtained from third-party commercial pricing services are reviewed by the Company, including in-depth validation procedures confirming the observability of inputs. The valuations are reviewed and validated monthly through the internal valuation committee price variance review, comparisons to internal pricing models, back testing to recent trades or monitoring of trading volumes. When available, the fair value of the Company's financial assets and liabilities are based on quoted prices of identical assets in active markets and therefore, reflected in Level 1. The valuation approaches and key inputs for each category of assets or liabilities that are classified within Level 2 and Level 3 of the fair value hierarchy are presented below. For fixed maturities classified as Level 2 assets, fair values are determined using a matrix-based market approach, based on prices obtained from third-party commercial pricing services and the Company’s matrix and analytics-based pricing models, which in each case incorporate a variety of market observable information as valuation inputs. The market observable inputs used for these fair value measurements, by fixed maturity asset class, are as follows: U.S. Treasuries: Fair value is determined using third-party commercial pricing services, with the primary inputs being stripped interest and principal U.S. Treasury yield curves that represent a U.S. Treasury zero-coupon curve. U.S. government agencies and authorities, State, municipalities and political subdivisions: Fair value is determined using third-party commercial pricing services, with the primary inputs being U.S. Treasury yield curves, trades of comparable securities, credit spreads off benchmark yields and issuer ratings. U.S. corporate public securities, Foreign corporate public securities and foreign governments: Fair value is determined using third-party commercial pricing services, with the primary inputs being benchmark yields, trades of comparable securities, issuer ratings, bids and credit spreads off benchmark yields. U.S. corporate private securities and Foreign corporate private securities: Fair values are determined using a matrix and analytics-based pricing model. The model incorporates the current level of risk-free interest rates, current corporate credit spreads, credit quality of the issuer and cash flow characteristics of the security. The model also considers a liquidity spread, the value of any collateral, the capital structure of the issuer, the presence of guarantees, and prices and quotes for comparably rated publicly traded securities. RMBS, CMBS and ABS: Fair value is determined using third-party commercial pricing services, with the primary inputs being credit spreads off benchmark yields, prepayment speed assumptions, current and forecasted loss severity, debt service coverage ratios, collateral type, payment priority within tranche and the vintage of the loans underlying the security. Generally, the Company does not obtain more than one vendor price from pricing services per instrument. The Company uses a hierarchy process in which prices are obtained from a primary vendor and, if that vendor is unable to provide the price, the next vendor in the hierarchy is contacted until a price is obtained or it is determined that a price cannot be obtained from a commercial pricing service. When a price cannot be obtained from a commercial pricing service, independent broker quotes are solicited. Securities priced using independent broker quotes are classified as Level 3. Fair values of privately placed bonds are determined primarily using a matrix-based pricing model and are generally classified as Level 2 assets. The model considers the current level of risk-free interest rates, current corporate spreads, the credit quality of the issuer and cash flow characteristics of the security. Also considered are factors such as the net worth of the borrower, the value of collateral, the capital structure of the borrower, the presence of guarantees and the Company's evaluation of the borrower's ability to compete in its relevant market. Using this data, the model generates estimated market values, which the Company considers reflective of the fair value of each privately placed bond. Equity securities : Level 2 and Level 3 equity securities, typically private equities or equity securities not traded on an exchange, are valued by other sources such as analytics or brokers. Derivatives : Derivatives are carried at fair value, which is determined using the Company's derivative accounting system in conjunction with observable key financial data from third-party sources, such as yield curves, exchange rates, S&P 500 Index prices, Overnight Index Swap ("OIS") rates, and Secured Overnight Financing Rate ("SOFR"). The Company uses SOFR discounting for valuations of interest rate derivatives; however, certain legacy positions may continue to be discounted on OIS. The Company uses OIS for valuations of collateralized interest rate derivatives, which are obtained from third-party sources. For those derivatives that are unable to be valued by the accounting system, the Company typically utilizes values established by third-party brokers. Counterparty credit risk is considered and incorporated in the Company's valuation process through counterparty credit rating requirements and monitoring of overall exposure. It is the Company's policy to transact only with investment grade counterparties with a credit rating of A- or better. The Company's nonperformance risk is also considered and incorporated in the Company's valuation process. The Company also has certain credit default swaps and options that are priced by third party vendors or by using models that primarily use market observable inputs, but contain inputs that are not observable to market participants, which have been classified as Level 3. The remaining derivative instruments are valued based on market observable inputs and are classified as Level 2. See the Derivative Financial Instruments Note to these Consolidated Financial Statements for more information. Contingent consideration: The fair value of the contingent consideration liability associated with the Company’s acquisitions uses unobservable inputs and as such are reported as Level 3. Unobservable inputs include projected revenues, duration of earnouts and other metrics as well as discount rate. Changes in the fair value of the contingent consideration are recorded in Operating expenses in the Company’s Consolidated Statements of Operations. Stabilizer and MCGs: The Company records reserves for Stabilizer and MCG contracts containing guaranteed credited rates. The guarantee is treated as an embedded derivative or a stand-alone derivative (depending on the underlying product) and is required to be reported at fair value. The estimated fair value is determined based on the present value of projected future claims, minus the present value of future guaranteed premiums. At inception of the contract, the Company projects a guaranteed premium to be equal to the present value of the projected future claims. The income associated with the contracts is projected using relevant actuarial and capital market assumptions, including benefits and related contract charges, over the anticipated life of the related contracts. The cash flow estimates are projected under multiple capital market scenarios using observable risk-free rates and other best estimate assumptions. These derivatives are classified as Level 3 liabilities. The discount rate used to determine the fair value of the Company's Stabilizer embedded derivative liabilities and MCG stand-alone derivative includes an adjustment to reflect the risk that these obligations will not be fulfilled ("nonperformance risk"). The nonperformance risk adjustment incorporates a blend of observable, similarly rated peer holding company credit spreads, adjusted to reflect the credit quality of the individual insurance subsidiary that issued the guarantee, as well as an adjustment to reflect the non-default spreads and the priority and recovery rates of policyholder claims. Embedded derivatives on reinsurance : The carrying value of embedded derivatives is estimated based upon the change in the fair value of the assets supporting the funds withheld payable under reinsurance agreements. The fair value of the embedded derivative is based on market observable inputs and is classified as Level 2. The remaining derivative instruments are classified as Level 3 and are estimated using the income approach. The fair value is calculated by estimating future cash flows for a certain discrete projection period, estimating the terminal value, if appropriate, and discounting these amounts to present value at a rate of return that considers the relative risk of the cash flows and the time value of money. Level 3 Financial Instruments The fair values of certain assets and liabilities are determined using prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement (i.e., Level 3 as defined by ASC Topic 820), including but not limited to liquidity spreads for investments within markets deemed not currently active. These valuations, whether derived internally or obtained from a third-party, use critical assumptions that are not widely available to estimate market participant expectations in valuing the asset or liability. In addition, the Company has determined, for certain financial instruments, an active market is such a significant input to determine fair value that the presence of an inactive market may lead to classification in Level 3. In light of the methodologies employed to obtain the fair values of financial assets and liabilities classified as Level 3, additional information is presented below. Significant Unobservable Inputs The Company's Level 3 fair value measurements of its fixed maturities, equity securities and equity and credit derivative contracts are primarily based on broker quotes for which the quantitative detail of the unobservable inputs is neither provided nor reasonably corroborated, thus negating the ability to perform a sensitivity analysis. The Company performs a review of broker quotes by performing a monthly price variance comparison and back tests broker quotes to recent trade prices. The following table summarizes the change in fair value of the Company's Level 3 assets and liabilities and transfers in and out of Level 3 for the period indicated : Year Ended December 31, 2024 Fair Value Realized/ Unrealized Gains (Losses) Included in: Purchases Issuances Sales Settlements Transfers Transfers Fair Value as of December 31 Change In Unrealized Gains (Losses) Included in Earnings (3) Change In (3) Net OCI Fixed maturities, including securities pledged: U.S. Government agencies and authorities $ 1 $ — $ — $ — $ — $ — $ — $ — $ (1) $ — $ — $ — U.S. corporate public securities 18 — (1) 49 — — (7) — — 59 — (2) U.S. corporate private securities 1,526 (4) 1 377 — (22) (246) — (135) 1,497 — (5) Foreign corporate public securities and foreign governments (1) — — — 60 — — — — — 60 — — Foreign corporate private securities (1) 436 (8) (33) 35 — (9) (51) 51 — 421 — (33) Residential mortgage-backed securities 57 (4) — 18 — — — — (4) 67 (4) — Other asset-backed securities 52 — — 3 — — (7) — (25) 23 — — Total fixed maturities including securities pledged 2,090 (16) (33) 542 — (31) (311) 51 (165) 2,127 (4) (40) Equity securities, at fair value 96 2 — — — — — — — 98 2 — Contingent consideration (51) 1 — — — — 48 — — (2) — — Stabilizer and MCGs (2) (9) (8) — — (2) — — — — (19) — — Embedded derivatives on (58) (1) — — — — 6 — — (53) — — Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements — — — 23 — — — — — 23 — — Assets held in separate accounts (4) 348 6 — 47 — (26) — 5 (40) 340 — — (1) Primarily U.S. dollar denominated. (2) All gains and losses on Level 3 liabilities are classified as realized gains (losses) for the purpose of this disclosure because it is impracticable to track realized and unrealized gains (losses) separately on a contract-by contract basis. These amounts are included in Net gains (losses) (3) For financial instruments still held as of December 31 amounts are included in Net investment income and Net gains (losses) in the Consolidated Statements of Operations or Unrealized gains (losses) on securities in the Consolidated Statements of Comprehensive Income. (4) The investment income and realized gains (losses) and change in unrealized gains (losses) included in net income for separate account assets are offset by an equal amount for separate account liabilities, which results in a net zero impact on Net income (loss) for the Company. Year Ended December 31, 2023 Fair Value Realized/ Unrealized Gains (Losses) Included in: Purchases Issuances Sales Settlements Transfers Transfers Fair Value as of December 31 Change In Unrealized Gains (Losses) Included in Earnings (3) Change In (3) Net OCI Fixed maturities, including securities pledged: U.S. Government agencies and authorities $ 1 $ — $ — $ — $ — $ — $ — $ — $ — $ 1 $ — $ — U.S. corporate public securities 20 1 — — — — — — (3) 18 — — U.S. corporate private securities 1,801 1 22 142 — (4) (219) 79 (296) 1,526 1 19 Foreign corporate public securities and foreign governments (1) 3 — — — — — — — (3) — — — Foreign corporate private securities (1) 432 3 9 129 — (14) (167) 51 (7) 436 3 8 Residential mortgage-backed securities 28 (4) — 31 — — — 2 — 57 (3) — Other asset-backed securities 64 — 1 15 — (2) (4) — (22) 52 — — Total fixed maturities including securities pledged 2,349 1 32 317 — (20) (390) 132 (331) 2,090 1 27 Equity securities, at fair value 196 (3) — 3 — — (100) — — 96 (3) — Contingent consideration (112) 61 (5) — — — — — — — (51) — — Stabilizer and MCGs (2) (6) (1) — — (2) — — — — (9) — — Embedded derivatives on (58) — — — — — — — — (58) — — Assets held in separate accounts (4) 347 1 — 8 — (21) — 14 (1) 348 — — (1) Primarily U.S. dollar denominated. (2) All gains and losses on Level 3 liabilities are classified as realized gains (losses) for the purpose of this disclosure because it is impracticable to track realized and unrealized gains (losses) separately on a contract-by contract basis. These amounts are included in Net gains (losses) in the Consolidated Statements of Operations. (3) For financial instruments still held as of December 31 amounts are included in Net investment income and Net gains (losses) in the Consolidated Statements of Operations or Unrealized gains (losses) on securities in the Consolidated Statements of Comprehensive Income. (4) The investment income and realized gains (losses) and change in unrealized gains (losses) included in net income for separate account assets are offset by an equal amount for separate account liabilities, which results in a net zero impact on Net income (loss) for the Company. For the years ended December 31, 2024 and 2023, the transfers in and out of Level 3 for fixed maturities were due to the variation in inputs relied upon for valuation each quarter. Securities that are primarily valued using independent broker quotes when prices are not available from one of the commercial pricing services are reflected as transfers into Level 3. When securities are valued using more widely available information, the securities are transferred out of Level 3 and into Level 1 or 2, as appropriate. Other Financial Instruments The following disclosures are made in accordance with the requirements of ASC Topic 825 which requires disclosure of fair value information about financial instruments, whether or not recognized at fair value on the Consolidated Balance Sheets. ASC Topic 825 excludes certain financial instruments, including insurance contracts and all nonfinancial instruments from its disclosure requirements. Accordingly, the aggregate fair value amounts presented do not represent the underlying value of the Company. The carrying values and estimated fair values of the Company's financial instruments as of the dates indicated: December 31, 2024 December 31, 2023 Carrying Fair Carrying Fair Assets: Fixed maturities, including securities pledged $ 27,454 $ 27,454 $ 28,611 $ 28,611 Equity securities 246 246 236 236 Mortgage loans on real estate 4,699 4,459 5,218 4,941 Policy loans 342 342 352 352 Cash, cash equivalents, short-term investments and short-term investments under securities loan agreements 2,535 2,535 2,165 2,165 Derivatives 303 303 311 311 Embedded derivatives on reinsurance 55 55 61 61 Other investments, including securities pledged 74 74 64 64 Assets held in separate accounts 101,676 101,676 93,133 93,133 Liabilities: Investment contract liabilities: Funding agreements without fixed maturities and deferred annuities (1) $ 31,082 $ 32,877 $ 32,848 $ 34,856 Funding agreements with fixed maturities 1,249 1,257 1,175 1,178 Supplementary contracts, immediate annuities and other 570 515 628 571 Stabilizer and MCGs 19 19 9 9 Derivatives 332 332 371 371 Embedded derivatives on reinsurance 41 41 49 49 Short-term debt 399 399 1 1 Long-term debt 2,103 2,023 2,097 1,998 (1) Certain amounts included in Funding agreements without fixed maturities and deferred annuities are also reflected within the Stabilizer and MCGs section of the table above. The following table presents the classification of financial instruments which are not carried at fair value on the Consolidated Balance Sheets: Financial Instrument Classification Mortgage loans on real estate Level 3 Policy loans Level 2 Other investments Level 2 Funding agreements without fixed maturities and deferred annuities Level 3 Funding agreements with fixed maturities Level 2 Supplementary contracts and immediate annuities Level 3 Short-term debt and Long-term debt Level 2

Deferred Policy Acquisition Cos

Deferred Policy Acquisition Costs and Value of Business Acquired	12 Months Ended
	Dec. 31, 2024
Insurance [Abstract]
Deferred Policy Acquisition Costs and Value of Business Acquired	Deferred Policy Acquisition Costs and Value of Business Acquired The following table presents a rollforward of DAC and VOBA for the periods indicated: DAC VOBA Wealth Solutions Deferred and Individual Annuities Health Solutions Voluntary (1) Businesses exited Balance as of January 1, 2022 $ 691 $ 144 $ 1,158 $ 473 Deferrals of commissions and expenses 59 55 — 5 Amortization expense (59) (28) (115) (39) Balance as of December 31, 2022 $ 691 $ 171 $ 1,043 $ 439 Deferrals of commissions and expenses 59 54 — 4 Amortization expense (55) (32) (105) (37) Balance as of December 31, 2023 $ 695 $ 193 $ 938 $ 406 Deferrals of commissions and expenses 60 58 — 3 Amortization expense (54) (36) (100) (33) Balance as of December 31, 2024 $ 701 215 $ 838 $ 376 (1) During the second quarter of 2024, the Company reclassified certain insurance products within the Health Solutions segment from Group to Voluntary. As a result, the rollforward above and the reconciliation table below have been updated for all periods presented to reflect this change. The following table shows a reconciliation of DAC and VOBA balances to the Consolidated Balance Sheets for the periods indicated: December 31, 2024 December 31, 2023 DAC: Wealth Solutions Deferred and Individual Annuities $ 701 $ 695 Health Solutions Voluntary 215 193 Businesses exited 838 938 Other 18 18 VOBA 376 406 Total $ 2,148 $ 2,250 The estimated amount of VOBA amortization expense, net of interest, during the next five years is presented in the following table. Actual amortization incurred during these years may vary as assumptions are modified to incorporate actual results and/or changes in best estimates of future results. Year Amount 2025 $ 30 2026 27 2027 25 2028 23 2029 22

Reserves for Future Policy Bene

Reserves for Future Policy Benefits and Contract Owner Account Balances	12 Months Ended
	Dec. 31, 2024
Insurance [Abstract]
Reserves for Future Policy Benefits and Contract Owner Account Balances	Reserves for Future Policy Benefits and Contract Owner Account Balances Health Solutions Group products include long-duration term life insurance, as well as long term disability products that are mostly employer paid. Health Solutions Voluntary products include long duration whole life insurance, critical illness, and accident and hospital indemnity insurance that are mostly employee paid. The following tables present the balances and changes in the liability for future policy benefits for Health Solutions Group, Health Solutions Voluntary, and Businesses Exited as of December 31, 2024 and 2023: Health Solutions Group Health Solutions Voluntary Businesses Exited 2024 2023 2024 2023 2024 2023 Present Value of Expected Net Premiums: Balance at January 1 $ 68 $ 77 $ 101 $ 97 $ 3,145 $ 4,244 Beginning balance at original discount rate 71 84 102 100 2,992 4,128 Reclassifications (2) (65) — 65 — — — Effect of change in cash flow assumptions (1) (6) (1) 6 110 (921) Effect of actual variances from expected experience — 11 40 8 (106) (91) Adjusted balance at January 1 5 89 206 114 2,996 3,116 Interest accrual — 2 8 4 158 196 Net premiums collected (1) (1) (20) (34) (16) (312) (320) Ending balance at original discount rate 4 71 180 102 2,842 2,992 Effects of changes in discount rate assumptions — (3) (9) (1) 30 153 Balance at end of period $ 4 $ 68 $ 171 $ 101 $ 2,872 $ 3,145 Present Value of Expected Future Policy Benefits: Balance at January 1 $ 899 $ 881 $ 307 $ 285 $ 7,538 $ 8,639 Beginning balance at original discount rate 918 913 307 294 7,404 8,644 Reclassifications (2) (150) — 150 — — — Effect of change in cash flow assumptions (12) (8) (1) 13 187 (805) Effect of actual variances from expected experience 10 (16) 54 9 (90) (123) Adjusted balance at January 1 766 889 510 316 7,501 7,716 Issuances 131 136 — — 14 17 Interest accrual 21 24 18 14 370 412 Benefit payments (117) (131) (41) (23) (747) (741) Ending balance at original discount rate 801 918 487 307 7,138 7,404 Effects of changes in discount rate assumptions (29) (19) (26) — (121) 134 Balance at end of period $ 772 $ 899 $ 461 $ 307 $ 7,017 $ 7,538 Net liability for future policy benefits $ 768 $ 831 $ 290 $ 206 $ 4,145 $ 4,392 Less: Reinsurance recoverable 330 315 9 — 4,056 4,342 Net liability for future policy benefits, after reinsurance recoverable $ 438 $ 516 $ 281 $ 206 $ 89 $ 50 (1) Net Premiums collected represent the portion of gross premiums collected from policyholders that is used to fund expected benefit payments. (2) During the second quarter 2024, the Company reclassified certain insurance products within the Health Solutions from Group to Voluntary. The table was not updated to reflect the reclassification impact on the comparative information and the impacts were primarily related to Net premiums collected and Benefit payments of $(17) and $(17), respectively. The following table presents a rollforward of the additional reserve liability for Businesses exited for the periods indicated: Businesses exited December 31, 2024 December 31, 2023 Balance at beginning of period $ 2,001 $ 2,107 Effect of change in cash flow assumptions (39) (44) Effect of actual variances from expected experience 14 (100) Adjusted balance at January 1 1,976 1,963 Interest accrual 83 84 Excess Benefits (404) (417) Assessments 228 371 Balance at end of period 1,883 2,001 Less: Reinsurance recoverable 1,832 1,950 Net additional liability, after reinsurance recoverable $ 51 $ 51 Future policy benefits include the liability for unpaid claims and claim adjustment expenses related to medical stop loss products within the Health Solutions segment. The following table presents a rollforward of the liability for unpaid claims and claim adjustment expenses for the periods indicated: Medical Stop Loss 2024 2023 Balance at January 1 $ 401 $ 398 Less: reinsurance recoverable (16) (6) Net balance at January 1 385 392 Incurred claims and claim adjustment expenses related to: Current year 1,538 1,042 Prior years 143 (8) Total incurred 1,681 1,034 Paid claim and claim adjustment expenses related to: Current year (964) (665) Prior years (512) (376) Total paid (1,476) (1,041) Net balance at December 31 590 385 Plus: reinsurance recoverable 5 16 Balance at December 31 $ 595 $ 401 Pricing, underwriting and reserving on the medical stop loss products are performed based on policy years and key metrics such as loss ratios are tracked, managed and reported on this basis. The majority of the medical stop loss policies renew in January of each year. For the year ended December 31, 2024, $143 of claims incurred on prior years is primarily attributed to incurred claims and unfavorable claim development for policy years effective during 2023. For the year ended December 31, 2023, $(8) of claims incurred on prior years is primarily attributed to favorable claim development partially offset by incurred claims for policy years effective during 2022. The Company tracks claim frequency by the number of claims paid for each policy year. Payments of medical stop loss claims are substantially complete within two years. The following tables present cumulative claim development information about incurred and paid claims and claim adjustment expenses, net of reinsurance, total IBNR, and claim frequencies for medical stop loss products as of December 31, 2024: Net cumulative incurred claims and claim adjustment expenses Incurred but not reported claims Cumulative number of reported claims December 31, 2022 (1) 2023 (1) 2024 2024 2024 Policy year 2022 $ 859 $ 872 $ 870 $ 2 26,060 2023 1,042 1,191 14 32,515 2024 1,538 574 24,560 Total 3,599 Cumulative paid claims and paid claim adjustment expenses, net of reinsurance (3,009) Total unpaid claims and claim adjustment expenses, net of reinsurance $ 590 (1) Unaudited Net cumulative paid claims and claim adjustment expenses December 31, 2022 (1) 2023 (1) 2024 Policy year 2022 $ 496 $ 862 $ 868 2023 665 1,177 2024 964 Total cumulative net paid claims and claim adjustment expenses, net of reinsurance $ 3,009 (1) Unaudited The reconciliation of the net liability for future policy benefits to the liability for future policy benefits in the Consolidated Balance Sheets is presented below: December 31, 2024 December 31, 2023 Health Solutions Group $ 768 $ 831 Health Solutions Voluntary 290 206 Businesses Exited - Future policy benefits 4,145 4,392 Businesses Exited - Additional liability 1,883 2,001 Business Exited - Other 1,284 1,335 Medical stop loss products 595 401 Other 367 394 Total $ 9,332 $ 9,560 The amount of undiscounted expected gross premiums and future benefit payments is presented in the table below: December 31, 2024 December 31, 2023 Undiscounted Discounted Undiscounted Discounted Health Solutions Group Expected future benefit payments $ 990 $ 801 $ 1,144 $ 918 Expected future gross premiums 11 8 271 214 Health Solutions Voluntary Expected future benefit payments 881 487 668 307 Expected future gross premiums 631 427 341 213 The following table presents the weighted average duration of the liability for future policy benefits and the weighted average interest rates for the periods indicated: Health Solutions Group Health Solutions Voluntary Businesses Exited December 31, 2024 December 31, 2023 December 31, 2024 December 31, 2023 December 31, 2024 December 31, 2023 Weighted average duration (in years) (1) 7 7 14 14 8 8 Interest accretion rate 4.0 % 4.0 % 5.1 % 5.2 % 5.0 % 4.9 % Current discount rate 5.4 % 4.9 % 5.7 % 5.1 % 5.6 % 5.1 % (1) Weighted average duration (in years) for Businesses Exited includes additional liability. The weighted average interest rates for the additional liability related to businesses exited were 4.3% and 4.2% for the periods ended December 31, 2024 and 2023, respectively. The following table presents a rollforward of Contract owner account balances for the periods indicated: Wealth Solutions Deferred Group and Individual Annuity Businesses Exited December 31, 2024 December 31, 2023 December 31, 2024 December 31, 2023 Balance at January 1 $ 31,139 $ 33,622 $ 4,635 $ 5,146 Deposits 2,505 2,309 287 288 Fee income (50) (9) (371) (373) Surrenders, withdrawals and benefits (5,127) (5,663) (544) (577) Net transfers (from) to the general account (1) 312 (5) 4 10 Interest credited 845 885 171 141 Ending Balance $ 29,624 $ 31,139 $ 4,182 $ 4,635 Weighted-average crediting rate 2.8 % 2.8 % 3.9 % 2.5 % Net amount at risk (2) $ 90 $ 123 $ 676 $ 734 Cash surrender value $ 29,169 $ 30,676 $ 1,236 $ 1,491 (1) Net transfers (from) to the general account for Wealth Solutions include transfers of $(1,149) and $(523) for 2024 and 2023, respectively related to Voya-managed institutional/mutual fund plan assets in trust that are not reflected on the Consolidated Balance Sheets. (2) For those guarantees of benefits that are payable in the event of death, the net amount at risk is generally defined as the current guaranteed minimum death benefit in excess of the current account balance at the balance sheet date and is calculated at a contract level. When a contract has both a living benefit and a death benefit, the Company calculates NAR at a contract level and aggregates the higher of the two values together. The following table presents a reconciliation of the Contract owner account balances to the Consolidated Balance Sheets for the periods indicated: December 31, 2024 December 31, 2023 Wealth Solutions Deferred group and individual annuity $ 29,624 $ 31,139 Businesses exited 4,182 4,635 Non-putable funding agreements 1,249 1,175 Business exited - Other 1,158 1,275 Other (1) 891 950 Total $ 37,104 $ 39,174 (1) Primarily consists of universal life contracts The following table summarizes detail on the differences between the interest rate being credited to contract holders as of the periods indicated, and the respective guaranteed minimum interest rates ("GMIRs"): Account Value (1) Excess of crediting rate over GMIR At GMIR Up to .50% Above GMIR 0.51% - 1.00% 1.01% - 1.50% Above GMIR 1.51% - 2.00% Above GMIR More than 2.00% Above GMIR Total As of December 31, 2024 Up to 1.00% $ 82 $ 4,378 $ 3,691 $ 1,705 $ 1,545 $ 928 $ 12,329 1.01% - 2.00% 437 106 54 7 2 6 612 2.01% - 3.00% 10,266 93 62 60 — 4 10,485 3.01% - 4.00% 8,368 150 — 1 — — 8,519 4.01% and Above 1,464 80 — — — — 1,544 Renewable beyond 12 months (MYGA) (2) 364 — — — 2 — 366 Total discretionary rate setting products $ 20,981 $ 4,807 $ 3,807 $ 1,773 $ 1,549 $ 938 $ 33,855 As of December 31, 2023 Up to 1.00% $ 120 $ 5,070 $ 3,460 $ 2,215 $ 863 $ 800 $ 12,528 1.01% - 2.00% 527 131 50 8 3 6 725 2.01% - 3.00% 11,225 93 63 108 — 3 11,492 3.01% - 4.00% 8,873 152 — 6 — — 9,031 4.01% and Above 1,566 83 — — — — 1,649 Renewable beyond 12 months (MYGA) (2) 428 — — — 3 — 431 Total discretionary rate setting products $ 22,739 $ 5,529 $ 3,573 $ 2,337 $ 869 $ 809 $ 35,856 (1) Includes only the account values for investment spread products with GMIRs and discretionary crediting rates, net of policy loans. Excludes Stabilizer products, which are fee based. (2)
Short-Duration Insurance and Deposit Contracts	Pricing, underwriting and reserving on the medical stop loss products are performed based on policy years and key metrics such as loss ratios are tracked, managed and reported on this basis. The majority of the medical stop loss policies renew in January of each year. For the year ended December 31, 2024, $143 of claims incurred on prior years is primarily attributed to incurred claims and unfavorable claim development for policy years effective during 2023. For the year ended December 31, 2023, $(8) of claims incurred on prior years is primarily attributed to favorable claim development partially offset by incurred claims for policy years effective during 2022.

Reinsurance

Reinsurance	12 Months Ended
	Dec. 31, 2024
Insurance [Abstract]
Reinsurance	Reinsurance The Company reinsures its business through a diversified group of reinsurers. However, the Company remains liable to the extent its reinsurers do not meet their obligations under the reinsurance agreements. Collectability of reinsurance balances are evaluated by monitoring ratings and evaluating the financial strength of its reinsurers. Large reinsurance recoverable balances with offshore or other non-accredited reinsurers are secured through various forms of collateral, including secured trusts, funds withheld accounts and irrevocable letters of credit ("LOC"). Information regarding the effect of reinsurance on the Consolidated Balance Sheets is as follows as of the periods indicated: December 31, 2024 Direct Assumed Ceded Total, Assets Premium receivable $ 205 $ 10 $ (238) $ (23) Reinsurance recoverable, net of allowance for credit losses — — 11,307 11,307 Total $ 205 $ 10 $ 11,069 $ 11,284 Liabilities Future policy benefits and contract owner account balances $ 45,540 $ 896 $ — $ 46,436 Liability for funds withheld under reinsurance agreements 103 — — 103 Total $ 45,643 $ 896 $ — $ 46,539 December 31, 2023 Direct Assumed Ceded Total, Assets Premium receivable $ 193 $ 9 $ (219) $ (17) Reinsurance recoverable, net of allowance for credit losses — — 11,999 11,999 Total $ 193 $ 9 $ 11,780 $ 11,982 Liabilities Future policy benefits and contract owner account balances $ 47,781 $ 953 $ — $ 48,734 Liability for funds withheld under reinsurance agreements 103 — — 103 Total $ 47,884 $ 953 $ — $ 48,837 Information regarding the effect of reinsurance on the Consolidated Statements of Operations is as follows for the periods indicated: Year Ended December 31, 2024 2023 2022 Premiums: Direct premiums $ 4,084 $ 3,599 $ 3,257 Reinsurance assumed 21 26 25 Reinsurance ceded (929) (908) (859) Net premiums $ 3,176 $ 2,717 $ 2,423 Fee income: Gross fee income $ 2,494 $ 2,303 $ 2,137 Reinsurance assumed 16 17 18 Reinsurance ceded (397) (404) (413) Net fee income $ 2,113 $ 1,916 $ 1,742 Interest credited and other benefits to contract owners / policyholders: Direct interest credited and other benefits to contract owners / policyholders $ 4,931 $ 4,322 $ 4,448 Reinsurance assumed 60 64 50 Reinsurance ceded (1,372) (1,350) (1,970) Net interest credited and other benefits to contract owners / policyholders $ 3,619 $ 3,036 $ 2,528 The Company has indemnity reinsurance agreements with Security Life of Denver Company ("SLD") and with a subsidiary of Lincoln National Corporation ("Lincoln"). Under these agreements, SLD and Lincoln contractually assumed certain policyholder liabilities and obligations, although the Company remains obligated to contract owners. Reinsurance recoverable, net of the allowance for credit losses, related to the agreement with SLD was $8.6 billion and $9.2 billion as of December 31, 2024 and 2023, respectively, on the Consolidated Balance Sheets. Reinsurance recoverable, net of the allowance for credit losses, related to the reinsurance agreement with Lincoln was $0.9 billion and $1.0 billion as of December 31, 2024 and 2023, respectively, on the Consolidated Balance Sheets. If the Company determines that a reinsurance agreement does not expose the reinsurer to a reasonable possibility of a significant loss from insurance risk, the Company records the agreement using the deposit method of accounting. As of December 31, 2024 and 2023, the Company had a deposit asset, net of the allowance for credit losses, of $1.1 billion and $1.2 billion, respectively, which is reported in Other assets on the Consolidated Balance Sheets.

Separate Accounts

Separate Accounts	12 Months Ended
	Dec. 31, 2024
Other Liabilities Disclosure [Abstract]
Separate Accounts	Separate Accounts The following tables present a rollforward of separate account liabilities for the Wealth Solutions stabilizer and deferred annuity business, including a reconciliation to the Consolidated Balance Sheets, for the periods indicated: December 31, 2024 December 31, 2023 Wealth Solutions Stabilizer Deferred Annuity Total Stabilizer Deferred Annuity Total Balance at January 1 $ 7,175 $ 82,310 $ 89,485 $ 7,196 $ 69,152 $ 76,348 Premiums and deposits 891 9,970 10,861 940 10,052 10,992 Fee income (33) (487) (520) (34) (426) (460) Surrenders, withdrawals and benefits (1,376) (12,539) (13,915) (1,342) (9,631) (10,973) Net transfers (from) to the separate account — (1,461) (1,461) — (518) (518) Investment performance 244 12,963 13,207 415 13,681 14,096 Balance at end of period $ 6,901 $ 90,756 $ 97,657 $ 7,175 $ 82,310 $ 89,485 Reconciliation to Consolidated Balance Sheets: Other variable products liabilities 4,019 3,648 Total Separate Account liabilities $ 101,676 $ 93,133 Stabilizer products allow the contract holder to select either the market value of the account or the book value of the account at termination. The book value of the account is equal to deposits plus interest, less any withdrawals. The fair value is estimated using the income approach. Cash surrender value represents the amount of the contract holders' account balances distributable at the balance sheet date, less certain surrender charges. The cash surrender value for Wealth Solutions deferred annuity products was $90,734 and $82,286, as of December 31, 2024 and 2023, respectively. The aggregate fair value of assets, by major investment asset category, supporting separate accounts were as follows for the periods indicated: December 31, 2024 December 31, 2023 US Treasury securities and obligations of US government corporations and agencies $ 913 $ 1,015 Corporate and foreign debt securities 2,493 2,528 Mortgage-backed securities 3,087 3,231 Equity securities (including mutual funds) 94,685 85,916 Cash, cash equivalents and short-term investments 437 399 Receivable for securities and accruals 61 44 Total $ 101,676 $ 93,133

Segments

Segments	12 Months Ended
	Dec. 31, 2024
Segment Reporting [Abstract]
Segments	Segments The Company provides its principal products and services through three segments: Wealth Solutions, Health Solutions and Investment Management. The Chief Executive Officer of Voya is the chief operating decision maker ("CODM") who assesses performance and makes final resource allocation decisions for the three operating segments. The CODM assesses segment performance by measuring Adjusted operating earnings before income taxes against internally developed annual targets, rolling quarterly forecasts, industry peers and investor expectations. The Wealth Solutions segment provides tax-deferred, employer-sponsored retirement plans and administrative services to corporate, education, healthcare, other non-profit and government entities, and stable value products to institutional clients where the Company may or may not be providing defined contribution products and services, as well as individual retirement accounts ("IRAs"), other retail financial products and comprehensive financial services to individual customers. The Health Solutions segment provides stop loss, group life, voluntary employee-paid and disability products to mid-sized and large businesses as well as benefit administration software solutions to employers and health plans. The Investment Management segment provides investment products and retirement solutions across a broad range of geographies, market sectors, investment styles and capitalization spectrums. Products and services are offered to institutional clients, including public, corporate and union retirement plans, endowments and foundations and insurance companies, as well as individual investors and general accounts of the Company's insurance subsidiaries and are distributed through the Company's direct sales force, consultant channel and intermediary partners (such as banks, broker-dealers and independent financial advisers). Corporate adjusted operating earnings before income taxes include corporate operations, corporate level assets and financial obligations, financing and interest expenses, dividend payments made to preferred shareholders, other items not allocated or directly related to the Company's segments, such as certain expenses of employee benefit plans, certain adjustments to short-term and long-term incentive accruals, intercompany eliminations, and investment income in excess of amounts attributable to the segments. Measurement Adjusted operating earnings before income taxes is a meaningful measure used by management to evaluate its business and segment performance. This measure enhances the understanding of the Company’s financial results by focusing on the operating performance and trends of the underlying core business segments. It excludes results from exited businesses and items that tend to be highly variable from period to period based on capital market conditions or other factors which distort the ability to make a meaningful evaluation of the Company's segments. The Company uses the same accounting policies and procedures to measure segment Adjusted operating earnings before income taxes as it does for the directly comparable U.S. GAAP measure Income (loss) before income taxes. Adjusted operating earnings before income taxes does not replace Income (loss) before income taxes as the U.S. GAAP measure of the Company’s consolidated results of operations. Therefore, the Company believes that it is useful to evaluate both measures when reviewing the Company’s financial and operating performance. Each segment’s Adjusted operating earnings before income taxes is calculated by adjusting Income (loss) before income taxes for the following items: • Net investment gains (losses), which include gains (losses) on the sale of securities, impairments, changes in the fair value of investments using the fair value option unrelated to the implied loan-backed security income recognition for certain mortgage-backed obligations, and changes in the fair value of derivative instruments, excluding gains (losses) associated with swap settlements and accrued interest. It also includes changes in the fair value of derivatives related to managed custody guarantees, net of related reserve increases (decreases), less the estimated cost of these benefits, changes in nonperformance spread, and changes in market risk benefits; • Income (loss) related to businesses exited or to be exited through reinsurance or divestment, which includes gains and (losses) associated with transactions to exit blocks of business, amortization of intangible assets and residual run-off activity; • Income (loss) attributable to noncontrolling interests to which the Company is not economically entitled, such as Allianz's stake in the results of VIM Holdings LLC (referred to as redeemable noncontrolling interest or Allianz noncontrolling interest) or the attribution of results from consolidated VIEs or VOEs; • Dividend payments made to preferred shareholders are included as reductions to reflect the Adjusted operating earnings before income taxes that are available to common shareholders; • Other adjustments may include the following items: • Income (loss) related to early extinguishment of debt; • Impairment of goodwill and intangible assets as these represent losses related to infrequent events and do not reflect normal, cash-settled expenses; • Amortization of acquisition-related intangible assets as well as contingent consideration fair value adjustments incurred in connection with certain acquisitions; • Expected return on plan assets net of interest costs associated with the Company's qualified defined benefit pension plan and immediate recognition of net actuarial gains (losses) related to all of the Company's pension and other postretirement benefit obligations and gains (losses) from plan amendments and curtailments. These amounts do not reflect cash-settled expenses; and • Other items not indicative of normal operations or performance of the Company's segments or that may be related to events such as capital or organizational restructurings, including certain costs related to debt and equity offerings, acquisition / merger integration expenses, severance and other third-party expenses associated with such activities, and expenses attributable to vacant real estate. Adjusted operating revenues is a measure of the Company's segment revenues. Each segment's Adjusted operating revenues are calculated by adjusting Total revenues to exclude the following items: • Net investment gains (losses); • Revenues related to businesses exited or to be exited through reinsurance or divestment; • Revenues attributable to noncontrolling interests, which represents the attribution of results from consolidated VIEs or VOEs; and • Other adjustments that primarily reflect fee income earned by the Company's broker-dealers for sales of nonproprietary products, which are reflected net of commission expense in the Company's segments’ operating revenues, other items where the income is passed on to third parties and the elimination of intercompany investment expenses included in Adjusted operating revenues. Significant Expenses • Administrative expenses are compensation, technology and other general costs, net of amounts capitalized and exclude commission expenses. • Premium taxes, fees and assessments are taxes on paid premium and third-party fees correlated to business volumes. • Net commissions are commissions paid net of amounts deferred. The following tables reconcile Adjusted operating revenues to Total revenues and Adjusted operating earnings before income taxes to Income (loss) before income taxes for the periods indicated: Year Ended December 31, 2024 Wealth Solutions Health Solutions Investment Management Corporate Total Revenues: External customer revenue (1) $ 1,332 $ 3,438 $ 920 $ 22 $ 5,712 Net investment income and Net gains (losses) 1,711 138 20 178 2,047 Income (loss) related to CIEs — — 288 3 291 Intersegment Fee income and elimination — — 79 (79) — Total revenues 8,050 Adjustments (138) 1 (325) (101) (563) (2) Adjusted operating revenues 2,905 3,577 982 23 7,487 Less: Interest credited and other benefits to contract owners/policyholders 849 2,602 — — 3,451 Administrative expenses 897 525 703 — 2,125 Premium taxes, fees and assessments — 186 — — 186 Net commissions 255 188 — — 443 DAC/VOBA and other intangibles amortization 84 36 — — 120 Financing costs and preferred dividends — — — 162 162 Other corporate — — — 66 66 Adjusted operating earnings before income taxes including Allianz noncontrolling interest 820 40 278 (205) 933 Less: Earnings (loss) attributable to Allianz noncontrolling interest — — 65 (2) 63 Adjusted operating earnings before income taxes 820 40 213 (203) 870 Plus adjustments: Net investment gains (losses) 50 Income (loss) related to businesses exited or to be exited through reinsurance or divestment (142) Income (loss) attributable to noncontrolling interests 75 Dividend payments made to preferred shareholders 41 Other adjustments (95) Income (loss) before income taxes $ 799 (1) Includes Fee income, Premiums, and Other revenue and excludes intersegment fee income and the related elimination. (2) Includes Net investment gains (losses) of $22, Revenues related to business exited or to be exited through reinsurance or divestment of $102, Revenues attributable to noncontrolling interests of $243, and Other adjustments of $196. Year Ended December 31, 2023 Wealth Solutions Health Solutions Investment Management Corporate Total Revenues: External customer revenue (1) $ 1,121 $ 2,948 $ 831 $ 60 $ 4,960 Net investment income and Net gains (losses) 1,663 130 26 268 2,087 Income (loss) related to CIEs — — 301 — 301 Intersegment Fee income and elimination — — 85 (85) — Total revenues 7,348 Adjustments (8) 4 (327) (195) (526) (2) Adjusted operating revenues 2,776 3,082 916 48 6,822 Less: Interest credited and other benefits to contract owners/policyholders 895 1,896 — — 2,790 Administrative expenses 931 506 690 — 2,127 Premium taxes, fees and assessments — 147 — — 147 Net commissions 229 186 — — 415 DAC/VOBA and other intangibles amortization 90 33 — — 123 Financing costs and preferred dividends — — — 161 161 Other corporate — — — 96 96 Adjusted operating earnings before income taxes including Allianz noncontrolling interest 632 315 225 (208) 964 Less: Earnings (loss) attributable to Allianz noncontrolling interest — — 49 (1) 48 Adjusted operating earnings before income taxes 632 315 177 (207) 916 Plus adjustments: Net investment gains (losses) (15) Income (loss) related to businesses exited or to be exited through reinsurance or divestment (182) Income (loss) attributable to noncontrolling interests 104 Dividend payments made to preferred shareholders 36 Other adjustments (180) Income (loss) before income taxes $ 678 (1) Includes Fee income, Premiums, and Other revenue and excludes intersegment fee income and the related elimination. (2) Includes Net investment gains (losses) of $(44), Revenues related to business exited or to be exited through reinsurance or divestment of $113, Revenues attributable to noncontrolling interests of $247, and Other adjustments of $210. Year Ended December 31, 2022 Wealth Solutions Health Solutions Investment Management Corporate Total Revenues: External customer revenue (1) $ 1,100 $ 2,448 $ 663 $ 102 $ 4,313 Net investment income and Net gains (losses) 1,566 135 14 (120) 1,595 Income (loss) related to CIEs — — 22 — 22 Intersegment Fee income and elimination — — 91 (91) — Total revenues 5,930 Adjustments 111 (1) (35) 175 250 (2) Adjusted operating revenues 2,778 2,582 756 67 6,183 Less: Interest credited and other benefits to contract owners/policyholders 886 1,680 — — 2,566 Administrative expenses 867 276 570 — 1,713 Premium taxes, fees and assessments — 126 — — 126 Net commissions 232 167 — — 399 DAC/VOBA and other intangibles amortization 95 29 — — 124 Financing costs and preferred dividends — — — 177 177 Other corporate — — — 142 142 Adjusted operating earnings before income taxes including Allianz noncontrolling interest 697 304 186 (253) 934 Less: Earnings (loss) attributable to Allianz noncontrolling interest — — 27 (1) 26 Adjusted operating earnings before income taxes 697 304 158 (251) 908 Plus adjustments: Net investment gains (losses) (190) Income (loss) related to businesses exited or to be exited through reinsurance or divestment (138) Income (loss) attributable to noncontrolling interests (77) Dividend payments made to preferred shareholders 36 Other adjustments (111) Income (loss) before income taxes $ 428 (1) Includes Fee income, Premiums, and Other revenue and excludes intersegment fee income and the related elimination. (2) Includes Net investment gains (losses) of $(215), Revenues related to business exited or to be exited through reinsurance or divestment of $(123), Revenues attributable to noncontrolling interests of $(33), and Other adjustments of $121. The summary below presents Total assets for the Company’s segments as of the dates indicated: December 31, 2024 December 31, 2023 Wealth Solutions $ 129,058 $ 122,318 Health Solutions 3,490 3,336 Investment Management 1,873 1,600 Corporate 24,940 25,527 Total assets, before consolidation (1) 159,361 152,781 Consolidation of investment entities 4,528 4,304 Total assets $ 163,889 $ 157,085 (1) Total assets, before consolidation includes the Company's direct investments in CIEs prior to consolidation, which are accounted for using the equity method or fair value option.

Goodwill and Other Intangible A

Goodwill and Other Intangible Assets	12 Months Ended
	Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Other Intangible Assets	Goodwill and Other Intangible Assets Goodwill The changes in the carrying amount of goodwill reported in the Company's operating segments were as follows: Wealth Solutions Health Solutions Investment Management Corporate (1) Consolidated Balance as of January 1, 2023 $ 17 $ 24 $ 286 $ — $ 327 Additions from business combinations (2) — 319 — 102 421 Balance as of December 31, 2023 17 343 286 102 748 Additions from business combinations — — — — — Balance as of December 31, 2024 $ 17 $ 343 $ 286 $ 102 $ 748 (1) Corporate includes goodwill that was acquired by the parent company and not pushed to a subsidiary within the Company’s reportable segments. The carrying value of goodwill within Corporate is allocated to Wealth Solutions, Health Solutions, and Investment Management reporting units as $72, $20 and $10, respectively. (2) See the Business, Basis of Presentation and Significant Accounting Policies Note for information on recent business combinations. During the fourth quarter of 2024, the Company performed its annual goodwill impairment assessment and determined there was no goodwill impairment as of December 31, 2024. There were no accumulated impairments associated with goodwill as of December 31, 2024 and 2023. Other Intangible Assets The Company’s indefinite-lived intangible assets, primarily related to the right to manage client assets, were valued using the multi-period excess earnings method, a form of the income approach, which relied upon significant assumptions, including the projected revenues and discount rate. The right to manage client assets was determined to have an indefinite life based on the open-ended nature of the right to manage, and the ability to continue to manage the assets with no specific termination date. During the fourth quarter of 2024, the Company completed an assessment for recoverability of its definite-lived intangible assets, and determined that the carrying value was recoverable. During the fourth quarter of 2023, as a result of the changes to the projected cash flows and using a discounted cash flow approach, the Company recognized an impairment loss of $33 in relation to management contract rights, which was included in Operating expenses The following table presents other intangible assets as of the dates indicated: Weighted December 31, 2024 December 31, 2023 Gross Accumulated Net Gross Accumulated Net Indefinite-life intangibles: Management contract rights N/A $ 350 $ — $ 350 $ 350 $ — $ 350 Total indefinite-life intangibles 350 — 350 350 — 350 Finite-life intangibles: Management contract rights 17 years 131 19 112 153 11 142 Customer relationship lists 17 years 325 145 180 325 128 197 Trademarks 8 years 15 4 11 15 2 13 Computer software 5 years 432 253 179 501 346 155 Total intangible assets $ 1,253 $ 421 $ 832 $ 1,344 $ 487 $ 857 Fully amortized computer software of $156 was written off during the year ended December 31, 2024. In addition, during the fourth quarter of 2024, $18 of management contracts related to a prior acquisition were derecognized and the related loss was recorded in Operating expenses in the Consolidated Statements of Operations and reported in the Investment Management segment. Amortization expense related to intangible assets was $96, $85 and $36 for the years ended December 31, 2024, 2023 and 2022, respectively. The estimated amortization of intangible assets are as follows: Year Amount 2025 $ 92 2026 78 2027 57 2028 34 2029 31

Share-based Incentive Compensat

Share-based Incentive Compensation Plans	12 Months Ended
	Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]
Share-based Incentive Compensation Plans	Share-based Incentive Compensation Plans Omnibus Incentive Plans The Company previously offered equity-based compensation awards to its employees and non-employee directors under various employee and non-employee incentive plans (together, the "Omnibus Plans"). On May 23, 2024, the Company's shareholders approved the Voya Financial, Inc. 2024 Omnibus Incentive Plan (the "2024 Omnibus Plan"), which is a successor to the Omnibus Plans, and no further grants shall be made pursuant to the Omnibus Plans. The 2024 Omnibus Plan provides for 8,000,000 shares of common stock to be initially available for issuance as equity-based compensation awards, less one share for every one share granted under the Omnibus Plans after December 31, 2023 and prior to the effective date of the 2024 Omnibus Plan. As of December 31, 2024, common stock reserved and available for issuance under the Omnibus Plans was 7,169,274 shares. The Omnibus Plans and the 2024 Omnibus Plan permit the granting of a wide range of equity-based awards, including RSUs, which represent the right to receive a number of shares of Company common stock upon vesting; restricted stock, which are shares of Company stock that are issued subject to sale and transfer restrictions until the vesting conditions are met; PSUs, which are RSUs subject to certain performance-based vesting conditions, and under which the number of shares of common stock delivered upon vesting varies with the level of achievement of performance criteria; and stock options. Grants of equity-based awards under the Omnibus Plans are approved in advance by the Compensation and Benefits Committee (the "Committee") of the Board of Directors of the Company, and are subject to such terms and conditions as the Committee may determine, including in respect of vesting and forfeiture, subject to certain limitations provided in the Omnibus Plans. Equity-based awards under the Omnibus Plans may carry dividend equivalent rights, pursuant to which notional dividends accumulate on unvested equity awards and are paid, in cash, upon vesting. Except for stock option awards made during 2015 and 2019, awards made under the Omnibus Plans, to date, have included dividend equivalent rights. Dividend equivalents are credited to the recipient and are paid only to the extent the applicable performance criteria and service conditions are met. During each of the years ended December 31, 2024, 2023 and 2022 the Company awarded RSUs and PSUs to its employees under the Omnibus Plans. The PSU awards entitle recipients to receive, upon vesting, a number of shares of common stock that ranges from 0% to 150% of the number of PSUs awarded, depending on the level of achievement of the specified performance conditions. The establishment and the achievement of performance objectives are determined and approved by the Committee. Except under certain termination conditions, RSUs and PSUs generally vest no earlier than one year from the date of the award and no later than three years from the date of the award. In the case of retirement (eligibility for which is based on the employee's age and years of service as provided in the relevant award agreement), awards vest in full, but subject to the satisfaction of any applicable performance criteria. In December 2015 and February 2019, the Company also awarded contingent stock options ("2015 Stock Options" and "2019 Stock Options," respectively) under the Omnibus Plans. All outstanding 2015 and 2019 Stock Options are vested as the necessary performance conditions were satisfied. If an award under the Omnibus Plans is forfeited, expired, terminated or otherwise lapses, the shares of Company common stock underlying that award will become available for issuance. Shares withheld by the Company to pay employee taxes for tax liabilities arising from awards other than stock options after December 31, 2023 are also available for reissuance. Shares which are withheld by or tendered to the Company to pay the exercise price of stock options (or are repurchased from an option holder by the Company with proceeds from the exercise of stock options) are not available for reissuance. Compensation Cost The fair value of stock options was estimated using the Black-Scholes option pricing model. The following is a summary of the assumptions used in this model for the stock options granted in 2015 and 2019: 2015 Stock Options 2019 Stock Options Expected volatility 28.6 % 26.5 % Expected term (in years) 6.02 5.99 Strike price $ 37.60 $ 50.03 Risk-free interest rate 2.1 % 2.7 % Expected dividend yield 0.11 % 1.00 % Weighted average estimated fair value $ 11.89 $ 13.78 For the 2015 Stock Options, the Company utilized the simplified method for the expected term calculations. At the time of grant, the Company did not have historical exercises on which to base its own estimate. Additionally, exercise data relating to employees of comparable companies was not easily obtainable. Furthermore, because the Company did not have historical stock prices for a period at least equal to the expected term, the Company estimated expected volatilities were based on the Company's life-to-date historical volatility using a weighted-average consisting 70% of historical peer group volatility and 30% of the historical volatility of the Company common stock. The contractual term for exercising the options is ten years. The vesting of the 2019 Stock Options was contingent on the satisfaction of performance conditions on or before December 31, 2020; the Company assumed for purposes of the award's fair value that such conditions would be met in full on or prior to such date. The Company utilized the simplified method for the expected term calculations. At the time of grant, the Company did not have historical exercises on which to base its own estimate. Additionally, exercise data relating to employees of comparable companies was not easily obtainable. Expected volatilities were based on the Company's life-to-date historical volatility. The contractual term for exercising the options is ten years. The fair value of the TSR component of the PSU awards was estimated using a Monte Carlo simulation. The following is a summary of the significant assumptions used to calculate the fair value of the TSR component of the PSU awards granted during the periods indicated: 2024 2023 2022 Expected volatility of the Company's common stock 27.76 % 30.43 % 34.37 % Average expected volatility of peer companies 34.00 % 41.53 % 49.41 % Expected term (in years) 2.86 2.85 2.85 Risk-free interest rate 4.41 % 4.42 % 1.71 % Expected dividend yield — % — % — % Average correlation coefficient of peer companies 61.10 % 65.80 % 71.50 % The following table summarizes share-based compensation expense, which includes expenses related to awards granted under the Omnibus Plans for the periods indicated: Year Ended December 31, 2024 2023 2022 RSUs $ 60 $ 81 $ 45 PSU awards 39 48 45 Total 99 129 90 Income tax benefit 25 31 24 Share-based compensation $ 74 $ 98 $ 66 The following table summarizes the unrecognized compensation cost and expected remaining weighted-average period of expense recognition as of December 31, 2024: RSU Awards PSU Awards Unrecognized compensation cost $ 28 $ 32 Expected remaining weighted-average period of expense recognition (in years) 0.83 1.19 Awards Outstanding The following table summarizes RSU and PSU awards activity under the Omnibus Plans and Director Plan for the periods indicated: RSU Awards PSU Awards (awards in millions) Number of Awards Weighted Average Grant Date Fair Value Number of Awards Weighted Average Grant Date Fair Value Outstanding at January 1, 2024 2.0 $ 67.06 2.2 $ 61.17 Adjusted for PSU performance factor — — (0.1) 46.94 Granted 0.9 67.70 0.7 59.21 Vested (0.9) 65.14 (0.6) 53.73 Forfeited (0.1) 69.87 — 68.42 Outstanding at December 31, 2024 1.9 $ 67.95 2.2 $ 63.48 Awards expected to vest as of December 31, 2024 1.9 $ 67.95 2.2 $ 63.48 The weighted-average grant date fair value for RSU awards granted during the years ended December 31, 2024, 2023 and 2022 was $67.70, $70.51 and $65.33, respectively. The weighted-average grant date fair value for PSU awards granted during the years ended December 31, 2024, 2023 and 2022 was $59.21, $66.10 and $56.67, respectively. The total fair value of shares vested for the years ended December 31, 2024, 2023, and 2022 was $104, $118 and $104, respectively. The following table summarizes the number of options under the Omnibus Plans for the periods indicated: Stock Options (awards in millions) Number of Awards Weighted Average Exercise Price Weighted Average Remaining Contractual Term (Years) Aggregate Intrinsic Value Outstanding as of January 1, 2024 1.2 $ 44.79 3.1 $ 34.30 Granted — — Exercised (0.4) 42.86 Forfeited — — Outstanding as of December 31, 2024 0.8 $ 45.71 2.7 $ 19.00 Vested, exercisable, as of December 31, 2024 0.8 45.71 2.7 19.00 The total intrinsic value of options exercised during the years ended December 31, 2024, 2023 and 2022 was $13, $16 and $5.

Shareholders' Equity

Shareholders' Equity	12 Months Ended
	Dec. 31, 2024
Equity [Abstract]
Shareholders' Equity	Shareholders' Equity Common Shares The following table presents the rollforward of common shares used in calculating the weighted average shares utilized in the basic earnings per common share calculation for the periods indicated: Common Shares (shares in millions) Issued Held in Treasury Outstanding Balance, January 1, 2022 109.0 1.2 107.8 Common Shares issued 0.1 — 0.1 Common Shares acquired - share repurchase — 11.7 (11.7) Share-based compensation programs 1.7 0.7 1.0 Treasury Stock retirement (13.0) (13.0) — Balance, December 31, 2022 97.8 0.6 97.2 Common Shares issued 9.7 — 9.7 Common Shares acquired - share repurchase — 5.4 (5.4) Share-based compensation programs 2.1 0.7 1.4 Treasury Stock retirement (6.0) (6.0) — Balance, December 31, 2023 103.6 0.7 102.9 Common Shares issued 0.1 — 0.1 Common Shares acquired - share repurchase — 8.6 (8.6) Share-based compensation programs 1.9 0.8 1.1 Balance, December 31, 2024 105.6 10.1 95.5 Dividends declared per share of Common Stock were as follows for the periods indicated: Year Ended December 31, 2024 2023 2022 Dividends declared per share of Common Stock $ 1.70 $ 1.20 $ 0.80 Share Repurchase Program From time to time, the Company's Board of Directors authorizes the Company to repurchase shares of its common stock. These authorizations permit stock repurchases up to a prescribed dollar amount and generally may be accomplished through various means, including, without limitation, open market transactions, privately negotiated transactions, forward, derivative, or accelerated repurchase, or automatic repurchase transactions, including 10b5-1 plans, or tender offers. Share repurchase authorizations typically expire if unused by a prescribed date. As of December 31, 2024, the aggregate amount remaining under the Company's share repurchase authorization is $761. This share repurchase authorization expires on December 31, 2025 (unless extended), and does not obligate the Company to purchase any shares. The authorization for the share repurchase program may be terminated, increased or decreased by the Company's Board at any time. The following table presents repurchases of the Company's common stock through share repurchase agreements with third-party financial institutions for the years ended December 31, 2024 and 2022. There were no repurchase agreements for the year ended December 31, 2023. 2024 Execution Date Payment Initial Shares Delivered Closing Date Additional Shares Delivered Total Shares Repurchased September 12, 2024 $ 100 1,061,853 November 5, 2024 222,007 1,283,860 2022 Execution Date Payment Initial Shares Delivered Closing Date Additional Shares Delivered Total Shares Repurchased June 21, 2022 $ 250 3,382,950 September 20, 2022 819,566 4,202,516 March 17, 2022 $ 275 3,305,786 May 11, 2022 890,112 4,195,898 The following table presents repurchases of the Company's common stock pursuant to 10b5-1 plans and through open market repurchases for the periods indicated: Year Ended December 31, 2024 2023 2022 Shares of common stock 7,295,206 5,365,303 3,295,800 Payment $ 535 $ 374 $ 225 Warrants On May 7, 2013, the Company issued warrants to purchase up to 26,050,846 shares of the Company's common stock equal in the aggregate to 9.99% of the issued and outstanding shares of common stock at that date. On May 10, 2023, the warrants were net share settled in accordance with their terms, resulting in the issuance of 9.6 million common shares. No warrants remain outstanding as of December 31, 2024 and 2023. Preferred Stock On June 11, 2019, the Company issued 300,000 shares of 5.35% Fixed-Rate Reset Non-Cumulative Preferred Stock, Series B ("the Series B preferred stock"), with a $0.01 par value per share and a liquidation preference of $1,000 per share, for aggregate net proceeds of $293. The Company deposited the Series B preferred stock under a deposit agreement with a depositary, which issued interests in fractional shares of the Series B preferred stock in the form of depositary shares ("Depositary Shares") evidenced by depositary receipts; each Depositary Share representing 1/40th interest in a share of the Series B preferred stock. On September 12, 2018, the Company issued 325,000 shares of 6.125% Fixed-Rate Reset Non-Cumulative Preferred Stock, Series A, with a $0.01 par value per share and a liquidation preference of $1,000 per share, for aggregate net proceeds of $319. On September 15, 2023, the rate on the Non-cumulative Preferred Stock, Series A was reset from 6.125% to 7.758% in accordance with the terms of the preferred stock and applies for the next five years. The ability of the Company to declare or pay dividends on, or purchase, redeem or otherwise acquire, shares of its common stock will be substantially restricted in the event that the Company does not declare and pay (or set aside) dividends on the Series A and Series B Preferred Stock for the last preceding dividend period. The Series A and Series B preferred stock are not subject to any mandatory redemption, sinking fund, retirement fund, purchase fund or similar provisions. The Company may, at its option, redeem the Series A preferred stock, (a) in whole but not in part, at any time, within 90 days after the occurrence of a "rating agency event," at a redemption price equal to $1,020 per share, plus an amount equal to any dividends per share of preferred stock that have accrued but not been declared and paid for the then-current dividend period to, but excluding, the redemption date and (b) (i) in whole but not in part, at any time within 90 days after the occurrence of a "regulatory capital event" or (ii) in whole or in part, from time to time, on September 15, 2023 or any subsequent "reset date," in each case, at a redemption price equal to $1,000 per share of preferred stock, plus an amount equal to any dividends per share of preferred stock that have accrued but not been declared and paid for the then-current dividend period to, but excluding, such redemption date. The Company may, at its option, redeem the Series B preferred stock, (a) in whole but not in part, at any time, within 90 days after the occurrence of a "rating agency event," at a redemption price equal to $1,020 per share (equivalent to $25.50 per Depositary Share), plus an amount equal to any accrued and unpaid dividends per share that have accrued but not been declared and paid for the then-current dividend period, but excluding, such redemption date and (b) (i) in whole but not in part, at any time, within 90 days after the occurrence of a "regulatory capital event," or (ii) in whole or in part, from time to time, on September 15, 2029 or any reset date, in each case, at a redemption price equal to $1,000 per share of the Series B preferred stock (equivalent to $25.00 per Depositary Share), plus an amount equal to any accrued and unpaid dividends per share that have accrued but not been declared and paid for the then-current dividend period to, but excluding, such redemption date. A "rating agency event" means that any nationally recognized statistical rating organization that then publishes a rating for the Company amends, clarifies or changes the criteria it uses to assign equity credit to securities like the preferred stock, which results in the lowering of the equity credit assigned to the preferred stock, as applicable, or shortens the length of time that the preferred stock is assigned a particular level of equity credit. A "regulatory capital event" means that the Company becomes subject to capital adequacy supervision by a capital regulator and the capital adequacy guidelines that apply to the Company as a result of being so subject set forth criteria pursuant to which the preferred stock would not qualify as capital under such capital adequacy guidelines, as the Company may determine at any time, in its sole discretion. As of December 31, 2024 and December 31, 2023, there were 100,000,000 shares of preferred stock authorized. Preferred stock issued and outstanding are as follows: December 31, 2024 December 31, 2023 Series Issued Outstanding Issued Outstanding 7.758% Non-cumulative Preferred Stock, Series A 325,000 325,000 325,000 325,000 5.35% Non-cumulative Preferred Stock, Series B 300,000 300,000 300,000 300,000 Total 625,000 625,000 625,000 625,000 The declaration of dividends on preferred stock per share and in the aggregate were as follows for the periods indicated: Series A Series B Year Ended: Per Share Aggregate Per Share Aggregate December 31, 2024 $ 77.58 $ 25 $ 53.50 $ 16 December 31, 2023 61.25 20 53.50 16 December 31, 2022 61.25 20 53.50 16 As of December 31, 2024, there were no preferred stock dividends in arrears.

Earnings per Common Share

Earnings per Common Share	12 Months Ended
	Dec. 31, 2024
Earnings Per Share [Abstract]
Earnings per Common Share	Earnings per Common Share The following table presents a reconciliation of Net income (loss) and shares used in calculating basic and diluted net income (loss) per common share for the periods indicated: (in millions, except for per share data) Year Ended December 31, Earnings 2024 2023 2022 Net income (loss) available to common shareholders: Net income (loss) $ 742 $ 729 $ 433 Less: Preferred stock dividends 41 36 36 Less: Net income (loss) attributable to noncontrolling interest and redeemable noncontrolling interest 75 104 (77) Net income (loss) available to common shareholders $ 626 $ 589 $ 474 Weighted-average common shares outstanding Basic 99.2 102.7 100.7 Dilutive Effects: Warrants (1) — 3.3 7.2 RSUs 1.1 1.2 0.9 PSUs 0.7 1.1 0.8 Stock Options 0.4 0.5 0.6 Diluted 101.4 108.8 110.2 Net income (loss) available to Voya Financial, Inc.'s common shareholders per common share (2) Basic $ 6.31 $ 5.74 $ 4.70 Diluted $ 6.17 $ 5.42 $ 4.30 (1) See the Shareholders' Equity Note to these Consolidated Financial Statements for additional information on warrants settled. (2) Basic and diluted earnings per share are calculated using unrounded, actual amounts. Therefore, the components of earnings per share may not sum to its corresponding total. Diluted earnings per share is computed assuming the issuance of restricted stock units, stock options, performance share units and warrants using the treasury stock method.

Insurance Subsidiaries

Insurance Subsidiaries	12 Months Ended
	Dec. 31, 2024
Insurance [Abstract]
Insurance Subsidiaries	Insurance Subsidiaries Principal Insurance Subsidiaries Statutory Equity and Income Each of Voya Financial, Inc.'s two principal insurance subsidiaries (the "Principal Insurance Subsidiaries") is subject to minimum risk-based capital ("RBC") requirements established by the insurance departments of their respective states of domicile. The formulas for determining the amount of RBC specify various weighting factors that are applied to financial balances or various levels of activity based on the perceived degree of risk. Regulatory compliance is determined by a ratio of total adjusted capital ("TAC"), as defined by the National Association of Insurance Commissioners ("NAIC"), to authorized control level RBC, as defined by the NAIC. Each of the Company's Principal Insurance Subsidiaries exceeded the minimum RBC requirements that would require any regulatory or corrective action for all periods presented herein. The Company's Principal Insurance Subsidiaries are each required to prepare statutory financial statements in accordance with statutory accounting practices prescribed or permitted by the insurance department of its respective state of domicile. Such statutory accounting practices primarily differ from U.S. GAAP by charging policy acquisition costs to expense as incurred, establishing future policy benefit liabilities and contract owner account balances using different actuarial assumptions as well as valuing investments and certain assets and accounting for deferred taxes on a different basis. Certain assets that are not admitted under statutory accounting principles are charged directly to surplus. Depending on the regulations of the insurance department of an insurance company's state of domicile, the entire amount or a portion of an insurance company's asset balance can be non-admitted based on the specific rules regarding admissibility. For the years ended December 31, 2024, 2023 and 2022, the Principal Insurance Subsidiaries have no prescribed or permitted practices that materially impact total capital and surplus. Statutory Net income (loss) for the years ended December 31, 2024, 2023 and 2022 and statutory capital and surplus as of December 31, 2024 and 2023 of the Company's Principal Insurance Subsidiaries are as follows: Statutory Net Income (Loss) Statutory Capital and Surplus 2024 2023 2022 2024 2023 Subsidiary Name (State of Domicile): Voya Retirement Insurance and Annuity Company ("VRIAC") (CT) $ 640 $ 577 $ 549 $ 2,033 $ 1,955 ReliaStar Life Insurance Company ("RLI") (MN) 163 401 418 1,098 1,447 All of the Company's Principal Insurance Subsidiaries have capital and surplus levels that exceed their respective regulatory minimum requirements. Insurance Subsidiaries Dividend Restrictions The states in which the insurance subsidiaries of Voya Financial, Inc. are domiciled impose certain restrictions on the subsidiaries' ability to pay dividends to their parent. These restrictions are based in part on the prior year's statutory income and surplus. In general, dividends up to specified levels are considered ordinary and may be paid without prior approval. Dividends in larger amounts, or "extraordinary" dividends, are subject to approval by the insurance commissioner of the state of domicile of the insurance subsidiary proposing to pay the dividend. Under the insurance laws applicable to Voya Financial, Inc.'s insurance subsidiaries domiciled in Connecticut and Minnesota, an "extraordinary" dividend or distribution is defined as a dividend or distribution that, together with other dividends and distributions made within the preceding twelve months, exceeds the greater of (i) 10% of the insurer's policyholder surplus as of the preceding December 31, or (ii) the insurer's net gain from operations for the twelve-month period ending the preceding December 31, in each case determined in accordance with statutory accounting principles. In addition, under the insurance laws of Connecticut and Minnesota, no dividend or other distribution exceeding an amount equal to a domestic insurance company's earned surplus may be paid without the domiciliary insurance regulator's prior approval. The Company's Principal Insurance Subsidiaries domiciled in Connecticut and Minnesota have both created ordinary dividend capacity in 2024. Any extraordinary dividend payment would be subject to domiciliary insurance regulatory approval, which can be granted or withheld at the discretion of the regulator. Principal Insurance Subsidiaries - Dividends and Return of Capital The following table summarizes dividends permitted to be paid by the Company's Principal Insurance Subsidiaries to Voya Financial, Inc. or Voya Holdings without the need for insurance regulatory approval and dividends and extraordinary distributions paid by each of the Company's Principal Insurance Subsidiaries to its parent for the periods indicated: Dividends Permitted without Approval Dividends Paid Extraordinary Distributions Paid Year Ended December 31, Year Ended December 31, 2025 2024 2024 2023 2024 2023 Subsidiary Name (State of domicile): Voya Retirement Insurance and Annuity Company (CT) $ 562 $ 473 $ 473 $ 310 $ — $ — ReliaStar Life Insurance Company (MN) 177 403 402 — — 747

Employee Benefit Arrangements

Employee Benefit Arrangements	12 Months Ended
	Dec. 31, 2024
Retirement Benefits [Abstract]
Employee Benefit Arrangements	Employee Benefit Arrangements Pension, Other Postretirement Benefit Plans and Other Benefit Plans Voya Financial, Inc.'s subsidiaries maintain both qualified and non-qualified defined benefit pension plans (the "Plans"). The Plans generally cover all employees and certain sales representatives who meet specified eligibility requirements. Pension benefits are based on a formula using compensation and length of service. Annual contributions are paid to the Plans at a rate necessary to adequately fund the accrued liabilities of the Plans calculated in accordance with legal requirements. The Plans comply with applicable regulations concerning investments and funding levels. The Voya Retirement Plan (the "Retirement Plan") is a tax qualified defined benefit plan, the benefits of which are guaranteed (within certain specified legal limits) by the Pension Benefit Guaranty Corporation ("PBGC"). Beginning January 1, 2012, the Retirement Plan adopted a cash balance pension formula instead of a final average pay ("FAP") formula, allowing all eligible employees to participate in the Retirement Plan. Participants earn an annual credit equal to 4% of eligible compensation. Interest is credited monthly based on a 30-year U.S. Treasury securities bond rate published by the Internal Revenue Service in the preceding August of each year. The accrued vested cash pension balance benefit is portable; participants can take it if they leave the Company. The Company also provides certain supplemental retirement benefits to eligible employees, non-qualified pension plans for insurance sales representatives who have entered into a career agent agreement and certain other individuals. These plans are non-qualified defined benefit plans, which means all benefits are payable from the general assets of the sponsoring company. The Company also offers deferred compensation plans for employees, including career agents and certain other individuals who meet the eligibility criteria. The Company’s deferred compensation commitment for employees is recorded on the Consolidated Balance Sheets in Other liabilities and totaled $330 and $302 as of December 31, 2024 and 2023, respectively. Voya Financial, Inc.'s subsidiaries also provide other postretirement and post-employment benefits to certain employees. These are primarily postretirement healthcare and life insurance benefits to retired employees and other eligible dependents and post-employment/pre-retirement plans provided to employees and former employees. The Company's other postretirement benefit obligation and unfunded status totaled $8 and $9 as of December 31, 2024 and 2023, respectively. Additionally, net periodic benefit for other postretirement benefits totaled $1, $1 and $2 for the years ended December 31, 2024, 2023 and 2022, respectively. Obligations, Funded Status and Net Periodic Benefit Costs The Company's Retirement Plan was fully funded in compliance with Employee Retirement Income Security Act ("ERISA") guidelines as of December 31, 2023, which is tested annually subsequent to this filing. The following tables summarize a reconciliation of beginning and ending balances of the benefit obligation and fair value of plan assets for the years ended December 31, 2024 and 2023 and the discount rate and interest credit rate used in determining pension benefit obligations as of December 31, 2024 and 2023 as well as the funded status of the Company's Plans as of December 31, 2024 and 2023: 2024 2023 Change in benefit obligation: Benefit obligations, January 1 $ 1,999 $ 1,943 Service cost 30 24 Interest cost 102 103 Net actuarial (gains) losses (1) (98) 44 Benefits paid (121) (115) Benefit obligations, December 31 (2) 1,912 1,999 Discount rate 5.88 % 5.28 % Interest credit rate 3.75 % 3.75 % Change in plan assets: Fair value of plan net assets, January 1 1,831 1,770 Actual return on plan assets 36 149 Employer contributions 28 27 Benefits paid (122) (115) Fair value of plan net assets, December 31 (3) 1,773 1,831 Unfunded status at end of year (4) $ (139) $ (168) (1) Includes actuarial (gain) loss of $(110) and $37 due to change in discount rate for the year ended December 31, 2024 and 2023, respectively. The discount rate increased 0.60% during 2024 driven by an increase in corporate AA yields. The discount rate decreased 0.19% during 2023 driven by a decrease in corporate AA yields. (2) Includes Retirement Plan benefit obligations of $1,581 and $1,649 as of December 31, 2024 and 2023, respectively, and non-qualified plan benefit obligations of $331 and $350 as of December 31, 2024 and 2023, respectively. (3) Represents Retirement Plan Assets. (4) Funded status is not indicative of the Company's ability to pay ongoing pension benefits or of its obligation to fund retirement trusts. Required pension funding for qualified plans is determined in accordance with ERISA regulations. In determining the discount rate assumption, the Company utilizes current market information provided by its plan actuaries including discounted cash flow analyses of the Company’s pension and general movements in the current market environment. The discount rate modeling process involves selecting a portfolio of high quality, noncallable bonds that will match the cash flows of the pension plans. The following table summarizes amounts related to the Plans recognized on the Consolidated Balance Sheets as of December 31, 2024 and 2023: 2024 2023 Amounts recognized in the Consolidated Balance Sheets consist of: (1) Prepaid benefit cost (2) $ 192 $ 182 Accrued benefit cost (2) (331) (350) Net amount recognized $ (139) $ (168) (1) Excludes other postretirement benefit obligations of $8 and $9 as of December 31, 2024 and 2023, respectively. (2) Prepaid benefit cost is included in Other assets on the Consolidated Balance Sheets. Accrued benefit cost is included in Other liabilities on the Consolidated Balance Sheets. There were no amounts related to the Plans recognized in AOCI as of December 31, 2024 and 2023. The following table summarizes information for the Plans with a projected benefit obligation and an accumulated benefit obligation in excess of plan assets as of December 31, 2024 and 2023: 2024 2023 Projected benefit obligation $ 331 $ 350 Accumulated benefit obligation 328 348 Fair value of plan assets — — Components of Net Periodic Benefit Cost The components of net periodic benefit costs recognized in Operating expenses in the Consolidated Statements of Operations, weighted-average assumptions used in determining net benefit cost of the Plans and other changes in plan assets and benefit obligations recognized in Other comprehensive income (loss) related to the Plans were as follows for the years ended December 31, 2024, 2023 and 2022: 2024 2023 2022 Net Periodic (Benefit) Costs Recognized in Consolidated Statements of Operations: Service cost $ 30 $ 24 $ 28 Interest cost 102 103 72 Expected return on plan assets (107) (100) (108) (Gain) loss recognized due to curtailment — — — Net (gain) loss recognition (26) (4) (6) Net periodic (benefit) costs $ (1) $ 23 $ (14) Discount rate 5.28 % 5.47 % 3.00 % Expected rate of return on plan assets 6.00 % 5.82 % 4.85 % Interest credit rate 3.75 % 3.00 % 2.80 % The expected return on plan assets is determined using the fair value of plan assets. The expected rate of return on plan assets is updated at least annually, taking into consideration the Retirement Plan’s asset allocation, historical returns on the types of assets held in the Retirement Plan's portfolio of assets ("the Fund") and the current economic environment. Based on these factors, it is expected that the Fund’s assets will earn an average percentage per year over the long term. This estimation is based on an active return on a compound basis, with a reduction for administrative expenses and non-Voya investment manager fees paid from the Fund. For estimation purposes, it is assumed the long-term asset mix will be consistent with the current mix. Changes in the asset mix could impact the amount of recorded pension income or expense, the funded status of the Plan, and the need for future cash contributions. Plan Assets The Retirement Plan is the Company's only defined benefit plan with plan assets in a trust. The primary financial objective of the Retirement Plan is to secure participant retirement benefits. As such, the key objective in the Retirement Plan’s financial management is to promote funded status (i.e., the ratio of market value of assets to liabilities) stability, while maintaining the funded status surplus. The investment strategy for the Fund balances the requirement to generate returns with the need to control risk. The asset mix is recognized as the primary mechanism to influence the reward and risk structure of the Fund in an effort to accomplish the Retirement Plan’s funding objectives. Desirable target allocations amongst identified asset classes are set and, within each asset class, careful consideration is given to balancing the portfolio among industry sectors, geographies, interest rate sensitivity, economic growth, currency and other factors affecting investment returns. The assets are managed by professional investment firms. They are bound by mandates and are measured against benchmarks. Consideration is given to balancing security concentration, investment style and reliance on particular active investment strategies, among other factors. The Company reviews its asset mix of the Fund on a regular basis. Generally, the pension committee of the Company will rebalance the Fund's asset mix to the target mix as individual portfolios approach their minimum or maximum levels. However, the Company has the discretion to deviate from these ranges or to manage investment performance using different criteria. Derivative contracts may be used for hedging purposes to reduce the Retirement Plan’s exposure to interest rate risk. Treasury futures are used to manage the interest rate risk in the Retirement Plan’s fixed maturity portfolio. The derivatives do not qualify for hedge accounting. The following table summarizes the Company's pension plan’s target allocation range and actual asset allocation by asset category as of December 31, 2024 and 2023: Actual Asset Allocation 2024 2023 Equity securities: Target allocation range 5%-13% 7%-12% Large-cap domestic 4.3 % 3.7 % Small/Mid-cap domestic 0.9 % 0.8 % International commingled funds 2.9 % 3.2 % Limited Partnerships 0.1 % 0.5 % Total equity securities 8.2 % 8.2 % Fixed maturities: Target allocation range 83%-87% 83%-87% U.S. Treasuries, short term investments, cash and futures 2.0 % 3.0 % U.S. Government agencies and authorities 4.7 % 0.3 % U.S. corporate, state and municipalities 66.8 % 71.3 % Foreign securities 12.3 % 9.8 % Total fixed maturities 85.8 % 84.4 % Other investments: Target allocation range 2%-10% 4%-8% Hedge funds 2.9 % 4.1 % Real estate 3.1 % 3.3 % Total other investments 6.0 % 7.4 % Total 100.0 % 100.0 % The following table summarizes the fair values of the pension plan assets by asset class as of December 31, 2024: Level 1 Level 2 Level 3 NAV Total Assets Fixed maturities, short-term investments and cash: Cash and cash equivalents $ 11 $ 7 $ — $ — $ 18 Short-term investment fund (1) — — — 19 19 U.S. Government securities 82 — — — 82 U.S. corporate, state and municipalities 10 1,102 72 — 1,184 Foreign securities — 198 20 — 218 Total fixed maturities 103 1,307 92 19 1,521 Equity securities: Total equity securities (2) 17 77 — 58 152 Other investments: Total other investments (3) — — — 100 100 Total assets $ 120 $ 1,384 $ 92 $ 177 $ 1,773 (1) This category includes common collective trust funds a short-term investment fund, which invests in a full range of high-quality, short-term money market securities. Participant's redemptions are processed by the following day. (2) Equity securities include two assets that use NAV to calculate fair value. Baillie Gifford Funds has a balance of $26 and uses a bottom up approach to stock picking. In determining the potential of a company, the fund manager analyzes industry background, competitive advantage, management attitudes and financial strength and valuation. There are no redemption restrictions in the Baillie Gifford Funds. Silchester has a fund balance of $26 that has an investment objective to achieve long-term growth primarily by investing in a diversified portfolio of equity securities of companies located in any country other than the United States. Contributions and redemptions are conducted on a monthly basis as of the last business day of each month with notice required. at least six (3) Other investments that use NAV to calculate fair value includes a real estate fund has a balance of $52 and is an actively managed core portfolio of equity real estate, whose performance objective is to outperform the National Council of Real Estate investment Fiduciaries Open-End Diversified Core ("NFI_ODCE") index and to achieve at least a 5.0% real rate of return (i.e., inflation-adjusted return), before advisory fees, over any given three The following table summarizes the fair values of the pension plan assets by asset class as of December 31, 2023: Level 1 Level 2 Level 3 NAV Total Assets Fixed maturities, short term investments and cash: Cash and cash equivalents $ 8 $ 1 $ — $ — $ 9 Short-term investment fund (1) — — — 21 21 U.S. Government securities 128 — — — 128 U.S. corporate, state and municipalities 10 1,121 65 — 1,196 Foreign securities — 170 20 — 190 Total fixed maturities 146 1,292 85 21 1,544 Equity securities: Total equity securities (2) 15 68 — 68 151 Other investments: Total other investments (3) — — — 136 136 Total assets $ 161 $ 1,360 $ 85 $ 225 $ 1,831 (1) See footnote 1 to previous table. (2) Equity securities include two assets that use NAV to calculate fair value. Baillie Gifford Funds has a balance of $25 and Silchester has a fund balance of $33. See footnote 2 to previous table for further information. (3) Other investments that use NAV to calculate fair value includes a real estate fund has a balance of $61 and a limited partnership with a balance of $75. See footnote 3 to previous table for further information. Pension plan assets are categorized into a three-level fair value hierarchy based upon the inputs available in evaluating each of the assets. Certain investments are measured at fair value using the NAV per share as a practical expedient and have not been classified in the fair value hierarchy. The leveling hierarchy is applied to the pension plans assets as follows: • Cash and cash equivalents : The carrying amounts for cash and cash equivalents reflect the assets' fair value. The fair values for cash and cash equivalents are determined based on quoted market prices and are classified as Level 1. • Short-term Investment Funds : Short term investment funds are estimated at NAV. See footnote (1) in fair value hierarchy table above for a description of the fund's redemption policies. • U.S. Government securities, corporate bonds and notes and foreign securities : Fair values for actively traded marketable bonds are determined based upon quoted market prices and are classified as Level 1 assets. Corporate bonds, ABS, U.S. agency bonds, and foreign securities use observable pricing method such as matrix pricing, market corroborated pricing or inputs such as yield curves and indices. These investments are classified as Level 2. • Equity securities : Fair values for actively traded equity securities are based upon a quoted market price determined in an active market and are included in Level 1. Collective trust use observable pricing method such as matrix pricing, market corroborated pricing or inputs such as yield curves and indices. These investments are classified as Level 2. Commingled funds are estimated at NAV per share. See footnote (2) in fair value hierarchy table above for a description of the fund's redemption policies. • Other investments: Other investments are estimated at NAV. See footnote (3) in fair value hierarchy table above for more information. Expected Future Contributions and Benefit Payments The following table summarizes the expected benefit payments for the Company's pension plans to be paid for the years indicated: 2025 $ 135 2026 136 2027 139 2028 143 2029 146 2030-2034 775 The Company expects that it will make a cash contribution of approximately $28 to the Plans in 2025. Defined Contribution Plans Certain of the Company’s subsidiaries sponsor defined contribution plans. The largest defined contribution plan is the Voya 401(k) Savings Plan (the "Savings Plan"). The assets of the Savings Plan are held in independently administered funds. Substantially all employees of the Company are eligible to participate, other than the Company’s agents. The Savings Plan is a tax qualified defined contribution plan. Savings Plan benefits are not guaranteed by the PBGC. The Savings Plan allows eligible participants to defer into the Savings Plan a specified percentage of eligible compensation on a pretax basis. The Company matches such pretax contributions, up to a maximum of 6% of eligible compensation, subject to IRS limits. Matching contributions are subject to a 4-year graded vesting schedule. Contributions made to the Savings Plan are subject to certain limits imposed by applicable law. These plans do not give rise to balance sheet provisions, other than relating to short-term timing differences included in Other liabilities. The amount of cost recognized for the defined contribution pension plans for the years ended December 31, 2024, 2023 and 2022 was $51, $44 and $36, respectively, and is recorded in Operating expenses in the Consolidated Statements of Operations.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Income (Loss)	12 Months Ended
	Dec. 31, 2024
Equity [Abstract]
Accumulated Other Comprehensive Income (Loss)	Accumulated Other Comprehensive Income (Loss) Shareholders' equity included the following components of AOCI as of the dates indicated: December 31, 2024 December 31, 2023 December 31, 2022 Fixed maturities, net of impairment $ (2,553) $ (2,370) $ (3,294) Derivatives (1) 66 64 125 Change in current discount rate (787) (890) (858) Deferred income tax asset (liability) (2) 810 794 969 Total (2,464) (2,402) (3,058) Pension and other postretirement benefits liability, net of tax 2 2 3 AOCI $ (2,462) $ (2,400) $ (3,055) (1) Gains and losses reported in AOCI from hedge transactions that resulted in the acquisition of an identified asset are reclassified into earnings in the same period or periods during which the asset acquired affects earnings. As of December 31, 2024, the portion of the AOCI that is expected to be reclassified into earnings within the next 12 months is $10. See the Derivative Financial Instruments Note to these Consolidated Financial Statements for additional information. (2) The Company uses the portfolio method to determine when stranded tax benefits (or detriments) are released from AOCI. Changes in AOCI, including the reclassification adjustments recognized in the Consolidated Statements of Operations were as follows for the periods indicated: December 31, 2024 Before-Tax Amount Income Tax (Benefit) After-Tax Amount Available-for-sale securities: Fixed maturities $ (208) $ 44 $ (164) Adjustments for amounts recognized in Net gains (losses) in the Consolidated Statements of Operations 26 (5) 21 Change in unrealized gains (losses) on available-for-sale securities (182) 39 (143) Derivatives: Derivatives 18 (1) (4) 14 Adjustments related to effective cash flow hedges for amounts recognized in Net investment income in the Consolidated Statements of Operations (16) 3 (13) Change in unrealized gains (losses) on derivatives 2 (1) 1 Change in current discount rate 103 (22) 81 Pension and other postretirement benefits liability: Amortization of prior service cost recognized in Operating expenses in the Consolidated Statements of Operations (1) (2) — (1) Change in pension and other postretirement benefits liability (1) — (1) Change in AOCI $ (78) $ 16 $ (62) (1) See the Derivative Financial Instruments Note to these Consolidated Financial Statements for additional information. (2) See the Employee Benefit Arrangements Note to these Consolidated Financial Statements for amounts reported in Net Periodic (Benefit) Costs. December 31, 2023 Before-Tax Amount Income Tax (Benefit) After-Tax Amount Available-for-sale securities: Fixed maturities $ 899 $ (189) $ 710 Adjustments for amounts recognized in Net gains (losses) in the Consolidated Statements of Operations 25 (5) 20 Change in unrealized gains (losses) on available-for-sale securities 924 (194) 730 Derivatives: Derivatives (43) (1) 9 (34) Adjustments related to effective cash flow hedges for amounts recognized in Net investment income in the Consolidated Statements of Operations (18) 4 (14) Change in unrealized gains (losses) on derivatives (61) 13 (48) Change in current discount rate (33) 7 (26) Pension and other postretirement benefits liability: Amortization of prior service cost recognized in Operating expenses in the Consolidated Statements of Operations (1) (2) — (1) Change in pension and other postretirement benefits liability (1) — (1) Change in AOCI $ 829 $ (174) $ 655 (1) See the Derivative Financial Instruments Note to these Consolidated Financial Statements for additional information. (2) See the Employee Benefit Arrangements Note to these Consolidated Financial Statements for amounts reported in Net Periodic (Benefit) Costs. December 31, 2022 Before-Tax Amount Income Tax (Benefit) After-Tax Amount Available-for-sale securities: Fixed maturities $ (6,569) $ 1,380 $ (5,189) Adjustments for amounts recognized in Net gains (losses) in the Consolidated Statements of Operations 78 (16) 62 Change in unrealized gains (losses) on available-for-sale securities (6,491) 1,364 (5,127) Derivatives: Derivatives 66 (1) (14) 52 Adjustments related to effective cash flow hedges for amounts recognized in Net investment income in the Consolidated Statements of Operations (20) 4 (16) Change in unrealized gains (losses) on derivatives 46 (10) 36 Change in current discount rate 290 (61) 229 Change in AOCI $ (6,155) $ 1,293 $ (4,862) (1) See the Derivative Financial Instruments Note to these Consolidated Financial Statements for additional information.

Revenue from Contracts with Cus

Revenue from Contracts with Customers	12 Months Ended
	Dec. 31, 2024
Revenue from Contract with Customer [Abstract]
Revenue from Contracts with Customers	Revenue from Contracts with Customers Financial services and software subscriptions and services revenue is disaggregated by type of service in the following table: Year Ended December 31, 2024 2023 2022 Wealth Solutions Advisory and R&A $ 625 $ 497 $ 525 Distribution and shareholder servicing 133 121 116 Investment Management Advisory, asset management and R&A 1,004 924 826 Distribution and shareholder servicing 153 146 145 Health Solutions R&A 26 18 17 Software subscriptions and services 206 205 — Corporate R&A 3 28 62 Total financial services and software subscriptions and services revenue 2,150 1,939 1,691 Revenue from other sources (1) 386 304 199 Total Fee income and Other revenue $ 2,536 $ 2,243 $ 1,890 (1) Primarily consists of revenue from insurance contracts and financial instruments. Net receivables of $361 and $339 are included in Other assets on the Consolidated Balance Sheets as of December 31, 2024 and 2023, respectively.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2023
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Income tax expense (benefit) consisted of the following for the periods indicated: Year Ended December 31, 2024 2023 2022 Current tax expense (benefit): Federal $ 1 $ 2 $ (6) Foreign 9 4 1 State 5 5 (3) Total current tax expense (benefit) 15 11 (8) Deferred tax expense (benefit): Federal 38 (50) 8 State 4 (12) (5) Total deferred tax expense (benefit) 42 (62) 3 Total income tax expense (benefit) $ 57 $ (51) $ (5) Income taxes were different from the amount computed by applying the federal income tax rate to Income (loss) before income taxes for the following reasons for the periods indicated: Year Ended December 31, 2024 2023 2022 Income (loss) before income taxes $ 799 $ 678 $ 428 Tax Rate 21.0 % 21.0 % 21.0 % Income tax expense (benefit) at federal statutory rate 168 142 90 Tax effect of: Valuation allowance 1 (1) 7 Dividends received deduction (49) (38) (44) State tax expense (benefit) 8 (6) (16) Noncontrolling interest (16) (22) 16 Tax credits (19) (17) (63) Nondeductible expenses 3 6 7 Security Life of Denver Company capital loss carryback (1) (38) (92) — Non-taxable Voya India gain (1) — (10) — Other (1) (13) (2) Income tax expense (benefit) $ 57 $ (51) $ (5) Effective tax rate 7.1 % (7.5) % (1.2) % (1) See Other Tax Matters section below Current Income Tax The Company had a current income tax receivable of $12 as of December 31, 2024 and 2023, which is included in Other assets on the Consolidated Balance Sheets. Temporary Differences The tax effects of temporary differences that give rise to deferred tax assets and deferred tax liabilities were as follows as of the dates indicated: December 31, 2024 2023 Deferred tax assets Federal and state loss carryforwards $ 1,421 $ 1,489 Net unrealized investment losses 522 484 Compensation and benefits 161 190 Current discount rate 165 187 Tax credits 154 131 Insurance Reserves — 9 Investments 47 5 Other assets 175 165 Total gross assets before valuation allowance 2,645 2,660 Less: Valuation allowance 96 95 Assets, net of valuation allowance 2,549 2,565 Deferred tax liabilities Deferred policy acquisition costs (324) (358) Insurance reserves (24) — Other liabilities (67) (47) Total gross liabilities (415) (405) Net deferred income tax asset (liability) $ 2,134 $ 2,160 The following table sets forth the federal, state and credit carryforwards for tax purposes as of the dates indicated: December 31, 2024 2023 Federal net operating loss carryforward $ 6,335 (1) $ 6,667 State net operating loss carryforward 2,412 (2) 2,454 Credit carryforward 154 (3) 131 (1) Approximately $3,320 of the net operating losses carryforwards ("NOL") not subject to expiration. $3,015 of the NOLs expire between 2025 and 2037 (2) Approximately $390 of the NOLs not subject to expiration. $2,022 of the NOLs expire between 2025 and 2043 (3) Expires between 2025 and 2044 As a result of the Benefitfocus acquisition in 2023, the Company acquired $62 of federal net operating losses ("NOL"), subject to a section 382 limitation. The Company expects to fully realize these NOLs prior to expiration. Valuation allowances are provided when it is considered more likely than not that some portion or all of the deferred tax assets ("DTA") will not be realized. As of December 31, 2024 and 2023, the Company had a total valuation allowance of $96 and $95, respectively. As of December 31, 2024 and 2023, $219 and $218, respectively, of this valuation allowance was allocated to continuing operations and $(123) and $(123) allocated to Other comprehensive income (loss) related to realized and unrealized capital losses, respectively. Significant judgment is required to evaluate the need for a valuation allowance against DTAs. The Company reviews all available positive and negative evidence to determine if a valuation allowance is recorded, including historical and projected pre-tax book income, tax planning strategies and reversals of temporary differences. As of December 31, 2024 and 2023, the Company had net unrealized capital losses of $2.5 billion and $2.3 billion, respectively, in AOCI. The Company expects this DTA to be utilized by its hold-to-maturity tax planning strategy. Additionally, income before income taxes available to the Company remained positive for the period. After evaluating the positive and negative evidence, the Company did not change its judgment regarding the realization of DTAs in 2024. The valuation allowance as of December 31, 2024 of $96 was against certain historic state net operating losses and state tax credits that were below more likely than not to be utilized. The Company will continue to assess all available evidence during future periods to evaluate any changes to the realization of these DTAs. Other Tax Matters On January 4, 2021, the Company completed a series of transactions pursuant to a Master Transaction Agreement with Resolution Life U.S. Holdings Inc. ("Resolution Life US"). As a part of these transactions, Resolution Life US acquired the Company's wholly owned subsidiary, Security Life of Denver Company ("SLD"). SLD generated capital losses in the 2023 and 2022 tax years, which are included in the tax return for the Company. The Company recorded a $38 and $92 tax benefit in 2024 and 2023, respectively, resulting in a decrease to the effective tax rate. On August 1, 2023, the Company acquired all remaining equity interest in Voya India. The transaction resulted in a GAAP-to-tax outside basis difference of $45 in 2023. The Company has asserted that its investment in India as of the August 1, 2023 acquisition date is permanently reinvested; therefore, no provision for U.S. federal and state income taxes or foreign withholding taxes was made in the Company’s 2023 consolidated financial statements related to the acquisition. In 2024, the Company made the assumption that future earnings would be distributed and recorded withholding taxes on the 2024 earnings. Unrecognized Tax Benefits Reconciliations of the change in the unrecognized income tax benefits were as follows for the periods indicated: Year Ended December 31, 2024 2023 2022 Balance at beginning of period $ 27 $ 33 $ 33 Additions (reductions) for tax positions related to current year — — — Additions (reductions) for tax positions related to prior years (3) (6) — Balance at end of period $ 24 $ 27 $ 33 The Company had $1 of unrecognized tax benefits as of December 31, 2024, 2023 and 2022, which would affect the Company's effective rate if recognized. Interest and Penalties The Company recognizes interest expense and penalties, if applicable, related to unrecognized tax benefits in tax expense net of federal income tax. The total amounts of gross accrued interest and penalties on the Company's Consolidated Balance Sheets as of December 31, 2024 and 2023 were immaterial. The Company recognized no gross interest (benefit) related to unrecognized tax in its Consolidated Statements of Operations for the years ended December 31, 2024, 2023 and 2022. The timing of the payment of the remaining accrued interest and penalties cannot be reasonably estimated. Tax Regulatory Matters For the tax years 2022 through 2024, the Company participates in the Internal Revenue Service ("IRS") Compliance Assurance Process ("CAP"), which is a continuous audit program provided by the IRS. For the 2023 tax year, the Company is in the Compliance Maintenance Bridge ("Bridge") phase of CAP. In the Bridge phase, the IRS did not conduct any review or provide any letters of assurance for that tax year. For the 2024 tax year, the Company is in the Compliance Maintenance Bridge Plus ("Bridge Plus") phase of CAP. In the Bridge Plus phase, the IRS will review the tax return and issue either a full or partial acceptance letter upon completion of review. The Company filed amended federal income tax returns for tax years 2012 through 2018 to claim a foreign tax credit instead of utilizing a foreign tax deduction. The Company does not anticipate an adjustment to its claim as filed. The audit of the claim is ongoing. Tax Legislative Matters In August 2022, the Inflation Reduction Act was signed into law creating the corporate alternative minimum tax ("CAMT"). In September 2024, the Department of Treasury issued proposed regulations providing additional guidance on the CAMT. While the Company does not expect to be subject to the CAMT for 2024, the Company continues to review the proposed regulations, and its CAMT determination will need to be evaluated in light of future guidance.

Financing Agreements

Financing Agreements	12 Months Ended
	Dec. 31, 2024
Debt Disclosure [Abstract]
Financing Agreements	Financing Agreements Short-term Debt As of December 31, 2024 and 2023, the Company had $399 and $1, respectively, of short-term borrowings outstanding consisting entirely of the current portion of long-term debt. Long-term Debt The following table summarizes the carrying value of the Company’s debt issued or borrowed and outstanding as of December 31, 2024 and 2023: Issuer Maturity 2024 2023 3.976% Senior Notes, due 2025 (2)(3) Voya Financial, Inc. 02/15/2025 $ 399 $ 390 3.65% Senior Notes, due 2026 (2)(3) Voya Financial, Inc. 06/15/2026 446 446 5.0% Senior Notes, due 2034 (2)(3) Voya Financial, Inc. 09/20/2034 395 — 5.7% Senior Notes, due 2043 (2)(3) Voya Financial, Inc. 07/15/2043 396 396 4.8% Senior Notes, due 2046 (2)(3) Voya Financial, Inc. 06/15/2046 297 297 4.7% Fixed-to-Floating Rate Junior Subordinated Notes, due 2048 (3)(4) Voya Financial, Inc. 01/23/2048 336 336 7.625% Voya Holdings Inc. debentures, due 2026 (1) Voya Holdings Inc. 08/15/2026 139 139 6.97% Voya Holdings Inc. debentures, due 2036 (1) Voya Holdings Inc. 08/15/2036 79 79 8.42% Equitable of Iowa Companies Capital Trust II Notes, due 2027 Equitable of Iowa Capital Trust II 04/01/2027 13 13 1.00% Windsor Property Loan Voya Retirement Insurance and Annuity Company 06/14/2027 2 2 Subtotal 2,502 2,098 Less: Current portion of long-term debt 399 1 Total $ 2,103 $ 2,097 (1) Guaranteed by ING Group. (2) Interest is paid semi-annually in arrears. (3) Guaranteed by Voya Holdings. (4) See the Junior Subordinated Notes section below. Unsecured senior debt, which consists of senior fixed rate notes and guarantees of fixed rate notes, ranks highest in priority, followed by subordinated debt, which consists of junior subordinated debt securities. The aggregate amounts of future principal payments of long-term debt issued by the Company at December 31, 2024 for the next five years and thereafter are $401 in 2025, $587 in 2026, $13 in 2027, $0 in 2028, $0 in 2029 and $1,518 thereafter. The aggregate amounts of future principal payments of long-term debt issued by Voya Financial, Inc. at December 31, 2024 for the next five years and thereafter are $400 in 2025, $447 in 2026, $0 in 2027, $0 in 2028, $0 in 2029 and $1,440 thereafter. As of December 31, 2024, the Company was in compliance with its debt covenants. Loss on Debt Extinguishment The Company did not incur a loss on debt extinguishment for the year ended December 31, 2024. The Company incurred a loss on debt extinguishment of $5 and $3 for the years ended December 31, 2023 and 2022, respectively, which was recorded in Interest expense in the Consolidated Statements of Operations. See Junior Subordinated Notes below for additional detail on debt extinguishment. Senior Notes On September 20, 2024, Voya Financial, Inc. issued $400 of unsecured 5.0% Senior Notes due 2034 (the "2034 Notes"). The 2034 Notes are fully, irrevocably, and unconditionally guaranteed by Voya Holdings Inc. Interest is paid semi-annually in arrears on March 20 and September 20 of each year, commencing on March 20, 2025. The offering resulted in aggregate net proceeds to the Company of $397, after deducting commissions and expenses. The Company used the net proceeds for the repayment at maturity of the $400 outstanding principal amount of its 3.976% Senior Notes on February 14, 2025. Junior Subordinated Notes Outstanding junior subordinated notes were as follows as of December 31, 2024: Issuer Issue Date Interest Rate (1) Scheduled Redemption Date Interest Rate Subsequent to Scheduled Redemption Date (2) Final Maturity Date Face Value Voya Financial, Inc. 01/23/2018 4.70% 01/23/2028 LIBOR + 2.084% 01/23/2048 (3) $ 340 (1) Prior to the scheduled redemption date, interest is paid semi-annually, in arrears. (2) In the event the securities are not redeemed on or before the scheduled redemption date, interest will accrue after such date at an annual rate of three month LIBOR plus the indicated margin, payable quarterly in arrears. In the event that LIBOR is unavailable, the calculation agent will determine a fallback rate at the time the calculations need to be performed. (3) Th e 4.70% F ixed-to-Floating Rate Junior Subordinated Notes due 2048 (the "2048 Notes") are guaranteed on an unsecured, junior subordinated basis by Voya Holdings. During the year ended December 31, 2023, the Company completed the redemption of all of outstanding principal amount of its 5.65% Fixed-to-Floating Rate Junior Subordinated Note, due 2053 at par. During the year ended December 31, 2022, the Company repurchased $357 and $10 par value of its 5.65% Fixed-to-Floating Rate Junior Subordinated Note, due 2053 and 4.7% Fixed-to-Floating Rate Junior Subordinated Note, due 2048, respectively, on the open market. The Company has the right to defer interest payments on the Junior Subordinated Notes for one or more consecutive interest periods for up to five years, without resulting in a default, during which time interest will be compounded. On or after the optional redemption dates, Voya Financial, Inc. may redeem the Junior Subordinated Notes in whole or in part for the principal amount being redeemed plus accrued and unpaid interest. Prior to the optional redemption dates, the Company may elect to redeem the Junior Subordinated Notes for the principal amount being redeemed upon the occurrence of certain events as defined in the indentures governing the Junior Subordinated Notes, plus accrued and unpaid interest. At any time following notice of the Company's plan to defer interest and during the period interest is deferred, the Company and its subsidiaries generally, with certain exceptions, may not make payments on or redeem or purchase any shares of the Company's common or preferred stock or any of the debt securities or guarantees that rank in liquidation on a parity with or are junior to the Junior Subordinated Notes. Aetna Notes ING Group guarantees the 7.625% Voya Holdings Inc. debentures, due 2026 and the 6.97% Voya Holdings Inc. debentures, due 2036 (collectively, the "Aetna Notes"), which were assumed by Voya Holdings in connection with the Company’s acquisition of Aetna’s life insurance and related businesses in 2000. Concurrent with the completion of the Company’s IPO, the Company entered into a shareholder agreement with ING Group that governs certain aspects of the Company’s continuing relationship. Pursuant to that agreement, the Company was obligated to reduce the aggregate outstanding principal amount of Aetna Notes to no more than zero as of December 31, 2019 or otherwise to make provision for ING Group's guarantee of any outstanding Aetna Notes in excess of such amounts. The Company's obligation to ING Group with respect to the Aetna Notes can be met, at the Company’s option, through redemptions, repurchases or by posting collateral with a third-party collateral agent, for the benefit of ING Group. If the Company fails to meet these obligations to ING Group, the Company has agreed to pay a prescribed quarterly fee of 1.25% per quarter to ING Group based on the outstanding principal amount of Aetna Notes for which provision has not been made, in excess of the limits set forth above. As of December 31, 2024 and 2023, the outstanding principal amount of the Aetna Notes was $218. As of December 31, 2024 and 2023, the amount of collateral required to avoid the payment of a fee to ING Group was $218. As of December 31, 2024 and 2023, the collateral balance was $227, comprised of a deposit of $215 to a control account with a third-party collateral agent an d $12 of letter of credit. Put Option Agreement for Senior Debt Issuance During 2015, the Company entered into an off-balance sheet 10-year put option agreement with a Delaware trust formed by the Company, in connection with the sale by the trust of pre-capitalized trust securities ("P-Caps"), that provides Voya Financial, Inc. the right, at any time over a 10-year period, to issue up to $500 principal amount of its 3.976% Senior Notes due 2025 ("3.976% Senior Notes") to the trust and receive in exchange a corresponding principal amount of U.S. Treasury securities that are held by the trust. The 3.976% Senior Notes will not be issued unless and until the put option is exercised. In return, the Company pays a semi-annual put premium to the trust at a rate of 1.875% per annum applied to the unexercised portion of the put option, and reimburses the trust for its expenses. The put premium and expense reimbursements are recorded in Operating expenses in the Consolidated Statements of Operations. If and when issued, the 3.976% Senior Notes will be guaranteed by Voya Holdings. Upon an event of default, the put option will be exercised automatically in full. The Company has a one-time right to unwind a prior voluntary exercise of the put option by repurchasing all of the 3.976% Senior Notes then held by the trust for U.S. Treasury securities. If the put option has been fully exercised, the 3.976% Senior Notes issued may be redeemed by the Company prior to their maturity at par or, if greater, at a make-whole redemption price, in each case plus accrued and unpaid interest to the date of redemption. The P-Caps are to be redeemed by the trust on February 15, 2025 or upon any early redemption of the 3.976% Senior Notes. On May 1, 2023, pursuant to the put option agreement, the Company exercised the put option to require the trust to purchase $400 aggregate principal amount of 3.976% Senior Notes in exchange for a corresponding amount of U.S. Treasury securities held by the trust. On May 3, 2023, the Company issued $400 aggregate principal amount of 3.976% Senior Notes to the trust and the Company received approximately $400 of U.S. Treasury securities. The proceeds from the sale of the U.S. Treasury securities were used to redeem the 5.650% Fixed-to-Floating Rate Junior Subordinated Notes due 2053 on May 15, 2023 (the "2053 Notes"). See Junior Subordinated Notes above. As of December 31, 2024, the Company may issue up to $100 principal amount of its 3.976% Senior Notes to the trust under the put option agreement. The put option agreement expired on February 15, 2025. Credit Facilities The Company uses credit facilities as part of its capital management practices. Total fees associated with credit facilities for the years ended 2024, 2023 and 2022 were $1, $1 and $2, respectively. The following table outlines the Company's credit facilities as of December 31, 2024: Obligor / Applicant Secured/ Unsecured Committed/ Uncommitted Expiration Capacity Utilization Unused Commitment Voya Financial, Inc. Unsecured Committed 05/01/2028 $ 500 $ — $ 500 Voya Financial, Inc. Unsecured Committed 04/07/2025 12 (2) 12 (1) — Total $ 512 $ 12 $ 500 (1) Amount utilized as collateral for outstanding Aetna Notes. (2) In March of 2024, the Company decreased the capacity of its letter of credit, expiring in 2025, from $200 to $12. This reduction was due to the reduced collateral requirements resulting from the maturity of a portion of the Aetna Notes. Additionally, the full capacity was not expected to be utilized through its expiration. Senior Unsecured Credit Facility As of December 31, 2024, the Company had a $500 senior unsecured credit facility with a syndicate of banks which expires May 1, 2028. The facility provides $500 of committed capacity for revolving loan borrowings and letters of credit issuances, including a sublimit for swingline (short-term) loans in an aggregate amount of up to $25. As of December 31, 2024, there were no amounts outstanding as revolving credit borrowings, no amounts of LOCs outstanding, and no amounts of swingline loans outstanding under the senior unsecured credit facility. Under the terms of the facility, the Company is required to maintain a minimum net worth of $4.998 billion, which may increase upon any future equity issuances by the Company.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Leases The Company leases its office space and certain equipment under operating leases, the longest term of which expires in 2039. The Company also currently has finance leases related to office space and service contracts. Right of use assets and lease liabilities are reflected in Other assets and Other liabilities During the years ended December 31, 2024 and 2023, the Company recorded an impairment of $0 and $14, respectively, on its right-of-use assets associated with leased office space, which is included in Operating expenses in the Consolidated Statements of Operations. The following table presents the lease costs and payments related to operating and finance leases for the years ended December 31, 2024, 2023 and 2022: 2024 2023 2022 Operating lease costs $ 26 $ 22 $ 21 Finance lease costs 11 9 19 Amortization of the right of use assets (1) 7 5 19 Payments for finance lease liabilities 10 20 21 Payments for operating lease liabilities 28 26 18 (1) Included in the finance lease costs. The future net minimum payments under non-cancelable leases are as follows as of December 31, 2024: Operating Leases Finance Leases 2025 $ 23 $ 12 2026 20 12 2027 18 12 2028 16 13 2029 12 13 Thereafter 51 27 Total undiscounted lease payments 140 89 Less: Imputed interest 28 15 Total Lease liabilities $ 112 $ 74 Commitments Through the normal course of investment operations, the Company commits to either purchase or sell securities, mortgage loans, or money market instruments, at a specified future date and at a specified price or yield. The inability of counterparties to honor these commitments may result in either a higher or lower replacement cost. Also, there is likely to be a change in the value of the securities underlying the commitments. As of December 31, 2024, the Company had off-balance sheet commitments to acquire mortgage loans of $221 and purchase limited partnerships and private placement investments of $1,617, of which $415 related to consolidated investment entities. Insurance Company Guaranty Fund Assessments The Company accrues the cost of future guaranty fund assessments based on estimates of insurance company insolvencies provided by the National Organization of Life and Health Insurance Guaranty Associations and the amount of premiums written in each state. The Company has estimated this undiscounted liability, which is included in Other liabilities on the Consolidated Balance Sheets, to be $3 and $1 as of December 31, 2024 and 2023, respectively. The Company has also recorded an asset, which is included in Other assets on the Consolidated Balance Sheets, of $21 and $10 as of December 31, 2024 and 2023, respectively, for future credits to premium taxes. The Company estimates its liabilities for future assessments under state insurance guaranty association laws. The Company believes the reserves established are adequate for future assessments relating to insurance companies that are currently subject to insolvency proceedings. Restricted Assets The Company is required to maintain assets on deposit with various regulatory authorities to support its insurance operations. The Company may also post collateral in connection with certain securities lending, repurchase agreements, funding agreements, credit facilities and derivative transactions. The fair value of restricted assets were as follows as of December 31, 2024 and 2023: 2024 2023 Fixed maturity collateral pledged to FHLB (1) $ 2,007 $ 1,956 FHLB restricted stock (2) 65 64 Fixed maturities-state and other deposits 35 37 Cash and cash equivalents 21 25 Securities pledged (3) 1,523 1,160 Total restricted assets $ 3,651 $ 3,242 (1) Included in Fixed maturities, available-for-sale, at fair value on the Consolidated Balance Sheets. (2) Included in Other investments on the Consolidated Balance Sheets. (3) Includes the fair value of loaned securities of $1,083 and $842 as of December 31, 2024 and 2023, respectively. In addition, as of December 31, 2024 and 2023, the Company delivered securities as collateral of $159 and $201, and repurchase agreements of $281 and $117, respectively. Loaned securities and securities delivered as collateral are included in Securities pledged on the Consolidated Balance Sheets. Federal Home Loan Bank Funding Agreements The Company is a member of the FHLB of Des Moines and the FHLB of Boston, and is required to pledge collateral to back funding agreements issued to the FHLB. As of December 31, 2024 and 2023, the Company had $1,249 and $1,175, respectively, in non-putable funding agreements, which are included in Contract owner account balances on the Consolidated Balance Sheets. Assets pledged to the FHLB are reflected in the table above. Litigation, Regulatory Matters and Loss Contingencies Litigation, regulatory and other loss contingencies arise in connection with the Company's activities as a diversified financial services firm. The Company is a defendant in a number of litigation matters, arising from the conduct of its business, both in the ordinary course and otherwise. In some of these matters, claimants seek to recover very large or indeterminate amounts, including compensatory, punitive, treble and exemplary damages. The variability in pleading requirements and past experience demonstrates that the monetary and other relief that may be requested in a lawsuit or claim often bears little relevance to the merits or potential value of a claim. As with other financial services companies, the Company periodically receives informal and formal requests for information from various state and federal governmental agencies and self-regulatory organizations in connection with inquiries and investigations of the products and practices of the Company or the financial services industry. For example, the Company is cooperating with a publicly reported, industry-wide investigation by the SEC regarding compliance with certain record-keeping requirements for business-related electronic communications on unapproved channels. While it is possible that an adverse outcome in certain cases could have a material adverse effect upon the Company's financial position, based on information currently known, management believes that neither the outcome of pending litigation and regulatory matters nor potential liabilities associated with other loss contingencies, are likely to have such an effect. However, given the large and indeterminate amounts sought in certain litigation and the inherent unpredictability of all such matters, it is possible that an adverse outcome in certain of the Company's litigation or regulatory matters, or liabilities arising from other loss contingencies, could, from time to time, have a material adverse effect upon the Company's results of operations or cash flows in a particular quarterly or annual period. For some matters, the Company is able to estimate a possible range of loss. For such matters in which a loss is probable, an accrual has been made. For matters where the Company, however, believes a loss is reasonably possible, but not probable, no accrual is required. For matters for which an accrual has been made, but there remains a reasonably possible range of loss in excess of the amounts accrued or for matters where no accrual is required, the Company develops an estimate of the unaccrued amounts of the reasonably possible range of losses. As of December 31, 2024, the Company estimates the aggregate range of reasonably possible losses, in excess of any amounts accrued for these matters as of such date, to be up to approximately $25. For other matters, the Company is currently not able to estimate the reasonably possible loss or range of loss. Litigation also includes Ravarino, et al. v. Voya Financial, Inc., et al. (USDC District of Connecticut, No. 3:21-cv-01658)(filed December 14, 2021). In this putative class action, the plaintiffs allege that the named defendants breached their fiduciary duties of prudence and loyalty in the administration of the Voya 401(k) Savings Plan. The plaintiffs claim that the named defendants did not exercise proper prudence in their management of allegedly poorly performing investment options, including proprietary funds, and passed excessive investment-management and other administrative fees for proprietary and non-proprietary funds onto plan participants. The plaintiffs also allege that the defendants engaged in self-dealing through the inclusion of the Voya Stable Value Option into the plan offerings and by setting the "crediting rate" for participants’ investment in the Stable Value Fund artificially low in relation to Voya’s general account investment returns in order to maximize the spread and Voya’s profits at the participants’ expense. The complaint seeks disgorgement of unjust profits as well as costs incurred. On June 13, 2023, the Court issued a ruling granting in part and denying in part Voya's motion to dismiss. The court largely dismissed the claims for breach of fiduciary duty. The remaining claims concern allegations of breaches of the ERISA prohibited transactions rule and a claim for failure to monitor the Voya Small Cap Growth fund. The Company continues to deny the allegations, which it believes are without merit, and intends to defend the case vigorously. In November 2022, the Company acquired Czech Asset Management, L.P. ("CAM"), pursuant to an agreement that provides for contingent consideration. On March 11, 2024, the Company received from the sellers a demand for arbitration of a claim that the full amount of the contingent consideration had become payable. On January 6, 2025, the Company and the sellers closed on a transaction that transferred CAM to the sellers and resolved the arbitration. Contingencies related to Performance-based Capital Allocations on Private Equity Funds Certain performance-based capital allocations related to sponsored private equity funds ("carried interest") are not final until the conclusion of an investment term specified in the relevant asset management contract. As a result, such carried interest, if accrued or paid to the Company during such term, is subject to later adjustment based on subsequent fund performance. If the fund’s cumulative investment return falls below specified investment return hurdles, some or all of the previously accrued carried interest is reversed to the extent that the Company is no longer entitled to the performance-based capital allocation. Should the fund’s cumulative investment return subsequently increase above specified investment return hurdles in future periods, previous reversals could be fully or partially recovered.

Consolidated and Nonconsolidate

Consolidated and Nonconsolidated Investment Entities	12 Months Ended
	Dec. 31, 2024
Consolidated Investment Entities [Abstract]
Consolidated and Nonconsolidated Investment Entities	Consolidated and Nonconsolidated Investment Entities The Company holds variable interests in certain investment entities in the form of debt or equity investments, as well as the right to receive management fees, performance fees, and carried interest. The Company consolidates certain entities under the VIE guidance when it is determined that the Company is the primary beneficiary. Alternatively, certain entities are consolidated under the VOE guidance when control is obtained through voting rights. Refer to the Consolidated Balance Sheets for the assets and liabilities of the Company's consolidated investment entities. The Company has no right to the benefits from, nor does it bear the risks associated with consolidated investment entities beyond the Company’s direct equity and debt investments in and management fees generated from these entities. Such direct investments amounted to approximately $366 and $316 as of December 31, 2024 and 2023, respectively. If the Company were to liquidate, the assets held by consolidated investment entities would not be available to the general creditors of the Company as a result of the liquidation. Consolidated VIEs and VOEs Collateral Loan Obligations Entities ("CLOs") The Company is involved in the design, creation, and the ongoing management of CLOs. These entities are created for the purpose of acquiring diversified portfolios of senior secured floating rate leveraged loans, and securitizing these assets by issuing multiple tranches of collateralized debt; thereby providing investors with a broad array of risk and return profiles. Also known as collateralized financing entities under Topic 810, CLOs are variable interest entities by definition. In return for providing collateral management services, the Company earns investment management fees and contingent performance fees. In addition to earning fee income, the Company often invests in the subordinated debt of entities formed to be the issuers of CLO offerings during their warehouse periods. The Company’s investments in these CLOs are repaid when the CLOs’ warehouse periods are closed and the CLO offerings are issued. The Company performs ongoing monitoring of the consolidation assessment for CLOs during and after their warehouse periods to determine if Voya remains the primary beneficiary of the CLOs. The fee income earned and investments held are included in the Company's ongoing consolidation assessment for each CLO. The Company was the primary beneficiary of 4 and 5 CLOs as of December 31, 2024 and 2023, respectively. Limited Partnerships ("LPs") The Company invests in and manages various limited partnerships, including private equity funds and hedge funds. The LPs generally have a ten-year life and a specified period during which investors can subscribe for limited partnership interests. Once the investors are admitted as limited partners, the investors are required to contribute capital when called by the general partners. The purpose of the LPs is to obtain subscriptions from limited partners and maximize the return to their partners by assembling a diversified portfolio of investments in private equity funds and other securities or assets with similar risk and return characteristics primarily through secondary market purchases. The majority of the investors in the LPs are unrelated parties to the Company. In return for subscriptions, each partner receives an equity interest in the LPs in proportion to its respective investment. These entities have been evaluated by the Company and are determined to be VIEs due to the equity holders, as a group, lacking the characteristics of a controlling financial interest. In return for serving as the general partner of and providing investment management services to these entities, the Company earns management fees and carried interest in the normal course of business. Additionally, the Company often holds an investment in each limited partnership it manages, generally in the form of general partner and limited partner interests. The fee income, carried interest, and investments held are included in the Company’s ongoing consolidation analysis for each limited partnership. The Company consolidated 13 and 11 partnerships, as of December 31, 2024 and 2023, respectively. The noncontrolling interest related to these partnerships increased from $1,685 at December 31, 2023 to $1,783 at December 31, 2024. Changes in market value, consolidations, deconsolidations, contributions and distributions related to these investments in partnerships directly impacts the noncontrolling interest component of Shareholders' Equity on the Company's Consolidated Balance Sheets. The change in noncontrolling interest was primarily driven by an increase in net contributions and favorable market appreciation in limited partnership investments. The Company records the noncontrolling interest using a lag methodology relying on the most recent financial information available. Fair Value Measurement Upon consolidation, the Company elected to apply the FVO for financial assets and financial liabilities held by CLOs and continued to measure these assets (primarily corporate loans) and liabilities (debt obligations issued by CLOs) at fair value in subsequent periods. The Company has elected the FVO to more closely align its accounting with the economics of its transactions and allows the Company to more effectively align changes in the fair value of CLO assets with a commensurate change in the fair value of CLO liabilities. Investments held by consolidated private equity funds are measured and reported at fair value in the Company's Consolidated Financial Statements. Changes in the fair value of consolidated investment entities are recorded as a separate line item within Income (loss) related to consolidated investment entities in the Company's Consolidated Statements of Operations. The methodology for measuring the fair value of financial assets and liabilities of consolidated investment entities, and the classification of these measurements in the fair value hierarchy is consistent with the methodology and classification applied by the Company to its investment portfolio, as discussed within the Fair Value Measurements (excluding Consolidated Investment Entities) Note to these Consolidated Financial Statements. As discussed in more detail below, the Company utilizes valuations obtained from third-party commercial pricing services, brokers and investment sponsors or third-party administrators that supply NAV (or its equivalent) per share used as a practical expedient. The valuations obtained from brokers and third-party commercial pricing services are non-binding. These valuations are reviewed on a monthly or quarterly basis depending on the entity and its underlying investments. Procedures include, but are not limited to, a review of underlying fund investor reports, review of top and worst performing funds requiring further scrutiny, review of variance from prior periods and review of variance from benchmarks, where applicable. In addition, the Company considers both macro and fund specific events that may impact the latest NAV supplied and determines if further adjustments of value should be made. Such changes, if any, are subject to senior management review. When a price cannot be obtained from a commercial pricing service, independent broker quotes are solicited. Securities priced using independent broker quotes are classified as Level 3. Broker quotes and prices obtained from pricing services are reviewed and validated through an internal valuation committee price variance review, comparisons to internal pricing models, back testing to recent trades or monitoring of trading volumes. Cash and Cash Equivalents The carrying amounts for cash reflect the assets’ fair values. The fair value for cash equivalents is determined based on quoted market prices. These assets are classified as Level 1. CLOs Corporate loans : Corporate loan investments, which comprise the majority of consolidated CLO portfolio collateral, are senior secured corporate loans maturing at various dates between 2025 and 2032, paying interest at SOFR, EURIBOR or PRIME plus a spread of up to 8.0%. As of December 31, 2024 and 2023, the unpaid principal balance exceeded the fair value of the corporate loans by approximately $17 and $46, respectively. Corporate loans are moved to non-accrual status when the investment defaults. Less than 1.0% of the collateral assets were in default as of December 31, 2024 and 2023. The fair values for corporate loans are determined using independent commercial pricing services. Fair value measurement based on pricing services may be classified in Level 2 or Level 3 depending on the type, complexity, observability and liquidity of the asset being measured. The inputs used by independent commercial pricing services, such as benchmark yields and credit risk adjustments, are those that are derived principally from or corroborated by observable market data. Hence, the fair value measurement of corporate loans priced by independent pricing service providers is classified within Level 2 of the fair value hierarchy. In addition, there are assets held with CLO portfolios that represent senior level debt of other third party CLOs. These CLO investments are classified within Level 3 of the fair value hierarchy. See description of fair value process for CLO notes below. CLO notes : The CLO notes are backed by a diversified loan portfolios consisting primarily of senior secured floating rate leveraged loans. Repayment risk is segmented into tranches with credit ratings of these tranches reflecting both the credit quality of underlying collateral as well as how much protection a given tranche is afforded by tranches that are subordinate to it. The most subordinated tranche bears the first loss and receives the residual payments, if any. The interest rates are generally variable rates based on SOFR or EURIBOR plus a pre-defined spread, which varies from 1.0% for the more senior tranches to 8.8% for the more subordinated tranches. CLO notes mature in 2034 and 2036, and have a weighted average maturity of 11 years as of December 31, 2024. The investors in this debt are not affiliated with the Company and have no recourse to the general credit of the Company for this debt. The fair values of the CLO notes are measured based on the fair value of the CLO's corporate loans, as the Company uses the measurement alternative available under ASU 2014-13 and determined that the inputs for measuring financial assets are more observable. The CLO notes are classified within Level 2 of the fair value hierarchy, consistent with the classification of the majority of the CLO financial assets. The Company reviews the detailed prices including comparisons to prior periods for reasonableness. The Company utilizes a formal pricing challenge process to request a review of any price during which time the vendor examines its assumptions and relevant market inputs to determine if a price change is warranted. The following narrative indicates the sensitivity of inputs: • Default Rate: An increase (decrease) in the expected default rate would likely increase (decrease) the discount margin (increase risk premium) used to value the CLO investments and CLO notes and, as a result, would potentially decrease the value of the CLO investments and CLO notes. • Recovery Rate: A decrease (increase) in the expected recovery of defaulted assets would potentially decrease (increase) the valuation of CLO investments and CLO notes. • Prepayment Rate: A decrease (increase) in the expected rate of collateral prepayments would potentially decrease (increase) the valuation of CLO investments and CLO notes as the expected weighted average life ("WAL") would increase (decrease). • Discount Margin (spread over SOFR): An increase (decrease) in the discount margin used to value the CLO investments and CLO notes would decrease (increase) the value of the CLO investments and CLO notes. Private Equity Funds As prescribed in ASC Topic 820, the unit of account for these investments is the interest in the investee fund. The Company owns an undivided interest in the fund portfolio and does not have the ability to dispose of individual assets and liabilities in the fund portfolio. Rather, the Company would be required to redeem or dispose of its entire interest in the investee fund. There is no current active market for interests in underlying private equity funds. Valuation is generally based on the valuations provided by the fund's general partner or investment manager. The valuations typically reflect the fair value of the Company's capital account balance of each fund investment, including unrealized capital gains (losses), as reported in the financial statements of the respective investee fund as of the respective year end or the latest available date. In circumstances where fair values are not provided, the Company seeks to determine the fair value of fund investments based upon other information provided by the fund's general partner or investment manager or from other sources. The fair value of securities received in-kind from fund investments is determined based on the restrictions around the securities. • Unrestricted, publicly traded securities are valued at the closing public market price on the reporting date; • Restricted, publicly traded securities may be valued at a discount from the closing public market price on the reporting date, depending on the circumstances; and • Privately held securities are valued by the directors/general partner of the investee fund, based on a variety of factors, including the price of recent transactions in the company's securities and the company's earnings, revenue and book value. In the case of direct investments or co-investments in private equity companies, the Company initially recognizes investments at cost and subsequently adjusts investments to fair value. On a quarterly basis, the Company reviews the general partner or lead investor's valuation of the investee company, taking into account other available information, such as indications of a market value through subsequent issues of capital or transactions between third parties, performance of the investee company during the period and public, comparable companies' analysis, where appropriate. Investments in these funds typically may not be fully redeemed at net asset value ("NAV") within 90 days because of inherent restriction on near term redemptions. As of December 31, 2024, certain private equity funds maintained revolving lines of credit of $1,308. As of December 31, 2023, certain private equity funds maintained term loans and revolving lines of credit of $1,330. The term loans were fully paid off during the year ended December 31, 2024, and the revolving lines of credit are eligible for renewal every three years; all loans bear interest at EURIBOR/SOFR plus 140 - 240 bps. The lines of credit are used for funding transactions before capital is called from investors, as well as for the financing of certain purchases. As of December 31, 2024 and 2023, outstanding borrowings amount to $1,153 and $1,198, respectively. The borrowings are reflected in Liabilities related to consolidated investment entities - other liabilities on the Company's Consolidated Balance Sheets. The borrowings are carried at an amount equal to the unpaid principal balance. The following table summarizes the fair value hierarchy levels of consolidated investment entities as of December 31, 2024: Level 1 Level 2 Level 3 NAV Total Assets VIEs Cash and cash equivalents $ 113 $ — $ — $ — $ 113 Corporate loans — 1,434 — — 1,434 Limited partnerships/corporations — — — 3,067 3,067 Other investments (1) — — 53 — 53 VOEs Cash and cash equivalents 2 — — — 2 Other investments (1) — — — 50 50 Total assets $ 115 $ 1,434 $ 53 $ 3,117 $ 4,719 Liabilities VIEs CLO notes $ — $ 1,101 $ — $ — $ 1,101 Total liabilities $ — $ 1,101 $ — $ — $ 1,101 (1) VIEs and VOEs - Other investments are reflected in Assets related to consolidated investment entities - Other assets on the Company's Consolidated Balance Sheets. The following table summarizes the fair value hierarchy levels of consolidated investment entities as of December 31, 2023: Level 1 Level 2 Level 3 NAV Total Assets VIEs Cash and cash equivalents $ 181 $ — $ — $ — $ 181 Corporate loans — 1,404 — — 1,404 Limited partnerships/corporations — — — 2,861 2,861 Total assets $ 181 $ 1,404 $ — $ 2,861 $ 4,446 Liabilities VIEs CLO notes $ — $ 1,332 $ — $ — $ 1,332 Total liabilities $ — $ 1,332 $ — $ — $ 1,332 Transfers of investments out of Level 3 and into Level 2 or Level 1, if any, are recorded as of the beginning of the period in which the transfer occurred. For the years ended December 31, 2024 and 2023, there were no transfers in or out of Level 3 or transfers between Level 1 and Level 2. Deconsolidation of Certain Investment Entities Certain investment entities that have historically been consolidated in the financial statements may require deconsolidation as of the reporting period because: (a) such funds have been liquidated or dissolved; or (b) the Company is no longer deemed to be the primary beneficiary of the VIEs/VOEs as it no longer has a controlling financial interest. The change in CLO’s consolidation status due to the close of the warehouse and the launch of the CLO do not meet the criteria described above as this transaction represents normal business operations of the entity. Refer to the CLO life cycle described above. The Company had four and two deconsolidations for the years ended December 31, 2024 and 2023, respectively. Because the Company was no longer deemed to be the primary beneficiary of the VIEs, it no longer had a controlling financial interest in the entities. For deconsolidated investment entities, the Company continues to serve as the general partner and/or investment manager until such entities are fully liquidated. Nonconsolidated VIEs The Company also holds variable interest in certain CLOs and LPs that are not consolidated as it has been determined that the Company is not the primary beneficiary. CLOs As of December 31, 2024 and December 31, 2023, the Company held $466 and $383 ownership interests, respectively, in unconsolidated CLOs, which also represent the Company's maximum exposure to loss. LPs As of December 31, 2024 and December 31, 2023, the Company held $1,836 and $1,621 ownership interests, respectively, in unconsolidated limited partnerships, which also represent the Company's maximum exposure to loss. Securitizations The Company invests in various tranches of securitization entities, including RMBS, CMBS and ABS. Through its investments, the Company is not obligated to provide any financial or other support to these entities. Each of the RMBS, CMBS and ABS entities are thinly capitalized by design and considered VIEs. The Company's involvement with these entities is limited to that of a passive investor. The Company has no unilateral right to appoint or remove the servicer, special servicer or investment manager, which are generally viewed to have the power to direct the activities that most significantly impact the securitization entities' economic performance, in any of these entities, nor does the Company function in any of these roles. The Company, through its investments or other arrangements, does not have the obligation to absorb losses or the right to receive benefits from the entity that could potentially be significant to the entity. Therefore, the Company is not the primary beneficiary and does not consolidate any of the RMBS, CMBS and ABS entities in which it holds investments. These investments are accounted for as investments available-for-sale as described in the Fair Value Measurements (excluding Consolidated Investment Entities) Note to these Consolidated Financial Statements and unrealized capital gains (losses) on these securities are recorded directly in AOCI, except for certain RMBS which are accounted for under the FVO whose change in fair value is reflected in Net gains (losses) in the Consolidated Statements of Operations. The Company’s maximum exposure to loss on these structured investments is limited to the amount of its investment. Refer to the Investments (excluding Consolidated Investment Entities) Note to these Consolidated Financial Statements for details regarding the carrying amounts and classifications of these assets.

Schedule I - Summary of Investm

Schedule I - Summary of Investments Other than Investments in Affiliates	12 Months Ended
	Dec. 31, 2024
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Abstract]
Schedule I - Summary of Investments Other than Investments in Affiliates	Voya Financial, Inc. Schedule I Summary of Investments Other than Investments in Affiliates As of December 31, 2024 (In millions) Type of Investments Cost Fair Value Amount Fixed maturities: U.S. Treasuries $ 524 $ 472 $ 472 U.S. Government agencies and authorities 29 30 30 State, municipalities, and political subdivisions 697 580 580 U.S. corporate public securities 7,938 7,008 7,008 U.S. corporate private securities 5,275 4,983 4,983 Foreign corporate public securities and foreign governments (1) 2,729 2,472 2,472 Foreign corporate private securities (1) 2,693 2,537 2,537 Residential mortgage-backed securities 3,709 3,471 3,471 Commercial mortgage-backed securities 3,677 3,132 3,132 Other asset-backed securities 2,779 2,769 2,769 Total fixed maturities, including securities pledged 30,050 27,454 27,454 Equity securities 246 246 246 Short-term investments 94 94 94 Mortgage loans on real estate 4,699 4,459 4,675 Policy loans 342 342 342 Limited partnerships/corporations 1,836 1,836 1,836 Derivatives (4) 303 303 Other investments, including securities pledged 74 74 74 Total investments $ 37,337 $ 34,808 $ 35,024 (1) Primarily U.S. dollar denominated.

Schedule II - Condensed Financi

Schedule II - Condensed Financial Information of Parent	12 Months Ended
	Dec. 31, 2024
Condensed Financial Information Disclosure [Abstract]
Schedule II - Condensed Financial Information of Parent	Voya Financial, Inc. Schedule II Condensed Financial Information of Parent Balance Sheets December 31, 2024 and 2023 (In millions, except share and per share data) As of December 31, 2024 2023 Assets: Investments: Fixed maturities, available-for-sale, at fair value (amortized cost of $0 and $6 as of 2024 and 2023, respectively) $ — $ 6 Equity securities, at fair value 3 3 Short-term investments 20 13 Limited partnerships/corporations 6 — Derivatives 14 10 Investments in subsidiaries 5,116 5,250 Total investments 5,159 5,282 Cash and cash equivalents 217 206 Short-term investments under securities loan agreements, including collateral delivered 1 1 Loans to subsidiaries and affiliates 392 293 Due from subsidiaries and affiliates — 8 Deferred income taxes 819 856 Other assets 6 7 Total assets $ 6,594 $ 6,653 Liabilities: Payables under securities loan and repurchase agreements, including collateral held $ — $ 10 Short-term debt 575 445 Long-term debt 1,871 1,865 Derivatives 22 9 Due to subsidiaries and affiliates 2 — Other liabilities 119 131 Total liabilities $ 2,589 $ 2,460 Shareholders' equity: Preferred stock ($0.01 par value per share; $625 aggregate liquidation preference as of 2024 and 2023) — — Common stock ($0.01 par value per share; 900,000,000 shares authorized; 105,592,281 and 103,584,699 shares issued as of 2024 and 2023, respectively; 95,497,265 and 102,854,569 shares outstanding as of 2024 and 2023, respectively) 1 1 Treasury stock (at cost; 10,095,016 and 730,130 shares as of 2024 and 2023, respectively) (754) (56) Additional paid-in capital 6,266 6,143 Accumulated other comprehensive income (loss) (2,462) (2,400) Retained earnings: Unappropriated 954 505 Total Voya Financial, Inc. shareholders' equity 4,005 4,193 Total liabilities and shareholders' equity $ 6,594 $ 6,653 The accompanying notes are an integral part of this Condensed Financial Information. Voya Financial, Inc. Schedule II Condensed Financial Information of Parent Statements of Operations For the Year Ended December 31, 2024, 2023 and 2022 (In millions) Year Ended December 31, 2024 2023 2022 Revenues: Net investment income $ 36 $ 38 $ 12 Net gains (losses) 20 65 (52) Other revenue 1 27 18 Total revenues 57 130 (22) Expenses: Interest expense 130 130 114 Operating expenses 5 35 30 Total expenses 135 165 144 Income (loss) before income taxes and equity in earnings (losses) of subsidiaries (78) (35) (166) Income tax expense (benefit) (18) (18) (86) Net income (loss) before equity in earnings (losses) of subsidiaries (60) (17) (80) Equity in earnings (losses) of subsidiaries, net of tax 727 642 590 Net income (loss) available to Voya Financial, Inc. 667 625 510 Less: Preferred stock dividends 41 36 36 Net income (loss) available to Voya Financial, Inc.'s common shareholders $ 626 $ 589 $ 474 The accompanying notes are an integral part of this Condensed Financial Information. Condensed Financial Information of Parent Statements of Comprehensive Income For the Year Ended December 31, 2024, 2023 and 2022 (In millions) Year Ended December 31, 2024 2023 2022 Net income (loss) available to Voya Financial, Inc. $ 667 $ 625 $ 510 Other comprehensive income (loss), after tax (62) 655 (4,862) Comprehensive income (loss) attributable to Voya Financial, Inc. $ 605 $ 1,280 $ (4,352) The accompanying notes are an integral part of this Condensed Financial Information. Voya Financial, Inc. Schedule II Condensed Financial Information of Parent Statements of Cash Flows For the Year Ended December 31, 2024, 2023 and 2022 (In millions) Year Ended December 31, 2024 2023 2022 Cash Flows from Operating Activities: Net income (loss) available to Voya Financial, Inc. $ 667 $ 625 $ 510 Adjustments to reconcile Net income (loss) available to Voya Financial, Inc. to Net cash used in operating activities: Equity in (earnings) losses of subsidiaries (727) (642) (590) Dividends from subsidiaries 861 1,057 502 Deferred income tax expense (benefit) 37 54 (35) Net gains (losses) (20) (65) 52 Change in: Other receivables and asset accruals 1 5 (21) Due from subsidiaries and affiliates 106 108 46 Other payables and accruals (12) — (10) Other, net (2) (7) 29 Net cash provided/(used) in operating activities 911 1,135 483 Cash Flows from Investing Activities: Proceeds from the sale, maturity, disposal or redemption of limited partnerships/corporations — 53 — Proceeds from the sale, maturity, disposal or redemption of fixed maturities 6 — 22 Acquisition of: Fixed maturities — — (16) Equity securities — (3) — Short-term investments, net (7) (13) 18 Derivatives, net 29 19 (37) Maturity (issuance) of short-term intercompany loans, net (99) (203) 34 Return of capital contribution from subsidiaries — — 708 Capital contributions to subsidiaries (60) (8) — Payments for business acquisitions, net of cash acquired — (584) — Collateral received (delivered), net (10) 15 (5) Other, net — (94) — Net cash provided/(used) in investing activities (141) (818) 724 The accompanying notes are an integral part of this Condensed Financial Information. Voya Financial, Inc. Schedule II Condensed Financial Information of Parent Statements of Cash Flows (Continued) For the Year Ended December 31, 2024, 2023 and 2022 (In millions) Year Ended December 31, 2024 2023 2022 Cash Flows from Financing Activities: Proceeds from issuance of debt with maturities of more than three months 397 400 — Repayment of debt with maturities of more than three months — (393) (366) Net proceeds from (repayments of) short-term loans to subsidiaries (269) 250 65 Proceeds from issuance of common stock, net 6 — 7 Share-based compensation (44) (47) (40) Common stock acquired - Share repurchase (640) (369) (750) Dividends paid on common stock (168) (125) (80) Dividends paid on preferred stock (41) (36) (36) Net cash used in financing activities (759) (320) (1,200) Net increase (decrease) in cash and cash equivalents 11 (3) 7 Cash and cash equivalents, beginning of period 206 209 202 Cash and cash equivalents, end of period $ 217 $ 206 $ 209 Supplemental cash flow information: Income taxes paid (received), net $ 5 $ 4 $ 14 Interest paid 110 111 111 The accompanying notes are an integral part of this Condensed Financial Information. 1. Business and Basis of Presentation The condensed financial information of Voya Financial, Inc. should be read in conjunction with the consolidated financial statements of Voya Financial, Inc. and its subsidiaries (collectively the "Company") and the notes thereto (the "Consolidated Financial Statements"). The accompanying financial information reflects the results of operations, financial position and cash flows for Voya Financial, Inc. The financial information is in conformity with accounting principles generally accepted in the United States, which require management to adopt accounting policies and make certain estimates and assumptions. Investments in subsidiaries are accounted for using the equity method of accounting. 2. Loans to Subsidiaries Voya Financial, Inc. maintains reciprocal loan agreements with subsidiaries to facilitate unanticipated short-term cash requirements that arise in the ordinary course of business. The following table summarizes the carrying value of Voya Financial, Inc.'s loans to subsidiaries for the periods indicated: As of December 31, Subsidiaries Rate Maturity Date 2024 2023 Voya Institutional Plan Services, LLC 4.50% 01/02/2025 $ 43 $ — Voya Institutional Plan Services, LLC 5.44% 01/02/2024 — 31 Voya Investment Management, LLC 4.57% 01/30/2025 50 — Voya Services Company 5.44% 01/02/2024 — 185 Voya Payroll Management, Inc. 5.44% 01/02/2024 — 11 Voya Payroll Management, Inc. 4.50% 01/02/2025 2 — Voya Holdings Inc. 5.53% 01/18/2024 — 44 Voya Holdings Inc. 5.51% 01/12/2024 — 22 Voya Holdings Inc. 4.57% 01/30/2025 5 — ReliaStar Life Insurance Company 4.50% 01/02/2025 68 — Voya Services Company 4.50% 01/02/2025 224 — Total $ 392 $ 293 Interest income earned on loans to subsidiaries was $24, $18 and $5 for the years ended December 31, 2024, 2023 and 2022, respectively. Interest income is included in Net investment income in the Condensed Statements of Operations. 3. Financing Agreements Debt Securities The following table summarizes Voya Financial, Inc.'s short-term debt borrowings for the periods indicated: As of December 31, 2024 2023 Intercompany financing - Subsidiaries $ 176 $ 445 Current portion of long-term debt 399 — Total $ 575 $ 445 Intercompany financing Under the reciprocal loan agreements with subsidiaries, interest is charged at the prevailing market interest rate for similar third-party borrowings for securities. As of December 31, 2024 and 2023, Voya Financial, Inc. was in compliance with its debt covenants. See Financing Agreements Note to the Consolidated Financial Statements for further information regarding long-term debt and the five-year maturities of long-term debt. Credit Facilities Voya Financial, Inc. uses credit facilities for contingent liquidity to be used as needed for general business purposes. As of December 31, 2024, unsecured and committed facilities totaled $512. Of the aggregate $512 capacity available, Voya Financial, Inc. utilized $12 in credit facilities outstanding as of December 31, 2024. Total fees associated with credit facilities in 2024, 2023 and 2022 totaled $1, $1 and $2, respectively. Guarantees In the normal course of business, Voya Financial, Inc. enters into indemnification agreements with financial institutions that issue surety bonds on behalf of Voya Financial, Inc. or its subsidiaries in connection with litigation matters. In addition, Voya Financial, Inc. provides guarantees to certain of its subsidiaries to support various business requirements: • Voya Financial, Inc. guarantees the obligations of Voya Holdings under the $13 principal amount of the 8.42% Equitable of Iowa Companies Capital Trust II Notes due 2027, and provides a back-to-back guarantee to ING Group in respect of its guarantee of $218 combined principal amount of Aetna Notes. • Voya Financial, Inc. and Voya Holdings provide a guarantee of payment of obligations to certain subsidiaries under certain surplus notes held by those subsidiaries. There were no assets or liabilities recognized by Voya Financial, Inc. as of December 31, 2024 and 2023 in relation to these intercompany indemnifications, guarantees or support agreements. As of December 31, 2024 and 2023, no guarantees existed in which Voya Financial, Inc. was required to currently perform under these arrangements. 4. Returns of Capital and Dividends Voya Financial, Inc. received returns of capital and dividends from the following subsidiaries for the periods indicated: Year Ended December 31, 2024 2023 2022 Voya Holdings Inc. $ 861 $ 1,057 $ 1,210 Total $ 861 $ 1,057 $ 1,210 5. Income Taxes As of December 31, 2024 and 2023, Voya Financial, Inc. held deferred tax assets related to loss and credit carryforwards, some of which have not been realized by its subsidiaries but have been reimbursed to the subsidiaries by Voya Financial, Inc. pursuant to the intercompany tax sharing agreement. The total deferred tax assets were primarily comprised of federal net operating loss, state net operating loss and credit carryforwards. Valuation allowances have been applied to a portion of the state deferred tax assets as of December 31, 2024 and 2023. Character, amount and estimated expiration date of the carryforwards and the related allowances are disclosed in the Income Taxes Note to the Consolidated Financial Statements. As of December 31, 2024 and 2023, Voya Financial, Inc. has recognized deferred tax assets of $819 and $856, respectively, primarily related to federal net operating loss carryforwards. As of December 31, 2024 and 2023, Voya Financial, Inc. had a current income tax receivable of $4 and $5, respectively. Tax Sharing Agreement Voya Financial, Inc. has entered into a federal tax sharing agreement with members of an affiliated group as defined in Section 1504 of the Internal Revenue Code of 1986, as amended. The agreement provides for the manner of calculation and the amounts/timing of the payments between the parties as well as other related matters in connection with the filing of consolidated federal income tax returns. The federal tax sharing agreement provides that Voya Financial, Inc. will pay its subsidiaries for the tax benefits of ordinary and capital losses only in the event that the consolidated tax group actually uses the tax benefit of losses generated. Voya Financial, Inc. has also entered into a state tax sharing agreement with each of the specific subsidiaries that are parties to the agreement. The state tax agreement applies to situations in which Voya Financial, Inc. and all or some of the subsidiaries join in the filing of a state or local franchise, income tax, or other tax return on a consolidated, combined or unitary basis.

Schedule III - Supplementary In

Schedule III - Supplementary Insurance Information	12 Months Ended
	Dec. 31, 2024
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Abstract]
Schedule III - Supplementary Insurance Information	Voya Financial, Inc. Schedule III Supplementary Insurance Information As of December 31, 2024 and 2023 (In millions) Segment DAC and VOBA Future Policy Benefits and Contract Owner Account Balances Unearned Premiums (1) 2024 Wealth Solutions $ 1,044 $ 30,090 $ — Health Solutions 234 2,444 — * Investment Management — — — Corporate 870 13,902 — Total $ 2,148 $ 46,436 $ — 2023 Wealth Solutions $ 1,064 $ 31,653 $ — Health Solutions 211 2,268 — * Investment Management — — — Corporate 975 14,813 — Total $ 2,250 $ 48,734 $ — (1) Represents unearned premiums associated with short-duration products of the Company's accident and health business. *Less than $1 Supplementary Insurance Information Years Ended December 31, 2024, 2023 and 2022 (In millions) Segment Net Investment Income (1)(2) Premiums and Fee Income (1)(2) Interest Credited and Other Benefits Amortization of DAC and VOBA Other Operating Expenses (1)(2) Premiums Written (Excluding Life) 2024 Wealth Solutions $ 1,735 $ 1,151 $ 834 $ 83 $ 1,261 $ — Health Solutions 145 3,225 2,602 36 951 2,462 Investment Management 20 953 — — 865 — Corporate 174 (40) 183 104 5 — Total $ 2,074 $ 5,289 $ 3,619 $ 223 $ 3,082 $ 2,462 2023 Wealth Solutions $ 1,807 $ 1,007 $ 872 $ 88 $ 1,242 $ — Health Solutions 135 2,748 1,895 33 903 2,120 Investment Management 26 903 — — 855 — Corporate 191 (25) 269 109 96 — Total $ 2,159 $ 4,633 $ 3,036 $ 230 $ 3,096 $ 2,120 2022 Wealth Solutions $ 2,006 $ 992 $ 868 $ 93 $ 1,192 $ — Health Solutions 134 2,454 1,680 29 577 1,849 Investment Management 9 745 — — 689 — Corporate 132 (26) (20) 118 84 — Total $ 2,281 $ 4,165 $ 2,528 $ 240 $ 2,542 $ 1,849 (1) Includes the elimination of certain intersegment revenues and expenses, primarily consisting of asset-based management and administration fees, which have been charged by Investment Management and eliminated in Corporate. (2) Includes the elimination of intercompany transactions between the Company and its consolidated investment entities, primarily the elimination of the Company's management fees expensed by the funds, recorded as operating revenues before the Company's consolidation of its consolidated investment entities and eliminated in the Investment Management segment.

Schedule IV - Reinsurance

Schedule IV - Reinsurance	12 Months Ended
	Dec. 31, 2024
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Abstract]
Schedule IV - Reinsurance	Voya Financial, Inc. Schedule IV Reinsurance Year Ended December 31, 2024, 2023 and 2022 (In millions) Gross Ceded Assumed Net Percentage 2024 Life insurance in force $ 583,218 $ 328,594 $ 4,671 $ 259,295 1.8 % Premiums: Life insurance $ 1,209 $ 530 $ 21 $ 700 3.0 % Accident and health insurance 2,847 388 — 2,459 — % Annuity contracts 28 11 — 17 — % Total premiums $ 4,084 $ 929 $ 21 $ 3,176 0.7 % 2023 Life insurance in force $ 596,806 $ 346,714 $ 4,963 $ 255,055 1.9 % Premiums: Life insurance $ 1,188 $ 571 $ 25 $ 642 3.9 % Accident and health insurance 2,359 323 — 2,036 — % Annuity contracts 52 14 1 39 2.6 % Total premiums $ 3,599 $ 908 $ 26 $ 2,717 1.0 % 2022 Life insurance in force $ 610,227 $ 368,598 $ 5,644 $ 247,273 2.3 % Premiums: Life insurance $ 1,198 $ 589 $ 24 $ 633 3.8 % Accident and health insurance 2,018 255 — 1,763 — % Annuity contracts 41 15 1 27 3.7 % Total premiums $ 3,257 $ 859 $ 25 $ 2,423 1.0 %

Schedule V - Valuation and Qual

Schedule V - Valuation and Qualifying Accounts	12 Months Ended
	Dec. 31, 2024
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]
Schedule V - Valuation and Qualifying Accounts	Voya Financial, Inc. Schedule V Valuation and Qualifying Accounts Year Ended December 31, 2024, 2023 and 2022 (In millions) Balance at January 1, Charged to Write-offs/ Balance at December 31, 2024 Valuation allowance on deferred tax assets (1) $ 95 $ 1 $ — $ 96 Allowance for credit losses on mortgage loans on real estate (2) 26 1 (3) 24 Allowance for credit losses on available-for-sale fixed maturity securities (2) 17 22 (1) 38 Allowance for credit losses on reinsurance recoverable 28 (12) — 16 Allowance for credit losses on deposit asset 1 — — 1 2023 Valuation allowance on deferred tax assets (1) $ 70 $ (1) $ 26 $ 95 Allowance for credit losses on mortgage loans on real estate (2) 18 11 (3) 26 Allowance for credit losses on available-for-sale fixed maturity securities (2) 12 10 (5) 17 Allowance for credit losses on reinsurance recoverable 32 (4) — 28 Allowance for credit losses on deposit asset 1 — — 1 2022 Valuation allowance on deferred tax assets (1) $ 63 $ 7 $ — $ 70 Allowance for credit losses on mortgage loans on real estate (2) 15 3 — 18 Allowance for credit losses on available-for-sale fixed maturity securities (2) 58 11 (57) 12 Allowance for credit losses on reinsurance recoverable 24 8 — 32 Allowance for credit losses on deposit asset — 1 — 1 (1) Refer to the Income Taxes Note to the accompanying Consolidated Financial Statements for more information. (2) Refer to the Investments (excluding Consolidated Investment Entities) Note to the accompanying Consolidated Financial Statements for more information.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Pay vs Performance Disclosure
Net income (loss) available to Voya Financial, Inc.	$ 667	$ 625	$ 510

Insider Trading Arrangements

Insider Trading Arrangements - shares	3 Months Ended
	Dec. 31, 2024	Sep. 30, 2024
Trading Arrangements, by Individual
Non-Rule 10b5-1 Arrangement Adopted	false
Adoption Date		September 16, 2024
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Trevor Ogle [Member]
Trading Arrangements, by Individual
Name		Trevor Ogle
Rule 10b5-1 Arrangement Adopted		true
Expiration Date		November 6, 2025
Aggregate Available	19,714

Insider Trading Policies and Pr

Insider Trading Policies and Procedures	12 Months Ended
	Dec. 31, 2024
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted	true

Cybersecurity Risk Management a

Cybersecurity Risk Management and Strategy Disclosure	12 Months Ended
	Dec. 31, 2024
Cybersecurity Risk Management, Strategy, and Governance [Line Items]
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]	Cybersecurity Risk Management and Strategy We maintain an information security program that seeks to comply with applicable regulatory requirements. The information security team, led by the Chief Information Security Officer ("CISO"), implements appropriate measures designed to safeguard sensitive information and protect our operations and systems against cyber threats. The information security team carries out continuous monitoring and evaluation of Voya’s technology and digital infrastructure with the goal of identifying and assessing threats and proactively mitigating potential risks. The CISO and the information security team provide regular updates to Voya's senior management, as further described under Cybersecurity Governance below. In addition, as part of its risk management strategy, Voya has an established and integrated cybersecurity incident response plan that focuses on incident detection, management and response. The information security team periodically reviews and updates the plan and tests playbooks within the plan through tabletop exercises. Voya's information security team is responsible for identifying, assessing, and managing cyber risk, with support from Voya's operational risk management team. Information security control tasks are performed under the direction and guidance of the CISO, who is designated under Voya’s risk management principles and policies to oversee the evaluation and mitigation of information security risks. Information security management is integrated into Voya’s overall risk management framework, which provides for a coordinated approach to addressing cybersecurity risk. As part of Voya’s overall information security program, we may engage and retain external assessors and consultants to help improve our security, stay aligned with industry best practices, evaluate external threats and, on an as-needed basis, perform forensic reviews of cybersecurity-related incidents or independent security assessments. With regard to risks posed by third-party vendors and service providers, Voya has a dedicated team that is responsible for evaluating, assessing, and addressing those risks, with the ultimate goal of protecting sensitive information and the security of our operations and systems supported by those vendors and providers using a risk-based approach. This team conducts due diligence on third-party vendors and service providers, including evaluating their information security controls and related measures, to identify potential risks and implement appropriate controls. Technology risks, including cybersecurity threats, undergo a thorough risk management assessment. We evaluate risks quantitatively and qualitatively to determine both the probability and potential severity of such risks and whether any such risks could materially affect Voya. We have experienced and may continue to experience cybersecurity incidents and threats that could materially affect our business strategy, results of operations or financial condition. There have been no known cybersecurity incidents that have materially affected us in the past three years. For more information about the cybersecurity related risks that we face, see Interruption or other operational failures in telecommunication, cybersecurity, information technology and other operational systems, including as a result of human and process error or a failure to maintain the security, integrity, confidentiality, or privacy of such systems, could harm our business in Risk Factors in Item 1A of this Annual Report on Form 10-K.
Cybersecurity Risk Management Processes Integrated [Flag]	true
Cybersecurity Risk Management Processes Integrated [Text Block]	Voya's information security team is responsible for identifying, assessing, and managing cyber risk, with support from Voya's operational risk management team. Information security control tasks are performed under the direction and guidance of the CISO, who is designated under Voya’s risk management principles and policies to oversee the evaluation and mitigation of information security risks. Information security management is integrated into Voya’s overall risk management framework, which provides for a coordinated approach to addressing cybersecurity risk. As part of Voya’s overall information security program, we may engage and retain external assessors and consultants to help improve our security, stay aligned with industry best practices, evaluate external threats and, on an as-needed basis, perform forensic reviews of cybersecurity-related incidents or independent security assessments. With regard to risks posed by third-party vendors and service providers, Voya has a dedicated team that is responsible for evaluating, assessing, and addressing those risks, with the ultimate goal of protecting sensitive information and the security of our operations and systems supported by those vendors and providers using a risk-based approach. This team conducts due diligence on third-party vendors and service providers, including evaluating their information security controls and related measures, to identify potential risks and implement appropriate controls.
Cybersecurity Risk Management Third Party Engaged [Flag]	true
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]	true
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]	false
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]	Technology risks, including cybersecurity threats, undergo a thorough risk management assessment. We evaluate risks quantitatively and qualitatively to determine both the probability and potential severity of such risks and whether any such risks could materially affect Voya. We have experienced and may continue to experience cybersecurity incidents and threats that could materially affect our business strategy, results of operations or financial condition. There have been no known cybersecurity incidents that have materially affected us in the past three years.
Cybersecurity Risk Board of Directors Oversight [Text Block]	Cybersecurity Governance As detailed above, the CISO and the information security team regularly assess and manage cybersecurity risks. Voya's information security leadership team has extensive information technology and information security experience, and the full team comprises over 100 employees with over 150 certifications from leading information security certification organizations. The CISO, who oversees the organization supporting the day-to-day operations of our information security program, brings over 30 years of professional IT experience in financial services. Before assuming his current role, the CISO served as Voya's Chief Technology Officer, where he was responsible for our infrastructure, cloud, and business resiliency office. Additional management of cybersecurity risks is conducted by Voya's Technology and Operational Risk Committee ("TORC"), which has been delegated authority by Voya's Management Risk Committee to provide oversight of operational risk, including information and technology risk, as well as related legal, compliance and regulatory risks. Members of the TORC include senior management with relevant expertise in operations, technology, information security, legal, compliance, data privacy and operational risk management. The information security team participates in the TORC meetings to discuss cybersecurity risks and mitigation treatment. The TORC provides guidance and direction in assessing, addressing, mitigating and monitoring cybersecurity risks within Voya.
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]	Voya’s Board committees include the Risk Committee, which provides support to the Board in its oversight of information technology, including cybersecurity risk. To assist the Board in fulfilling its oversight function, the Risk Committee is responsible for overseeing cybersecurity risk and collaborates with the Audit Committee on the related disclosures. The Risk Committee receives regular updates from the CISO on cybersecurity-related matters and reports regularly to the full Board.
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]	Voya’s Board committees include the Risk Committee, which provides support to the Board in its oversight of information technology, including cybersecurity risk. To assist the Board in fulfilling its oversight function, the Risk Committee is responsible for overseeing cybersecurity risk and collaborates with the Audit Committee on the related disclosures. The Risk Committee receives regular updates from the CISO on cybersecurity-related matters and reports regularly to the full Board.
Cybersecurity Risk Role of Management [Text Block]	As detailed above, the CISO and the information security team regularly assess and manage cybersecurity risks. Voya's information security leadership team has extensive information technology and information security experience, and the full team comprises over 100 employees with over 150 certifications from leading information security certification organizations. The CISO, who oversees the organization supporting the day-to-day operations of our information security program, brings over 30 years of professional IT experience in financial services. Before assuming his current role, the CISO served as Voya's Chief Technology Officer, where he was responsible for our infrastructure, cloud, and business resiliency office. Additional management of cybersecurity risks is conducted by Voya's Technology and Operational Risk Committee ("TORC"), which has been delegated authority by Voya's Management Risk Committee to provide oversight of operational risk, including information and technology risk, as well as related legal, compliance and regulatory risks. Members of the TORC include senior management with relevant expertise in operations, technology, information security, legal, compliance, data privacy and operational risk management. The information security team participates in the TORC meetings to discuss cybersecurity risks and mitigation treatment. The TORC provides guidance and direction in assessing, addressing, mitigating and monitoring cybersecurity risks within Voya.
Cybersecurity Risk Management Positions or Committees Responsible [Flag]	true
Cybersecurity Risk Management Positions or Committees Responsible [Text Block]	The CISO, who oversees the organization supporting the day-to-day operations of our information security program, brings over 30 years of professional IT experience in financial services. Before assuming his current role, the CISO served as Voya's Chief Technology Officer, where he was responsible for our infrastructure, cloud, and business resiliency office. Additional management of cybersecurity risks is conducted by Voya's Technology and Operational Risk Committee ("TORC"), which has been delegated authority by Voya's Management Risk Committee to provide oversight of operational risk, including information and technology risk, as well as related legal, compliance and regulatory risks. Members of the TORC include senior management with relevant expertise in operations, technology, information security, legal, compliance, data privacy and operational risk management. The information security team participates in the TORC meetings to discuss cybersecurity risks and mitigation treatment. The TORC provides guidance and direction in assessing, addressing, mitigating and monitoring cybersecurity risks within Voya.
Cybersecurity Risk Management Expertise of Management Responsible [Text Block]	Voya's information security leadership team has extensive information technology and information security experience, and the full team comprises over 100 employees with over 150 certifications from leading information security certification organizations. The CISO, who oversees the organization supporting the day-to-day operations of our information security program, brings over 30 years of professional IT experience in financial services. Before assuming his current role, the CISO served as Voya's Chief Technology Officer, where he was responsible for our infrastructure, cloud, and business resiliency office.
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]	The Risk Committee receives regular updates from the CISO on cybersecurity-related matters and reports regularly to the full Board.
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]	true

Business, Basis of Presentati_2

Business, Basis of Presentation and Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2024
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying Consolidated Financial Statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States ("U.S. GAAP"). The Consolidated Financial Statements include the accounts of Voya Financial, Inc. and its subsidiaries, as well as other voting interest entities ("VOEs") and variable interest entities ("VIEs") in which the Company has a controlling financial interest. See the Consolidated and Nonconsolidated Investment Entities Note to these Consolidated Financial Statements. Intercompany transactions and balances have been eliminated.
Estimates and Assumptions	Estimates and Assumptions The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. Those estimates are inherently subject to change and actual results could differ from those estimates, and the differences may be material to the Consolidated Financial Statements. The Company has identified the following accounts and policies as the most significant in that they involve a higher degree of judgment, are subject to a significant degree of variability and/or contain significant accounting estimates: • Reserves for future policy benefits; • Valuation of investments and derivatives; • Investment impairments; • Goodwill and other intangible assets; • Income taxes; • Contingencies; and • Employee benefit plans.
Fair Value Measurement	Fair Value Measurement The Company measures the fair value of its financial assets and liabilities based on assumptions used by market participants in pricing the asset or liability, which may include inherent risk, restrictions on the sale or use of an asset, or nonperformance risk, including the Company's own credit risk. The estimate of fair value is the price that would be received to sell an asset or transfer a liability ("exit price") in an orderly transaction between market participants in the principal market, or the most advantageous market in the absence of a principal market, for that asset or liability. The Company uses a number of valuation sources to determine the fair values of its financial assets and liabilities, including quoted market prices, third-party commercial pricing services, third-party brokers, industry-standard, vendor-provided software that models the value based on market observable inputs, and other internal modeling techniques based on projected cash flows. The following table presents the classification of financial instruments which are not carried at fair value on the Consolidated Balance Sheets: Financial Instrument Classification Mortgage loans on real estate Level 3 Policy loans Level 2 Other investments Level 2 Funding agreements without fixed maturities and deferred annuities Level 3 Funding agreements with fixed maturities Level 2 Supplementary contracts and immediate annuities Level 3 Short-term debt and Long-term debt Level 2
Investments	Investments The accounting policies for the Company's principal investments are as follows: Fixed Maturities and Equity Securities : The Company measures its equity securities at fair value and recognizes any changes in fair value in net income. The Company's fixed maturities are generally designated as available-for-sale. In addition, the Company has fixed maturities accounted for using the fair value option ("FVO"). Available-for-sale securities are reported at fair value and unrealized capital gains (losses) on these securities are recorded directly in Accumulated other comprehensive income ("AOCI") and presented net of Deferred income taxes. Trading securities are valued at fair value, with the changes in fair value recorded in Net gains (losses) and interest income recorded in Net investment income in the Consolidated Statements of Operations. In addition, certain fixed maturities have embedded derivatives, which are reported with the host contract on the Consolidated Balance Sheets. In connection with funds withheld reinsurance treaties, the Company has elected the FVO for certain of its fixed maturities to better match the measurement of those assets and related embedded derivative liabilities in the Consolidated Statements of Operations. Certain collateralized mortgage obligations ("CMOs"), primarily interest-only and principal-only strips, are accounted for as hybrid instruments and valued at fair value with changes in the fair value recorded in Net gains (losses). Changes in fair value associated with derivatives purchased to hedge CMOs are also recorded in Net gains (losses). Purchases and sales of fixed maturities and equity securities, excluding private placements, are recorded on the trade date. Purchases and sales of private placements and mortgage loans are recorded on the closing date. Investment gains and losses on sales of securities are generally determined on a first-in-first-out ("FIFO") basis. Interest income on fixed maturities is recorded when earned using an effective yield method, giving effect to amortization of premiums and accretion of discounts. Dividends on equity securities are recorded when declared. Such dividends and interest income are recorded in Net investment income. Included within fixed maturities are loan-backed securities, including residential mortgage-backed securities ("RMBS"), commercial mortgage-backed securities ("CMBS") and asset-backed securities ("ABS"). Amortization of the premium or discount from the purchase of these securities considers the estimated timing and amount of prepayments of the underlying loans. Actual prepayment experience is periodically reviewed and effective yields are recalculated when differences arise between the prepayments originally anticipated and the actual prepayments received and currently anticipated. Prepayment assumptions for single-class and multi-class mortgage-backed securities ("MBS") and ABS are estimated by management using inputs obtained from third-party specialists, including broker-dealers, and based on management's knowledge of the current market. For prepayment-sensitive securities such as interest-only and principal-only strips, inverse floaters and credit-sensitive MBS and ABS securities, which represent beneficial interests in securitized financial assets that are not of high credit quality or that have been credit impaired, the effective yield is recalculated on a prospective basis. For all other MBS and ABS, the effective yield is recalculated on a retrospective basis. Short-term Investments : Short-term investments include investments with remaining maturities of one year or less, but greater than three months, at the time of purchase. These investments are stated at fair value. Mortgage Loans on Real Estate : The Company's mortgage loans on real estate are all commercial mortgage loans, which are reported at amortized cost, net of allowance for credit losses. Amortized cost is the principal balance outstanding, net of deferred loan fees and costs. Accrued interest receivable is reported in Accrued investment income on the Consolidated Balance Sheets. Mortgage loans are evaluated by the Company's investment professionals, including an appraisal of loan-specific credit quality, property characteristics and market trends. Loan performance is continuously monitored on a loan-specific basis throughout the year. The Company's review includes submitted appraisals, operating statements, rent revenues and annual inspection reports, among other items. This review evaluates whether the properties are performing at a consistent and acceptable level to secure the debt. Management estimates the credit loss allowance balance using a factor-based method of probability of default and loss given default which incorporates relevant available information, from internal and external sources, relating to past events, current conditions, and reasonable and supportable forecasts. Included in the factor-based method are the consideration of debt type, capital market factors and market vacancy rates, and loan-specific risk characteristics such as debt service coverage ratios (“DSC”), loan-to-value (“LTV”), collateral size, seniority of the loan, segmentation and property types. The allowance for credit losses is a valuation account that is deducted from the loans’ amortized cost basis to present the net amount expected to be collected on the loans. The change in the allowance for credit losses is recorded in Net gains (losses). Loans are written off against the allowance when management believes the uncollectability of a loan balance is confirmed. Expected recoveries do not exceed the aggregate of amounts previously written-off and expected to be written-off. Mortgages are rated for the purpose of quantifying the level of risk. Those loans with higher risk are placed on a watch list and are closely monitored for collateral deficiency or other credit events that may lead to a potential loss of principal or interest. The Company defines delinquent mortgage loans consistent with industry practice as 60 days past due. Commercial mortgage loans are placed on non-accrual status when 90 days in arrears if the Company has concerns regarding the collectability of future payments, or if a loan has matured without being paid off or extended. Factors considered may include conversations with the borrower, loss of major tenant, bankruptcy of borrower or major tenant, decreased property cash flow, number of days past due, or various other circumstances. Based on an assessment as to the collectability of the principal, a determination is made either to apply against the book value or apply according to the contractual terms of the loan. Funds recovered in excess of book value would then be applied to recover expenses, impairments, and then interest. Accrual of interest resumes after factors resulting in doubts about collectability have improved. For those mortgages that are determined to require foreclosure, expected credit losses are based on the fair value of the underlying collateral, net of estimated costs to obtain and sell at the point of foreclosure. Property obtained from foreclosed mortgage loans is recorded in Other investments on the Consolidated Balance Sheets. Policy Loans : Policy loans are carried at an amount equal to the unpaid balance. Interest income on such loans is recorded as earned in Net investment income using the contractually agreed upon interest rate. Generally, interest is capitalized on the policy's anniversary date. Valuation allowances are not established for policy loans, as these loans are collateralized by the cash surrender value of the associated insurance contracts. Any unpaid principal or interest on the loan is deducted from the account value or the death benefit prior to settlement of the policy. Limited Partnerships/Corporations : The Company uses the equity method of accounting for investments in limited partnership interests that are not consolidated, which primarily consist of investments in private equity funds, hedge funds and other VIEs for which the Company is not the primary beneficiary. Generally, the Company records its share of earnings using a lag methodology, relying on the most recent financial information available, typically not to exceed three months. The Company's earnings from limited partnership interests accounted for under the equity method are recorded in Net investment income. Other Investments : Other investments are comprised primarily of Federal Home Loan Bank ("FHLB") stock and property obtained from foreclosed mortgage loans, as well as other miscellaneous investments. The Company is a member of the FHLB system and is required to own a certain amount of FHLB stock based on the level of borrowings and other factors. FHLB stock is carried at cost, classified as a restricted security and periodically evaluated for impairment based on ultimate recovery of par value. Securities Pledged : The Company engages in securities lending whereby certain securities from its portfolio are loaned to other institutions, through a lending agent, for short periods of time. The Company has the right to approve any institution with whom the lending agent transacts on its behalf. Initial collateral, primarily cash, is required at an agreed-upon percentage of the market value of the loaned securities. The lending agent retains the collateral and invests it in short-term liquid assets on behalf of the Company. The market value of the loaned securities is monitored on a daily basis with additional collateral obtained or refunded as the market value of the loaned securities fluctuates. The lending agent indemnifies the Company against losses resulting from the failure of a counterparty to return securities pledged where collateral is insufficient to cover the loss. See also Repurchase Agreements below. Investment Impairments The Company evaluates its available-for-sale investments quarterly to determine whether a decline in fair value below the amortized cost basis has resulted from credit loss or other factors. This evaluation process entails considerable judgment and estimation. Factors considered in this analysis include, but are not limited to, the extent to which the fair value has been less than amortized cost, the issuer's financial condition and near-term prospects, future economic conditions and market forecasts, interest rate changes and changes in ratings of the security. A severe unrealized loss position on a fixed maturity may not have any impact on (a) the ability of the issuer to service all scheduled interest and principal payments and (b) the evaluation of recoverability of all contractual cash flows or the ability to recover an amount at least equal to its amortized cost based on the present value of the expected future cash flows to be collected. When assessing the Company's intent to sell a security, or if it is more likely than not it will be required to sell a security before recovery of its amortized cost basis, management evaluates facts and circumstances such as, but not limited to, decisions to rebalance the investment portfolio and sales of investments to meet cash flow or capital needs. When the Company has determined it has the intent to sell, or if it is more likely than not that the Company will be required to sell a security before recovery of its amortized cost basis, and the fair value has declined below amortized cost ("intent impairment"), the individual security is written down from amortized cost to fair value, and a corresponding charge is recorded in Net gains (losses) as impairments in the Consolidated Statements of Operations. For available-for-sale securities that do not meet the intent impairment criteria but the Company has determined that a credit loss exists, the present value of cash flows expected to be collected from the security are compared to the amortized cost basis of the security. If the present value of cash flows expected to be collected is less than the amortized cost basis, a credit loss allowance is recorded for the credit loss, limited by the amount that the fair value is less than the amortized cost basis. The Company uses the following methodology and significant inputs in determining whether a credit loss exists: • When determining collectability and the period over which the value is expected to recover for U.S. and foreign corporate securities, foreign government securities and state and political subdivision securities, the Company applies the same considerations utilized in its overall impairment evaluation process, which incorporates information regarding the specific security, the industry and geographic area in which the issuer operates and overall macroeconomic conditions. Projected future cash flows are estimated using assumptions derived from the Company's best estimates of likely scenario-based outcomes, after giving consideration to a variety of variables that includes, but is not limited to: general payment terms of the security; the likelihood that the issuer can service the scheduled interest and principal payments; the quality and amount of any credit enhancements; the security's position within the capital structure of the issuer; possible corporate restructurings or asset sales by the issuer; and changes to the rating of the security or the issuer by rating agencies. • Additional considerations are made when assessing the unique features that apply to certain structured securities, such as subprime, Alt-A, non-agency RMBS, CMBS and ABS. These additional factors for structured securities include, but are not limited to: the quality of underlying collateral; expected prepayment speeds; loan-to-value ratios; debt service coverage ratios; current and forecasted loss severity; consideration of the payment terms of the underlying assets backing a particular security; and the payment priority within the tranche structure of the security. • When determining the amount of the credit loss for U.S. and foreign corporate securities, foreign government securities and state and political subdivision securities, the Company considers the estimated fair value as the recovery value when available information does not indicate that another value is more appropriate. When information is identified that indicates a recovery value other than estimated fair value, the Company considers in the determination of recovery value the same considerations utilized in its overall impairment evaluation process, which incorporates available information and the Company's best estimate of scenario-based outcomes regarding the specific security and issuer; possible corporate restructurings or asset sales by the issuer; the quality and amount of any credit enhancements; the security's position within the capital structure of the issuer; fundamentals of the industry and geographic area in which the security issuer operates; and the overall macroeconomic conditions. • The Company performs a discounted cash flow analysis comparing the current amortized cost of a security to the present value of future cash flows expected to be received, including estimated defaults and prepayments. The discount rate is generally the effective interest rate of the fixed maturity prior to impairment. Changes in the allowance for credit losses are recorded in Net gains (losses) as impairments. Losses are charged against the allowance when the Company believes the uncollectability of an available-for-sale security is confirmed or when either of the criteria regarding intent or requirement to sell is met.
Derivatives	Derivatives The Company's use of derivatives is limited mainly to economic hedging to reduce the Company's exposure to cash flow variability of assets and liabilities, interest rate risk, credit risk, exchange rate risk and market risk. It is the Company's policy not to offset amounts recognized for derivative instruments and amounts recognized for the right to reclaim cash collateral or the obligation to return cash collateral arising from derivative instruments executed with the same counterparty under a master netting arrangement, which provides the Company with the legal right of offset. However, in accordance with the Chicago Mercantile Exchange ("CME") rules related to the variation margin payments, the Company is required to adjust the derivative balances with the variation margin payments related to its cleared derivatives executed through CME. The Company enters into interest rate, equity market, credit default and currency contracts, including swaps, futures, forwards, caps, floors and options, to reduce and manage various risks associated with changes in value, yield, price, cash flow or exchange rates of assets or liabilities held or intended to be held, or to assume or reduce credit exposure associated with a referenced asset, index or pool. The Company also utilizes options and futures on equity indices to reduce and manage risks associated with its universal life-type ("UL-type") and annuity products. Derivative contracts are reported as Derivatives assets or liabilities on the Consolidated Balance Sheets at fair value. Changes in the fair value of derivatives are recorded in Net gains (losses) in the Consolidated Statements of Operations. Gains (losses) and net investment income related to derivatives are reflected as adjustments to reconcile Net cash flows from operating activities, and the net cash activity from derivatives is reflected in Net cash flows from investing activities, in the Consolidated Statements of Cash Flows. Any noncash activity, to the extent it is material, is excluded and reflected in a noncash supplementary schedule related to investing and financing activities. To qualify for hedge accounting, at the inception of the hedging relationship, the Company formally documents its risk management objective and strategy for undertaking the hedging transaction, as well as its designation of the hedge as either (a) a hedge of the exposure to changes in the estimated fair value of a recognized asset or liability or an identified portion thereof that is attributable to a particular risk ("fair value hedge") or (b) a hedge of a forecasted transaction or of the variability of cash flows that is attributable to interest rate risk to be received or paid related to a recognized asset or liability ("cash flow hedge"). In this documentation, the Company sets forth how the hedging instrument is expected to hedge the designated risks related to the hedged item and sets forth the method that will be used to retrospectively and prospectively assess the hedging instrument's effectiveness and the method that will be used to measure ineffectiveness. A derivative designated as a hedging instrument must be assessed as being highly effective in offsetting the designated risk of the hedged item. Hedge effectiveness is formally assessed at inception and periodically throughout the life of the designated hedging relationship. • Fair Value Hedge : For derivative instruments that are designated and qualify as a fair value hedge, the entire change in the fair value of the hedging instrument included in the assessment of hedge effectiveness is recorded in the same line item in the Consolidated Statements of Operations as impacted by the hedged item. • Cash Flow Hedge : For derivative instruments that are designated and qualify as a cash flow hedge, the entire change in the fair value of the hedging instrument included in the assessment of hedge effectiveness is reported as a component of AOCI. Those amounts are subsequently reclassified to earnings when the hedged item affects earnings, and are reported in the same line item in the Consolidated Statements of Operations as impacted by the hedged item. Even if a derivative qualifies for hedge accounting treatment, there may be an element of ineffectiveness of the hedge. The ineffective portion of a hedging relationship subject to hedge accounting is recognized in Net gains (losses). When hedge accounting is discontinued because it is determined that the derivative is no longer expected to be highly effective in offsetting changes in the estimated fair value or cash flows of a hedged item, the derivative continues to be carried on the Consolidated Balance Sheets at its estimated fair value, with subsequent changes in estimated fair value recognized currently in Net gains (losses). The carrying value of the hedged asset or liability under a fair value hedge is no longer adjusted for changes in its estimated fair value due to the hedged risk, and the cumulative adjustment to its carrying value is amortized into income over the remaining life of the hedged item. Provided the hedged forecasted transaction is still probable of occurrence, the changes in estimated fair value of derivatives recorded in Other comprehensive income (loss) related to discontinued cash flow hedges are released into the Consolidated Statements of Operations when the Company's earnings are affected by the variability in cash flows of the hedged item. When hedge accounting is discontinued because it is no longer probable that the forecasted transactions will occur on the anticipated date, or within two months of that date, the derivative continues to be carried on the Consolidated Balance Sheets at its estimated fair value, with changes in estimated fair value recognized currently in Net gains (losses). Derivative gains and losses recorded in Other comprehensive income (loss) pursuant to the discontinued cash flow hedge of a forecasted transaction that is no longer probable are recognized immediately in Net gains (losses). The Company also has investments in certain fixed maturities and has issued certain UL-type and annuity products that contain embedded derivatives for which fair value is at least partially determined by levels of or changes in domestic and/or foreign interest rates (short-term or long-term), exchange rates, prepayment rates, equity markets or credit ratings/spreads. Embedded derivatives within fixed maturities are included with the host contract on the Consolidated Balance Sheets, and changes in the fair value of the embedded derivatives are recorded in Net gains (losses). Embedded derivatives within certain UL-type and annuity products are included in Future policy benefits on the Consolidated Balance Sheets, and changes in the fair value of the embedded derivatives are recorded in Net gains (losses).
Cash and Cash Equivalents	Cash and Cash Equivalents
Deferred Policy Acquisition Costs and Value of Business Acquired	Deferred Policy Acquisition Costs and Value of Business Acquired Deferred policy acquisition costs ("DAC") represent policy acquisition costs that have been capitalized and are subject to amortization. Capitalized costs are incremental, direct costs of contract acquisition and certain other costs related directly to successful acquisition activities. Such costs consist principally of commissions, underwriting, sales and contract issuance and processing expenses directly related to the successful acquisition of new and renewal business. Indirect or unsuccessful acquisition costs, maintenance, product development and overhead expenses are charged to expense as incurred. Value of business acquired ("VOBA") represents the outstanding value of in-force business acquired and is subject to amortization. The value is based on the present value of estimated net cash flows embedded in the insurance contracts at the time of the acquisition and increased for subsequent deferrable expenses on purchased policies. DAC/VOBA amortization is recorded in Net amortization of Deferred policy acquisition costs and Value of business acquired in the Consolidated Statements of Operations. Amortization Methodologies The Company amortizes DAC/VOBA related to certain traditional life insurance contracts, certain accident and health insurance contracts and deferred annuity contracts on a constant level basis over the expected term of the related contracts. Contracts are grouped for amortization purposes by product or market type and issue year cohort on a basis consistent with those used in estimating the associated liability or other related balance, where applicable. The principal assumption deemed critical to the DAC/VOBA amortization is the estimated contract term, which incorporates mortality and persistency, and represents management’s best estimate of future outcome. The Company periodically reviews this assumption against actual experience and, based on additional information that becomes available, updates the assumption. Changes in contract term estimates are reflected prospectively in amortization expense as of the beginning of the reporting period in which the change is made. VOBA is subject to recoverability testing; DAC is not. The Company performs testing to assess the recoverability of VOBA on an annual basis, or more frequently if circumstances indicate a potential loss recognition issue exists. If VOBA is not deemed recoverable, charges will be applied against the VOBA balance before an additional reserve is established. Internal Replacements Contract owners may periodically exchange one contract for another, or make modifications to an existing contract. These transactions are identified as internal replacements. Internal replacements that are determined to result in substantially unchanged contracts are accounted for as continuations of the replaced contracts. Any costs associated with the issuance of the new contracts are considered maintenance costs and expensed as incurred. Unamortized DAC/VOBA related to the replaced contracts continue to be deferred and amortized in connection with the new contracts. Internal replacements that are determined to result in contracts that are substantially changed are accounted for as extinguishments of the replaced contracts, and any unamortized DAC/VOBA related to the replaced contracts are written off to the same account in which amortization is reported in the Consolidated Statements of Operations.
Goodwill	Goodwill Goodwill arises in connection with business combinations and represents the excess of cost of the acquisition over the fair value of identifiable net assets acquired. Goodwill is not amortized, but is tested for impairment annually, or more frequently if events or changes in circumstances indicate that the asset might be impaired. Goodwill is assigned to a reporting unit at the date the goodwill is initially recorded and is tested for impairment at that level. A reporting unit is an operating segment, or a unit one level below the operating segment if discrete financial information is prepared and regularly reviewed by management at that level. Once goodwill has been assigned to a reporting unit, it is no longer associated with a particular acquisition and all of the activities within the reporting unit, whether acquired or organically grown, are available to support the value of goodwill. The Company tests goodwill for impairment annually in the fourth quarter by either performing a qualitative assessment or a quantitative test. The qualitative impairment assessment is an assessment of relevant events and circumstances to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, including goodwill. The Company may elect not to perform the qualitative impairment assessment for some or all of its reporting units and instead perform a quantitative impairment test which involves comparing a reporting unit’s fair value to its carrying value, including goodwill. If the carrying value of a reporting unit exceeds its estimated fair value, an impairment loss is recognized in an amount equal to that excess, limited to the carrying amount of goodwill allocated to the reporting unit. Subsequent reversal of goodwill impairment losses is not permitted. In performing the quantitative impairment test, the Company is required to make significant estimates in determining the fair value of a reporting unit including, but not limited to, projected revenues and operating margins, applicable discount and growth rates and comparative market multiples.
Other Intangible Assets	Other Intangible Assets Intangible assets identified upon the acquisition of a business are recorded at fair value as of the acquisition date. Indefinite-lived intangible assets are not amortized, but are tested for impairment annually, or more frequently if events or changes in circumstances indicate that the asset might be impaired. Impairment testing for indefinite-lived intangible assets primarily consists of a qualitative assessment to determine if a quantitative assessment is needed for a comparison of the fair value of the intangible asset with its carrying value. If a quantitative assessment is deemed necessary and the carrying amount of the intangible asset exceeds its estimated fair value, an impairment loss is recognized in an amount equal to that excess. In performing the quantitative impairment test, the Company is required to make significant estimates in determining the fair value of an indefinite-lived intangible asset including, but not limited to, projected revenues and discount rates. Finite-lived intangible assets are amortized over their estimated useful lives as related benefits emerge and are reviewed periodically for indicators of change in useful lives or impairment. If facts and circumstances suggest possible impairment, the sum of the estimated undiscounted future cash flows expected to result from the use of the asset is compared to the carrying value of the asset. If the carrying value of the asset exceeds the undiscounted cash flows, the asset is written down to its fair value determined using discounted cash flows. Impairment losses and amortization of intangible assets are recognized in Operating expenses in the Consolidated Statements of Operations.
Contract Costs Associated with Certain Financial Services Contracts	Contract Costs Associated with Certain Revenue Contracts Contract cost assets represent costs incurred to obtain or fulfill contracts for non-insurance financial services and software subscriptions and services that are expected to be recovered and, thus, have been capitalized and are subject to amortization. Capitalized contract costs include incremental costs of obtaining a contract and fulfillment costs that relate directly to a contract and generate or enhance resources of the Company that are used to satisfy performance obligations. Capitalized contract costs are amortized on a straight-line basis over the estimated lives of the contracts, which typically range from 5 to 15 years. Capitalized contract costs are included in Other assets on the Consolidated Balance Sheets, and costs expensed as incurred are included in Operating expenses in the Consolidated Statements of Operations.
Future Policy Benefits and Contract Owner Accounts	Future Policy Benefits and Contract Owner Account Balances Future Policy Benefits The Company establishes and carries actuarially-determined reserves that are calculated to meet its future obligations, including estimates of unpaid claims and claims that the Company believes have been incurred but have not yet been reported as of the balance sheet date. • Reserves for long-duration traditional life insurance contracts (term insurance, participating and non-participating whole life insurance and traditional group life insurance) and accident and health insurance represent the present value of future benefits to be paid to or on behalf of contract owners and related expenses, less the present value of future net premiums. • Reserves for payout contracts with life contingencies are equal to the present value of future payments. Principal assumptions used to establish liabilities for future policy benefits include interest rate, mortality, morbidity, policy lapse, contract renewal, payment of subsequent premiums or deposits by the contract owner, retirement, inflation, and benefit utilization. Other than interest rate assumptions, these assumptions are based on Company experience and periodically reviewed against industry standards. The Company reviews these assumptions at least annually and updates them if necessary. In addition to assumption updates, the Company adjusts reserves for actual experience in the period in which the experience occurs. Changes in, or deviations from, the assumptions used can significantly affect the Company's reserve levels and related results of operations. Remeasurements of the reserves as a result of assumption updates and adjustments for actual experience are recognized in Policyholder benefits in the Consolidated Statements of Operations. Interest rates used in discounting the reserves are based on an upper-medium grade (low-credit-risk) fixed-income instrument yield derived from observable market data. A 30-year forward rate is used for periods beyond the last observable market point. Reserves are remeasured quarterly to reflect changes in the discount rate, with the resulting change recorded in AOCI. Locked-in interest rates used to determine interest accretion on reserves for new contracts sold are based on the upper-medium grade (low-credit-risk) fixed-income instrument yield applicable at the time the business was issued. Locked-in interest accretion rates for contracts in-force as of January 1, 2021, the transition date for Targeted Improvements for Long-Duration Contracts, are based on the locked-in interest rates in effect for those contracts immediately prior to the transition date. Interest accretion is recorded in Policyholder benefits. Short Duration Contracts and Premium Deficiency Reserve The Company’s Health Solutions segment offers short duration insurance contracts including individual excess risk medical stop loss (“medical stop loss”) products. The short duration contracts’ liabilities include liabilities for unpaid claims and claims adjustment expenses which are an estimate of ultimate costs of settling claims, including claims that have been incurred but not reported ("IBNR"). IBNR is not discounted and is reported in Future policy benefits on the Consolidated Balance Sheets. The Company establishes the unpaid claims liability using actuarial methodologies and claim development assumptions based on Company experience. In addition, analysis of claim reporting speeds as well as feedback from members of pricing, underwriting and claims teams are also factored in the review and update of claim development experience assumptions that occurs at least quarterly. Adjustments to the unpaid claim liability resulting from these reviews are recognized in Policyholder benefits in the Consolidated Statements of Operations in the period the adjustment occurs. A premium deficiency reserve may be established when a loss is expected based on significant changes in anticipated experience. The Company considers anticipated investment income in determining if a premium deficiency exists. Contract Owner Account Balances Contract owner account balances relate to UL-type and investment-type contracts, as follows: • Account balances for funding agreements with fixed maturities are calculated using the amount deposited with the Company, less withdrawals, plus interest accrued to the ending valuation date. Interest on these contracts is accrued by a predetermined index, plus a spread or a fixed rate, established at the issue date of the contract. • Account balances for UL-type contracts, including variable universal life ("VUL") contracts, are equal to cumulative deposits, less charges, withdrawals and account values released upon death, plus credited interest thereon. • Account balances for fixed annuities and payout contracts without life contingencies are equal to cumulative deposits, less charges and withdrawals, plus credited interest thereon. Credited interest rates vary by product and range up to 5.1%. Account balances for group immediate annuities without life contingent payouts are equal to the discounted value of the payment at the implied break-even rate. Product Guarantees and Additional Reserves The Company calculates additional reserve liabilities for certain UL-type products, certain variable annuity guaranteed benefits and variable funding products. The Company periodically evaluates its estimates and adjusts the additional liability balance, with a related charge or credit to benefit expense, if actual experience or other evidence suggests that earlier assumptions should be revised. Changes in, or deviations from, the assumptions used can significantly affect the Company's reserve levels and related results of operations. Universal and Variable Universal Life : The Company establishes additional reserves on universal life ("UL") and VUL contracts, primarily related to secondary guarantees and paid-up guarantees, for the portion of contract assessments received in early years that will be used to compensate the Company for benefits provided in later years. These reserves are calculated by estimating the expected value of benefits payable and recognizing those benefits ratably over the accumulation period based on total expected assessments, using interest rates consistent with the underlying contracts' interest crediting rates. Included are contracts where the Company contractually guaranteed a death benefit even when there is insufficient value to cover monthly mortality and expense charges, whereas otherwise the contract would typically lapse ("no lapse guarantee"), and other provisions that would produce expected gains from the insurance benefit function followed by losses from that function in later years. Additional reserves for UL and VUL contracts are recorded in Future policy benefits on the Consolidated Balance Sheets. Stabilizer and MCG : Guaranteed credited rates give rise to an embedded derivative in the stabilizer ("Stabilizer") products and a stand-alone derivative for managed custody guarantee products ("MCG"). These derivatives are measured at estimated fair value and recorded in Contract owner account balances. Changes in estimated fair value that are not related to attributed fees collected or payments made, are reported in Net gains (losses) in the Consolidated Statements of Operations. The estimated fair value of the Stabilizer embedded derivative and MCG stand-alone derivative is determined based on the present value of projected future claims, minus the present value of future guaranteed premiums. At inception of the contract, the Company projects a guaranteed premium to be equal to the present value of the projected future claims. The income associated with the contracts is projected using actuarial and capital market assumptions, including benefits and related contract charges, over the anticipated life of the related contracts. The cash flow estimates are projected under multiple capital market scenarios using observable risk-free rates and other best estimate assumptions. The liabilities for the Stabilizer embedded derivative and the MCG stand-alone derivative include a risk margin to capture uncertainties related to policyholder behavior assumptions. The margin represents additional compensation a market participant would require to assume these risks. The discount rate used to determine the fair value of the liabilities for the Stabilizer embedded derivative and the MCG stand-alone derivative includes an adjustment to reflect the risk that these obligations will not be fulfilled ("nonperformance risk"). Separate Accounts Separate account assets and liabilities generally represent funds maintained to meet specific investment objectives of contract owners or participants who bear the investment risk, subject, in limited cases, to minimum guaranteed rates. Investment income and investment gains and losses generally accrue directly to such contract owners. The assets of each account are legally segregated and are not subject to claims that arise out of any other business of the Company. Separate account assets supporting variable options under variable annuity contracts are invested, as designated by the contract owner or participant under a contract, in shares of mutual funds that are managed by the Company or in other selected mutual funds not managed by the Company. The Company reports separately, as assets and liabilities, investments held in the separate accounts and liabilities of separate accounts if: • Such separate accounts are legally recognized; • Assets supporting the contract liabilities are legally insulated from the Company's general account liabilities; • Investments are directed by the contract owner or participant; and • All investment performance, net of contract fees and assessments, is passed through to the contract owner. The Company reports separate account assets that meet the above criteria at fair value on the Consolidated Balance Sheets based on the fair value of the underlying investments. The underlying investments include mutual funds, short-term investments, cash and fixed maturities. Separate account liabilities equal separate account assets. Investment income and net realized and unrealized capital gains (losses) of the separate accounts, however, are not reflected in the Consolidated Statements of Operations, and the Consolidated Statements of Cash Flows do not reflect investment activity of the separate accounts. Short-term and Long-term Debt Short-term and long-term debt are carried on the Consolidated Balance Sheets at an amount equal to the unpaid principal balance, net of any remaining unamortized discount or premium and any direct and incremental costs attributable to issuance. Discounts, premiums and direct and incremental costs are amortized as a component of Interest expense in the Consolidated Statements of Operations over the life of the debt using the effective interest method of amortization. Repurchase Agreements The Company engages in dollar repurchase agreements with MBS ("dollar rolls") and repurchase agreements with other collateral types to increase its return on investments and improve liquidity. Such arrangements meet the requirements to be accounted for as financing arrangements. The Company enters into dollar roll transactions by selling existing MBS and concurrently entering into an agreement to repurchase similar securities within a short time frame at a lower price. Under repurchase agreements, the Company borrows cash from a counterparty at an agreed upon interest rate for an agreed upon time frame and pledges collateral in the form of securities. At the end of the agreement, the counterparty returns the collateral to the Company, and the Company, in turn, repays the loan amount along with the additional agreed upon interest.
Recognition of Insurance Revenue and Related Benefits	Recognition of Revenue Insurance Revenue and Related Benefits Premiums related to traditional life insurance contracts and payout contracts with life contingencies are recognized in Premiums in the Consolidated Statements of Operations when due from the contract owner. When premiums are due over a significantly shorter period than the period over which benefits are provided, any gross premium in excess of the net premium (i.e., the portion of the gross premium required to provide for expected future benefits and expenses) is deferred and recognized into revenue in a constant relationship to insurance in force. Benefits are recorded in Policyholder benefits in the Consolidated Statements of Operations when incurred. Amounts received as payment for investment-type, UL-type, fixed annuities, and payout contracts without life contingencies are reported as deposits to contract owner account balances. Revenues from these contracts consist primarily of fees assessed against the contract owner account balance for mortality and policy administration charges and are reported in Fee income in the Consolidated Statements of Operations. Surrender charges are reported in Other revenue in the Consolidated Statements of Operations. In addition, the Company earns investment income from the investment of contract deposits in the Company's general account portfolio, which is reported in Net investment income in the Consolidated Statements of Operations. Benefits and expenses for these products include claims in excess of related account balances, expenses of contract administration and interest credited to contract owner account balances. Performance-based Capital Allocations on Private Equity Funds Under asset management arrangements for certain of its sponsored private equity funds, the Company, as General Partner, is entitled to receive performance-based capital allocations ("carried interest") when the return on assets under management for such funds exceeds prescribed investment return hurdles or other performance targets. Carried interest is accrued quarterly based on measuring cumulative fund performance against the stated performance hurdle, as if the fund was liquidated at its estimated fair value as of the applicable balance sheet date.
Income Taxes	Income Taxes The Company’s provision for income taxes is based on income and expense reported in the financial statements after adjustments for permanent differences between the financial statements and consolidated federal income tax return. Permanent differences include the dividends received deduction, tax credits and non-controlling interest. As a result of permanent differences, the effective tax rate reflected in the financial statements may be different than the actual rate in the income tax return. Current income tax receivable or payable is recognized within Other assets or Other liabilities, respectively, in the Consolidated Balance Sheets. Temporary differences between the Company's financial statements and income tax return create deferred tax assets and liabilities. Deferred tax assets represent the tax benefit of future deductible temporary differences, net operating loss carryforwards and tax credit carryforwards. The Company's deferred tax assets and liabilities are measured at the balance sheet date using enacted tax rates expected to apply to taxable income in the years the temporary differences are expected to reverse. The Company evaluates and tests the recoverability of its deferred tax assets. Deferred tax assets are reduced by a valuation allowance if, based on the weight of evidence, it is more likely than not that some portion, or all, of the deferred tax assets will not be realized. Considerable judgment and the use of estimates are required in determining whether a valuation allowance is necessary and, if so, the amount of such valuation allowance. In evaluating the need for a valuation allowance, the Company considers many factors, including the nature and character of the deferred tax assets and liabilities, the amount and character of book income or losses in recent years, projected future taxable income and future reversals of temporary differences, tax planning strategies the Company would employ to avoid a tax benefit from expiring unused, and the length of time carryforwards can be utilized. The Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not to be sustained under examination by the applicable taxing authority. The Company also considers positions that have been reviewed and agreed to as part of an examination by the applicable taxing authority. For items that meet the more-likely-than-not recognition threshold, the Company measures the tax position as the largest amount of benefit that is more than 50% likely to be realized upon ultimate resolution with the applicable tax authority that has full knowledge of all relevant information. Reinsurance The Company utilizes reinsurance agreements in most aspects of its insurance business to reduce its exposure to large losses. Such reinsurance permits recovery of a portion of losses from reinsurers, although it does not discharge the primary liability of the Company as direct insurer of the risks reinsured. For each of its reinsurance agreements, the Company determines whether the agreement provides indemnification against loss or liability relating to insurance risk. The Company reviews contractual features, particularly those that may limit the amount of insurance risk to which the reinsurer is subject or features that delay the timely reimbursement of claims. The assumptions used to account for both long and short-duration reinsurance agreements are consistent with those used for the underlying contracts, with the exception of the interest accretion rate on reinsurance recoverable assets associated with in-force business reinsured. Ceded Future policy benefits and Contract owner account balances are reported gross on the Consolidated Balance Sheets. Long Duration : For reinsurance of long-duration contracts that transfer significant insurance risk, the difference, if any, between the amounts paid and benefits received related to the underlying contracts is included in the expected net cost of reinsurance, which is recorded in Premium receivable and reinsurance recoverable or Other liabilities, as appropriate, on the Consolidated Balance Sheets. Short-duration : For prospective reinsurance of short-duration contracts that meet the criteria for reinsurance accounting, amounts paid are recorded as ceded premiums and ceded unearned premiums and are reflected as a component of Premiums in the Consolidated Statements of Operations and Other assets on the Consolidated Balance Sheets, respectively. Ceded unearned premiums are amortized through premiums over the remaining contract period in proportion to the amount of protection provided. If the Company determines that a reinsurance agreement does not expose the reinsurer to a reasonable possibility of a significant loss from insurance risk, the Company records the agreement using the deposit method of accounting. Deposits received are included in Other liabilities, and deposits made are included in Other assets on the Consolidated Balance Sheets. As amounts are paid or received, consistent with the underlying contracts, the deposit assets or liabilities are adjusted. Accounting for reinsurance requires use of assumptions and estimates, particularly related to the future performance of the underlying business and the potential impact of counterparty credit risks. The Company reviews assumptions used to establish assets and liabilities relating to ceded and assumed reinsurance at least annually and updates them if necessary. In addition to the assumption updates, the Company adjusts these assets or liabilities for actual experience in the period in which the experience occurs. The Company also evaluates the financial strength of potential reinsurers and continually monitors the financial condition of reinsurers. Reinsurance recoverable and deposit asset balances are reported net of the allowance for credit losses on the Company’s Consolidated Balance Sheets. Management estimates the credit loss allowance balance using a factor-based method of probability of default and loss given default which incorporates relevant available information, from internal and external sources, relating to past events, current conditions, and reasonable and supportable forecasts. Included in the factor-based method are the consideration of capital market factors, counterparty financial information and ratings, and reinsurance agreement-specific risk characteristics such as collateral type, collateral size, and covenant strength. The allowance for credit losses is a valuation account that is deducted from the reinsurance recoverable balance to present the net amount expected to be collected on the reinsurance recoverable. The change in the allowance for credit losses is recorded in Policyholder benefits in the Consolidated Statements of Operations. Current reinsurance recoverable balances deemed probable of recovery and payable balances under reinsurance agreements are included in Premium receivable and reinsurance recoverable and Other liabilities, respectively. Such assets and liabilities relating to reinsurance agreements with the same reinsurer are recorded net on the Consolidated Balance Sheets if a right of offset exists within the reinsurance agreement. Premiums, Fee income and Policyholder benefits are reported net of reinsurance ceded. The Company has entered into coinsurance funds withheld reinsurance arrangements that contain embedded derivatives for which carrying value is estimated based on the change in the fair value of the assets supporting the funds withheld payable under the agreements.
Employee Benefit Plans	Employee Benefits Plans The Company sponsors and/or administers various plans that provide defined benefit pension and other postretirement benefit plans covering eligible employees, sales representatives, and other individuals. The plans are generally funded through payments, determined by periodic actuarial calculations, to trustee-administered funds. A defined benefit plan is a pension plan that defines an amount of pension benefit that an employee will receive upon retirement, usually dependent on one or more factors such as age, years of service, and compensation. The liability recognized in respect of defined benefit pension plans is the present value of the projected pension benefit obligation ("PBO") at the balance sheet date, less the fair value of plan assets, together with adjustments for unrecognized past service costs. This liability is included in Other liabilities on the Consolidated Balance Sheets. The PBO is defined as the actuarially calculated present value of vested and non-vested pension benefits accrued based on future salary levels. The Company recognizes the funded status of the PBO for pension plans and the accumulated postretirement benefit obligation ("APBO") for other postretirement plans on the Consolidated Balance Sheets. Net periodic benefit cost is determined using management estimates and actuarial assumptions to derive service cost, interest cost and expected return on plan assets for a particular year and is included in Operating expenses in the Consolidated Statements of Operations. The obligations and expenses associated with these plans require use of assumptions, such as discount rate, expected rate of return on plan assets, rate of future compensation increases and healthcare cost trend rates, as well as assumptions regarding participant demographics, such as age of retirement, withdrawal rates and mortality. Management determines these assumptions based on a variety of factors, such as historical performance of the plan and its assets, currently available market and industry data and expected benefit payout streams. Actual results could vary significantly from assumptions based on changes, such as economic and market conditions, demographics of participants in the plans and amendments to benefits provided under the plans. These differences may have a significant effect on the Company's Consolidated Financial Statements and liquidity. Differences between the expected return and the actual return on plan assets and actuarial gains (losses) are immediately recognized in Operating expenses in the Consolidated Statements of Operations. For postretirement healthcare and other benefits to retirees, the expected costs of these benefits are accrued in Other liabilities over the period of employment using an accounting methodology similar to that for defined benefit pension plans. Actuarial gains (losses) are immediately recognized in Operating expenses in the Consolidated Statements of Operations.
Share-based Compensation	Share-based Compensation The Company grants certain employees and directors share-based compensation awards under various plans. Share-based compensation plans are subject to certain vesting conditions. The Company measures the cost of its share-based awards at their grant date fair value, which in the case of restricted stock units ("RSUs ") and performance share units ("PSUs"), is based upon the market value of the Company's common stock on the date of grant. The Company grants certain PSU awards, which are subject to attainment of specified total shareholder return ("TSR") targets relative to a specified peer group. The number of TSR-based PSU awards expected to be earned, based on achievement of the market condition, is factored into the grant date Monte Carlo valuation for the award. Fair value of stock options is determined using a Black-Scholes options valuation methodology. Compensation expense is principally related to the granting of performance share units and restricted stock units and is recognized in Operating expenses in the Consolidated Statements of Operations over the requisite service period. The majority of awards granted are provided in the first quarter of each year. The Company includes estimated forfeitures in the calculation of share-based compensation expense. The liability related to cash-settled awards is recorded within Other liabilities on the Consolidated Balance Sheets. Unlike equity-settled awards, which have a fixed grant-date fair value, the fair value of unvested cash-settled awards is remeasured at the end of each reporting period until the awards vest. All excess tax benefits and tax deficiencies related to share-based compensation are reported in Net income (loss).
Earnings Per Common Share	Earnings per Common Share Basic earnings per common share ("EPS") is computed by dividing earnings available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted EPS is computed assuming the issuance of restricted stock units, stock options, performance share units and warrants using the treasury stock method. Basic and diluted earnings per share are calculated using unrounded, actual amounts. Under the treasury stock method, the Company utilizes the average market price to determine the amount of cash that would be available to repurchase shares if the common shares vested. The net incremental share count issued represents the potential dilutive or anti-dilutive securities. For any period where a loss from continuing operations available to common shareholders is experienced, shares used in the diluted EPS calculation represent basic shares, as using diluted shares would be anti-dilutive to the calculation.
Treasury Stock	Treasury Stock All amounts paid to repurchase common stock are recorded as Treasury stock on the Consolidated Balance Sheets. When Treasury stock is retired and the purchase price is greater than par, an excess of purchase price over par is allocated between additional paid-in capital and retained earnings (deficit). Shares that are retired are determined on a first in, first out ("FIFO") basis.
Consolidation and Noncontrolling Interests	Consolidation and Noncontrolling Interests In the normal course of business, the Company invests in, provides investment management services to, and has transactions with, various collateralized loan obligation ("CLO") entities, private equity funds, real estate funds, funds-of-hedge funds, single strategy hedge funds, insurance entities, securitizations and other investment entities. In certain instances, the Company serves as the investment manager, making day-to-day investment decisions concerning the assets of these entities. These entities are considered to be either VIEs or VOEs, and the consolidation guidance requires an assessment involving judgments and analysis to determine (a) whether an entity in which the Company holds a variable interest is a VIE and (b) whether the Company's involvement, through holding interests directly or indirectly in the entity or contractually through other variable interests (e.g., management and performance related fees), would give it a controlling financial interest. The Company consolidates entities in which it, directly or indirectly, is determined to have a controlling financial interest. Consolidation conclusions are reviewed quarterly to identify whether any reconsideration events have occurred. • VIEs: The Company consolidates VIEs for which it is the primary beneficiary at the time it becomes involved with a VIE. An entity is a VIE if it has equity investors who, as a group, lack the characteristics of a controlling financial interest or it does not have sufficient equity at risk to finance its expected activities without additional subordinated financial support from other parties. The primary beneficiary (a) has the power to direct the activities of the entity that most significantly impact the entity's economic performance and (b) has the obligation to absorb losses or the right to receive benefits from the entity that could potentially be significant to the entity. • VOEs: For entities determined not to be VIEs, the Company consolidates entities in which it holds greater than 50% of the voting interest, or, for limited partnerships, when the Company owns a majority of the limited partnership's kick-out rights through voting interests. Noncontrolling interest represents the interests of shareholders, other than the Company, in consolidated entities. In the Consolidated Statements of Operations, Net income (loss) attributable to noncontrolling interest represents such shareholders' interests in the earnings and losses of those entities, or the attribution of results from consolidated VIEs or VOEs to which the Company is not economically entitled. The Company has a redeemable noncontrolling interest associated with Allianz's 24% economic stake in VIM Holdings, which is reflected within Mezzanine equity on the Consolidated Balance Sheets. This redeemable noncontrolling interest has been classified as Mezzanine equity because in the event of a change in control of the Company, which is not solely within the control of the Company, the redeemable noncontrolling interest could become redeemable for cash or other assets at the option of the holder. A change in control of the Company is not considered probable as of December 31, 2024; therefore, the redeemable noncontrolling interest has not been remeasured to its redemption value.
Contingencies	Contingencies A loss contingency is an existing condition, situation or set of circumstances involving uncertainty as to possible loss that will ultimately be resolved when one or more future events occur or fail to occur. Examples of loss contingencies include pending or threatened adverse litigation, threat of expropriation of assets and actual or possible claims and assessments. Amounts related to loss contingencies are accrued and recorded in Other liabilities on the Consolidated Balance Sheets if it is probable that a loss has been incurred and the amount can be reasonably estimated, based on the Company's best estimate of the ultimate outcome.
Adoption of New Accounting Pronouncements and Future Adoption of Accounting Pronouncements	Adoption of New Pronouncements Equity Securities Subject to Contractual Sale Restrictions In June 2022, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2022-03, "Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions" ("ASU 2022-03"), which clarifies that contractual restrictions on equity security sales are not considered part of the security unit of account and, therefore, are not considered in measuring the fair value. In addition, the restrictions cannot be recognized and measured as separate units of account. Disclosures on such restrictions are also required. The provisions of ASU 2022-03 were adopted prospectively on January 1, 2024. The adoption did not have an impact on the Company's financial condition, results of operations, or cash flows. Segment Disclosures In November 2023, the FASB issued ASU 2023-07 "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures" ("ASU 2023-07"), which requires all current annual disclosures about segment profit/loss and assets to be reported in interim periods, as well as enhanced disclosures about significant segment expenses. The provisions of ASU 2023-07 were adopted retrospectively for the fiscal year December 31, 2024. The adoption did not have an impact on the Company's financial condition, results of operations, or cash flows. Required disclosure changes have been included in the Segments Note to these Consolidated Financial Statements. Restated prior period disclosures are based on the significant segment expense categories disclosed in the Company's segment footnote. Future Adoption of Accounting Pronouncements Disaggregation of Income Statement Expenses In November 2024, the FASB issued ASU 2024-03, "Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses" ("ASU 2024-03"), which requires the following disclosures: • Disclose the amounts of (a) employee compensation; (b) depreciation; and (c) intangible asset amortization included in each relevant expense caption. • Include certain amounts that are already required to be disclosed under U.S. GAAP in the same disclosure as the other disaggregation requirements. • Disclose a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively. • Disclose the total amount of selling expenses and, in annual reporting periods, an entity’s definition of selling expenses. The amendments are effective for annual periods beginning after December 15, 2026, and interim periods beginning after December 15, 2027, and should be applied either prospectively or retrospectively. The Company is in the process of determining the disclosures that may be required by the adoption of the provisions of ASU 2024-03. Profits Interest and Similar Awards In March 2024, the FASB issued ASU 2024-01, "Compensation - Stock Compensation (Topic 718): Scope Application of Profits Interest and Similar Awards" ("ASU 2024-01"), which adds incremental clarity for how profits interests should be accounted. ASU 2024-01 is effective for annual periods beginning after December 15, 2024 and interim periods within those annual periods with early adoption permitted. The Company intends to adopt ASU 2024-01 as of January 1, 2025 on a prospective basis, and does not expect this ASU to have a material impact on the Company's financial condition, results of operations, or cash flows. Income Tax Disclosures In December 2023, the FASB issued ASU 2023-09, "Income Taxes (Topic 740): Improvements to Income Tax Disclosures" ("ASU 2023-09"), which requires: • A tabular rate reconciliation of (1) reported income tax expense/benefit from continuing operations, to (2) the product of the income/loss from continuing operations before income taxes and the statutory federal income tax rate, using specific categories, as well as disclosure of certain reconciling items based on a 5% threshold. • Year-to-date net income taxes paid, disaggregated by federal, state, and foreign, as well as disaggregated information on net income taxes paid to an individual jurisdiction based on a 5% threshold. The amendments are effective for annual periods beginning after December 15, 2024 and should be applied prospectively, with retrospective application permitted. Early adoption is also permitted. The Company is in the process of determining the disclosures that may be required by the adoption of the provisions of ASU 2023-09. Climate Related Disclosures In March 2024, the SEC adopted a final rule under SEC Release No. 33-11275, The Enhancement and Standardization of Climate-Related Disclosures for Investors, to enhance and standardize climate-related disclosures. The rule will require companies to disclose material Scope 1 and Scope 2 greenhouse gas emissions; climate-related risks, governance, and oversight; and the financial effects of severe weather events and other natural conditions. These disclosures will be phased in beginning with the Company's annual report for the year ending December 31, 2025. While the implementation of this rule is pending the outcome of legal challenges, the Company is assessing the disclosures that may be required by the adoption in the event that the stay is lifted.

Investments (excluding Consol_2

Investments (excluding Consolidated Investment Entities) (Tables)	12 Months Ended
	Dec. 31, 2024
Investments, Debt and Equity Securities [Abstract]
Available-for-sale and fair value option ("FVO") fixed maturities	Available-for-sale and FVO fixed maturities were as follows as of December 31, 2024: Amortized Cost Gross Unrealized Capital Gains Gross Unrealized Capital Losses Embedded Derivatives (2) Allowance for credit losses Fair Value Fixed maturities: U.S. Treasuries $ 524 $ — $ 52 $ — $ — $ 472 U.S. Government agencies and authorities 29 1 — — — 30 State, municipalities and political subdivisions 697 — 117 — — 580 U.S. corporate public securities 7,938 124 1,054 — — 7,008 U.S. corporate private securities 5,275 43 329 — 6 4,983 Foreign corporate public securities and foreign governments (1) 2,729 32 287 — 2 2,472 Foreign corporate private securities (1) 2,693 22 169 — 9 2,537 Residential mortgage-backed securities 3,709 27 261 (4) — 3,471 Commercial mortgage-backed securities 3,677 4 532 — 17 3,132 Other asset-backed securities 2,779 39 45 — 4 2,769 Total fixed maturities, including securities pledged 30,050 292 2,846 (4) 38 27,454 Less: Securities pledged 1,665 — 149 — — 1,516 Total fixed maturities $ 28,385 $ 292 $ 2,697 $ (4) $ 38 $ 25,938 (1) Primarily U.S. dollar denominated. (2) Embedded derivatives within fixed maturity securities are reported with the host investment. The changes in fair value of embedded derivatives are reported in Net gains (losses) in the Consolidated Statements of Operations. Available-for-sale and FVO fixed maturities were as follows as of December 31, 2023: Amortized Cost Gross Unrealized Capital Gains Gross Unrealized Capital Losses Embedded Derivatives (2) Allowance for credit losses Fair Value Fixed maturities: U.S. Treasuries $ 417 $ 7 $ 21 $ — $ — $ 403 U.S. Government agencies and authorities 54 3 1 — — 56 State, municipalities and political subdivisions 871 1 101 — — 771 U.S. corporate public securities 8,402 168 904 — — 7,666 U.S. corporate private securities 5,040 44 324 — — 4,760 Foreign corporate public securities and foreign governments (1) 2,928 47 270 — 3 2,702 Foreign corporate private securities (1) 2,916 27 129 — 2 2,812 Residential mortgage-backed securities 3,695 36 257 2 — 3,476 Commercial mortgage-backed securities 4,147 1 644 — 9 3,495 Other asset-backed securities 2,528 16 71 — 3 2,470 Total fixed maturities, including securities pledged 30,998 350 2,722 2 17 28,611 Less: Securities pledged 1,232 — 72 — — 1,160 Total fixed maturities $ 29,766 $ 350 $ 2,650 $ 2 $ 17 $ 27,451 (1) Primarily U.S. dollar denominated. (2) Embedded derivatives within fixed maturity securities are reported with the host investment. The changes in fair value of embedded derivatives are reported in Net gains (losses) in the Consolidated Statements of Operations.
Investments Classified by Contractual Maturity Date	The amortized cost and fair value of fixed maturities, including securities pledged, as of December 31, 2024, are shown below by contractual maturity. Actual maturities may differ from contractual maturities as securities may be restructured, called or prepaid. MBS and Other ABS are shown separately because they are not due at a single maturity date. Amortized Fair Due to mature: One year or less $ 607 $ 581 After one year through five years 3,946 3,819 After five years through ten years 3,723 3,590 After ten years 11,609 10,092 Mortgage-backed securities 7,386 6,603 Other asset-backed securities 2,779 2,769 Fixed maturities, including securities pledged $ 30,050 $ 27,454
Schedule of Securities Financing Transactions	The following table presents Securities pledged as of the dates indicated: December 31, 2024 December 31, 2023 Securities pledged/obligations under repurchase agreements (1) $ 281 $ 117 Securities loaned to lending agent (2) 1,083 842 Securities pledged as collateral (2)(3) 159 201 Total $ 1,523 $ 1,160 (1) Comprised of other asset-backed securities and included in Securities pledged and Payables under securities loan and repurchase agreements, including collateral held on the Consolidated Balance Sheets. (2) Included in Securities pledged on the Consolidated Balance Sheets. (3) See Collateral within the Derivative Financial Instruments Note to these Consolidated Financial Statements for more information.
Schedule of Securities Borrowed Under Securities Lending Transactions	The following table presents collateral held by asset class that the Company pledged under securities lending as of the dates indicated: December 31, 2024 December 31, 2023 U.S. Treasuries $ 22 $ 14 U.S. corporate public securities 601 568 Short-term investments 241 55 Foreign corporate public securities and foreign governments 258 238 Total (1) $ 1,122 $ 875 (1) As of December 31, 2024 and 2023, liabilities to return cash collateral were $736 and $660, respectively, and included in Payables under securities loan and repurchase agreements, including collateral held on the Consolidated Balance Sheets.
Allowance for Credit Loss on Available-for-sale Fixed Maturity Securities	Allowance for credit losses The following table presents a rollforward of the allowance for credit losses on available-for-sale fixed maturity securities for the period presented: Year Ended December 31, 2024 U.S. corporate private securities Commercial mortgage-backed securities Foreign corporate public securities and foreign governments Foreign corporate private securities Other asset-backed securities Total Balance as of January 1 $ — $ 9 $ 3 $ 2 $ 3 $ 17 Credit losses on securities for which credit losses were not previously recorded 6 9 — 8 1 24 Reductions for securities sold during the period — — (1) — — (1) Increase (decrease) on securities with allowance recorded in previous period — (1) — (1) — (2) Balance as of December 31 $ 6 $ 17 $ 2 $ 9 $ 4 $ 38 Year Ended December 31, 2023 U.S. corporate private securities Commercial mortgage-backed securities Foreign corporate public securities and foreign governments Foreign corporate private securities Other asset-backed securities Total Balance as of January 1 $ — $ — $ 9 $ 2 $ 1 $ 12 Credit losses on securities for which credit losses were not previously recorded — 9 — — 2 11 Reductions for securities sold during the period — — (5) — — (5) Increase (decrease) on securities with allowance recorded in previous period — — (1) — — (1) Balance as of December 31 $ — $ 9 $ 3 $ 2 $ 3 $ 17
Schedule of Unrealized Loss on Investments	The following tables present available-for-sale fixed maturities, including securities pledged, for which an allowance for credit losses has not been recorded by investment category and duration as of the dates indicated: As of December 31, 2024 Twelve Months or Less More Than Twelve Months Below Amortized Cost Total Fair Value Unrealized Capital Losses Fair Value Unrealized Capital Losses Fair Value Unrealized Capital Losses U.S. Treasuries $ 304 $ 20 $ 133 $ 32 $ 437 $ 52 U.S. Government agencies and authorities 14 — — — 14 — State, municipalities and political subdivisions 7 — 562 117 569 117 U.S. corporate public securities 818 35 4,215 1,019 5,033 1,054 U.S. corporate private securities 546 13 2,845 316 3,391 329 Foreign corporate public securities and foreign governments 450 17 1,285 270 1,735 287 Foreign corporate private securities 490 12 1,468 157 1,958 169 Residential mortgage-backed 311 8 1,210 253 1,521 261 Commercial mortgage-backed 24 — 2,751 532 2,775 532 Other asset-backed 93 2 315 43 408 45 Total $ 3,057 $ 107 $ 14,784 $ 2,739 $ 17,841 $ 2,846 As of December 31, 2023 Twelve Months or Less More Than Twelve Months Below Amortized Cost Total Fair Value Unrealized Capital Losses Fair Value Unrealized Capital Losses Fair Value Unrealized Capital Losses U.S. Treasuries $ 99 $ 3 $ 109 $ 18 $ 208 $ 21 U.S. Government agencies and authorities — — 3 1 3 1 State, municipalities and political subdivisions 20 — 731 101 751 101 U.S. corporate public securities 321 17 5,101 887 5,422 904 U.S. corporate private securities 176 7 3,365 317 3,541 324 Foreign corporate public securities and foreign governments 82 2 1,749 268 1,831 270 Foreign corporate private securities 189 5 2,101 124 2,290 129 Residential mortgage-backed 114 3 1,354 254 1,468 257 Commercial mortgage-backed 84 2 3,269 642 3,353 644 Other asset-backed 136 3 1,156 68 1,292 71 Total $ 1,221 $ 42 $ 18,938 $ 2,680 $ 20,159 $ 2,722
Mortgage Loans by Loan to Value Ratio	The following tables present commercial mortgage loans by year of origination and LTV ratio as of the dates indicated. The information is updated as of December 31, 2024 and 2023, respectively. As of December 31, 2024 Year of Origination Loan-to-Value Ratios 0% - 50% >50% - 60% >60% - 70% >70% - 80% >80% and above Total 2024 $ 138 $ 131 $ 15 $ — $ — $ 284 2023 96 221 40 — — 357 2022 239 282 95 — — 616 2021 240 184 95 — — 519 2020 184 71 — — — 255 Prior 2,500 148 2 — 18 2,668 Total $ 3,397 $ 1,037 $ 247 $ — $ 18 $ 4,699 As of December 31, 2023 Year of Origination Loan-to-Value Ratios 0% - 50% >50% - 60% >60% - 70% >70% - 80% >80% and above Total 2023 $ 150 $ 222 $ — $ — $ — $ 372 2022 252 326 73 — — 651 2021 244 214 209 — — 667 2020 168 112 — 10 16 306 2019 238 68 28 — — 334 Prior 2,586 280 4 — 18 2,888 Total $ 3,638 $ 1,222 $ 314 $ 10 $ 34 $ 5,218
Mortgage Loans by Debt Service Coverage Ratio	The following tables present commercial mortgage loans by year of origination and DSC ratio as of the dates indicated. The information is updated as of December 31, 2024 and 2023, respectively. As of December 31, 2024 Debt Service Coverage Ratios Year of Origination >1.5x >1.25x - 1.5x >1.0x - 1.25x <1.0x Total (1) 2024 $ 161 $ 93 $ 28 $ 2 $ 284 2023 118 180 48 11 357 2022 295 101 76 144 616 2021 258 16 97 148 519 2020 207 20 20 8 255 Prior 2,018 219 346 85 2,668 Total $ 3,057 $ 629 $ 615 $ 398 $ 4,699 (1) No commercial mortgage loans were secured by land or construction loans As of December 31, 2023 Debt Service Coverage Ratios Year of Origination >1.5x >1.25x - 1.5x >1.0x - 1.25x <1.0x Total (1) 2023 $ 189 $ 116 $ 67 $ — $ 372 2022 204 68 192 187 651 2021 260 14 64 329 667 2020 211 24 21 50 306 2019 203 26 84 21 334 Prior 2,216 264 255 153 2,888 Total $ 3,283 $ 512 $ 683 $ 740 $ 5,218 (1) No commercial mortgage loans were secured by land or construction loans
Mortgage Loans by Geographic Location of Collateral	The following tables present the commercial mortgage loans by year of origination and U.S. region as of the dates indicated. The information is updated as of December 31, 2024 and 2023, respectively. As of December 31, 2024 Year of Origination U.S. Region Pacific South Atlantic Middle Atlantic West South Central Mountain East North Central New England West North Central East South Central Total 2024 $ 58 $ 80 $ 41 $ 57 $ 20 $ 9 $ 7 $ 3 $ 9 $ 284 2023 49 85 12 101 39 39 3 26 3 357 2022 140 122 49 98 89 92 5 1 20 616 2021 95 51 113 93 96 47 9 15 — 519 2020 61 118 17 10 12 15 — 7 15 255 Prior 707 632 619 176 211 134 51 109 29 2,668 Total $ 1,110 $ 1,088 $ 851 $ 535 $ 467 $ 336 $ 75 $ 161 $ 76 $ 4,699 As of December 31, 2023 Year of Origination U.S. Region Pacific South Atlantic Middle Atlantic West South Central Mountain East North Central New England West North Central East South Central Total 2023 $ 69 $ 77 $ 12 $ 101 $ 39 $ 42 $ 3 $ 26 $ 3 $ 372 2022 140 132 47 100 113 93 5 1 20 651 2021 96 63 124 148 111 75 9 40 1 667 2020 63 155 17 10 12 26 — 7 16 306 2019 53 100 10 74 45 4 14 13 21 334 Prior 734 605 765 189 214 171 47 144 19 2,888 Total $ 1,155 $ 1,132 $ 975 $ 622 $ 534 $ 411 $ 78 $ 231 $ 80 $ 5,218
Mortgage Loans by Property Type of Collateral	The following tables present the commercial mortgage loans by year of origination and property type as of the dates indicated. The information is updated as of December 31, 2024 and 2023, respectively. As of December 31, 2024 Year of Origination Property Type Retail Industrial Apartments Office Hotel/Motel Other Mixed Use Total 2024 $ 58 $ 154 $ 57 $ 15 $ — $ — $ — $ 284 2023 124 172 13 16 32 — — 357 2022 79 261 222 35 10 9 — 616 2021 35 128 218 111 — 18 9 519 2020 55 48 56 96 — — — 255 Prior 610 713 640 437 67 155 46 2,668 Total $ 961 $ 1,476 $ 1,206 $ 710 $ 109 $ 182 $ 55 $ 4,699 As of December 31, 2023 Year of Origination Property Type Retail Industrial Apartments Office Hotel/Motel Other Mixed Use Total 2023 $ 125 $ 164 $ 33 $ 18 $ 32 $ — $ — $ 372 2022 79 263 255 34 10 10 — 651 2021 36 145 335 123 — 18 10 667 2020 57 49 72 128 — — — 306 2019 45 82 160 36 11 — — 334 Prior 780 755 618 463 60 163 49 2,888 Total $ 1,122 $ 1,458 $ 1,473 $ 802 $ 113 $ 191 $ 59 $ 5,218
Allowance for Credit Losses for Commercial Mortgage Loans	The following table summarizes activity in the allowance for losses for commercial mortgage loans for the periods indicated: December 31, 2024 December 31, 2023 Allowance for credit losses, beginning of period $ 26 $ 18 Credit losses on mortgage loans for which credit losses were not previously recorded 1 2 Increase (decrease) on mortgage loans with an allowance recorded in previous period — 9 Provision for expected credit losses 27 29 Write-offs (3) (3) Allowance for credit losses, end of period $ 24 $ 26
Financing Receivable, Past Due	The following table presents the payment status of commercial mortgage loans as of the dates indicated: December 31, 2024 December 31, 2023 Current $ 4,673 $ 5,202 30-59 days past due — — 60-89 days past due — — Greater than 90 days past due 26 16 Total $ 4,699 $ 5,218
Net Investment Income	The following table summarizes Net investment income by investment type for the periods indicated: Year Ended December 31, 2024 2023 2022 Fixed maturities $ 1,678 $ 1,766 $ 1,940 Equity securities 19 21 12 Mortgage loans on real estate 234 249 237 Policy loans 20 20 21 Short-term investments and cash equivalents 40 39 13 Limited partnerships and other 159 135 118 Gross investment income 2,150 2,230 2,341 Less: Investment expenses 76 71 60 Net investment income $ 2,074 $ 2,159 $ 2,281
Realized Gain (Loss) on Investments	Net gains (losses) were as follows for the periods indicated: Year Ended December 31, 2024 2023 2022 Fixed maturities, available-for-sale, including securities pledged $ (48) $ (31) $ (30) Fixed maturities, at fair value option (167) (100) (920) Equity securities, at fair value 6 3 (39) Derivatives 193 29 305 Embedded derivatives - fixed maturities (6) (1) (9) Other derivatives 2 — — Standalone derivatives (1) — (12) Managed custody guarantees 4 (2) (5) Stabilizer (14) (1) 19 Mortgage loans (1) (12) — Other investments 5 43 5 Net gains (losses) $ (27) $ (72) $ (686)
Gain (Loss) on Securities	Proceeds from the sale of fixed maturities, available-for-sale, and equity securities and the related gross realized gains and losses, before tax, were as follows for the periods indicated: Year Ended December 31, 2024 2023 2022 Proceeds on sales $ 3,510 $ 5,393 $ 5,448 Gross gains 50 69 100 Gross losses (62) 78 109

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	12 Months Ended
	Dec. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Notional Amounts of Outstanding Derivative Positions	The notional amounts and fair values of derivatives were as follows as of the dates indicated: December 31, 2024 December 31, 2023 Notional Asset Fair Value Liability Fair Value Notional Asset Fair Value Liability Fair Value Derivatives: Qualifying for hedge accounting (1) Fair value hedges (2) : Interest rate contracts (3) $ — $ — $ — $ — $ — $ — Foreign exchange contracts 106 6 — 98 — 4 Cash flow hedges: Interest rate contracts 11 — — 12 — — Foreign exchange contracts 623 46 2 718 33 7 Derivatives: Non-qualifying for hedge accounting (1) Interest rate contracts 14,633 246 313 16,773 270 354 Foreign exchange contracts 203 3 6 183 4 2 Equity contracts 286 2 9 255 4 2 Credit contracts 97 — 2 137 — 2 Embedded derivatives and MCGs: Within fixed maturity investments (4) N/A — 4 N/A 2 — Within reinsurance agreements (5) N/A 55 41 N/A 61 49 MCGs (6) N/A — 4 N/A — 8 Stabilizer (6) N/A — 15 N/A — 1 Total $ 358 $ 396 $ 374 $ 429 (1) Open derivative contracts are reported as Derivatives assets or liabilities at fair value on the Consolidated Balance Sheets. (2) Total carrying amount of hedged assets and liabilities was $307 and $106 as of December 31, 2024 and 2023, respectively. (3) Cumulative amount of fair value hedging adjustments included in the carrying amount of hedged assets and liabilities was $(8) and $(6) as of December 31, 2024 and 2023, respectively, of which includes $2 and $0, respectively, of hedging adjustments on discontinued hedging relationships. (4) Included in Fixed maturities, available-for-sale, at fair value on the Consolidated Balance Sheets. (5) Included in Other liabilities, Other assets, and Premium receivable and reinsurance recoverable on the Consolidated Balance Sheets. (6) Included in Contract owner account balances on the Consolidated Balance Sheets. N/A - Not applicable
Offsetting Assets and Liabilities	The Company does not offset any derivative assets and liabilities in the Consolidated Balance Sheets. The disclosures set out in the table below include the fair values of Over-The-Counter (“OTC”) and cleared derivatives excluding exchange traded contracts subject to master netting agreements or similar agreements as of the dates indicated: Gross Amount Recognized (1) Counterparty Netting (2) Cash Collateral Netting (2) Securities Collateral Netting (2) Net receivables/ payables December 31, 2024 Derivative assets $ 303 $ (261) $ (34) $ (3) $ 5 Derivative liabilities 332 (261) (58) (6) 7 December 31, 2023 Derivative assets 311 (216) (76) (8) 11 Derivative liabilities 370 (216) (150) (3) 1 (1) As of December 31, 2024, gross amounts exclude asset and liability exchange traded contracts of $0 and $0, respectively. As of December 31, 2023, gross amounts exclude asset and liability exchange traded contracts of $0 and $1, respectively. (2) Represents the netting of receivable with payable balances, net of collateral, for the same counterparty under eligible netting agreements.
Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance	The location and effect of derivatives qualifying for hedge accounting on the Consolidated Statements of Operations and Consolidated Statements of Comprehensive Income are as follows for the periods indicated: Year Ended December 31, 2024 2023 2022 Interest Rate Contracts Foreign Exchange Contracts Interest Rate Contracts Foreign Exchange Contracts Interest Rate Contracts Foreign Exchange Contracts Location of Gain (Loss) Reclassified from AOCI into Income Net investment income Net investment income and Net gains (losses) Net investment income Net investment income and Net gains (losses) Net investment income Net investment income and Net gains (losses) Amount of Gain (Loss) Recognized in Other Comprehensive Income (1) $ — $ 18 $ — $ (43) $ (2) $ 70 Amount of Gain (Loss) Reclassified from AOCI — 16 — 10 — 11 (1) See the Accumulated Other Comprehensive Income (Loss) Note to these Consolidated Financial Statements for additional information. The location and amount of gain (loss) recognized in the Consolidated Statements of Operations for derivatives qualifying for hedge accounting are as follows for the periods indicated: Year Ended December 31, 2024 2023 2022 Net investment Income Net gains (losses) Net investment Income Net gains (losses) Net investment Income Net gains (losses) Total amounts of line items presented in the statements of operations in which the effects of fair value or cash flow hedges are recorded $ 2,074 $ (27) $ 2,159 $ (72) $ 2,281 $ (686) Fair value hedges: Interest rate contracts: Hedged items — 2 — — — — Derivatives designated as hedging instruments (1) — (2) — — — — Foreign exchange contracts: Hedged items — (6) — 3 — (6) Derivatives designated as hedging instruments (1) — 8 — (1) — 7 Cash flow hedges: Foreign exchange contracts: Gain (loss) reclassified from AOCI into income (2) 10 6 10 — 11 — (1) For the years ended December 31, 2024, 2023, and 2022 $2, $2 and $1, respectively, of the change in derivative instruments designated and qualifying as fair value hedges were excluded from the assessment of hedge effectiveness and recognized currently in earnings. (2) See the Accumulated Other Comprehensive Income (Loss) Note to these Consolidated Financial Statements for additional information. The location and effect of derivatives not designated as hedging instruments on the Consolidated Statements of Operations are as follows for the periods indicated: Location of Gain (Loss) Recognized on Derivative Year Ended December 31, 2024 2023 2022 Derivatives: Non-qualifying for hedge accounting Interest rate contracts Net gains (losses) $ 170 $ 15 $ 334 Foreign exchange contracts Net gains (losses) (8) — (1) Equity contracts Net gains (losses) 18 14 (32) Credit contracts Net gains (losses) 1 1 (3) Embedded derivatives and MCGs: Within fixed maturity investments Net gains (losses) (6) (1) (9) Within reinsurance agreements (1) Policyholder benefits (3) (37) 217 MCGs Net gains (losses) 4 (2) (5) Stabilizer Net gains (losses) (14) (1) 19 Total $ 162 $ (11) $ 520 (1) For the years ended December 31, 2024, 2023, and 2022, the amount excludes gains (losses) from standalone derivatives of $(1), $0, and $(12), respectively, recognized in Net gains (losses).

Fair Value Measurements (excl_2

Fair Value Measurements (excluding Consolidated Investment Entities) (Tables)	12 Months Ended
	Dec. 31, 2024
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis	The following table presents the Company's hierarchy for its assets and liabilities measured at fair value on a recurring basis as of December 31, 2024: Level 1 Level 2 Level 3 Total Assets: Fixed maturities, including securities pledged: U.S. Treasuries $ 402 $ 70 $ — $ 472 U.S. Government agencies and authorities — 30 — 30 State, municipalities and political subdivisions — 580 — 580 U.S. corporate public securities — 6,949 59 7,008 U.S. corporate private securities — 3,486 1,497 4,983 Foreign corporate public securities and foreign governments (1) — 2,412 60 2,472 Foreign corporate private securities (1) — 2,116 421 2,537 Residential mortgage-backed securities — 3,404 67 3,471 Commercial mortgage-backed securities — 3,132 — 3,132 Other asset-backed securities — 2,746 23 2,769 Total fixed maturities, including securities pledged 402 24,925 2,127 27,454 Equity securities 148 — 98 246 Derivatives: Interest rate contracts — 246 — 246 Foreign exchange contracts — 55 — 55 Equity contracts — 2 — 2 Embedded derivative on reinsurance — 55 — 55 Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements 2,511 1 23 2,535 Assets held in separate accounts 95,946 5,390 340 101,676 Total assets $ 99,007 $ 30,674 $ 2,588 $ 132,269 Liabilities: Contingent consideration $ — $ — $ 2 $ 2 Stabilizer and MCGs — — 19 19 Derivatives: Interest rate contracts 11 302 — 313 Foreign exchange contracts — 8 — 8 Equity contracts — 9 — 9 Credit contracts — 2 — 2 Embedded derivative on reinsurance — (12) (2) 53 41 Total liabilities $ 11 $ 309 $ 74 $ 394 (1) Primarily U.S. dollar denominated. (2) The Company classifies the embedded derivative within liabilities given the underlying nature of the balance and the right-of-offset. The following table presents the Company's hierarchy for its assets and liabilities measured at fair value on a recurring basis as of December 31, 2023: Level 1 Level 2 Level 3 Total Assets: Fixed maturities, including securities pledged: U.S. Treasuries $ 346 $ 57 $ — $ 403 U.S. Government agencies and authorities — 55 1 56 State, municipalities and political subdivisions — 771 — 771 U.S. corporate public securities — 7,648 18 7,666 U.S. corporate private securities — 3,234 1,526 4,760 Foreign corporate public securities and foreign governments (1) — 2,702 — 2,702 Foreign corporate private securities (1) — 2,376 436 2,812 Residential mortgage-backed securities — 3,419 57 3,476 Commercial mortgage-backed securities — 3,495 — 3,495 Other asset-backed securities — 2,418 52 2,470 Total fixed maturities, including securities pledged 346 26,175 2,090 28,611 Equity securities 140 — 96 236 Derivatives: Interest rate contracts 7 263 — 270 Foreign exchange contracts — 37 — 37 Equity contracts — 4 — 4 Embedded derivative on reinsurance — 61 — 61 Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements 2,148 17 — 2,165 Assets held in separate accounts 87,180 5,605 348 93,133 Total assets $ 89,821 $ 32,162 $ 2,534 $ 124,517 Liabilities: Contingent consideration $ — $ — $ 51 $ 51 Stabilizer and MCGs — — 9 9 Derivatives: Interest rate contracts — 354 — 354 Foreign exchange contracts — 13 — 13 Equity contracts — 2 — 2 Credit contracts — 2 — 2 Embedded derivative on reinsurance — (9) (2) 58 49 Total liabilities $ — $ 362 $ 118 $ 480 (1) Primarily U.S. dollar denominated. (2) The Company classifies the embedded derivative within liabilities given the underlying nature of the balance and the right-of-offset.
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation	The following table summarizes the change in fair value of the Company's Level 3 assets and liabilities and transfers in and out of Level 3 for the period indicated : Year Ended December 31, 2024 Fair Value Realized/ Unrealized Gains (Losses) Included in: Purchases Issuances Sales Settlements Transfers Transfers Fair Value as of December 31 Change In Unrealized Gains (Losses) Included in Earnings (3) Change In (3) Net OCI Fixed maturities, including securities pledged: U.S. Government agencies and authorities $ 1 $ — $ — $ — $ — $ — $ — $ — $ (1) $ — $ — $ — U.S. corporate public securities 18 — (1) 49 — — (7) — — 59 — (2) U.S. corporate private securities 1,526 (4) 1 377 — (22) (246) — (135) 1,497 — (5) Foreign corporate public securities and foreign governments (1) — — — 60 — — — — — 60 — — Foreign corporate private securities (1) 436 (8) (33) 35 — (9) (51) 51 — 421 — (33) Residential mortgage-backed securities 57 (4) — 18 — — — — (4) 67 (4) — Other asset-backed securities 52 — — 3 — — (7) — (25) 23 — — Total fixed maturities including securities pledged 2,090 (16) (33) 542 — (31) (311) 51 (165) 2,127 (4) (40) Equity securities, at fair value 96 2 — — — — — — — 98 2 — Contingent consideration (51) 1 — — — — 48 — — (2) — — Stabilizer and MCGs (2) (9) (8) — — (2) — — — — (19) — — Embedded derivatives on (58) (1) — — — — 6 — — (53) — — Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements — — — 23 — — — — — 23 — — Assets held in separate accounts (4) 348 6 — 47 — (26) — 5 (40) 340 — — (1) Primarily U.S. dollar denominated. (2) All gains and losses on Level 3 liabilities are classified as realized gains (losses) for the purpose of this disclosure because it is impracticable to track realized and unrealized gains (losses) separately on a contract-by contract basis. These amounts are included in Net gains (losses) (3) For financial instruments still held as of December 31 amounts are included in Net investment income and Net gains (losses) in the Consolidated Statements of Operations or Unrealized gains (losses) on securities in the Consolidated Statements of Comprehensive Income. (4) The investment income and realized gains (losses) and change in unrealized gains (losses) included in net income for separate account assets are offset by an equal amount for separate account liabilities, which results in a net zero impact on Net income (loss) for the Company. Year Ended December 31, 2023 Fair Value Realized/ Unrealized Gains (Losses) Included in: Purchases Issuances Sales Settlements Transfers Transfers Fair Value as of December 31 Change In Unrealized Gains (Losses) Included in Earnings (3) Change In (3) Net OCI Fixed maturities, including securities pledged: U.S. Government agencies and authorities $ 1 $ — $ — $ — $ — $ — $ — $ — $ — $ 1 $ — $ — U.S. corporate public securities 20 1 — — — — — — (3) 18 — — U.S. corporate private securities 1,801 1 22 142 — (4) (219) 79 (296) 1,526 1 19 Foreign corporate public securities and foreign governments (1) 3 — — — — — — — (3) — — — Foreign corporate private securities (1) 432 3 9 129 — (14) (167) 51 (7) 436 3 8 Residential mortgage-backed securities 28 (4) — 31 — — — 2 — 57 (3) — Other asset-backed securities 64 — 1 15 — (2) (4) — (22) 52 — — Total fixed maturities including securities pledged 2,349 1 32 317 — (20) (390) 132 (331) 2,090 1 27 Equity securities, at fair value 196 (3) — 3 — — (100) — — 96 (3) — Contingent consideration (112) 61 (5) — — — — — — — (51) — — Stabilizer and MCGs (2) (6) (1) — — (2) — — — — (9) — — Embedded derivatives on (58) — — — — — — — — (58) — — Assets held in separate accounts (4) 347 1 — 8 — (21) — 14 (1) 348 — — (1) Primarily U.S. dollar denominated. (2) All gains and losses on Level 3 liabilities are classified as realized gains (losses) for the purpose of this disclosure because it is impracticable to track realized and unrealized gains (losses) separately on a contract-by contract basis. These amounts are included in Net gains (losses) in the Consolidated Statements of Operations. (3) For financial instruments still held as of December 31 amounts are included in Net investment income and Net gains (losses) in the Consolidated Statements of Operations or Unrealized gains (losses) on securities in the Consolidated Statements of Comprehensive Income. (4) The investment income and realized gains (losses) and change in unrealized gains (losses) included in net income for separate account assets are offset by an equal amount for separate account liabilities, which results in a net zero impact on Net income (loss) for the Company. (5) Represents the reduction in expected earn out associated with a prior acquisition within the Investment Management segment. This change is included within Operating expenses in the Consolidated Statements of Operations.
Fair Value, by Balance Sheet Grouping	The carrying values and estimated fair values of the Company's financial instruments as of the dates indicated: December 31, 2024 December 31, 2023 Carrying Fair Carrying Fair Assets: Fixed maturities, including securities pledged $ 27,454 $ 27,454 $ 28,611 $ 28,611 Equity securities 246 246 236 236 Mortgage loans on real estate 4,699 4,459 5,218 4,941 Policy loans 342 342 352 352 Cash, cash equivalents, short-term investments and short-term investments under securities loan agreements 2,535 2,535 2,165 2,165 Derivatives 303 303 311 311 Embedded derivatives on reinsurance 55 55 61 61 Other investments, including securities pledged 74 74 64 64 Assets held in separate accounts 101,676 101,676 93,133 93,133 Liabilities: Investment contract liabilities: Funding agreements without fixed maturities and deferred annuities (1) $ 31,082 $ 32,877 $ 32,848 $ 34,856 Funding agreements with fixed maturities 1,249 1,257 1,175 1,178 Supplementary contracts, immediate annuities and other 570 515 628 571 Stabilizer and MCGs 19 19 9 9 Derivatives 332 332 371 371 Embedded derivatives on reinsurance 41 41 49 49 Short-term debt 399 399 1 1 Long-term debt 2,103 2,023 2,097 1,998 (1) Certain amounts included in Funding agreements without fixed maturities and deferred annuities are also reflected within the Stabilizer and MCGs section of the table above. The following table summarizes the fair value hierarchy levels of consolidated investment entities as of December 31, 2024: Level 1 Level 2 Level 3 NAV Total Assets VIEs Cash and cash equivalents $ 113 $ — $ — $ — $ 113 Corporate loans — 1,434 — — 1,434 Limited partnerships/corporations — — — 3,067 3,067 Other investments (1) — — 53 — 53 VOEs Cash and cash equivalents 2 — — — 2 Other investments (1) — — — 50 50 Total assets $ 115 $ 1,434 $ 53 $ 3,117 $ 4,719 Liabilities VIEs CLO notes $ — $ 1,101 $ — $ — $ 1,101 Total liabilities $ — $ 1,101 $ — $ — $ 1,101 (1) VIEs and VOEs - Other investments are reflected in Assets related to consolidated investment entities - Other assets on the Company's Consolidated Balance Sheets. The following table summarizes the fair value hierarchy levels of consolidated investment entities as of December 31, 2023: Level 1 Level 2 Level 3 NAV Total Assets VIEs Cash and cash equivalents $ 181 $ — $ — $ — $ 181 Corporate loans — 1,404 — — 1,404 Limited partnerships/corporations — — — 2,861 2,861 Total assets $ 181 $ 1,404 $ — $ 2,861 $ 4,446 Liabilities VIEs CLO notes $ — $ 1,332 $ — $ — $ 1,332 Total liabilities $ — $ 1,332 $ — $ — $ 1,332
Fair Value Disclosure of Asset and Liability Not Measured at Fair Value	The following table presents the classification of financial instruments which are not carried at fair value on the Consolidated Balance Sheets: Financial Instrument Classification Mortgage loans on real estate Level 3 Policy loans Level 2 Other investments Level 2 Funding agreements without fixed maturities and deferred annuities Level 3 Funding agreements with fixed maturities Level 2 Supplementary contracts and immediate annuities Level 3 Short-term debt and Long-term debt Level 2

Deferred Policy Acquisition C_2

Deferred Policy Acquisition Costs and Value of Business Acquired (Tables)	12 Months Ended
	Dec. 31, 2024
Insurance [Abstract]
Deferred Policy Acquisition Costs and Value of Business Acquired	The following table presents a rollforward of DAC and VOBA for the periods indicated: DAC VOBA Wealth Solutions Deferred and Individual Annuities Health Solutions Voluntary (1) Businesses exited Balance as of January 1, 2022 $ 691 $ 144 $ 1,158 $ 473 Deferrals of commissions and expenses 59 55 — 5 Amortization expense (59) (28) (115) (39) Balance as of December 31, 2022 $ 691 $ 171 $ 1,043 $ 439 Deferrals of commissions and expenses 59 54 — 4 Amortization expense (55) (32) (105) (37) Balance as of December 31, 2023 $ 695 $ 193 $ 938 $ 406 Deferrals of commissions and expenses 60 58 — 3 Amortization expense (54) (36) (100) (33) Balance as of December 31, 2024 $ 701 215 $ 838 $ 376 (1) During the second quarter of 2024, the Company reclassified certain insurance products within the Health Solutions segment from Group to Voluntary. As a result, the rollforward above and the reconciliation table below have been updated for all periods presented to reflect this change. The following table shows a reconciliation of DAC and VOBA balances to the Consolidated Balance Sheets for the periods indicated: December 31, 2024 December 31, 2023 DAC: Wealth Solutions Deferred and Individual Annuities $ 701 $ 695 Health Solutions Voluntary 215 193 Businesses exited 838 938 Other 18 18 VOBA 376 406 Total $ 2,148 $ 2,250
Estimated Amount of VOBA Amortization Expense	The estimated amount of VOBA amortization expense, net of interest, during the next five years is presented in the following table. Actual amortization incurred during these years may vary as assumptions are modified to incorporate actual results and/or changes in best estimates of future results. Year Amount 2025 $ 30 2026 27 2027 25 2028 23 2029 22

Reserves for Future Policy Be_2

Reserves for Future Policy Benefits and Contract Owner Account Balances (Tables)	12 Months Ended
	Dec. 31, 2024
Insurance [Abstract]
Liability for Future Policy Benefit, Activity	The following tables present the balances and changes in the liability for future policy benefits for Health Solutions Group, Health Solutions Voluntary, and Businesses Exited as of December 31, 2024 and 2023: Health Solutions Group Health Solutions Voluntary Businesses Exited 2024 2023 2024 2023 2024 2023 Present Value of Expected Net Premiums: Balance at January 1 $ 68 $ 77 $ 101 $ 97 $ 3,145 $ 4,244 Beginning balance at original discount rate 71 84 102 100 2,992 4,128 Reclassifications (2) (65) — 65 — — — Effect of change in cash flow assumptions (1) (6) (1) 6 110 (921) Effect of actual variances from expected experience — 11 40 8 (106) (91) Adjusted balance at January 1 5 89 206 114 2,996 3,116 Interest accrual — 2 8 4 158 196 Net premiums collected (1) (1) (20) (34) (16) (312) (320) Ending balance at original discount rate 4 71 180 102 2,842 2,992 Effects of changes in discount rate assumptions — (3) (9) (1) 30 153 Balance at end of period $ 4 $ 68 $ 171 $ 101 $ 2,872 $ 3,145 Present Value of Expected Future Policy Benefits: Balance at January 1 $ 899 $ 881 $ 307 $ 285 $ 7,538 $ 8,639 Beginning balance at original discount rate 918 913 307 294 7,404 8,644 Reclassifications (2) (150) — 150 — — — Effect of change in cash flow assumptions (12) (8) (1) 13 187 (805) Effect of actual variances from expected experience 10 (16) 54 9 (90) (123) Adjusted balance at January 1 766 889 510 316 7,501 7,716 Issuances 131 136 — — 14 17 Interest accrual 21 24 18 14 370 412 Benefit payments (117) (131) (41) (23) (747) (741) Ending balance at original discount rate 801 918 487 307 7,138 7,404 Effects of changes in discount rate assumptions (29) (19) (26) — (121) 134 Balance at end of period $ 772 $ 899 $ 461 $ 307 $ 7,017 $ 7,538 Net liability for future policy benefits $ 768 $ 831 $ 290 $ 206 $ 4,145 $ 4,392 Less: Reinsurance recoverable 330 315 9 — 4,056 4,342 Net liability for future policy benefits, after reinsurance recoverable $ 438 $ 516 $ 281 $ 206 $ 89 $ 50 (1) Net Premiums collected represent the portion of gross premiums collected from policyholders that is used to fund expected benefit payments. (2) During the second quarter 2024, the Company reclassified certain insurance products within the Health Solutions from Group to Voluntary. The table was not updated to reflect the reclassification impact on the comparative information and the impacts were primarily related to Net premiums collected and Benefit payments of $(17) and $(17), respectively. The following table presents a rollforward of the additional reserve liability for Businesses exited for the periods indicated: Businesses exited December 31, 2024 December 31, 2023 Balance at beginning of period $ 2,001 $ 2,107 Effect of change in cash flow assumptions (39) (44) Effect of actual variances from expected experience 14 (100) Adjusted balance at January 1 1,976 1,963 Interest accrual 83 84 Excess Benefits (404) (417) Assessments 228 371 Balance at end of period 1,883 2,001 Less: Reinsurance recoverable 1,832 1,950 Net additional liability, after reinsurance recoverable $ 51 $ 51 Future policy benefits include the liability for unpaid claims and claim adjustment expenses related to medical stop loss products within the Health Solutions segment. The following table presents a rollforward of the liability for unpaid claims and claim adjustment expenses for the periods indicated: Medical Stop Loss 2024 2023 Balance at January 1 $ 401 $ 398 Less: reinsurance recoverable (16) (6) Net balance at January 1 385 392 Incurred claims and claim adjustment expenses related to: Current year 1,538 1,042 Prior years 143 (8) Total incurred 1,681 1,034 Paid claim and claim adjustment expenses related to: Current year (964) (665) Prior years (512) (376) Total paid (1,476) (1,041) Net balance at December 31 590 385 Plus: reinsurance recoverable 5 16 Balance at December 31 $ 595 $ 401 Pricing, underwriting and reserving on the medical stop loss products are performed based on policy years and key metrics such as loss ratios are tracked, managed and reported on this basis. The majority of the medical stop loss policies renew in January of each year. For the year ended December 31, 2024, $143 of claims incurred on prior years is primarily attributed to incurred claims and unfavorable claim development for policy years effective during 2023. For the year ended December 31, 2023, $(8) of claims incurred on prior years is primarily attributed to favorable claim development partially offset by incurred claims for policy years effective during 2022. The Company tracks claim frequency by the number of claims paid for each policy year. Payments of medical stop loss claims are substantially complete within two years. The following tables present cumulative claim development information about incurred and paid claims and claim adjustment expenses, net of reinsurance, total IBNR, and claim frequencies for medical stop loss products as of December 31, 2024: Net cumulative incurred claims and claim adjustment expenses Incurred but not reported claims Cumulative number of reported claims December 31, 2022 (1) 2023 (1) 2024 2024 2024 Policy year 2022 $ 859 $ 872 $ 870 $ 2 26,060 2023 1,042 1,191 14 32,515 2024 1,538 574 24,560 Total 3,599 Cumulative paid claims and paid claim adjustment expenses, net of reinsurance (3,009) Total unpaid claims and claim adjustment expenses, net of reinsurance $ 590 (1) Unaudited Net cumulative paid claims and claim adjustment expenses December 31, 2022 (1) 2023 (1) 2024 Policy year 2022 $ 496 $ 862 $ 868 2023 665 1,177 2024 964 Total cumulative net paid claims and claim adjustment expenses, net of reinsurance $ 3,009 (1) Unaudited The reconciliation of the net liability for future policy benefits to the liability for future policy benefits in the Consolidated Balance Sheets is presented below: December 31, 2024 December 31, 2023 Health Solutions Group $ 768 $ 831 Health Solutions Voluntary 290 206 Businesses Exited - Future policy benefits 4,145 4,392 Businesses Exited - Additional liability 1,883 2,001 Business Exited - Other 1,284 1,335 Medical stop loss products 595 401 Other 367 394 Total $ 9,332 $ 9,560 The amount of undiscounted expected gross premiums and future benefit payments is presented in the table below: December 31, 2024 December 31, 2023 Undiscounted Discounted Undiscounted Discounted Health Solutions Group Expected future benefit payments $ 990 $ 801 $ 1,144 $ 918 Expected future gross premiums 11 8 271 214 Health Solutions Voluntary Expected future benefit payments 881 487 668 307 Expected future gross premiums 631 427 341 213 The following table presents the weighted average duration of the liability for future policy benefits and the weighted average interest rates for the periods indicated: Health Solutions Group Health Solutions Voluntary Businesses Exited December 31, 2024 December 31, 2023 December 31, 2024 December 31, 2023 December 31, 2024 December 31, 2023 Weighted average duration (in years) (1) 7 7 14 14 8 8 Interest accretion rate 4.0 % 4.0 % 5.1 % 5.2 % 5.0 % 4.9 % Current discount rate 5.4 % 4.9 % 5.7 % 5.1 % 5.6 % 5.1 % (1) Weighted average duration (in years) for Businesses Exited includes additional liability.
Policyholder Account Balance	The following table presents a rollforward of Contract owner account balances for the periods indicated: Wealth Solutions Deferred Group and Individual Annuity Businesses Exited December 31, 2024 December 31, 2023 December 31, 2024 December 31, 2023 Balance at January 1 $ 31,139 $ 33,622 $ 4,635 $ 5,146 Deposits 2,505 2,309 287 288 Fee income (50) (9) (371) (373) Surrenders, withdrawals and benefits (5,127) (5,663) (544) (577) Net transfers (from) to the general account (1) 312 (5) 4 10 Interest credited 845 885 171 141 Ending Balance $ 29,624 $ 31,139 $ 4,182 $ 4,635 Weighted-average crediting rate 2.8 % 2.8 % 3.9 % 2.5 % Net amount at risk (2) $ 90 $ 123 $ 676 $ 734 Cash surrender value $ 29,169 $ 30,676 $ 1,236 $ 1,491 (1) Net transfers (from) to the general account for Wealth Solutions include transfers of $(1,149) and $(523) for 2024 and 2023, respectively related to Voya-managed institutional/mutual fund plan assets in trust that are not reflected on the Consolidated Balance Sheets. (2) For those guarantees of benefits that are payable in the event of death, the net amount at risk is generally defined as the current guaranteed minimum death benefit in excess of the current account balance at the balance sheet date and is calculated at a contract level. When a contract has both a living benefit and a death benefit, the Company calculates NAR at a contract level and aggregates the higher of the two values together. The following table presents a reconciliation of the Contract owner account balances to the Consolidated Balance Sheets for the periods indicated: December 31, 2024 December 31, 2023 Wealth Solutions Deferred group and individual annuity $ 29,624 $ 31,139 Businesses exited 4,182 4,635 Non-putable funding agreements 1,249 1,175 Business exited - Other 1,158 1,275 Other (1) 891 950 Total $ 37,104 $ 39,174 (1) Primarily consists of universal life contracts The following table summarizes detail on the differences between the interest rate being credited to contract holders as of the periods indicated, and the respective guaranteed minimum interest rates ("GMIRs"): Account Value (1) Excess of crediting rate over GMIR At GMIR Up to .50% Above GMIR 0.51% - 1.00% 1.01% - 1.50% Above GMIR 1.51% - 2.00% Above GMIR More than 2.00% Above GMIR Total As of December 31, 2024 Up to 1.00% $ 82 $ 4,378 $ 3,691 $ 1,705 $ 1,545 $ 928 $ 12,329 1.01% - 2.00% 437 106 54 7 2 6 612 2.01% - 3.00% 10,266 93 62 60 — 4 10,485 3.01% - 4.00% 8,368 150 — 1 — — 8,519 4.01% and Above 1,464 80 — — — — 1,544 Renewable beyond 12 months (MYGA) (2) 364 — — — 2 — 366 Total discretionary rate setting products $ 20,981 $ 4,807 $ 3,807 $ 1,773 $ 1,549 $ 938 $ 33,855 As of December 31, 2023 Up to 1.00% $ 120 $ 5,070 $ 3,460 $ 2,215 $ 863 $ 800 $ 12,528 1.01% - 2.00% 527 131 50 8 3 6 725 2.01% - 3.00% 11,225 93 63 108 — 3 11,492 3.01% - 4.00% 8,873 152 — 6 — — 9,031 4.01% and Above 1,566 83 — — — — 1,649 Renewable beyond 12 months (MYGA) (2) 428 — — — 3 — 431 Total discretionary rate setting products $ 22,739 $ 5,529 $ 3,573 $ 2,337 $ 869 $ 809 $ 35,856 (1) Includes only the account values for investment spread products with GMIRs and discretionary crediting rates, net of policy loans. Excludes Stabilizer products, which are fee based. (2)
Schedule of Liability for Unpaid Claims and Claims Adjustment Expense	Future policy benefits include the liability for unpaid claims and claim adjustment expenses related to medical stop loss products within the Health Solutions segment. The following table presents a rollforward of the liability for unpaid claims and claim adjustment expenses for the periods indicated: Medical Stop Loss 2024 2023 Balance at January 1 $ 401 $ 398 Less: reinsurance recoverable (16) (6) Net balance at January 1 385 392 Incurred claims and claim adjustment expenses related to: Current year 1,538 1,042 Prior years 143 (8) Total incurred 1,681 1,034 Paid claim and claim adjustment expenses related to: Current year (964) (665) Prior years (512) (376) Total paid (1,476) (1,041) Net balance at December 31 590 385 Plus: reinsurance recoverable 5 16 Balance at December 31 $ 595 $ 401
Short-Duration Insurance Contracts, Claims Development	The following tables present cumulative claim development information about incurred and paid claims and claim adjustment expenses, net of reinsurance, total IBNR, and claim frequencies for medical stop loss products as of December 31, 2024: Net cumulative incurred claims and claim adjustment expenses Incurred but not reported claims Cumulative number of reported claims December 31, 2022 (1) 2023 (1) 2024 2024 2024 Policy year 2022 $ 859 $ 872 $ 870 $ 2 26,060 2023 1,042 1,191 14 32,515 2024 1,538 574 24,560 Total 3,599 Cumulative paid claims and paid claim adjustment expenses, net of reinsurance (3,009) Total unpaid claims and claim adjustment expenses, net of reinsurance $ 590 (1) Unaudited Net cumulative paid claims and claim adjustment expenses December 31, 2022 (1) 2023 (1) 2024 Policy year 2022 $ 496 $ 862 $ 868 2023 665 1,177 2024 964 Total cumulative net paid claims and claim adjustment expenses, net of reinsurance $ 3,009 (1) Unaudited

Reinsurance (Tables)

Reinsurance (Tables)	12 Months Ended
	Dec. 31, 2024
Insurance [Abstract]
Effects of Reinsurance	Information regarding the effect of reinsurance on the Consolidated Balance Sheets is as follows as of the periods indicated: December 31, 2024 Direct Assumed Ceded Total, Assets Premium receivable $ 205 $ 10 $ (238) $ (23) Reinsurance recoverable, net of allowance for credit losses — — 11,307 11,307 Total $ 205 $ 10 $ 11,069 $ 11,284 Liabilities Future policy benefits and contract owner account balances $ 45,540 $ 896 $ — $ 46,436 Liability for funds withheld under reinsurance agreements 103 — — 103 Total $ 45,643 $ 896 $ — $ 46,539 December 31, 2023 Direct Assumed Ceded Total, Assets Premium receivable $ 193 $ 9 $ (219) $ (17) Reinsurance recoverable, net of allowance for credit losses — — 11,999 11,999 Total $ 193 $ 9 $ 11,780 $ 11,982 Liabilities Future policy benefits and contract owner account balances $ 47,781 $ 953 $ — $ 48,734 Liability for funds withheld under reinsurance agreements 103 — — 103 Total $ 47,884 $ 953 $ — $ 48,837 Information regarding the effect of reinsurance on the Consolidated Statements of Operations is as follows for the periods indicated: Year Ended December 31, 2024 2023 2022 Premiums: Direct premiums $ 4,084 $ 3,599 $ 3,257 Reinsurance assumed 21 26 25 Reinsurance ceded (929) (908) (859) Net premiums $ 3,176 $ 2,717 $ 2,423 Fee income: Gross fee income $ 2,494 $ 2,303 $ 2,137 Reinsurance assumed 16 17 18 Reinsurance ceded (397) (404) (413) Net fee income $ 2,113 $ 1,916 $ 1,742 Interest credited and other benefits to contract owners / policyholders: Direct interest credited and other benefits to contract owners / policyholders $ 4,931 $ 4,322 $ 4,448 Reinsurance assumed 60 64 50 Reinsurance ceded (1,372) (1,350) (1,970) Net interest credited and other benefits to contract owners / policyholders $ 3,619 $ 3,036 $ 2,528

Separate Accounts (Tables)

Separate Accounts (Tables)	12 Months Ended
	Dec. 31, 2024
Other Liabilities Disclosure [Abstract]
Separate Account, Liability	The following tables present a rollforward of separate account liabilities for the Wealth Solutions stabilizer and deferred annuity business, including a reconciliation to the Consolidated Balance Sheets, for the periods indicated: December 31, 2024 December 31, 2023 Wealth Solutions Stabilizer Deferred Annuity Total Stabilizer Deferred Annuity Total Balance at January 1 $ 7,175 $ 82,310 $ 89,485 $ 7,196 $ 69,152 $ 76,348 Premiums and deposits 891 9,970 10,861 940 10,052 10,992 Fee income (33) (487) (520) (34) (426) (460) Surrenders, withdrawals and benefits (1,376) (12,539) (13,915) (1,342) (9,631) (10,973) Net transfers (from) to the separate account — (1,461) (1,461) — (518) (518) Investment performance 244 12,963 13,207 415 13,681 14,096 Balance at end of period $ 6,901 $ 90,756 $ 97,657 $ 7,175 $ 82,310 $ 89,485 Reconciliation to Consolidated Balance Sheets: Other variable products liabilities 4,019 3,648 Total Separate Account liabilities $ 101,676 $ 93,133
Fair Value, Separate Account Investment	The aggregate fair value of assets, by major investment asset category, supporting separate accounts were as follows for the periods indicated: December 31, 2024 December 31, 2023 US Treasury securities and obligations of US government corporations and agencies $ 913 $ 1,015 Corporate and foreign debt securities 2,493 2,528 Mortgage-backed securities 3,087 3,231 Equity securities (including mutual funds) 94,685 85,916 Cash, cash equivalents and short-term investments 437 399 Receivable for securities and accruals 61 44 Total $ 101,676 $ 93,133

Segments (Tables)

Segments (Tables)	12 Months Ended
	Dec. 31, 2024
Segment Reporting [Abstract]
Schedule of Operating Earnings Before Income Taxes from Segments	The following tables reconcile Adjusted operating revenues to Total revenues and Adjusted operating earnings before income taxes to Income (loss) before income taxes for the periods indicated: Year Ended December 31, 2024 Wealth Solutions Health Solutions Investment Management Corporate Total Revenues: External customer revenue (1) $ 1,332 $ 3,438 $ 920 $ 22 $ 5,712 Net investment income and Net gains (losses) 1,711 138 20 178 2,047 Income (loss) related to CIEs — — 288 3 291 Intersegment Fee income and elimination — — 79 (79) — Total revenues 8,050 Adjustments (138) 1 (325) (101) (563) (2) Adjusted operating revenues 2,905 3,577 982 23 7,487 Less: Interest credited and other benefits to contract owners/policyholders 849 2,602 — — 3,451 Administrative expenses 897 525 703 — 2,125 Premium taxes, fees and assessments — 186 — — 186 Net commissions 255 188 — — 443 DAC/VOBA and other intangibles amortization 84 36 — — 120 Financing costs and preferred dividends — — — 162 162 Other corporate — — — 66 66 Adjusted operating earnings before income taxes including Allianz noncontrolling interest 820 40 278 (205) 933 Less: Earnings (loss) attributable to Allianz noncontrolling interest — — 65 (2) 63 Adjusted operating earnings before income taxes 820 40 213 (203) 870 Plus adjustments: Net investment gains (losses) 50 Income (loss) related to businesses exited or to be exited through reinsurance or divestment (142) Income (loss) attributable to noncontrolling interests 75 Dividend payments made to preferred shareholders 41 Other adjustments (95) Income (loss) before income taxes $ 799 (1) Includes Fee income, Premiums, and Other revenue and excludes intersegment fee income and the related elimination. (2) Includes Net investment gains (losses) of $22, Revenues related to business exited or to be exited through reinsurance or divestment of $102, Revenues attributable to noncontrolling interests of $243, and Other adjustments of $196. Year Ended December 31, 2023 Wealth Solutions Health Solutions Investment Management Corporate Total Revenues: External customer revenue (1) $ 1,121 $ 2,948 $ 831 $ 60 $ 4,960 Net investment income and Net gains (losses) 1,663 130 26 268 2,087 Income (loss) related to CIEs — — 301 — 301 Intersegment Fee income and elimination — — 85 (85) — Total revenues 7,348 Adjustments (8) 4 (327) (195) (526) (2) Adjusted operating revenues 2,776 3,082 916 48 6,822 Less: Interest credited and other benefits to contract owners/policyholders 895 1,896 — — 2,790 Administrative expenses 931 506 690 — 2,127 Premium taxes, fees and assessments — 147 — — 147 Net commissions 229 186 — — 415 DAC/VOBA and other intangibles amortization 90 33 — — 123 Financing costs and preferred dividends — — — 161 161 Other corporate — — — 96 96 Adjusted operating earnings before income taxes including Allianz noncontrolling interest 632 315 225 (208) 964 Less: Earnings (loss) attributable to Allianz noncontrolling interest — — 49 (1) 48 Adjusted operating earnings before income taxes 632 315 177 (207) 916 Plus adjustments: Net investment gains (losses) (15) Income (loss) related to businesses exited or to be exited through reinsurance or divestment (182) Income (loss) attributable to noncontrolling interests 104 Dividend payments made to preferred shareholders 36 Other adjustments (180) Income (loss) before income taxes $ 678 (1) Includes Fee income, Premiums, and Other revenue and excludes intersegment fee income and the related elimination. (2) Includes Net investment gains (losses) of $(44), Revenues related to business exited or to be exited through reinsurance or divestment of $113, Revenues attributable to noncontrolling interests of $247, and Other adjustments of $210. Year Ended December 31, 2022 Wealth Solutions Health Solutions Investment Management Corporate Total Revenues: External customer revenue (1) $ 1,100 $ 2,448 $ 663 $ 102 $ 4,313 Net investment income and Net gains (losses) 1,566 135 14 (120) 1,595 Income (loss) related to CIEs — — 22 — 22 Intersegment Fee income and elimination — — 91 (91) — Total revenues 5,930 Adjustments 111 (1) (35) 175 250 (2) Adjusted operating revenues 2,778 2,582 756 67 6,183 Less: Interest credited and other benefits to contract owners/policyholders 886 1,680 — — 2,566 Administrative expenses 867 276 570 — 1,713 Premium taxes, fees and assessments — 126 — — 126 Net commissions 232 167 — — 399 DAC/VOBA and other intangibles amortization 95 29 — — 124 Financing costs and preferred dividends — — — 177 177 Other corporate — — — 142 142 Adjusted operating earnings before income taxes including Allianz noncontrolling interest 697 304 186 (253) 934 Less: Earnings (loss) attributable to Allianz noncontrolling interest — — 27 (1) 26 Adjusted operating earnings before income taxes 697 304 158 (251) 908 Plus adjustments: Net investment gains (losses) (190) Income (loss) related to businesses exited or to be exited through reinsurance or divestment (138) Income (loss) attributable to noncontrolling interests (77) Dividend payments made to preferred shareholders 36 Other adjustments (111) Income (loss) before income taxes $ 428 (1) Includes Fee income, Premiums, and Other revenue and excludes intersegment fee income and the related elimination. (2) Includes Net investment gains (losses) of $(215), Revenues related to business exited or to be exited through reinsurance or divestment of $(123), Revenues attributable to noncontrolling interests of $(33), and Other adjustments of $121.
Schedule of Revenue from Segments	The following tables reconcile Adjusted operating revenues to Total revenues and Adjusted operating earnings before income taxes to Income (loss) before income taxes for the periods indicated: Year Ended December 31, 2024 Wealth Solutions Health Solutions Investment Management Corporate Total Revenues: External customer revenue (1) $ 1,332 $ 3,438 $ 920 $ 22 $ 5,712 Net investment income and Net gains (losses) 1,711 138 20 178 2,047 Income (loss) related to CIEs — — 288 3 291 Intersegment Fee income and elimination — — 79 (79) — Total revenues 8,050 Adjustments (138) 1 (325) (101) (563) (2) Adjusted operating revenues 2,905 3,577 982 23 7,487 Less: Interest credited and other benefits to contract owners/policyholders 849 2,602 — — 3,451 Administrative expenses 897 525 703 — 2,125 Premium taxes, fees and assessments — 186 — — 186 Net commissions 255 188 — — 443 DAC/VOBA and other intangibles amortization 84 36 — — 120 Financing costs and preferred dividends — — — 162 162 Other corporate — — — 66 66 Adjusted operating earnings before income taxes including Allianz noncontrolling interest 820 40 278 (205) 933 Less: Earnings (loss) attributable to Allianz noncontrolling interest — — 65 (2) 63 Adjusted operating earnings before income taxes 820 40 213 (203) 870 Plus adjustments: Net investment gains (losses) 50 Income (loss) related to businesses exited or to be exited through reinsurance or divestment (142) Income (loss) attributable to noncontrolling interests 75 Dividend payments made to preferred shareholders 41 Other adjustments (95) Income (loss) before income taxes $ 799 (1) Includes Fee income, Premiums, and Other revenue and excludes intersegment fee income and the related elimination. (2) Includes Net investment gains (losses) of $22, Revenues related to business exited or to be exited through reinsurance or divestment of $102, Revenues attributable to noncontrolling interests of $243, and Other adjustments of $196. Year Ended December 31, 2023 Wealth Solutions Health Solutions Investment Management Corporate Total Revenues: External customer revenue (1) $ 1,121 $ 2,948 $ 831 $ 60 $ 4,960 Net investment income and Net gains (losses) 1,663 130 26 268 2,087 Income (loss) related to CIEs — — 301 — 301 Intersegment Fee income and elimination — — 85 (85) — Total revenues 7,348 Adjustments (8) 4 (327) (195) (526) (2) Adjusted operating revenues 2,776 3,082 916 48 6,822 Less: Interest credited and other benefits to contract owners/policyholders 895 1,896 — — 2,790 Administrative expenses 931 506 690 — 2,127 Premium taxes, fees and assessments — 147 — — 147 Net commissions 229 186 — — 415 DAC/VOBA and other intangibles amortization 90 33 — — 123 Financing costs and preferred dividends — — — 161 161 Other corporate — — — 96 96 Adjusted operating earnings before income taxes including Allianz noncontrolling interest 632 315 225 (208) 964 Less: Earnings (loss) attributable to Allianz noncontrolling interest — — 49 (1) 48 Adjusted operating earnings before income taxes 632 315 177 (207) 916 Plus adjustments: Net investment gains (losses) (15) Income (loss) related to businesses exited or to be exited through reinsurance or divestment (182) Income (loss) attributable to noncontrolling interests 104 Dividend payments made to preferred shareholders 36 Other adjustments (180) Income (loss) before income taxes $ 678 (1) Includes Fee income, Premiums, and Other revenue and excludes intersegment fee income and the related elimination. (2) Includes Net investment gains (losses) of $(44), Revenues related to business exited or to be exited through reinsurance or divestment of $113, Revenues attributable to noncontrolling interests of $247, and Other adjustments of $210. Year Ended December 31, 2022 Wealth Solutions Health Solutions Investment Management Corporate Total Revenues: External customer revenue (1) $ 1,100 $ 2,448 $ 663 $ 102 $ 4,313 Net investment income and Net gains (losses) 1,566 135 14 (120) 1,595 Income (loss) related to CIEs — — 22 — 22 Intersegment Fee income and elimination — — 91 (91) — Total revenues 5,930 Adjustments 111 (1) (35) 175 250 (2) Adjusted operating revenues 2,778 2,582 756 67 6,183 Less: Interest credited and other benefits to contract owners/policyholders 886 1,680 — — 2,566 Administrative expenses 867 276 570 — 1,713 Premium taxes, fees and assessments — 126 — — 126 Net commissions 232 167 — — 399 DAC/VOBA and other intangibles amortization 95 29 — — 124 Financing costs and preferred dividends — — — 177 177 Other corporate — — — 142 142 Adjusted operating earnings before income taxes including Allianz noncontrolling interest 697 304 186 (253) 934 Less: Earnings (loss) attributable to Allianz noncontrolling interest — — 27 (1) 26 Adjusted operating earnings before income taxes 697 304 158 (251) 908 Plus adjustments: Net investment gains (losses) (190) Income (loss) related to businesses exited or to be exited through reinsurance or divestment (138) Income (loss) attributable to noncontrolling interests (77) Dividend payments made to preferred shareholders 36 Other adjustments (111) Income (loss) before income taxes $ 428 (1) Includes Fee income, Premiums, and Other revenue and excludes intersegment fee income and the related elimination. (2) Includes Net investment gains (losses) of $(215), Revenues related to business exited or to be exited through reinsurance or divestment of $(123), Revenues attributable to noncontrolling interests of $(33), and Other adjustments of $121.
Schedule of Assets from Segments	The summary below presents Total assets for the Company’s segments as of the dates indicated: December 31, 2024 December 31, 2023 Wealth Solutions $ 129,058 $ 122,318 Health Solutions 3,490 3,336 Investment Management 1,873 1,600 Corporate 24,940 25,527 Total assets, before consolidation (1) 159,361 152,781 Consolidation of investment entities 4,528 4,304 Total assets $ 163,889 $ 157,085 (1) Total assets, before consolidation includes the Company's direct investments in CIEs prior to consolidation, which are accounted for using the equity method or fair value option.

Goodwill and Other Intangible_2

Goodwill and Other Intangible Assets (Tables)	12 Months Ended
	Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	The changes in the carrying amount of goodwill reported in the Company's operating segments were as follows: Wealth Solutions Health Solutions Investment Management Corporate (1) Consolidated Balance as of January 1, 2023 $ 17 $ 24 $ 286 $ — $ 327 Additions from business combinations (2) — 319 — 102 421 Balance as of December 31, 2023 17 343 286 102 748 Additions from business combinations — — — — — Balance as of December 31, 2024 $ 17 $ 343 $ 286 $ 102 $ 748 (1) Corporate includes goodwill that was acquired by the parent company and not pushed to a subsidiary within the Company’s reportable segments. The carrying value of goodwill within Corporate is allocated to Wealth Solutions, Health Solutions, and Investment Management reporting units as $72, $20 and $10, respectively. (2) See the Business, Basis of Presentation and Significant Accounting Policies Note for information on recent business combinations.
Schedule of other intangible assets	The following table presents other intangible assets as of the dates indicated: Weighted December 31, 2024 December 31, 2023 Gross Accumulated Net Gross Accumulated Net Indefinite-life intangibles: Management contract rights N/A $ 350 $ — $ 350 $ 350 $ — $ 350 Total indefinite-life intangibles 350 — 350 350 — 350 Finite-life intangibles: Management contract rights 17 years 131 19 112 153 11 142 Customer relationship lists 17 years 325 145 180 325 128 197 Trademarks 8 years 15 4 11 15 2 13 Computer software 5 years 432 253 179 501 346 155 Total intangible assets $ 1,253 $ 421 $ 832 $ 1,344 $ 487 $ 857
Schedule of estimated amortization expense of intangible assets	The estimated amortization of intangible assets are as follows: Year Amount 2025 $ 92 2026 78 2027 57 2028 34 2029 31

Share-based Incentive Compens_2

Share-based Incentive Compensation Plans (Tables)	12 Months Ended
	Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]
Schedule of Valuation Assumptions	The fair value of stock options was estimated using the Black-Scholes option pricing model. The following is a summary of the assumptions used in this model for the stock options granted in 2015 and 2019: 2015 Stock Options 2019 Stock Options Expected volatility 28.6 % 26.5 % Expected term (in years) 6.02 5.99 Strike price $ 37.60 $ 50.03 Risk-free interest rate 2.1 % 2.7 % Expected dividend yield 0.11 % 1.00 % Weighted average estimated fair value $ 11.89 $ 13.78 2024 2023 2022 Expected volatility of the Company's common stock 27.76 % 30.43 % 34.37 % Average expected volatility of peer companies 34.00 % 41.53 % 49.41 % Expected term (in years) 2.86 2.85 2.85 Risk-free interest rate 4.41 % 4.42 % 1.71 % Expected dividend yield — % — % — % Average correlation coefficient of peer companies 61.10 % 65.80 % 71.50 %
Schedule of Compensation Cost Recognized and Related Income Tax Benefit for Stock Based Compensation Plans	The following table summarizes share-based compensation expense, which includes expenses related to awards granted under the Omnibus Plans for the periods indicated: Year Ended December 31, 2024 2023 2022 RSUs $ 60 $ 81 $ 45 PSU awards 39 48 45 Total 99 129 90 Income tax benefit 25 31 24 Share-based compensation $ 74 $ 98 $ 66 The following table summarizes the unrecognized compensation cost and expected remaining weighted-average period of expense recognition as of December 31, 2024: RSU Awards PSU Awards Unrecognized compensation cost $ 28 $ 32 Expected remaining weighted-average period of expense recognition (in years) 0.83 1.19
RSU and PSU Award Activity	The following table summarizes RSU and PSU awards activity under the Omnibus Plans and Director Plan for the periods indicated: RSU Awards PSU Awards (awards in millions) Number of Awards Weighted Average Grant Date Fair Value Number of Awards Weighted Average Grant Date Fair Value Outstanding at January 1, 2024 2.0 $ 67.06 2.2 $ 61.17 Adjusted for PSU performance factor — — (0.1) 46.94 Granted 0.9 67.70 0.7 59.21 Vested (0.9) 65.14 (0.6) 53.73 Forfeited (0.1) 69.87 — 68.42 Outstanding at December 31, 2024 1.9 $ 67.95 2.2 $ 63.48 Awards expected to vest as of December 31, 2024 1.9 $ 67.95 2.2 $ 63.48
Option Activity	The following table summarizes the number of options under the Omnibus Plans for the periods indicated: Stock Options (awards in millions) Number of Awards Weighted Average Exercise Price Weighted Average Remaining Contractual Term (Years) Aggregate Intrinsic Value Outstanding as of January 1, 2024 1.2 $ 44.79 3.1 $ 34.30 Granted — — Exercised (0.4) 42.86 Forfeited — — Outstanding as of December 31, 2024 0.8 $ 45.71 2.7 $ 19.00 Vested, exercisable, as of December 31, 2024 0.8 45.71 2.7 19.00

Shareholders' Equity (Tables)

Shareholders' Equity (Tables)	12 Months Ended
	Dec. 31, 2024
Equity [Abstract]
Schedule of Common Stock Outstanding Roll Forward	The following table presents the rollforward of common shares used in calculating the weighted average shares utilized in the basic earnings per common share calculation for the periods indicated: Common Shares (shares in millions) Issued Held in Treasury Outstanding Balance, January 1, 2022 109.0 1.2 107.8 Common Shares issued 0.1 — 0.1 Common Shares acquired - share repurchase — 11.7 (11.7) Share-based compensation programs 1.7 0.7 1.0 Treasury Stock retirement (13.0) (13.0) — Balance, December 31, 2022 97.8 0.6 97.2 Common Shares issued 9.7 — 9.7 Common Shares acquired - share repurchase — 5.4 (5.4) Share-based compensation programs 2.1 0.7 1.4 Treasury Stock retirement (6.0) (6.0) — Balance, December 31, 2023 103.6 0.7 102.9 Common Shares issued 0.1 — 0.1 Common Shares acquired - share repurchase — 8.6 (8.6) Share-based compensation programs 1.9 0.8 1.1 Balance, December 31, 2024 105.6 10.1 95.5
Dividends Declared	Dividends declared per share of Common Stock were as follows for the periods indicated: Year Ended December 31, 2024 2023 2022 Dividends declared per share of Common Stock $ 1.70 $ 1.20 $ 0.80 The declaration of dividends on preferred stock per share and in the aggregate were as follows for the periods indicated: Series A Series B Year Ended: Per Share Aggregate Per Share Aggregate December 31, 2024 $ 77.58 $ 25 $ 53.50 $ 16 December 31, 2023 61.25 20 53.50 16 December 31, 2022 61.25 20 53.50 16
Accelerated Share Repurchases	The following table presents repurchases of the Company's common stock through share repurchase agreements with third-party financial institutions for the years ended December 31, 2024 and 2022. There were no repurchase agreements for the year ended December 31, 2023. 2024 Execution Date Payment Initial Shares Delivered Closing Date Additional Shares Delivered Total Shares Repurchased September 12, 2024 $ 100 1,061,853 November 5, 2024 222,007 1,283,860 2022 Execution Date Payment Initial Shares Delivered Closing Date Additional Shares Delivered Total Shares Repurchased June 21, 2022 $ 250 3,382,950 September 20, 2022 819,566 4,202,516 March 17, 2022 $ 275 3,305,786 May 11, 2022 890,112 4,195,898
Open Market Repurchase	The following table presents repurchases of the Company's common stock pursuant to 10b5-1 plans and through open market repurchases for the periods indicated: Year Ended December 31, 2024 2023 2022 Shares of common stock 7,295,206 5,365,303 3,295,800 Payment $ 535 $ 374 $ 225
Schedule of Preferred Stock Issued and Outstanding	As of December 31, 2024 and December 31, 2023, there were 100,000,000 shares of preferred stock authorized. Preferred stock issued and outstanding are as follows: December 31, 2024 December 31, 2023 Series Issued Outstanding Issued Outstanding 7.758% Non-cumulative Preferred Stock, Series A 325,000 325,000 325,000 325,000 5.35% Non-cumulative Preferred Stock, Series B 300,000 300,000 300,000 300,000 Total 625,000 625,000 625,000 625,000

Earnings per Common Share Earni

Earnings per Common Share Earnings per Common Share (Tables)	12 Months Ended
	Dec. 31, 2024
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	The following table presents a reconciliation of Net income (loss) and shares used in calculating basic and diluted net income (loss) per common share for the periods indicated: (in millions, except for per share data) Year Ended December 31, Earnings 2024 2023 2022 Net income (loss) available to common shareholders: Net income (loss) $ 742 $ 729 $ 433 Less: Preferred stock dividends 41 36 36 Less: Net income (loss) attributable to noncontrolling interest and redeemable noncontrolling interest 75 104 (77) Net income (loss) available to common shareholders $ 626 $ 589 $ 474 Weighted-average common shares outstanding Basic 99.2 102.7 100.7 Dilutive Effects: Warrants (1) — 3.3 7.2 RSUs 1.1 1.2 0.9 PSUs 0.7 1.1 0.8 Stock Options 0.4 0.5 0.6 Diluted 101.4 108.8 110.2 Net income (loss) available to Voya Financial, Inc.'s common shareholders per common share (2) Basic $ 6.31 $ 5.74 $ 4.70 Diluted $ 6.17 $ 5.42 $ 4.30 (1) See the Shareholders' Equity Note to these Consolidated Financial Statements for additional information on warrants settled. (2) Basic and diluted earnings per share are calculated using unrounded, actual amounts. Therefore, the components of earnings per share may not sum to its corresponding total. Diluted earnings per share is computed assuming the issuance of restricted stock units, stock options, performance share units and warrants using the treasury stock method.

Insurance Subsidiaries (Tables)

Insurance Subsidiaries (Tables)	12 Months Ended
	Dec. 31, 2024
Insurance [Abstract]
Schedule of Statutory Net Income (Loss)	Statutory Net income (loss) for the years ended December 31, 2024, 2023 and 2022 and statutory capital and surplus as of December 31, 2024 and 2023 of the Company's Principal Insurance Subsidiaries are as follows: Statutory Net Income (Loss) Statutory Capital and Surplus 2024 2023 2022 2024 2023 Subsidiary Name (State of Domicile): Voya Retirement Insurance and Annuity Company ("VRIAC") (CT) $ 640 $ 577 $ 549 $ 2,033 $ 1,955 ReliaStar Life Insurance Company ("RLI") (MN) 163 401 418 1,098 1,447
Schedule of Dividends Permitted and Dividends Paid and Return of Capital Distributions	The following table summarizes dividends permitted to be paid by the Company's Principal Insurance Subsidiaries to Voya Financial, Inc. or Voya Holdings without the need for insurance regulatory approval and dividends and extraordinary distributions paid by each of the Company's Principal Insurance Subsidiaries to its parent for the periods indicated: Dividends Permitted without Approval Dividends Paid Extraordinary Distributions Paid Year Ended December 31, Year Ended December 31, 2025 2024 2024 2023 2024 2023 Subsidiary Name (State of domicile): Voya Retirement Insurance and Annuity Company (CT) $ 562 $ 473 $ 473 $ 310 $ — $ — ReliaStar Life Insurance Company (MN) 177 403 402 — — 747

Employee Benefit Arrangements (

Employee Benefit Arrangements (Tables)	12 Months Ended
	Dec. 31, 2024
Retirement Benefits [Abstract]
Changes in Projected Benefit Obligations, Fair Value of Plan Assets, and Funded Status of Plan	The following tables summarize a reconciliation of beginning and ending balances of the benefit obligation and fair value of plan assets for the years ended December 31, 2024 and 2023 and the discount rate and interest credit rate used in determining pension benefit obligations as of December 31, 2024 and 2023 as well as the funded status of the Company's Plans as of December 31, 2024 and 2023: 2024 2023 Change in benefit obligation: Benefit obligations, January 1 $ 1,999 $ 1,943 Service cost 30 24 Interest cost 102 103 Net actuarial (gains) losses (1) (98) 44 Benefits paid (121) (115) Benefit obligations, December 31 (2) 1,912 1,999 Discount rate 5.88 % 5.28 % Interest credit rate 3.75 % 3.75 % Change in plan assets: Fair value of plan net assets, January 1 1,831 1,770 Actual return on plan assets 36 149 Employer contributions 28 27 Benefits paid (122) (115) Fair value of plan net assets, December 31 (3) 1,773 1,831 Unfunded status at end of year (4) $ (139) $ (168) (1) Includes actuarial (gain) loss of $(110) and $37 due to change in discount rate for the year ended December 31, 2024 and 2023, respectively. The discount rate increased 0.60% during 2024 driven by an increase in corporate AA yields. The discount rate decreased 0.19% during 2023 driven by a decrease in corporate AA yields. (2) Includes Retirement Plan benefit obligations of $1,581 and $1,649 as of December 31, 2024 and 2023, respectively, and non-qualified plan benefit obligations of $331 and $350 as of December 31, 2024 and 2023, respectively. (3) Represents Retirement Plan Assets. (4)
Schedule of Defined Benefit Plan Amounts Recognized in Balance Sheet and Accumulated Other Comprehensive Income (Loss)	The following table summarizes amounts related to the Plans recognized on the Consolidated Balance Sheets as of December 31, 2024 and 2023: 2024 2023 Amounts recognized in the Consolidated Balance Sheets consist of: (1) Prepaid benefit cost (2) $ 192 $ 182 Accrued benefit cost (2) (331) (350) Net amount recognized $ (139) $ (168) (1) Excludes other postretirement benefit obligations of $8 and $9 as of December 31, 2024 and 2023, respectively. (2) Prepaid benefit cost is included in Other assets on the Consolidated Balance Sheets. Accrued benefit cost is included in Other liabilities on the Consolidated Balance Sheets.
Schedule of Projected Benefit Obligation and Accumulated Benefit Obligation in Excess of Plan Assets	The following table summarizes information for the Plans with a projected benefit obligation and an accumulated benefit obligation in excess of plan assets as of December 31, 2024 and 2023: 2024 2023 Projected benefit obligation $ 331 $ 350 Accumulated benefit obligation 328 348 Fair value of plan assets — —
Schedule of Components of Net Periodic Benefit Cost	The components of net periodic benefit costs recognized in Operating expenses in the Consolidated Statements of Operations, weighted-average assumptions used in determining net benefit cost of the Plans and other changes in plan assets and benefit obligations recognized in Other comprehensive income (loss) related to the Plans were as follows for the years ended December 31, 2024, 2023 and 2022: 2024 2023 2022 Net Periodic (Benefit) Costs Recognized in Consolidated Statements of Operations: Service cost $ 30 $ 24 $ 28 Interest cost 102 103 72 Expected return on plan assets (107) (100) (108) (Gain) loss recognized due to curtailment — — — Net (gain) loss recognition (26) (4) (6) Net periodic (benefit) costs $ (1) $ 23 $ (14) Discount rate 5.28 % 5.47 % 3.00 % Expected rate of return on plan assets 6.00 % 5.82 % 4.85 % Interest credit rate 3.75 % 3.00 % 2.80 %
Schedule of Allocation of Plan Assets	The following table summarizes the Company's pension plan’s target allocation range and actual asset allocation by asset category as of December 31, 2024 and 2023: Actual Asset Allocation 2024 2023 Equity securities: Target allocation range 5%-13% 7%-12% Large-cap domestic 4.3 % 3.7 % Small/Mid-cap domestic 0.9 % 0.8 % International commingled funds 2.9 % 3.2 % Limited Partnerships 0.1 % 0.5 % Total equity securities 8.2 % 8.2 % Fixed maturities: Target allocation range 83%-87% 83%-87% U.S. Treasuries, short term investments, cash and futures 2.0 % 3.0 % U.S. Government agencies and authorities 4.7 % 0.3 % U.S. corporate, state and municipalities 66.8 % 71.3 % Foreign securities 12.3 % 9.8 % Total fixed maturities 85.8 % 84.4 % Other investments: Target allocation range 2%-10% 4%-8% Hedge funds 2.9 % 4.1 % Real estate 3.1 % 3.3 % Total other investments 6.0 % 7.4 % Total 100.0 % 100.0 % The following table summarizes the fair values of the pension plan assets by asset class as of December 31, 2024: Level 1 Level 2 Level 3 NAV Total Assets Fixed maturities, short-term investments and cash: Cash and cash equivalents $ 11 $ 7 $ — $ — $ 18 Short-term investment fund (1) — — — 19 19 U.S. Government securities 82 — — — 82 U.S. corporate, state and municipalities 10 1,102 72 — 1,184 Foreign securities — 198 20 — 218 Total fixed maturities 103 1,307 92 19 1,521 Equity securities: Total equity securities (2) 17 77 — 58 152 Other investments: Total other investments (3) — — — 100 100 Total assets $ 120 $ 1,384 $ 92 $ 177 $ 1,773 (1) This category includes common collective trust funds a short-term investment fund, which invests in a full range of high-quality, short-term money market securities. Participant's redemptions are processed by the following day. (2) Equity securities include two assets that use NAV to calculate fair value. Baillie Gifford Funds has a balance of $26 and uses a bottom up approach to stock picking. In determining the potential of a company, the fund manager analyzes industry background, competitive advantage, management attitudes and financial strength and valuation. There are no redemption restrictions in the Baillie Gifford Funds. Silchester has a fund balance of $26 that has an investment objective to achieve long-term growth primarily by investing in a diversified portfolio of equity securities of companies located in any country other than the United States. Contributions and redemptions are conducted on a monthly basis as of the last business day of each month with notice required. at least six (3) Other investments that use NAV to calculate fair value includes a real estate fund has a balance of $52 and is an actively managed core portfolio of equity real estate, whose performance objective is to outperform the National Council of Real Estate investment Fiduciaries Open-End Diversified Core ("NFI_ODCE") index and to achieve at least a 5.0% real rate of return (i.e., inflation-adjusted return), before advisory fees, over any given three The following table summarizes the fair values of the pension plan assets by asset class as of December 31, 2023: Level 1 Level 2 Level 3 NAV Total Assets Fixed maturities, short term investments and cash: Cash and cash equivalents $ 8 $ 1 $ — $ — $ 9 Short-term investment fund (1) — — — 21 21 U.S. Government securities 128 — — — 128 U.S. corporate, state and municipalities 10 1,121 65 — 1,196 Foreign securities — 170 20 — 190 Total fixed maturities 146 1,292 85 21 1,544 Equity securities: Total equity securities (2) 15 68 — 68 151 Other investments: Total other investments (3) — — — 136 136 Total assets $ 161 $ 1,360 $ 85 $ 225 $ 1,831 (1) See footnote 1 to previous table. (2) Equity securities include two assets that use NAV to calculate fair value. Baillie Gifford Funds has a balance of $25 and Silchester has a fund balance of $33. See footnote 2 to previous table for further information. (3) Other investments that use NAV to calculate fair value includes a real estate fund has a balance of $61 and a limited partnership with a balance of $75. See footnote 3 to previous table for further information.
Schedule of Expected Benefit Payments	The following table summarizes the expected benefit payments for the Company's pension plans to be paid for the years indicated: 2025 $ 135 2026 136 2027 139 2028 143 2029 146 2030-2034 775

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Income (Loss) (Tables)	12 Months Ended
	Dec. 31, 2024
Equity [Abstract]
Schedule of Accumulated Other Comprehensive Income	Shareholders' equity included the following components of AOCI as of the dates indicated: December 31, 2024 December 31, 2023 December 31, 2022 Fixed maturities, net of impairment $ (2,553) $ (2,370) $ (3,294) Derivatives (1) 66 64 125 Change in current discount rate (787) (890) (858) Deferred income tax asset (liability) (2) 810 794 969 Total (2,464) (2,402) (3,058) Pension and other postretirement benefits liability, net of tax 2 2 3 AOCI $ (2,462) $ (2,400) $ (3,055) (1) Gains and losses reported in AOCI from hedge transactions that resulted in the acquisition of an identified asset are reclassified into earnings in the same period or periods during which the asset acquired affects earnings. As of December 31, 2024, the portion of the AOCI that is expected to be reclassified into earnings within the next 12 months is $10. See the Derivative Financial Instruments Note to these Consolidated Financial Statements for additional information. (2)
Schedule of Amounts Recognized in Other Comprehensive Income	Changes in AOCI, including the reclassification adjustments recognized in the Consolidated Statements of Operations were as follows for the periods indicated: December 31, 2024 Before-Tax Amount Income Tax (Benefit) After-Tax Amount Available-for-sale securities: Fixed maturities $ (208) $ 44 $ (164) Adjustments for amounts recognized in Net gains (losses) in the Consolidated Statements of Operations 26 (5) 21 Change in unrealized gains (losses) on available-for-sale securities (182) 39 (143) Derivatives: Derivatives 18 (1) (4) 14 Adjustments related to effective cash flow hedges for amounts recognized in Net investment income in the Consolidated Statements of Operations (16) 3 (13) Change in unrealized gains (losses) on derivatives 2 (1) 1 Change in current discount rate 103 (22) 81 Pension and other postretirement benefits liability: Amortization of prior service cost recognized in Operating expenses in the Consolidated Statements of Operations (1) (2) — (1) Change in pension and other postretirement benefits liability (1) — (1) Change in AOCI $ (78) $ 16 $ (62) (1) See the Derivative Financial Instruments Note to these Consolidated Financial Statements for additional information. (2) See the Employee Benefit Arrangements Note to these Consolidated Financial Statements for amounts reported in Net Periodic (Benefit) Costs. December 31, 2023 Before-Tax Amount Income Tax (Benefit) After-Tax Amount Available-for-sale securities: Fixed maturities $ 899 $ (189) $ 710 Adjustments for amounts recognized in Net gains (losses) in the Consolidated Statements of Operations 25 (5) 20 Change in unrealized gains (losses) on available-for-sale securities 924 (194) 730 Derivatives: Derivatives (43) (1) 9 (34) Adjustments related to effective cash flow hedges for amounts recognized in Net investment income in the Consolidated Statements of Operations (18) 4 (14) Change in unrealized gains (losses) on derivatives (61) 13 (48) Change in current discount rate (33) 7 (26) Pension and other postretirement benefits liability: Amortization of prior service cost recognized in Operating expenses in the Consolidated Statements of Operations (1) (2) — (1) Change in pension and other postretirement benefits liability (1) — (1) Change in AOCI $ 829 $ (174) $ 655 (1) See the Derivative Financial Instruments Note to these Consolidated Financial Statements for additional information. (2) See the Employee Benefit Arrangements Note to these Consolidated Financial Statements for amounts reported in Net Periodic (Benefit) Costs. December 31, 2022 Before-Tax Amount Income Tax (Benefit) After-Tax Amount Available-for-sale securities: Fixed maturities $ (6,569) $ 1,380 $ (5,189) Adjustments for amounts recognized in Net gains (losses) in the Consolidated Statements of Operations 78 (16) 62 Change in unrealized gains (losses) on available-for-sale securities (6,491) 1,364 (5,127) Derivatives: Derivatives 66 (1) (14) 52 Adjustments related to effective cash flow hedges for amounts recognized in Net investment income in the Consolidated Statements of Operations (20) 4 (16) Change in unrealized gains (losses) on derivatives 46 (10) 36 Change in current discount rate 290 (61) 229 Change in AOCI $ (6,155) $ 1,293 $ (4,862) (1) See the Derivative Financial Instruments Note to these Consolidated Financial Statements for additional information.

Revenue from Contracts with C_2

Revenue from Contracts with Customers (Tables)	12 Months Ended
	Dec. 31, 2024
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	Financial services and software subscriptions and services revenue is disaggregated by type of service in the following table: Year Ended December 31, 2024 2023 2022 Wealth Solutions Advisory and R&A $ 625 $ 497 $ 525 Distribution and shareholder servicing 133 121 116 Investment Management Advisory, asset management and R&A 1,004 924 826 Distribution and shareholder servicing 153 146 145 Health Solutions R&A 26 18 17 Software subscriptions and services 206 205 — Corporate R&A 3 28 62 Total financial services and software subscriptions and services revenue 2,150 1,939 1,691 Revenue from other sources (1) 386 304 199 Total Fee income and Other revenue $ 2,536 $ 2,243 $ 1,890 (1) Primarily consists of revenue from insurance contracts and financial instruments.

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2024
Income Tax Disclosure [Abstract]
Schedule of Components of Income Tax Expense (Benefit)	Income tax expense (benefit) consisted of the following for the periods indicated: Year Ended December 31, 2024 2023 2022 Current tax expense (benefit): Federal $ 1 $ 2 $ (6) Foreign 9 4 1 State 5 5 (3) Total current tax expense (benefit) 15 11 (8) Deferred tax expense (benefit): Federal 38 (50) 8 State 4 (12) (5) Total deferred tax expense (benefit) 42 (62) 3 Total income tax expense (benefit) $ 57 $ (51) $ (5)
Schedule of Effective Income Tax Rate Reconciliation	Income taxes were different from the amount computed by applying the federal income tax rate to Income (loss) before income taxes for the following reasons for the periods indicated: Year Ended December 31, 2024 2023 2022 Income (loss) before income taxes $ 799 $ 678 $ 428 Tax Rate 21.0 % 21.0 % 21.0 % Income tax expense (benefit) at federal statutory rate 168 142 90 Tax effect of: Valuation allowance 1 (1) 7 Dividends received deduction (49) (38) (44) State tax expense (benefit) 8 (6) (16) Noncontrolling interest (16) (22) 16 Tax credits (19) (17) (63) Nondeductible expenses 3 6 7 Security Life of Denver Company capital loss carryback (1) (38) (92) — Non-taxable Voya India gain (1) — (10) — Other (1) (13) (2) Income tax expense (benefit) $ 57 $ (51) $ (5) Effective tax rate 7.1 % (7.5) % (1.2) % (1) See Other Tax Matters section below
Schedule of Deferred Tax Assets and Liabilities	The tax effects of temporary differences that give rise to deferred tax assets and deferred tax liabilities were as follows as of the dates indicated: December 31, 2024 2023 Deferred tax assets Federal and state loss carryforwards $ 1,421 $ 1,489 Net unrealized investment losses 522 484 Compensation and benefits 161 190 Current discount rate 165 187 Tax credits 154 131 Insurance Reserves — 9 Investments 47 5 Other assets 175 165 Total gross assets before valuation allowance 2,645 2,660 Less: Valuation allowance 96 95 Assets, net of valuation allowance 2,549 2,565 Deferred tax liabilities Deferred policy acquisition costs (324) (358) Insurance reserves (24) — Other liabilities (67) (47) Total gross liabilities (415) (405) Net deferred income tax asset (liability) $ 2,134 $ 2,160
Summary of Operating Loss Carryforwards	The following table sets forth the federal, state and credit carryforwards for tax purposes as of the dates indicated: December 31, 2024 2023 Federal net operating loss carryforward $ 6,335 (1) $ 6,667 State net operating loss carryforward 2,412 (2) 2,454 Credit carryforward 154 (3) 131 (1) Approximately $3,320 of the net operating losses carryforwards ("NOL") not subject to expiration. $3,015 of the NOLs expire between 2025 and 2037 (2) Approximately $390 of the NOLs not subject to expiration. $2,022 of the NOLs expire between 2025 and 2043 (3) Expires between 2025 and 2044
Schedule of Unrecognized Tax Benefits	Reconciliations of the change in the unrecognized income tax benefits were as follows for the periods indicated: Year Ended December 31, 2024 2023 2022 Balance at beginning of period $ 27 $ 33 $ 33 Additions (reductions) for tax positions related to current year — — — Additions (reductions) for tax positions related to prior years (3) (6) — Balance at end of period $ 24 $ 27 $ 33

Financing Agreements (Tables)

Financing Agreements (Tables)	12 Months Ended
	Dec. 31, 2024
Debt Disclosure [Abstract]
Long-term Debt Securities Issued and Outstanding	The following table summarizes the carrying value of the Company’s debt issued or borrowed and outstanding as of December 31, 2024 and 2023: Issuer Maturity 2024 2023 3.976% Senior Notes, due 2025 (2)(3) Voya Financial, Inc. 02/15/2025 $ 399 $ 390 3.65% Senior Notes, due 2026 (2)(3) Voya Financial, Inc. 06/15/2026 446 446 5.0% Senior Notes, due 2034 (2)(3) Voya Financial, Inc. 09/20/2034 395 — 5.7% Senior Notes, due 2043 (2)(3) Voya Financial, Inc. 07/15/2043 396 396 4.8% Senior Notes, due 2046 (2)(3) Voya Financial, Inc. 06/15/2046 297 297 4.7% Fixed-to-Floating Rate Junior Subordinated Notes, due 2048 (3)(4) Voya Financial, Inc. 01/23/2048 336 336 7.625% Voya Holdings Inc. debentures, due 2026 (1) Voya Holdings Inc. 08/15/2026 139 139 6.97% Voya Holdings Inc. debentures, due 2036 (1) Voya Holdings Inc. 08/15/2036 79 79 8.42% Equitable of Iowa Companies Capital Trust II Notes, due 2027 Equitable of Iowa Capital Trust II 04/01/2027 13 13 1.00% Windsor Property Loan Voya Retirement Insurance and Annuity Company 06/14/2027 2 2 Subtotal 2,502 2,098 Less: Current portion of long-term debt 399 1 Total $ 2,103 $ 2,097 (1) Guaranteed by ING Group. (2) Interest is paid semi-annually in arrears. (3) Guaranteed by Voya Holdings. (4) See the Junior Subordinated Notes section below. Outstanding junior subordinated notes were as follows as of December 31, 2024: Issuer Issue Date Interest Rate (1) Scheduled Redemption Date Interest Rate Subsequent to Scheduled Redemption Date (2) Final Maturity Date Face Value Voya Financial, Inc. 01/23/2018 4.70% 01/23/2028 LIBOR + 2.084% 01/23/2048 (3) $ 340 (1) Prior to the scheduled redemption date, interest is paid semi-annually, in arrears. (2) In the event the securities are not redeemed on or before the scheduled redemption date, interest will accrue after such date at an annual rate of three month LIBOR plus the indicated margin, payable quarterly in arrears. In the event that LIBOR is unavailable, the calculation agent will determine a fallback rate at the time the calculations need to be performed. (3) Th e 4.70% F ixed-to-Floating Rate Junior Subordinated Notes due 2048 (the "2048 Notes") are guaranteed on an unsecured, junior subordinated basis by Voya Holdings.
Credit Facilities	The following table outlines the Company's credit facilities as of December 31, 2024: Obligor / Applicant Secured/ Unsecured Committed/ Uncommitted Expiration Capacity Utilization Unused Commitment Voya Financial, Inc. Unsecured Committed 05/01/2028 $ 500 $ — $ 500 Voya Financial, Inc. Unsecured Committed 04/07/2025 12 (2) 12 (1) — Total $ 512 $ 12 $ 500 (1) Amount utilized as collateral for outstanding Aetna Notes. (2) In March of 2024, the Company decreased the capacity of its letter of credit, expiring in 2025, from $200 to $12. This reduction was due to the reduced collateral requirements resulting from the maturity of a portion of the Aetna Notes. Additionally, the full capacity was not expected to be utilized through its expiration.

Commitments and Contingencies (

Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Schedule of Lease Costs	The following table presents the lease costs and payments related to operating and finance leases for the years ended December 31, 2024, 2023 and 2022: 2024 2023 2022 Operating lease costs $ 26 $ 22 $ 21 Finance lease costs 11 9 19 Amortization of the right of use assets (1) 7 5 19 Payments for finance lease liabilities 10 20 21 Payments for operating lease liabilities 28 26 18 (1) Included in the finance lease costs.
Schedule of Future Net Minimum Payments Under Non-cancelable Operating Leases	The future net minimum payments under non-cancelable leases are as follows as of December 31, 2024: Operating Leases Finance Leases 2025 $ 23 $ 12 2026 20 12 2027 18 12 2028 16 13 2029 12 13 Thereafter 51 27 Total undiscounted lease payments 140 89 Less: Imputed interest 28 15 Total Lease liabilities $ 112 $ 74
Schedule of Future Net Minimum Payments Under Non-cancelable Finance Leases	The future net minimum payments under non-cancelable leases are as follows as of December 31, 2024: Operating Leases Finance Leases 2025 $ 23 $ 12 2026 20 12 2027 18 12 2028 16 13 2029 12 13 Thereafter 51 27 Total undiscounted lease payments 140 89 Less: Imputed interest 28 15 Total Lease liabilities $ 112 $ 74
Schedule of Restricted Assets	The fair value of restricted assets were as follows as of December 31, 2024 and 2023: 2024 2023 Fixed maturity collateral pledged to FHLB (1) $ 2,007 $ 1,956 FHLB restricted stock (2) 65 64 Fixed maturities-state and other deposits 35 37 Cash and cash equivalents 21 25 Securities pledged (3) 1,523 1,160 Total restricted assets $ 3,651 $ 3,242 (1) Included in Fixed maturities, available-for-sale, at fair value on the Consolidated Balance Sheets. (2) Included in Other investments on the Consolidated Balance Sheets. (3) Includes the fair value of loaned securities of $1,083 and $842 as of December 31, 2024 and 2023, respectively. In addition, as of December 31, 2024 and 2023, the Company delivered securities as collateral of $159 and $201, and repurchase agreements of $281 and $117, respectively. Loaned securities and securities delivered as collateral are included in Securities pledged on the Consolidated Balance Sheets.

Consolidated and Nonconsolida_2

Consolidated and Nonconsolidated Investment Entities (Tables)	12 Months Ended
	Dec. 31, 2024
Consolidated Investment Entities [Abstract]
Fair Value, by Balance Sheet Grouping	The carrying values and estimated fair values of the Company's financial instruments as of the dates indicated: December 31, 2024 December 31, 2023 Carrying Fair Carrying Fair Assets: Fixed maturities, including securities pledged $ 27,454 $ 27,454 $ 28,611 $ 28,611 Equity securities 246 246 236 236 Mortgage loans on real estate 4,699 4,459 5,218 4,941 Policy loans 342 342 352 352 Cash, cash equivalents, short-term investments and short-term investments under securities loan agreements 2,535 2,535 2,165 2,165 Derivatives 303 303 311 311 Embedded derivatives on reinsurance 55 55 61 61 Other investments, including securities pledged 74 74 64 64 Assets held in separate accounts 101,676 101,676 93,133 93,133 Liabilities: Investment contract liabilities: Funding agreements without fixed maturities and deferred annuities (1) $ 31,082 $ 32,877 $ 32,848 $ 34,856 Funding agreements with fixed maturities 1,249 1,257 1,175 1,178 Supplementary contracts, immediate annuities and other 570 515 628 571 Stabilizer and MCGs 19 19 9 9 Derivatives 332 332 371 371 Embedded derivatives on reinsurance 41 41 49 49 Short-term debt 399 399 1 1 Long-term debt 2,103 2,023 2,097 1,998 (1) Certain amounts included in Funding agreements without fixed maturities and deferred annuities are also reflected within the Stabilizer and MCGs section of the table above. The following table summarizes the fair value hierarchy levels of consolidated investment entities as of December 31, 2024: Level 1 Level 2 Level 3 NAV Total Assets VIEs Cash and cash equivalents $ 113 $ — $ — $ — $ 113 Corporate loans — 1,434 — — 1,434 Limited partnerships/corporations — — — 3,067 3,067 Other investments (1) — — 53 — 53 VOEs Cash and cash equivalents 2 — — — 2 Other investments (1) — — — 50 50 Total assets $ 115 $ 1,434 $ 53 $ 3,117 $ 4,719 Liabilities VIEs CLO notes $ — $ 1,101 $ — $ — $ 1,101 Total liabilities $ — $ 1,101 $ — $ — $ 1,101 (1) VIEs and VOEs - Other investments are reflected in Assets related to consolidated investment entities - Other assets on the Company's Consolidated Balance Sheets. The following table summarizes the fair value hierarchy levels of consolidated investment entities as of December 31, 2023: Level 1 Level 2 Level 3 NAV Total Assets VIEs Cash and cash equivalents $ 181 $ — $ — $ — $ 181 Corporate loans — 1,404 — — 1,404 Limited partnerships/corporations — — — 2,861 2,861 Total assets $ 181 $ 1,404 $ — $ 2,861 $ 4,446 Liabilities VIEs CLO notes $ — $ 1,332 $ — $ — $ 1,332 Total liabilities $ — $ 1,332 $ — $ — $ 1,332

Business, Basis of Presentati_3

Business, Basis of Presentation and Significant Accounting Policies (Details)		12 Months Ended
	Jan. 24, 2023 USD ($)	Dec. 31, 2024 USD ($) segment	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)
Accounting Policies [Line Items]
Number of operating segments | segment		3
Net gains (losses)		$ (27,000,000)	$ (72,000,000)	$ (686,000,000)
Goodwill		748,000,000	748,000,000	327,000,000
Payments for business acquisitions, net of cash acquired		0	584,000,000	2,000,000
Contract cost assets		105,000,000	98,000,000
Amortization expense		21,000,000	20,000,000	$ 21,000,000
Impairment loss for contract costs capitalized		$ 0
Fixed Annuities And Payout Contracts Without Life Contingencies [Member]
Accounting Policies [Line Items]
Credited interest rate maximum on fixed annuities and payout contracts without life contingencies		5.10%
Minimum
Accounting Policies [Line Items]
Weighted Average Amortization Lives		5 years
Minimum | Software subscriptions and services
Accounting Policies [Line Items]
Revenue from contract with customer, contract term		1 year
Maximum
Accounting Policies [Line Items]
Weighted Average Amortization Lives		15 years
Maximum | Software subscriptions and services
Accounting Policies [Line Items]
Revenue from contract with customer, contract term		3 years
Commercial Portfolio Segment
Accounting Policies [Line Items]
Threshold period past due		60 days
Threshold period past due, nonaccrual		90 days
Customer relationship lists
Accounting Policies [Line Items]
Weighted Average Amortization Lives		17 years
Computer software
Accounting Policies [Line Items]
Weighted Average Amortization Lives		5 years
Benefitfocus
Accounting Policies [Line Items]
Payments to acquire businesses	$ 583,000,000
Goodwill	319,000,000
Payments for merger related costs	595,000,000
Payments for business acquisitions, net of cash acquired	558,000,000
Cash acquired from acquisition	25,000,000
Business combination, recognized identifiable assets acquired and liabilities assumed, cash and equivalents	49,000,000
Business combination, recognized identifiable assets acquired and liabilities assumed, intangible assets, other than goodwill	275,000,000
Business combination, recognized identifiable assets acquired and liabilities assumed, deferred tax assets	45,000,000
Business combination, recognized identifiable assets acquired and liabilities assumed, lease obligation	91,000,000
Benefitfocus | Customer relationship lists
Accounting Policies [Line Items]
Finite-lived intangible assets acquired	$ 190,000,000
Acquired finite-lived intangible assets, weighted average useful life	15 years
Benefitfocus | Computer software
Accounting Policies [Line Items]
Finite-lived intangible assets acquired	$ 70,000,000
Acquired finite-lived intangible assets, weighted average useful life	5 years
Voya India
Accounting Policies [Line Items]
Net gains (losses)		$ 45,000,000	$ 45,000,000
Goodwill		$ 102,000,000
Voya India
Accounting Policies [Line Items]
Subsidiary, ownership percentage, parent		49%
SLK
Accounting Policies [Line Items]
Subsidiary, ownership percentage, noncontrolling owner		51%
VIM Holdings
Accounting Policies [Line Items]
Subsidiary, ownership percentage, noncontrolling owner		24%
OneAmerica
Accounting Policies [Line Items]
Payments to acquire businesses		$ 50,000,000
Other payments to acquire businesses		160,000,000
VFI SLK
Accounting Policies [Line Items]
Payments to acquire businesses		$ 53,000,000

Investments (excluding Consol_3

Investments (excluding Consolidated Investment Entities) - Fixed Maturities (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, Amortized Cost	$ 26,536	$ 27,690
Securities pledged, Amortized Cost	1,665	1,232
Allowance for credit losses	38	17	$ 12	$ 58
U.S. Treasuries
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, Amortized Cost	524	417
Fixed maturities, including securities pledged, Gross Unrealized Capital Gains	0	7
Fixed maturities, including securities pledged,Gross Unrealized Capital Losses	52	21
Embedded Derivatives	0	0
Allowance for credit losses	0	0
Fixed maturities, Fair Value	472	403
U.S. Government agencies and authorities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, Amortized Cost	29	54
Fixed maturities, including securities pledged, Gross Unrealized Capital Gains	1	3
Fixed maturities, including securities pledged,Gross Unrealized Capital Losses	0	1
Embedded Derivatives	0	0
Allowance for credit losses	0	0
Fixed maturities, Fair Value	30	56
State, municipalities, and political subdivisions
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, Amortized Cost	697	871
Fixed maturities, including securities pledged, Gross Unrealized Capital Gains	0	1
Fixed maturities, including securities pledged,Gross Unrealized Capital Losses	117	101
Embedded Derivatives	0	0
Allowance for credit losses	0	0
Fixed maturities, Fair Value	580	771
U.S. corporate public securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, Amortized Cost	7,938	8,402
Fixed maturities, including securities pledged, Gross Unrealized Capital Gains	124	168
Fixed maturities, including securities pledged,Gross Unrealized Capital Losses	1,054	904
Embedded Derivatives	0	0
Allowance for credit losses	0	0
Fixed maturities, Fair Value	7,008	7,666
U.S. corporate private securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, Amortized Cost	5,275	5,040
Fixed maturities, including securities pledged, Gross Unrealized Capital Gains	43	44
Fixed maturities, including securities pledged,Gross Unrealized Capital Losses	329	324
Embedded Derivatives	0	0
Allowance for credit losses	6	0	0
Fixed maturities, Fair Value	4,983	4,760
Foreign corporate public securities and foreign governments
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, Amortized Cost	2,729	2,928
Fixed maturities, including securities pledged, Gross Unrealized Capital Gains	32	47
Fixed maturities, including securities pledged,Gross Unrealized Capital Losses	287	270
Embedded Derivatives	0	0
Allowance for credit losses	2	3	9
Fixed maturities, Fair Value	2,472	2,702
Foreign corporate private securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, Amortized Cost	2,693	2,916
Fixed maturities, including securities pledged, Gross Unrealized Capital Gains	22	27
Fixed maturities, including securities pledged,Gross Unrealized Capital Losses	169	129
Embedded Derivatives	0	0
Allowance for credit losses	9	2	2
Fixed maturities, Fair Value	2,537	2,812
Residential mortgage-backed securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, Amortized Cost	3,709	3,695
Fixed maturities, including securities pledged, Gross Unrealized Capital Gains	27	36
Fixed maturities, including securities pledged,Gross Unrealized Capital Losses	261	257
Embedded Derivatives	(4)	2
Allowance for credit losses	0	0
Fixed maturities, Fair Value	3,471	3,476
Commercial mortgage-backed securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, Amortized Cost	3,677	4,147
Fixed maturities, including securities pledged, Gross Unrealized Capital Gains	4	1
Fixed maturities, including securities pledged,Gross Unrealized Capital Losses	532	644
Embedded Derivatives	0	0
Allowance for credit losses	17	9	$ 0
Fixed maturities, Fair Value	3,132	3,495
Other asset-backed securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, Amortized Cost	2,779	2,528
Fixed maturities, including securities pledged, Gross Unrealized Capital Gains	39	16
Fixed maturities, including securities pledged,Gross Unrealized Capital Losses	45	71
Embedded Derivatives	0	0
Allowance for credit losses	4	3
Fixed maturities, Fair Value	2,769	2,470
Fixed maturities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, Amortized Cost	30,050	30,998
Total fixed maturities, less securities pledged, Amortized Cost	28,385	29,766
Fixed maturities, including securities pledged, Gross Unrealized Capital Gains	292	350
Total fixed maturities, less securities pledged, Gross Unrealized Capital Gains	292	350
Fixed maturities, including securities pledged,Gross Unrealized Capital Losses	2,846	2,722
Total fixed maturities, less securities pledged, Gross Unrealized Capital Losses	2,697	2,650
Embedded Derivatives	(4)	2
Allowance for credit losses	38	17
Fixed maturities, Fair Value	27,454	28,611
Total fixed maturities, less securities pledged, Fair Value	25,938	27,451
Collateral pledged
Available-for-sale Securities, Including Securities Pledged [Line Items]
Securities pledged	1,523	1,160
Collateral pledged | Fixed maturities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Securities pledged, Amortized Cost	1,665	1,232
Securities pledged, Gross Unrealized Capital Gains	0	0
Securities pledged, Gross Unrealized Capital Losses	149	72
Embedded Derivatives	0	0
Allowance for credit losses	0	0
Securities pledged	$ 1,516	$ 1,160

Investments (excluding Consol_4

Investments (excluding Consolidated Investment Entities) - Debt Maturities (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, Amortized Cost	$ 26,536	$ 27,690
Fixed maturities, single issuers in excess of total equity	no	no
Fixed maturities
Available-for-sale Securities, Including Securities Pledged [Line Items]
One year or less, Amortized Cost	$ 607
After one year through five years, Amortized Cost	3,946
After five years through ten years, Amortized Cost	3,723
After ten years, Amortized Cost	11,609
Fixed maturities, Amortized Cost	30,050	$ 30,998
One year or less, Fair Value	581
After one year through five years, Fair Value	3,819
After five years through ten years, Fair Value	3,590
After ten years, Fair Value	10,092
Fixed maturities, Fair Value	27,454	28,611
Mortgage-backed securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Without single maturity date, Amortized Cost	7,386
Without single maturity date, Fair Value	6,603
Other asset-backed securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Without single maturity date, Amortized Cost	2,779
Fixed maturities, Amortized Cost	2,779	2,528
Without single maturity date, Fair Value	2,769
Fixed maturities, Fair Value	$ 2,769	$ 2,470

Investments (excluding Consol_5

Investments (excluding Consolidated Investment Entities) - Repurchase Agreements and Securities Pledged (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Available-for-sale Securities, Including Securities Pledged [Line Items]
Rate required of collateral as a percent of market value of loans securities	102%
Payables under securities loan and repurchase agreements, including collateral held	$ 1,309	$ 1,121
Collateral pledged
Available-for-sale Securities, Including Securities Pledged [Line Items]
Securities Sold under Agreements to Repurchase, Asset	0	0
Total securities pledged	1,523	1,160
Securities pledged
Available-for-sale Securities, Including Securities Pledged [Line Items]
Securities pledged/obligations under repurchase agreements	281	117
Securities loaned to lending agent	1,083	842
Securities pledged as collateral	159	201
Short-term investments
Available-for-sale Securities, Including Securities Pledged [Line Items]
Securities received as collateral	736	660
Fixed maturities | Collateral pledged
Available-for-sale Securities, Including Securities Pledged [Line Items]
Total securities pledged	1,516	1,160
U.S. Treasuries
Available-for-sale Securities, Including Securities Pledged [Line Items]
Payables under securities loan and repurchase agreements, including collateral held	22	14
U.S. corporate public securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Payables under securities loan and repurchase agreements, including collateral held	601	568
Short-term investments
Available-for-sale Securities, Including Securities Pledged [Line Items]
Payables under securities loan and repurchase agreements, including collateral held	241	55
Foreign corporate public securities and foreign governments
Available-for-sale Securities, Including Securities Pledged [Line Items]
Payables under securities loan and repurchase agreements, including collateral held	258	238
Total
Available-for-sale Securities, Including Securities Pledged [Line Items]
Payables under securities loan and repurchase agreements, including collateral held	1,122	$ 875
fixed maturities and other investment | Collateral pledged
Available-for-sale Securities, Including Securities Pledged [Line Items]
Total securities pledged	1,523
Other investments, including securities pledged | Collateral pledged
Available-for-sale Securities, Including Securities Pledged [Line Items]
Total securities pledged	$ 7

Investments (excluding Consol_6

Investments (excluding Consolidated Investment Entities) - Allowance for Credit Losses on Available-for-sale fixed maturity securities (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Mar. 31, 2024	Dec. 31, 2024	Dec. 31, 2023
Debt Securities, Available-for-Sale, Allowance for Credit Loss [Roll Forward]
Allowance for credit losses on available-for-sale fixed maturity securities, beginning balance	$ 17	$ 17	$ 12
Credit losses on securities for which credit losses were not previously recorded		24	11
Reductions for securities sold during the period		(1)	(5)
Increase (decrease) on securities with allowance recorded in previous period		(2)	(1)
Allowance for credit losses on available-for-sale fixed maturity securities, ending balance		38	17
U.S. corporate public securities
Debt Securities, Available-for-Sale, Allowance for Credit Loss [Roll Forward]
Allowance for credit losses on available-for-sale fixed maturity securities, beginning balance	0	0
Allowance for credit losses on available-for-sale fixed maturity securities, ending balance		0	0
Residential mortgage-backed securities
Debt Securities, Available-for-Sale, Allowance for Credit Loss [Roll Forward]
Allowance for credit losses on available-for-sale fixed maturity securities, beginning balance	0	0
Allowance for credit losses on available-for-sale fixed maturity securities, ending balance		0	0
Commercial mortgage-backed securities
Debt Securities, Available-for-Sale, Allowance for Credit Loss [Roll Forward]
Allowance for credit losses on available-for-sale fixed maturity securities, beginning balance	9	9	0
Credit losses on securities for which credit losses were not previously recorded		9	9
Reductions for securities sold during the period		0	0
Increase (decrease) on securities with allowance recorded in previous period		(1)	0
Allowance for credit losses on available-for-sale fixed maturity securities, ending balance		17	9
Foreign Corporate Public Securities and Foreign Governments [Member]
Debt Securities, Available-for-Sale, Allowance for Credit Loss [Roll Forward]
Allowance for credit losses on available-for-sale fixed maturity securities, beginning balance	3	3	9
Credit losses on securities for which credit losses were not previously recorded		0	0
Reductions for securities sold during the period		(1)	(5)
Increase (decrease) on securities with allowance recorded in previous period		0	(1)
Allowance for credit losses on available-for-sale fixed maturity securities, ending balance		2	3
Foreign corporate private securities
Debt Securities, Available-for-Sale, Allowance for Credit Loss [Roll Forward]
Allowance for credit losses on available-for-sale fixed maturity securities, beginning balance	2	2	2
Credit losses on securities for which credit losses were not previously recorded		8	0
Reductions for securities sold during the period		0	0
Increase (decrease) on securities with allowance recorded in previous period		(1)	0
Allowance for credit losses on available-for-sale fixed maturity securities, ending balance		9	2
Other asset-backed securities
Debt Securities, Available-for-Sale, Allowance for Credit Loss [Roll Forward]
Allowance for credit losses on available-for-sale fixed maturity securities, beginning balance	3	3	1
Credit losses on securities for which credit losses were not previously recorded		1	2
Reductions for securities sold during the period		0	0
Increase (decrease) on securities with allowance recorded in previous period		0	0
Allowance for credit losses on available-for-sale fixed maturity securities, ending balance		4	3
U.S. corporate private securities
Debt Securities, Available-for-Sale, Allowance for Credit Loss [Roll Forward]
Allowance for credit losses on available-for-sale fixed maturity securities, beginning balance	0	0	0
Credit losses on securities for which credit losses were not previously recorded	0	6
Reductions for securities sold during the period	0	0
Increase (decrease) on securities with allowance recorded in previous period	$ 0	0
Allowance for credit losses on available-for-sale fixed maturity securities, ending balance		$ 6	$ 0

Investments (excluding Consol_7

Investments (excluding Consolidated Investment Entities) - Unrealized Capital Losses (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve Months or Less Below Amortized Cost, Fair Value	$ 3,057	$ 1,221
Twelve Months or Less Below Amortized Cost, Unrealized Capital Losses	107	42
More Than Twelve Months Below Amortized Cost, Fair Value	14,784	18,938
More Than Twelve Months Below Amortized Cost, Unrealized Capital Losses	2,739	2,680
Total, Fair Value	17,841	20,159
Total, Unrealized Capital Losses	$ 2,846	2,722
Minimum
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed Maturities Average Duration	6 years
Maximum
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed Maturities Average Duration	6 years 6 months
U.S. Treasuries
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve Months or Less Below Amortized Cost, Fair Value	$ 304	99
Twelve Months or Less Below Amortized Cost, Unrealized Capital Losses	20	3
More Than Twelve Months Below Amortized Cost, Fair Value	133	109
More Than Twelve Months Below Amortized Cost, Unrealized Capital Losses	32	18
Total, Fair Value	437	208
Total, Unrealized Capital Losses	52	21
U.S. Government agencies and authorities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve Months or Less Below Amortized Cost, Fair Value	14	0
Twelve Months or Less Below Amortized Cost, Unrealized Capital Losses	0	0
More Than Twelve Months Below Amortized Cost, Fair Value	0	3
More Than Twelve Months Below Amortized Cost, Unrealized Capital Losses	0	1
Total, Fair Value	14	3
Total, Unrealized Capital Losses	0	1
State, municipalities, and political subdivisions
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve Months or Less Below Amortized Cost, Fair Value	7	20
Twelve Months or Less Below Amortized Cost, Unrealized Capital Losses	0	0
More Than Twelve Months Below Amortized Cost, Fair Value	562	731
More Than Twelve Months Below Amortized Cost, Unrealized Capital Losses	117	101
Total, Fair Value	569	751
Total, Unrealized Capital Losses	117	101
U.S. corporate public securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve Months or Less Below Amortized Cost, Fair Value	818	321
Twelve Months or Less Below Amortized Cost, Unrealized Capital Losses	35	17
More Than Twelve Months Below Amortized Cost, Fair Value	4,215	5,101
More Than Twelve Months Below Amortized Cost, Unrealized Capital Losses	1,019	887
Total, Fair Value	5,033	5,422
Total, Unrealized Capital Losses	1,054	904
U.S. corporate private securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve Months or Less Below Amortized Cost, Fair Value	546	176
Twelve Months or Less Below Amortized Cost, Unrealized Capital Losses	13	7
More Than Twelve Months Below Amortized Cost, Fair Value	2,845	3,365
More Than Twelve Months Below Amortized Cost, Unrealized Capital Losses	316	317
Total, Fair Value	3,391	3,541
Total, Unrealized Capital Losses	329	324
Foreign corporate public securities and foreign governments
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve Months or Less Below Amortized Cost, Fair Value	450	82
Twelve Months or Less Below Amortized Cost, Unrealized Capital Losses	17	2
More Than Twelve Months Below Amortized Cost, Fair Value	1,285	1,749
More Than Twelve Months Below Amortized Cost, Unrealized Capital Losses	270	268
Total, Fair Value	1,735	1,831
Total, Unrealized Capital Losses	287	270
Foreign corporate private securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve Months or Less Below Amortized Cost, Fair Value	490	189
Twelve Months or Less Below Amortized Cost, Unrealized Capital Losses	12	5
More Than Twelve Months Below Amortized Cost, Fair Value	1,468	2,101
More Than Twelve Months Below Amortized Cost, Unrealized Capital Losses	157	124
Total, Fair Value	1,958	2,290
Total, Unrealized Capital Losses	169	129
Residential mortgage-backed securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve Months or Less Below Amortized Cost, Fair Value	311	114
Twelve Months or Less Below Amortized Cost, Unrealized Capital Losses	8	3
More Than Twelve Months Below Amortized Cost, Fair Value	1,210	1,354
More Than Twelve Months Below Amortized Cost, Unrealized Capital Losses	253	254
Total, Fair Value	1,521	1,468
Total, Unrealized Capital Losses	261	257
Commercial mortgage-backed securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve Months or Less Below Amortized Cost, Fair Value	24	84
Twelve Months or Less Below Amortized Cost, Unrealized Capital Losses	0	2
More Than Twelve Months Below Amortized Cost, Fair Value	2,751	3,269
More Than Twelve Months Below Amortized Cost, Unrealized Capital Losses	532	642
Total, Fair Value	2,775	3,353
Total, Unrealized Capital Losses	532	644
Other asset-backed securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve Months or Less Below Amortized Cost, Fair Value	93	136
Twelve Months or Less Below Amortized Cost, Unrealized Capital Losses	2	3
More Than Twelve Months Below Amortized Cost, Fair Value	315	1,156
More Than Twelve Months Below Amortized Cost, Unrealized Capital Losses	43	68
Total, Fair Value	408	1,292
Total, Unrealized Capital Losses	$ 45	$ 71

Investments (excluding Consol_8

Investments (excluding Consolidated Investment Entities) - Evaluating Securities for Impairments (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Intent impairments	$ 13	$ 27
Intent impairments			$ 23

Investments (excluding Consol_9

Investments (excluding Consolidated Investment Entities) - Debt Restructuring (Details)	12 Months Ended
	Dec. 31, 2024 loan
Commercial mortgage loans
Financing Receivable, Troubled Debt Restructuring [Table]
Number of troubled debt restructuring contracts	0

Investments (excluding Conso_10

Investments (excluding Consolidated Investment Entities) - Loans by Loan to Value Ratio (Details) - USD ($) $ in Millions	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2024	Dec. 31, 2023
Schedule of Loans by Loan to Value Ratio [Line Items]
Targeted maximum amount of mortgage loans lended, percent of estimated fair value of underlying real estate		75%
Benchmark loan to value ratio, greater than indicates unpaid loan amount exceeds underlying collateral		100%
Debt service coverage benchmark ratio		100%
0% - 50%
Schedule of Loans by Loan to Value Ratio [Line Items]
Loan to Value Ratio, minimum	0%	0%
Loan to Value Ratio, maximum	50%	50%
50% - 60%
Schedule of Loans by Loan to Value Ratio [Line Items]
Loan to Value Ratio, minimum	50%	50%
Loan to Value Ratio, maximum	60%	60%
60% - 70%
Schedule of Loans by Loan to Value Ratio [Line Items]
Loan to Value Ratio, minimum	60%	60%
Loan to Value Ratio, maximum	70%	70%
70% - 80%
Schedule of Loans by Loan to Value Ratio [Line Items]
Loan to Value Ratio, minimum	70%	70%
Loan to Value Ratio, maximum	80%	80%
Debt-to-Value Ratio, 80 to 100 Percent
Schedule of Loans by Loan to Value Ratio [Line Items]
Loan to Value Ratio, minimum	80%	80%
Year of Origination 2024 [Member] | 0% - 50%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		$ 138
Year of Origination 2024 [Member] | 50% - 60%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		131
Year of Origination 2024 [Member] | 60% - 70%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		15
Year of Origination 2024 [Member] | 70% - 80%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		0
Year of Origination 2024 [Member] | Debt-to-Value Ratio, 80 to 100 Percent
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		0
Year of Origination 2023 | 0% - 50%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		96	$ 150
Year of Origination 2023 | 50% - 60%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		221	222
Year of Origination 2023 | 60% - 70%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		40	0
Year of Origination 2023 | 70% - 80%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		0	0
Year of Origination 2023 | Debt-to-Value Ratio, 80 to 100 Percent
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		0	0
Year of Origination 2022 | 0% - 50%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		239	252
Year of Origination 2022 | 50% - 60%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		282	326
Year of Origination 2022 | 60% - 70%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		95	73
Year of Origination 2022 | 70% - 80%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		0	0
Year of Origination 2022 | Debt-to-Value Ratio, 80 to 100 Percent
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		0	0
Year of Origination 2021 | 0% - 50%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		240	244
Year of Origination 2021 | 50% - 60%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		184	214
Year of Origination 2021 | 60% - 70%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		95	209
Year of Origination 2021 | 70% - 80%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		0	0
Year of Origination 2021 | Debt-to-Value Ratio, 80 to 100 Percent
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		0	0
Year of Origination 2020 | 0% - 50%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		184	168
Year of Origination 2020 | 50% - 60%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		71	112
Year of Origination 2020 | 60% - 70%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		0	0
Year of Origination 2020 | 70% - 80%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		0	10
Year of Origination 2020 | Debt-to-Value Ratio, 80 to 100 Percent
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		0	16
Year of Origination 2019 | 0% - 50%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		2,500	238
Year of Origination 2019 | 50% - 60%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		148	68
Year of Origination 2019 | 60% - 70%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		2	28
Year of Origination 2019 | 70% - 80%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		0	0
Year of Origination 2019 | Debt-to-Value Ratio, 80 to 100 Percent
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		18	0
Year of Origination 2018 | 0% - 50%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans			2,586
Year of Origination 2018 | 50% - 60%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans			280
Year of Origination 2018 | 60% - 70%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans			4
Year of Origination 2018 | 70% - 80%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans			0
Year of Origination 2018 | Debt-to-Value Ratio, 80 to 100 Percent
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans			18
Total Segment | 0% - 50%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		3,397	3,638
Total Segment | 50% - 60%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		1,037	1,222
Total Segment | 60% - 70%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		247	314
Total Segment | 70% - 80%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		0	10
Total Segment | Debt-to-Value Ratio, 80 to 100 Percent
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		$ 18	$ 34

Investments (excluding Conso_11

Investments (excluding Consolidated Investment Entities) - Loans by Debt Service Coverage Ratio (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
>1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Debt Service Coverage Ratio, minimum	150%
>1.25x - 1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Debt Service Coverage Ratio, minimum	125%
Debt Service Coverage Ratio, maximum	150%
>1.0x - 1.25x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Debt Service Coverage Ratio, minimum	100%
Debt Service Coverage Ratio, maximum	125%
Less than 1.0x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Debt Service Coverage Ratio, maximum	100%
Total Segment
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	$ 4,699	$ 5,218
Year of Origination 2024 [Member] | >1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	161
Year of Origination 2024 [Member] | >1.25x - 1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	93
Year of Origination 2024 [Member] | >1.0x - 1.25x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	28
Year of Origination 2024 [Member] | Less than 1.0x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	2
Year of Origination 2024 [Member] | Total Segment
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	284
Year of Origination 2023 | >1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	118	189
Year of Origination 2023 | >1.25x - 1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	180	116
Year of Origination 2023 | >1.0x - 1.25x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	48	67
Year of Origination 2023 | Less than 1.0x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	11	0
Year of Origination 2023 | Total Segment
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	357	372
Year of Origination 2022 | >1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	295	204
Year of Origination 2022 | >1.25x - 1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	101	68
Year of Origination 2022 | >1.0x - 1.25x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	76	192
Year of Origination 2022 | Less than 1.0x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	144	187
Year of Origination 2022 | Total Segment
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	616	651
Year of Origination 2021 | >1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	258	260
Year of Origination 2021 | >1.25x - 1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	16	14
Year of Origination 2021 | >1.0x - 1.25x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	97	64
Year of Origination 2021 | Less than 1.0x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	148	329
Year of Origination 2021 | Total Segment
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	519	667
Year of Origination 2020 | >1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	207	211
Year of Origination 2020 | >1.25x - 1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	20	24
Year of Origination 2020 | >1.0x - 1.25x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	20	21
Year of Origination 2020 | Less than 1.0x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	8	50
Year of Origination 2020 | Total Segment
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	255	306
Year of Origination 2019 | >1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	2,018	203
Year of Origination 2019 | >1.25x - 1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	219	26
Year of Origination 2019 | >1.0x - 1.25x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	346	84
Year of Origination 2019 | Less than 1.0x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	85	21
Year of Origination 2019 | Total Segment
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	2,668	334
Year of Origination 2018 | >1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans		2,216
Year of Origination 2018 | >1.25x - 1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans		264
Year of Origination 2018 | >1.0x - 1.25x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans		255
Year of Origination 2018 | Less than 1.0x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans		153
Year of Origination 2018 | Total Segment
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans		2,888
Total Segment | >1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	3,057	3,283
Total Segment | >1.25x - 1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	629	512
Total Segment | >1.0x - 1.25x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	615	683
Total Segment | Less than 1.0x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	398	740
Total Segment | Total Segment
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	$ 4,699	$ 5,218

Investments (excluding Conso_12

Investments (excluding Consolidated Investment Entities) - Loans by U.S. Region (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Year of Origination 2024 [Member] | Pacific
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	$ 58
Year of Origination 2024 [Member] | South Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	80
Year of Origination 2024 [Member] | Middle Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	41
Year of Origination 2024 [Member] | West South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	57
Year of Origination 2024 [Member] | Mountain
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	20
Year of Origination 2024 [Member] | East North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	9
Year of Origination 2024 [Member] | New England
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	7
Year of Origination 2024 [Member] | West North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	3
Year of Origination 2024 [Member] | East South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	9
Year of Origination 2024 [Member] | Total Segment
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	284
Year of Origination 2023 | Pacific
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	49	$ 69
Year of Origination 2023 | South Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	85	77
Year of Origination 2023 | Middle Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	12	12
Year of Origination 2023 | West South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	101	101
Year of Origination 2023 | Mountain
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	39	39
Year of Origination 2023 | East North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	39	42
Year of Origination 2023 | New England
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	3	3
Year of Origination 2023 | West North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	26	26
Year of Origination 2023 | East South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	3	3
Year of Origination 2023 | Total Segment
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	357	372
Year of Origination 2022 | Pacific
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	140	140
Year of Origination 2022 | South Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	122	132
Year of Origination 2022 | Middle Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	49	47
Year of Origination 2022 | West South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	98	100
Year of Origination 2022 | Mountain
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	89	113
Year of Origination 2022 | East North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	92	93
Year of Origination 2022 | New England
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	5	5
Year of Origination 2022 | West North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	1	1
Year of Origination 2022 | East South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	20	20
Year of Origination 2022 | Total Segment
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	616	651
Year of Origination 2021 | Pacific
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	95	96
Year of Origination 2021 | South Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	51	63
Year of Origination 2021 | Middle Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	113	124
Year of Origination 2021 | West South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	93	148
Year of Origination 2021 | Mountain
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	96	111
Year of Origination 2021 | East North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	47	75
Year of Origination 2021 | New England
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	9	9
Year of Origination 2021 | West North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	15	40
Year of Origination 2021 | East South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	0	1
Year of Origination 2021 | Total Segment
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	519	667
Year of Origination 2020 | Pacific
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	61	63
Year of Origination 2020 | South Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	118	155
Year of Origination 2020 | Middle Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	17	17
Year of Origination 2020 | West South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	10	10
Year of Origination 2020 | Mountain
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	12	12
Year of Origination 2020 | East North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	15	26
Year of Origination 2020 | New England
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2020 | West North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	7	7
Year of Origination 2020 | East South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	15	16
Year of Origination 2020 | Total Segment
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	255	306
Year of Origination 2019 | Pacific
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	707	53
Year of Origination 2019 | South Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	632	100
Year of Origination 2019 | Middle Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	619	10
Year of Origination 2019 | West South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	176	74
Year of Origination 2019 | Mountain
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	211	45
Year of Origination 2019 | East North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	134	4
Year of Origination 2019 | New England
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	51	14
Year of Origination 2019 | West North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	109	13
Year of Origination 2019 | East South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	29	21
Year of Origination 2019 | Total Segment
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	2,668	334
Year of Origination 2018 | Pacific
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		734
Year of Origination 2018 | South Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		605
Year of Origination 2018 | Middle Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		765
Year of Origination 2018 | West South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		189
Year of Origination 2018 | Mountain
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		214
Year of Origination 2018 | East North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		171
Year of Origination 2018 | New England
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		47
Year of Origination 2018 | West North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		144
Year of Origination 2018 | East South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		19
Year of Origination 2018 | Total Segment
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		2,888
Total Segment | Pacific
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	1,110	1,155
Total Segment | South Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	1,088	1,132
Total Segment | Middle Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	851	975
Total Segment | West South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	535	622
Total Segment | Mountain
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	467	534
Total Segment | East North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	336	411
Total Segment | New England
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	75	78
Total Segment | West North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	161	231
Total Segment | East South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	76	80
Total Segment | Total Segment
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	$ 4,699	$ 5,218

Investments (excluding Conso_13

Investments (excluding Consolidated Investment Entities) - Loans by Property Type (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Year of Origination 2024 [Member] | Retail
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	$ 58
Year of Origination 2024 [Member] | Industrial
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	154
Year of Origination 2024 [Member] | Apartments
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	57
Year of Origination 2024 [Member] | Office
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	15
Year of Origination 2024 [Member] | Hotel/Motel
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	0
Year of Origination 2024 [Member] | Other
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	0
Year of Origination 2024 [Member] | Mixed Use
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	0
Year of Origination 2024 [Member] | Total Segment
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	284
Year of Origination 2023 | Retail
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	124	$ 125
Year of Origination 2023 | Industrial
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	172	164
Year of Origination 2023 | Apartments
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	13	33
Year of Origination 2023 | Office
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	16	18
Year of Origination 2023 | Hotel/Motel
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	32	32
Year of Origination 2023 | Other
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2023 | Mixed Use
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2023 | Total Segment
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	357	372
Year of Origination 2022 | Retail
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	79	79
Year of Origination 2022 | Industrial
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	261	263
Year of Origination 2022 | Apartments
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	222	255
Year of Origination 2022 | Office
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	35	34
Year of Origination 2022 | Hotel/Motel
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	10	10
Year of Origination 2022 | Other
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	9	10
Year of Origination 2022 | Mixed Use
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2022 | Total Segment
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	616	651
Year of Origination 2021 | Retail
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	35	36
Year of Origination 2021 | Industrial
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	128	145
Year of Origination 2021 | Apartments
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	218	335
Year of Origination 2021 | Office
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	111	123
Year of Origination 2021 | Hotel/Motel
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2021 | Other
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	18	18
Year of Origination 2021 | Mixed Use
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	9	10
Year of Origination 2021 | Total Segment
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	519	667
Year of Origination 2020 | Retail
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	55	57
Year of Origination 2020 | Industrial
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	48	49
Year of Origination 2020 | Apartments
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	56	72
Year of Origination 2020 | Office
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	96	128
Year of Origination 2020 | Hotel/Motel
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2020 | Other
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2020 | Mixed Use
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2020 | Total Segment
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	255	306
Year of Origination 2019 | Retail
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	610	45
Year of Origination 2019 | Industrial
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	713	82
Year of Origination 2019 | Apartments
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	640	160
Year of Origination 2019 | Office
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	437	36
Year of Origination 2019 | Hotel/Motel
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	67	11
Year of Origination 2019 | Other
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	155	0
Year of Origination 2019 | Mixed Use
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	46	0
Year of Origination 2019 | Total Segment
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	2,668	334
Year of Origination 2018 | Retail
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		780
Year of Origination 2018 | Industrial
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		755
Year of Origination 2018 | Apartments
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		618
Year of Origination 2018 | Office
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		463
Year of Origination 2018 | Hotel/Motel
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		60
Year of Origination 2018 | Other
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		163
Year of Origination 2018 | Mixed Use
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		49
Year of Origination 2018 | Total Segment
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		2,888
Total Segment | Retail
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	961	1,122
Total Segment | Industrial
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	1,476	1,458
Total Segment | Apartments
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	1,206	1,473
Total Segment | Office
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	710	802
Total Segment | Hotel/Motel
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	109	113
Total Segment | Other
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	182	191
Total Segment | Mixed Use
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	55	59
Total Segment | Total Segment
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	$ 4,699	$ 5,218

Investments (excluding Conso_14

Investments (excluding Consolidated Investment Entities) - Allowance for Losses for Commercial Mortgage Loans (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Allowance for Loan and Lease Losses [Roll Forward]
Allowance for losses for commercial mortgage loans, beginning balance	$ 26
Allowance for losses for commercial mortgage loans, ending balance	24	$ 26
Commercial Portfolio Segment
Allowance for Loan and Lease Losses [Roll Forward]
Allowance for losses for commercial mortgage loans, beginning balance	26	18	$ 15
Credit losses on securities for which credit losses were not previously recorded	1	2
Increase (decrease) on mortgage loans with an allowance recorded in previous period	0	9
Provision for expected credit losses	27	29
Writeoffs	(3)	(3)	0
Allowance for losses for commercial mortgage loans, ending balance	$ 24	$ 26	$ 18

Investments (excluding Conso_15

Investments (excluding Consolidated Investment Entities) - Past due commercial mortgage loans (Details) - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Financing Receivable, Past Due [Line Items]
Investments in fixed maturities that did not produce net investment income	$ 26,000,000	$ 16,000,000
Financing receivable, nonaccrual, interest income	$ 0	0
Commercial Portfolio Segment
Financing Receivable, Past Due [Line Items]
Threshold period past due, nonaccrual	90 days
Commercial Portfolio Segment | Current
Financing Receivable, Past Due [Line Items]
Commercial mortgage loans	$ 4,673,000,000	5,202,000,000
Commercial Portfolio Segment | 30 to 59 Days Past Due
Financing Receivable, Past Due [Line Items]
Commercial mortgage loans	0	0
Commercial Portfolio Segment | 60-89 Days Past Due
Financing Receivable, Past Due [Line Items]
Commercial mortgage loans	0	0
Commercial Portfolio Segment | Greater than 90 Days Past Due
Financing Receivable, Past Due [Line Items]
Commercial mortgage loans	26,000,000	16,000,000
Commercial Portfolio Segment | Total Segment
Financing Receivable, Past Due [Line Items]
Commercial mortgage loans	$ 4,699,000,000	$ 5,218,000,000

Investments (excluding Conso_16

Investments (excluding Consolidated Investment Entities) - Net Investment Income (Details) - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Schedule of Investment Income, Reported Amounts, by Category [Line Items]
Gross investment income	$ 2,150,000,000	$ 2,230,000,000	$ 2,341,000,000
Less: Investment expenses	76,000,000	71,000,000	60,000,000
Net investment income	2,074,000,000	2,159,000,000	2,281,000,000
Investments in fixed maturities that did not produce net investment income	26,000,000	16,000,000
Fixed maturities
Schedule of Investment Income, Reported Amounts, by Category [Line Items]
Gross investment income	1,678,000,000	1,766,000,000	1,940,000,000
Investments in fixed maturities that did not produce net investment income	18,000,000	10,000,000
Equity securities
Schedule of Investment Income, Reported Amounts, by Category [Line Items]
Gross investment income	19,000,000	21,000,000	12,000,000
Mortgage loans on real estate
Schedule of Investment Income, Reported Amounts, by Category [Line Items]
Gross investment income	234,000,000	249,000,000	237,000,000
Policy loans
Schedule of Investment Income, Reported Amounts, by Category [Line Items]
Gross investment income	20,000,000	20,000,000	21,000,000
Short-term investments and cash equivalents
Schedule of Investment Income, Reported Amounts, by Category [Line Items]
Gross investment income	40,000,000	39,000,000	13,000,000
Other
Schedule of Investment Income, Reported Amounts, by Category [Line Items]
Gross investment income	$ 159,000,000	$ 135,000,000	$ 118,000,000

Investments (excluding Conso_17

Investments (excluding Consolidated Investment Entities) - Net Gains (Losses) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Available-for-sale Securities, Including Securities Pledged [Line Items]
Net gains (losses)	$ (27)	$ (72)	$ (686)
Voya India
Available-for-sale Securities, Including Securities Pledged [Line Items]
Net gains (losses)	45	45
Embedded derivatives - fixed maturities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Net gains (losses)	(6)	(1)	(9)
Other derivatives, net
Available-for-sale Securities, Including Securities Pledged [Line Items]
Net gains (losses)	2	0	0
Standalone derivatives
Available-for-sale Securities, Including Securities Pledged [Line Items]
Net gains (losses)	(1)	0	(12)
Managed Custody Guarantees
Available-for-sale Securities, Including Securities Pledged [Line Items]
Net gains (losses)	4	(2)	(5)
Stabilizer
Available-for-sale Securities, Including Securities Pledged [Line Items]
Net gains (losses)	(14)	(1)	19
Derivatives
Available-for-sale Securities, Including Securities Pledged [Line Items]
Net gains (losses)	193	29	305
Mortgage loans on real estate
Available-for-sale Securities, Including Securities Pledged [Line Items]
Net gains (losses)	(1)	(12)	0
Other investments, including securities pledged
Available-for-sale Securities, Including Securities Pledged [Line Items]
Net gains (losses)	5	43	5
Fixed maturities, available-for-sale, including securities pledged
Available-for-sale Securities, Including Securities Pledged [Line Items]
Net gains (losses)	(48)	(31)	(30)
Fixed maturities, at fair value using the fair value option
Available-for-sale Securities, Including Securities Pledged [Line Items]
Net gains (losses)	(167)	(100)	(920)
Equity securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Net gains (losses)	$ 6	$ 3	$ (39)

Investments (excluding Conso_18

Investments (excluding Consolidated Investment Entities) - Proceeds and Realized Gains and Losses from the Sale of Fixed Maturities (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Proceeds on sales	$ 3,510	$ 5,393	$ 5,448
Gross gains	50	69	100
Gross losses	$ (62)	$ 78	$ 109

Derivative Financial Instrume_3

Derivative Financial Instruments - Notional and Fair Values (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Derivatives, Fair Value [Line Items]
Asset Fair Value	$ 358	$ 374
Liability Fair Value	396	429
Interest rate contracts
Derivatives, Fair Value [Line Items]
Hedged asset, fair value hedge	307	106
Hedged asset, fair value hedge, cumulative increase (decrease)	(8)	(6)
Hedged asset, discontinued fair value hedge, cumulative increase (decrease)	2	0
Designated as Hedging Instrument | Fair Value Hedging | Interest rate contracts
Derivatives, Fair Value [Line Items]
Notional Amount	0	0
Designated as Hedging Instrument | Fair Value Hedging | Foreign exchange contracts
Derivatives, Fair Value [Line Items]
Notional Amount	106	98
Designated as Hedging Instrument | Cash Flow Hedging | Interest rate contracts
Derivatives, Fair Value [Line Items]
Notional Amount	11	12
Designated as Hedging Instrument | Cash Flow Hedging | Foreign exchange contracts
Derivatives, Fair Value [Line Items]
Notional Amount	623	718
Designated as Hedging Instrument | Derivatives | Fair Value Hedging | Interest rate contracts
Derivatives, Fair Value [Line Items]
Asset Fair Value	0	0
Liability Fair Value	0	0
Designated as Hedging Instrument | Derivatives | Fair Value Hedging | Foreign exchange contracts
Derivatives, Fair Value [Line Items]
Asset Fair Value	6	0
Liability Fair Value	0	4
Designated as Hedging Instrument | Derivatives | Cash Flow Hedging | Interest rate contracts
Derivatives, Fair Value [Line Items]
Asset Fair Value	0	0
Liability Fair Value	0	0
Designated as Hedging Instrument | Derivatives | Cash Flow Hedging | Foreign exchange contracts
Derivatives, Fair Value [Line Items]
Asset Fair Value	46	33
Liability Fair Value	2	7
Not Designated as Hedging Instrument | Interest rate contracts
Derivatives, Fair Value [Line Items]
Notional Amount	14,633	16,773
Not Designated as Hedging Instrument | Foreign exchange contracts
Derivatives, Fair Value [Line Items]
Notional Amount	203	183
Not Designated as Hedging Instrument | Equity contracts
Derivatives, Fair Value [Line Items]
Notional Amount	286	255
Not Designated as Hedging Instrument | Fixed maturities
Derivatives, Fair Value [Line Items]
Asset Fair Value	0	2
Liability Fair Value	4	0
Not Designated as Hedging Instrument | Within reinsurance agreements
Derivatives, Fair Value [Line Items]
Asset Fair Value	55	61
Liability Fair Value	41	49
Not Designated as Hedging Instrument | Managed Custody Guarantees
Derivatives, Fair Value [Line Items]
Asset Fair Value	0	0
Liability Fair Value	4	8
Not Designated as Hedging Instrument | Stabilizer
Derivatives, Fair Value [Line Items]
Asset Fair Value	0	0
Liability Fair Value	15	1
Not Designated as Hedging Instrument | Credit Default Swap
Derivatives, Fair Value [Line Items]
Notional Amount	97	137
Not Designated as Hedging Instrument | Derivatives | Interest rate contracts
Derivatives, Fair Value [Line Items]
Asset Fair Value	246	270
Liability Fair Value	313	354
Not Designated as Hedging Instrument | Derivatives | Foreign exchange contracts
Derivatives, Fair Value [Line Items]
Asset Fair Value	3	4
Liability Fair Value	6	2
Not Designated as Hedging Instrument | Derivatives | Equity contracts
Derivatives, Fair Value [Line Items]
Asset Fair Value	2	4
Liability Fair Value	9	2
Not Designated as Hedging Instrument | Derivatives | Credit Default Swap
Derivatives, Fair Value [Line Items]
Asset Fair Value	0	0
Liability Fair Value	$ 2	$ 2

Derivative Financial Instrume_4

Derivative Financial Instruments - Offsetting Assets and Liabilities (Details) - USD ($)	Dec. 31, 2024	Dec. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Gross Amount Recognized, Assets	$ 303,000,000	$ 311,000,000
Counterparty netting, Assets	(261,000,000)	(216,000,000)
Cash collateral netting, Assets	(34,000,000)	(76,000,000)
Securities collateral netting, Assets	(3,000,000)	(8,000,000)
Net receivables/payables, Assets	5,000,000	11,000,000
Gross Amount Recognized, Liabilities	332,000,000	370,000,000
Counterparty netting, Liabilities	(261,000,000)	(216,000,000)
Cash collateral netting, Liabilities	(58,000,000)	(150,000,000)
Securities collateral netting, Liabilities	(6,000,000)	(3,000,000)
Net receivables/payables, Liabilities	7,000,000	1,000,000
Excluded asset exchange traded contract	0	0
Excluded Liability Exchange Traded Contracts	$ 0	$ 1,000,000

Derivative Financial Instrume_5

Derivative Financial Instruments - Collateral (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Payables under securities loan agreement, including collateral held | Over the Counter
Derivatives, Fair Value [Line Items]
Securities held as collateral	$ 33	$ 84
Payables under securities loan agreement, including collateral held | Cleared Derivative Contract
Derivatives, Fair Value [Line Items]
Securities held as collateral	56	147
Securities pledged
Derivatives, Fair Value [Line Items]
Securities held as collateral	4	11
Securities pledged as collateral	$ 159	$ 201

Derivative Financial Instrume_6

Derivative Financial Instruments - Net Realized Gains (Losses) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Derivatives, Fair Value [Line Items]
Net investment income	$ 2,074	$ 2,159	$ 2,281
Net gains (losses)	(27)	(72)	(686)
Gain (loss) reclassified from AOCI into income(2)	$ 162	$ (11)	$ 520
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Policyholder benefits, Net gains (losses)	Policyholder benefits, Net gains (losses)	Policyholder benefits, Net gains (losses)
Fixed maturities
Derivatives, Fair Value [Line Items]
Net gains (losses)	$ (6)	$ (1)	$ (9)
Gain (loss) reclassified from AOCI into income(2)	(6)	(1)	(9)
Within reinsurance agreements
Derivatives, Fair Value [Line Items]
Gain (loss) reclassified from AOCI into income(2)	(3)	(37)	217
Within reinsurance agreements | Level 3 | Assets measured on recurring basis
Derivatives, Fair Value [Line Items]
Fair Value, Assets and Liabilities Measured on Recurring Basis, Gain (Loss) Included in Earnings	2	2	1
Total Realized/Unrealized Gains (Losses) Included in Net income	(1)	0	(12)
Managed Custody Guarantees
Derivatives, Fair Value [Line Items]
Net gains (losses)	4	(2)	(5)
Gain (loss) reclassified from AOCI into income(2)	4	(2)	(5)
Stabilizer and MCGs
Derivatives, Fair Value [Line Items]
Net gains (losses)	(14)	(1)	19
Gain (loss) reclassified from AOCI into income(2)	(14)	(1)	19
Not Designated as Hedging Instrument | Credit Default Swap
Derivatives, Fair Value [Line Items]
Gain (loss) reclassified from AOCI into income(2)	1	1	(3)
Not Designated as Hedging Instrument | Interest rate contracts
Derivatives, Fair Value [Line Items]
Gain (loss) reclassified from AOCI into income(2)	170	15	334
Not Designated as Hedging Instrument | Foreign exchange contracts
Derivatives, Fair Value [Line Items]
Gain (loss) reclassified from AOCI into income(2)	(8)	0	(1)
Not Designated as Hedging Instrument | Equity contracts
Derivatives, Fair Value [Line Items]
Gain (loss) reclassified from AOCI into income(2)	18	14	(32)
Other Comprehensive Income (Loss) | Designated as Hedging Instrument | Cash Flow Hedging | Interest rate contracts
Derivatives, Fair Value [Line Items]
Amount of Gain or (Loss) Recognized on Other Comprehensive Income / Reclassified from Accumulated Other Comprehensive Income	0	0	(2)
Other Comprehensive Income (Loss) | Designated as Hedging Instrument | Cash Flow Hedging | Foreign exchange contracts
Derivatives, Fair Value [Line Items]
Amount of Gain or (Loss) Recognized on Other Comprehensive Income / Reclassified from Accumulated Other Comprehensive Income	18	(43)	70
Net Investment Income | Fair Value Hedging | Interest rate contracts
Derivatives, Fair Value [Line Items]
Gain (loss) reclassified from AOCI into income(2)	0	0	0
Net Investment Income | Fair Value Hedging | Foreign exchange contracts
Derivatives, Fair Value [Line Items]
Gain (loss) reclassified from AOCI into income(2)	0	0	0
Net Investment Income | Designated as Hedging Instrument | Cash Flow Hedging | Interest rate contracts
Derivatives, Fair Value [Line Items]
Amount of Gain or (Loss) Recognized on Other Comprehensive Income / Reclassified from Accumulated Other Comprehensive Income	0	0	0
Net Investment Income | Designated as Hedging Instrument | Cash Flow Hedging | Foreign exchange contracts
Derivatives, Fair Value [Line Items]
Amount of Gain or (Loss) Recognized on Other Comprehensive Income / Reclassified from Accumulated Other Comprehensive Income	16	10	11
Gain (loss) reclassified from AOCI into income(2)	10	10	11
Net Investment Income | Designated as Hedging Instrument | Fair Value Hedging | Interest rate contracts
Derivatives, Fair Value [Line Items]
Gain (loss) reclassified from AOCI into income(2)	0	0	0
Net Investment Income | Designated as Hedging Instrument | Fair Value Hedging | Foreign exchange contracts
Derivatives, Fair Value [Line Items]
Gain (loss) reclassified from AOCI into income(2)	0	0	0
Other net realized capital gains/losses | Fair Value Hedging | Interest rate contracts
Derivatives, Fair Value [Line Items]
Gain (loss) reclassified from AOCI into income(2)	2	0	0
Other net realized capital gains/losses | Fair Value Hedging | Foreign exchange contracts
Derivatives, Fair Value [Line Items]
Gain (loss) reclassified from AOCI into income(2)	(6)	3	(6)
Other net realized capital gains/losses | Designated as Hedging Instrument | Cash Flow Hedging | Foreign exchange contracts
Derivatives, Fair Value [Line Items]
Gain (loss) reclassified from AOCI into income(2)	6	0	0
Other net realized capital gains/losses | Designated as Hedging Instrument | Fair Value Hedging | Interest rate contracts
Derivatives, Fair Value [Line Items]
Gain (loss) reclassified from AOCI into income(2)	(2)	0	0
Other net realized capital gains/losses | Designated as Hedging Instrument | Fair Value Hedging | Foreign exchange contracts
Derivatives, Fair Value [Line Items]
Gain (loss) reclassified from AOCI into income(2)	$ 8	$ (1)	$ 7

Fair Value Measurements (excl_3

Fair Value Measurements (excluding Consolidated Investment Entities) - Fair Value Measurement (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets held in separate accounts	$ 101,676	$ 93,133
Total assets	163,889	157,085
Derivatives	332	371
Total liabilities	157,882	151,032
Fixed maturities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	27,454	28,611
U.S. Treasuries
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	472	403
U.S. Government agencies and authorities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	30	56
State, municipalities, and political subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	580	771
U.S. corporate public securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	7,008	7,666
U.S. corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	4,983	4,760
Foreign corporate public securities and foreign governments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	2,472	2,702
Foreign corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	2,537	2,812
Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	3,471	3,476
Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	3,132	3,495
Other asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	2,769	2,470
Assets measured on recurring basis
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements	2,535	2,165
Assets held in separate accounts	101,676	93,133
Total assets	132,269	124,517
Contingent consideration liability	2	51
Total liabilities	394	480
Assets measured on recurring basis | Stabilizer and MCGs
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment contract liabilities	19	9
Assets measured on recurring basis | Credit Default Swap
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	2	2
Assets measured on recurring basis | Interest rate contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	246	270
Derivatives	313	354
Assets measured on recurring basis | Foreign exchange contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	55	37
Derivatives	8	13
Assets measured on recurring basis | Equity contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	2	4
Derivatives	9	2
Assets measured on recurring basis | Embedded derivatives on reinsurance .
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	55	61
Embedded derivative on reinsurance liability	(41)	(49)
Assets measured on recurring basis | Fixed maturities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	27,454	28,611
Assets measured on recurring basis | U.S. Treasuries
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	472	403
Assets measured on recurring basis | U.S. Government agencies and authorities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	30	56
Assets measured on recurring basis | State, municipalities, and political subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	580	771
Assets measured on recurring basis | U.S. corporate public securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	7,008	7,666
Assets measured on recurring basis | U.S. corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	4,983	4,760
Assets measured on recurring basis | Foreign corporate public securities and foreign governments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	2,472	2,702
Assets measured on recurring basis | Foreign corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	2,537	2,812
Assets measured on recurring basis | Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	3,471	3,476
Assets measured on recurring basis | Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	3,132	3,495
Assets measured on recurring basis | Other asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	2,769	2,470
Assets measured on recurring basis | Equity securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity securities	246	236
Assets measured on recurring basis | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements	2,511	2,148
Assets held in separate accounts	95,946	87,180
Total assets	99,007	89,821
Contingent consideration liability	0	0
Total liabilities	11	0
Assets measured on recurring basis | Level 1 | Stabilizer and MCGs
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment contract liabilities	0	0
Assets measured on recurring basis | Level 1 | Credit Default Swap
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	0	0
Assets measured on recurring basis | Level 1 | Interest rate contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	0	7
Derivatives	11	0
Assets measured on recurring basis | Level 1 | Foreign exchange contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	0	0
Derivatives	0	0
Assets measured on recurring basis | Level 1 | Equity contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	0	0
Derivatives	0	0
Assets measured on recurring basis | Level 1 | Embedded derivatives on reinsurance .
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	0
Embedded derivative on reinsurance liability	0	0
Assets measured on recurring basis | Level 1 | Fixed maturities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	402	346
Assets measured on recurring basis | Level 1 | U.S. Treasuries
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	402	346
Assets measured on recurring basis | Level 1 | U.S. Government agencies and authorities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	0	0
Assets measured on recurring basis | Level 1 | State, municipalities, and political subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	0	0
Assets measured on recurring basis | Level 1 | U.S. corporate public securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	0	0
Assets measured on recurring basis | Level 1 | U.S. corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	0	0
Assets measured on recurring basis | Level 1 | Foreign corporate public securities and foreign governments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	0	0
Assets measured on recurring basis | Level 1 | Foreign corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	0	0
Assets measured on recurring basis | Level 1 | Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	0	0
Assets measured on recurring basis | Level 1 | Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	0	0
Assets measured on recurring basis | Level 1 | Other asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	0	0
Assets measured on recurring basis | Level 1 | Equity securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity securities	148	140
Assets measured on recurring basis | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements	1	17
Assets held in separate accounts	5,390	5,605
Total assets	30,674	32,162
Contingent consideration liability	0	0
Total liabilities	309	362
Assets measured on recurring basis | Level 2 | Stabilizer and MCGs
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment contract liabilities	0	0
Assets measured on recurring basis | Level 2 | Credit Default Swap
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	2	2
Assets measured on recurring basis | Level 2 | Interest rate contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	246	263
Derivatives	302	354
Assets measured on recurring basis | Level 2 | Foreign exchange contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	55	37
Derivatives	8	13
Assets measured on recurring basis | Level 2 | Equity contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	2	4
Derivatives	9	2
Assets measured on recurring basis | Level 2 | Embedded derivatives on reinsurance .
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	55	61
Embedded derivative on reinsurance liability	(12)	(9)
Assets measured on recurring basis | Level 2 | Fixed maturities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	24,925	26,175
Assets measured on recurring basis | Level 2 | U.S. Treasuries
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	70	57
Assets measured on recurring basis | Level 2 | U.S. Government agencies and authorities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	30	55
Assets measured on recurring basis | Level 2 | State, municipalities, and political subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	580	771
Assets measured on recurring basis | Level 2 | U.S. corporate public securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	6,949	7,648
Assets measured on recurring basis | Level 2 | U.S. corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	3,486	3,234
Assets measured on recurring basis | Level 2 | Foreign corporate public securities and foreign governments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	2,412	2,702
Assets measured on recurring basis | Level 2 | Foreign corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	2,116	2,376
Assets measured on recurring basis | Level 2 | Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	3,404	3,419
Assets measured on recurring basis | Level 2 | Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	3,132	3,495
Assets measured on recurring basis | Level 2 | Other asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	2,746	2,418
Assets measured on recurring basis | Level 2 | Equity securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity securities	0	0
Assets measured on recurring basis | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements	23	0
Assets held in separate accounts	340	348
Total assets	2,588	2,534
Contingent consideration liability	2	51
Total liabilities	74	118
Assets measured on recurring basis | Level 3 | Stabilizer and MCGs
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment contract liabilities	19	9
Assets measured on recurring basis | Level 3 | Credit Default Swap
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	0	0
Assets measured on recurring basis | Level 3 | Interest rate contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	0	0
Derivatives	0	0
Assets measured on recurring basis | Level 3 | Foreign exchange contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	0	0
Derivatives	0	0
Assets measured on recurring basis | Level 3 | Equity contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	0	0
Derivatives	0	0
Assets measured on recurring basis | Level 3 | Embedded derivatives on reinsurance .
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	0	0
Embedded derivative on reinsurance liability	(53)	(58)
Assets measured on recurring basis | Level 3 | Fixed maturities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	2,127	2,090
Assets measured on recurring basis | Level 3 | U.S. Treasuries
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	0	0
Assets measured on recurring basis | Level 3 | U.S. Government agencies and authorities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	0	1
Assets measured on recurring basis | Level 3 | State, municipalities, and political subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	0	0
Assets measured on recurring basis | Level 3 | U.S. corporate public securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	59	18
Assets measured on recurring basis | Level 3 | U.S. corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	1,497	1,526
Assets measured on recurring basis | Level 3 | Foreign corporate public securities and foreign governments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	60	0
Assets measured on recurring basis | Level 3 | Foreign corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	421	436
Assets measured on recurring basis | Level 3 | Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	67	57
Assets measured on recurring basis | Level 3 | Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	0	0
Assets measured on recurring basis | Level 3 | Other asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	23	52
Assets measured on recurring basis | Level 3 | Equity securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity securities	$ 98	$ 96

Fair Value Measurements (excl_4

Fair Value Measurements (excluding Consolidated Investment Entities) - Level 3 Financial Instruments (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Derivatives Rollforward:
Fair Value, Net Derivative Asset (Liability), Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Net gains (losses)
Assets measured on recurring basis | Level 3 | Embedded derivatives on reinsurance .
Derivatives Rollforward:
Fair Value, Derivatives, beginning balance	$ (58)	$ (58)
Total Realized/Unrealized Gains (Losses) Included in Net income	(1)	0	$ (12)
Total Realized/Unrealized Gains (Losses) Included in OCI	0	0
Purchases	0	0
Issuances	0	0
Sales	0	0
Settlements	6	0
Transfers in to Level 3	0	0
Transfers out of Level 3	0	0
Fair Value, Derivatives, ending balance	(53)	(58)	(58)
Change in Unrealized Gains (Losses) in Earnings	0	0
Fair Value, Net Derivative Asset (Liability), Recurring Basis, Still Held, Unrealized Gain (Loss), OCI	0	0
Assets measured on recurring basis | Level 3 | U.S. government agencies and authorities
Assets Rollforward:
Assets, Fair Value, beginning balance	1	1
Total Realized/Unrealized Gains (Losses) Included in Net income	0	0
Total Realized/Unrealized Gains (Losses) Included in OCI	0	0
Purchases	0	0
Issuances	0	0
Sales	0	0
Settlements	0	0
Transfers into Level 3	0	0
Transfers out of Level 3	(1)	0
Assets, Fair Value, ending balance	0	1	1
Change In Unrealized Gains (Losses) Included in Earnings	0	0
Fair Value, Asset (Liability), Recurring Basis, Still Held, Unrealized Gain (Loss), OCI	0	0
Assets measured on recurring basis | Level 3 | U.S. corporate public securities
Assets Rollforward:
Assets, Fair Value, beginning balance	18	20
Total Realized/Unrealized Gains (Losses) Included in Net income	0	1
Total Realized/Unrealized Gains (Losses) Included in OCI	(1)	0
Purchases	49	0
Issuances	0	0
Sales	0	0
Settlements	(7)	0
Transfers into Level 3	0	0
Transfers out of Level 3	0	(3)
Assets, Fair Value, ending balance	59	18	20
Change In Unrealized Gains (Losses) Included in Earnings	0	0
Fair Value, Asset (Liability), Recurring Basis, Still Held, Unrealized Gain (Loss), OCI	(2)	0
Assets measured on recurring basis | Level 3 | U.S. corporate private securities
Assets Rollforward:
Assets, Fair Value, beginning balance	1,526	1,801
Total Realized/Unrealized Gains (Losses) Included in Net income	(4)	1
Total Realized/Unrealized Gains (Losses) Included in OCI	1	22
Purchases	377	142
Issuances	0	0
Sales	(22)	(4)
Settlements	(246)	(219)
Transfers into Level 3	0	79
Transfers out of Level 3	(135)	(296)
Assets, Fair Value, ending balance	1,497	1,526	1,801
Change In Unrealized Gains (Losses) Included in Earnings	0	1
Fair Value, Asset (Liability), Recurring Basis, Still Held, Unrealized Gain (Loss), OCI	(5)	19
Assets measured on recurring basis | Level 3 | Foreign corporate public securities and foreign governments
Assets Rollforward:
Assets, Fair Value, beginning balance	0	3
Total Realized/Unrealized Gains (Losses) Included in Net income	0	0
Total Realized/Unrealized Gains (Losses) Included in OCI	0	0
Purchases	60	0
Issuances	0	0
Sales	0	0
Settlements	0	0
Transfers into Level 3	0	0
Transfers out of Level 3	0	(3)
Assets, Fair Value, ending balance	60	0	3
Change In Unrealized Gains (Losses) Included in Earnings	0	0
Fair Value, Asset (Liability), Recurring Basis, Still Held, Unrealized Gain (Loss), OCI	0	0
Assets measured on recurring basis | Level 3 | Foreign corporate private securities
Assets Rollforward:
Assets, Fair Value, beginning balance	436	432
Total Realized/Unrealized Gains (Losses) Included in Net income	(8)	3
Total Realized/Unrealized Gains (Losses) Included in OCI	(33)	9
Purchases	35	129
Issuances	0	0
Sales	(9)	(14)
Settlements	(51)	(167)
Transfers into Level 3	51	51
Transfers out of Level 3	0	(7)
Assets, Fair Value, ending balance	421	436	432
Change In Unrealized Gains (Losses) Included in Earnings	0	3
Fair Value, Asset (Liability), Recurring Basis, Still Held, Unrealized Gain (Loss), OCI	(33)	8
Assets measured on recurring basis | Level 3 | Residential mortgage-backed securities
Assets Rollforward:
Assets, Fair Value, beginning balance	57	28
Total Realized/Unrealized Gains (Losses) Included in Net income	(4)	(4)
Total Realized/Unrealized Gains (Losses) Included in OCI	0	0
Purchases	18	31
Issuances	0	0
Sales	0	0
Settlements	0	0
Transfers into Level 3	0	2
Transfers out of Level 3	(4)	0
Assets, Fair Value, ending balance	67	57	28
Change In Unrealized Gains (Losses) Included in Earnings	(4)	(3)
Fair Value, Asset (Liability), Recurring Basis, Still Held, Unrealized Gain (Loss), OCI	0	0
Assets measured on recurring basis | Level 3 | Other asset-backed securities
Assets Rollforward:
Assets, Fair Value, beginning balance	52	64
Total Realized/Unrealized Gains (Losses) Included in Net income	0	0
Total Realized/Unrealized Gains (Losses) Included in OCI	0	1
Purchases	3	15
Issuances	0	0
Sales	0	(2)
Settlements	(7)	(4)
Transfers into Level 3	0	0
Transfers out of Level 3	(25)	(22)
Assets, Fair Value, ending balance	23	52	64
Change In Unrealized Gains (Losses) Included in Earnings	0	0
Fair Value, Asset (Liability), Recurring Basis, Still Held, Unrealized Gain (Loss), OCI	0	0
Assets measured on recurring basis | Level 3 | Fixed maturities
Assets Rollforward:
Assets, Fair Value, beginning balance	2,090	2,349
Total Realized/Unrealized Gains (Losses) Included in Net income	(16)	1
Total Realized/Unrealized Gains (Losses) Included in OCI	(33)	32
Purchases	542	317
Issuances	0	0
Sales	(31)	(20)
Settlements	(311)	(390)
Transfers into Level 3	51	132
Transfers out of Level 3	(165)	(331)
Assets, Fair Value, ending balance	2,127	2,090	2,349
Change In Unrealized Gains (Losses) Included in Earnings	(4)	1
Fair Value, Asset (Liability), Recurring Basis, Still Held, Unrealized Gain (Loss), OCI	(40)	27
Assets measured on recurring basis | Level 3 | Equity securities
Assets Rollforward:
Assets, Fair Value, beginning balance	96	196
Total Realized/Unrealized Gains (Losses) Included in Net income	2	(3)
Total Realized/Unrealized Gains (Losses) Included in OCI	0	0
Purchases	0	3
Issuances	0	0
Sales	0	0
Settlements	0	(100)
Transfers into Level 3	0	0
Transfers out of Level 3	0	0
Assets, Fair Value, ending balance	98	96	196
Change In Unrealized Gains (Losses) Included in Earnings	2	(3)
Fair Value, Asset (Liability), Recurring Basis, Still Held, Unrealized Gain (Loss), OCI	0	0
Assets measured on recurring basis | Level 3 | Contingent Consideration
Assets Rollforward:
Fair Value, Asset (Liability), Recurring Basis, Still Held, Unrealized Gain (Loss), OCI	0	0
Liabilities Rollforward:
Liabilities, Beginning Balance	(51)	(112)
Total Realized/Unrealized Gains (Losses) Included in Net income	1	61
Total Realized/Unrealized Gains (Losses) Included in OCI	0	0
Purchases	0	0
Issuances	0	0
Sales	0	0
Settlements	48	0
Transfers into Level 3	0	0
Transfers out of Level 3	0	0
Liabilities, Ending Balance	(2)	(51)	(112)
Change In Unrealized Gains (Losses) Included in Earnings	0	0
Assets measured on recurring basis | Level 3 | Stabilizer and MCGs
Assets Rollforward:
Fair Value, Asset (Liability), Recurring Basis, Still Held, Unrealized Gain (Loss), OCI	0	0
Liabilities Rollforward:
Liabilities, Beginning Balance	(9)	(6)
Total Realized/Unrealized Gains (Losses) Included in Net income	(8)	(1)
Total Realized/Unrealized Gains (Losses) Included in OCI	0	0
Purchases	0	0
Issuances	(2)	(2)
Sales	0	0
Settlements	0	0
Transfers into Level 3	0	0
Transfers out of Level 3	0	0
Liabilities, Ending Balance	(19)	(9)	(6)
Change In Unrealized Gains (Losses) Included in Earnings	0	0
Assets measured on recurring basis | Level 3 | Assets held in separate accounts
Assets Rollforward:
Assets, Fair Value, beginning balance	348	347
Total Realized/Unrealized Gains (Losses) Included in Net income	6	1
Total Realized/Unrealized Gains (Losses) Included in OCI	0	0
Purchases	47	8
Issuances	0	0
Sales	(26)	(21)
Settlements	0	0
Transfers into Level 3	5	14
Transfers out of Level 3	(40)	(1)
Assets, Fair Value, ending balance	340	348	$ 347
Change In Unrealized Gains (Losses) Included in Earnings	0	0
Fair Value, Asset (Liability), Recurring Basis, Still Held, Unrealized Gain (Loss), OCI	0	$ 0
Assets measured on recurring basis | Level 3 | Cash and cash equivalents
Assets Rollforward:
Purchases	23
Assets, Fair Value, ending balance	$ 23

Fair Value Measurements (excl_5

Fair Value Measurements (excluding Consolidated Investment Entities) - Other Financial Instruments (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets held in separate accounts	$ 101,676	$ 93,133
Derivatives	332	371
Carrying Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fixed maturities, including securities pledged	27,454	28,611
Equity securities	246	236
Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements	2,535	2,165
Derivatives	303	311
Other Investments	74	64
Assets held in separate accounts	101,676	93,133
Short-term debt	399	1
Long-term debt	2,103	2,097
Carrying Value | Stabilizer and MCGs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivatives	19	9
Carrying Value | Other derivatives, net
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivatives	332	371
Carrying Value | Embedded derivatives on reinsurance .
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivatives	55	61
Derivatives	41	49
Carrying Value | Funding agreements without fixed maturities and deferred annuities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investment contract liabilities	31,082	32,848
Carrying Value | Funding agreements with fixed maturities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investment contract liabilities	1,249	1,175
Carrying Value | Supplementary contracts, immediate annuities and other
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investment contract liabilities	570	628
Carrying Value | Mortgage loans on real estate
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Loans	4,699	5,218
Carrying Value | Policy loans
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Loans	342	352
Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fixed maturities, including securities pledged	27,454	28,611
Equity securities	246	236
Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements	2,535	2,165
Derivatives	303	311
Other Investments	74	64
Assets held in separate accounts	101,676	93,133
Short-term debt	399	1
Long-term debt	2,023	1,998
Fair Value | Stabilizer and MCGs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivatives	19	9
Fair Value | Other derivatives, net
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivatives	332	371
Fair Value | Embedded derivatives on reinsurance .
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivatives	55	61
Derivatives	41	49
Fair Value | Funding agreements without fixed maturities and deferred annuities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investment contract liabilities	32,877	34,856
Fair Value | Funding agreements with fixed maturities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investment contract liabilities	1,257	1,178
Fair Value | Supplementary contracts, immediate annuities and other
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investment contract liabilities	515	571
Fair Value | Mortgage loans on real estate
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Loans	4,459	4,941
Fair Value | Policy loans
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Loans	$ 342	$ 352

Deferred Policy Acquisition C_3

Deferred Policy Acquisition Costs and Value of Business Acquired - DAC and VOBA Activity (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]
Beginning balance	$ 2,250
Ending balance	2,148	$ 2,250
Movement Analysis Of Value of Business Acquired VOBA [Roll Forward]
Beginning balance	406	439	$ 473
Deferrals of commissions and expenses	3	4	5
Amortization expense	(33)	(37)	(39)
Ending balance	376	406	439
Wealth Solutions
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]
Beginning balance	695	691	691
Deferrals of commissions and expenses	60	59	59
Amortization expense	(54)	(55)	(59)
Ending balance	701	695	691
Businesses exited
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]
Beginning balance	938	1,043	1,158
Deferrals of commissions and expenses	0	0	0
Amortization expense	(100)	(105)	(115)
Ending balance	838	938	1,043
Other
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]
Beginning balance	18
Ending balance	18	18
Health Solutions
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]
Beginning balance	193	171	144
Deferrals of commissions and expenses	58	54	55
Amortization expense	(36)	(32)	(28)
Ending balance	$ 215	$ 193	$ 171

Deferred Policy Acquisition C_4

Deferred Policy Acquisition Costs and Value of Business Acquired - VOBA Amortization Expense (Details) $ in Millions	Dec. 31, 2024 USD ($)
Insurance [Abstract]
2025	$ 30
2026	27
2027	25
2028	23
2029	$ 22

Reserves for Future Policy Be_3

Reserves for Future Policy Benefits and Contract Owner Account Balances - Future Policy Benefits (Details) $ in Millions	3 Months Ended	12 Months Ended
	Jun. 30, 2024 USD ($)	Dec. 31, 2024 USD ($) yr	Dec. 31, 2023 USD ($) yr	Dec. 31, 2022 USD ($)
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Net liability for future policy benefits		$ 9,332	$ 9,560
Current discount rate		4.30%	4.20%
Liability for Claims and Claims Adjustment Expense		$ 595	$ 401	$ 398
Health Solutions Group
Liability for Future Policy Benefit, Expected Net Premium [Roll Forward]
Beginning balance		68	77
Beginning balance at original discount rate		71	84
Effect of change in cash flow assumptions		(1)	(6)
Effect of actual variances from expected experience		0	11
Adjusted balance at January 1		5	89
Interest accrual		0	2
Net premiums collected		(1)	(20)
Ending balance at original discount rate		4	71
Liability for Future Policy Benefit, Expected Net Premium, Period Increase (Decrease)		(65)
Effects of changes in discount rate assumptions		0	(3)
Ending balance		4	68
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Beginning balance		899	881
Beginning balance at original discount rate		918	913
Effect of change in cash flow assumptions		(12)	(8)
Effect of actual variances from expected experience		10	(16)
Adjusted balance at January 1		766	889
Issuances		131	136
Interest accrual		21	24
Benefit payments		(117)	(131)
Assessments		(150)
Ending balance at original discount rate		801	918
Effects of changes in discount rate assumptions		(29)	(19)
Ending balance		772	899
Net liability for future policy benefits		768	831
Less: Reinsurance recoverable		330	315
Net liability for future policy benefits, after reinsurance recoverable		438	516
Undiscounted, Expected future benefit payments		990	1,144
Undiscounted, Expected future gross premiums		11	271
Discounted, Expected future benefit payments		801	918	913
Discounted, Expected future gross premiums		$ 8	$ 214
Weighted average duration (in years) | yr		7	7
Interest accretion rate		4%	4%
Current discount rate		5.40%	4.90%
Liability for future policy benefit expected net premium reclassification	$ 17
liability for future policy benefit expected future policy benefit reclassification	17
Health Solutions Voluntary
Liability for Future Policy Benefit, Expected Net Premium [Roll Forward]
Beginning balance		$ 101	$ 97
Beginning balance at original discount rate		102	100
Effect of change in cash flow assumptions		(1)	6
Effect of actual variances from expected experience		40	8
Adjusted balance at January 1		206	114
Interest accrual		8	4
Net premiums collected		(34)	(16)
Ending balance at original discount rate		180	102
Liability for Future Policy Benefit, Expected Net Premium, Period Increase (Decrease)		65
Effects of changes in discount rate assumptions		(9)	(1)
Ending balance		171	101
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Beginning balance		307	285
Beginning balance at original discount rate		307	294
Effect of change in cash flow assumptions		(1)	13
Effect of actual variances from expected experience		54	9
Adjusted balance at January 1		510	316
Issuances		0	0
Interest accrual		18	14
Benefit payments		(41)	(23)
Assessments		150
Ending balance at original discount rate		487	307
Effects of changes in discount rate assumptions		(26)	0
Ending balance		461	307
Net liability for future policy benefits		290	206
Less: Reinsurance recoverable		9	0
Net liability for future policy benefits, after reinsurance recoverable		281	206
Undiscounted, Expected future benefit payments		881	668
Undiscounted, Expected future gross premiums		631	341
Discounted, Expected future benefit payments		487	307	294
Discounted, Expected future gross premiums		$ 427	$ 213
Weighted average duration (in years) | yr		14,000,000	14,000,000
Interest accretion rate		5.10%	5.20%
Current discount rate		5.70%	5.10%
Liability for future policy benefit expected net premium reclassification	(17)
liability for future policy benefit expected future policy benefit reclassification	$ (17)
Businesses Exited
Liability for Future Policy Benefit, Expected Net Premium [Roll Forward]
Beginning balance		$ 3,145	$ 4,244
Beginning balance at original discount rate		2,992	4,128
Effect of change in cash flow assumptions		110	(921)
Effect of actual variances from expected experience		(106)	(91)
Adjusted balance at January 1		2,996	3,116
Interest accrual		158	196
Net premiums collected		(312)	(320)
Ending balance at original discount rate		2,842	2,992
Effects of changes in discount rate assumptions		30	153
Ending balance		2,872	3,145
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Beginning balance		7,538	8,639
Beginning balance at original discount rate		7,404	8,644
Effect of change in cash flow assumptions		187	(805)
Effect of actual variances from expected experience		(90)	(123)
Adjusted balance at January 1		7,501	7,716
Issuances		14	17
Interest accrual		370	412
Benefit payments		(747)	(741)
Ending balance at original discount rate		7,138	7,404
Effects of changes in discount rate assumptions		(121)	134
Ending balance		7,017	7,538
Net liability for future policy benefits		4,145	4,392
Less: Reinsurance recoverable		4,056	4,342
Net liability for future policy benefits, after reinsurance recoverable		89	50
Discounted, Expected future benefit payments		$ 7,138	$ 7,404	$ 8,644
Weighted average duration (in years) | yr		8,000,000	8,000,000
Interest accretion rate		5%	4.90%
Current discount rate		5.60%	5.10%
Businesses Exited – Additional liability
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Beginning balance		$ 2,107
Effect of change in cash flow assumptions		(39)	$ (44)
Effect of actual variances from expected experience		14	(100)
Adjusted balance at January 1		1,976	1,963
Interest accrual		83	84
Benefit payments		(404)	(417)
Assessments		228	371
Ending balance		2,001	2,107
Net liability for future policy benefits		1,883	2,001
Less: Reinsurance recoverable		1,832	1,950
Net liability for future policy benefits, after reinsurance recoverable		51	51
Other
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Net liability for future policy benefits		367	394
business exited, other
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Net liability for future policy benefits		$ 1,284	$ 1,335

Reserves for Future Policy Be_4

Reserves for Future Policy Benefits and Contract Owner Account Balances - Contract Owner Account Balances (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Policyholder Account Balance [Roll Forward]
Beginning balance	$ 39,174
Interest credited	992	$ 1,076	$ 962
Ending balance	37,104	39,174
Contract owner account balance	37,104	39,174
Net transfers (from) to the separate account	(1,149)	(523)
Up to 1.00%
Policyholder Account Balance [Roll Forward]
Beginning balance	12,528
Ending balance	12,329	12,528
Contract owner account balance	12,329	12,528
1.01% - 2.00%
Policyholder Account Balance [Roll Forward]
Beginning balance	725
Ending balance	612	725
Contract owner account balance	612	725
2.01% - 3.00%
Policyholder Account Balance [Roll Forward]
Beginning balance	11,492
Ending balance	10,485	11,492
Contract owner account balance	10,485	11,492
3.01% - 4.00%
Policyholder Account Balance [Roll Forward]
Beginning balance	9,031
Ending balance	8,519	9,031
Contract owner account balance	8,519	9,031
4.01% and Above
Policyholder Account Balance [Roll Forward]
Beginning balance	1,649
Ending balance	1,544	1,649
Contract owner account balance	1,544	1,649
Renewable beyond 12 months (MYGA)
Policyholder Account Balance [Roll Forward]
Beginning balance	431
Ending balance	366	431
Contract owner account balance	366	431
Total
Policyholder Account Balance [Roll Forward]
Beginning balance	35,856
Ending balance	33,855	35,856
Contract owner account balance	33,855	35,856
At GMIR
Policyholder Account Balance [Roll Forward]
Beginning balance	22,739
Ending balance	20,981	22,739
Contract owner account balance	20,981	22,739
At GMIR | Up to 1.00%
Policyholder Account Balance [Roll Forward]
Beginning balance	120
Ending balance	82	120
Contract owner account balance	82	120
At GMIR | 1.01% - 2.00%
Policyholder Account Balance [Roll Forward]
Beginning balance	527
Ending balance	437	527
Contract owner account balance	437	527
At GMIR | 2.01% - 3.00%
Policyholder Account Balance [Roll Forward]
Beginning balance	11,225
Ending balance	10,266	11,225
Contract owner account balance	10,266	11,225
At GMIR | 3.01% - 4.00%
Policyholder Account Balance [Roll Forward]
Beginning balance	8,873
Ending balance	8,368	8,873
Contract owner account balance	8,368	8,873
At GMIR | 4.01% and Above
Policyholder Account Balance [Roll Forward]
Beginning balance	1,566
Ending balance	1,464	1,566
Contract owner account balance	1,464	1,566
At GMIR | Renewable beyond 12 months (MYGA)
Policyholder Account Balance [Roll Forward]
Beginning balance	428
Ending balance	364	428
Contract owner account balance	364	428
Up to .50% Above GMIR
Policyholder Account Balance [Roll Forward]
Beginning balance	5,529
Ending balance	4,807	5,529
Contract owner account balance	4,807	5,529
Up to .50% Above GMIR | Up to 1.00%
Policyholder Account Balance [Roll Forward]
Beginning balance	5,070
Ending balance	4,378	5,070
Contract owner account balance	4,378	5,070
Up to .50% Above GMIR | 1.01% - 2.00%
Policyholder Account Balance [Roll Forward]
Beginning balance	131
Ending balance	106	131
Contract owner account balance	106	131
Up to .50% Above GMIR | 2.01% - 3.00%
Policyholder Account Balance [Roll Forward]
Beginning balance	93
Ending balance	93	93
Contract owner account balance	93	93
Up to .50% Above GMIR | 3.01% - 4.00%
Policyholder Account Balance [Roll Forward]
Beginning balance	152
Ending balance	150	152
Contract owner account balance	150	152
Up to .50% Above GMIR | 4.01% and Above
Policyholder Account Balance [Roll Forward]
Beginning balance	83
Ending balance	80	83
Contract owner account balance	80	83
Up to .50% Above GMIR | Renewable beyond 12 months (MYGA)
Policyholder Account Balance [Roll Forward]
Beginning balance	0
Ending balance	0	0
Contract owner account balance	0	0
0.51% - 1.00% Above GMIR
Policyholder Account Balance [Roll Forward]
Beginning balance	3,573
Ending balance	3,807	3,573
Contract owner account balance	3,807	3,573
0.51% - 1.00% Above GMIR | Up to 1.00%
Policyholder Account Balance [Roll Forward]
Beginning balance	3,460
Ending balance	3,691	3,460
Contract owner account balance	3,691	3,460
0.51% - 1.00% Above GMIR | 1.01% - 2.00%
Policyholder Account Balance [Roll Forward]
Beginning balance	50
Ending balance	54	50
Contract owner account balance	54	50
0.51% - 1.00% Above GMIR | 2.01% - 3.00%
Policyholder Account Balance [Roll Forward]
Beginning balance	63
Ending balance	62	63
Contract owner account balance	62	63
0.51% - 1.00% Above GMIR | 3.01% - 4.00%
Policyholder Account Balance [Roll Forward]
Beginning balance	0
Ending balance	0	0
Contract owner account balance	0	0
0.51% - 1.00% Above GMIR | 4.01% and Above
Policyholder Account Balance [Roll Forward]
Beginning balance	0
Ending balance	0	0
Contract owner account balance	0	0
0.51% - 1.00% Above GMIR | Renewable beyond 12 months (MYGA)
Policyholder Account Balance [Roll Forward]
Beginning balance	0
Ending balance	0	0
Contract owner account balance	0	0
1.01% - 1.50% Above GMIR
Policyholder Account Balance [Roll Forward]
Beginning balance	2,337
Ending balance	1,773	2,337
Contract owner account balance	1,773	2,337
1.01% - 1.50% Above GMIR | Up to 1.00%
Policyholder Account Balance [Roll Forward]
Beginning balance	2,215
Ending balance	1,705	2,215
Contract owner account balance	1,705	2,215
1.01% - 1.50% Above GMIR | 1.01% - 2.00%
Policyholder Account Balance [Roll Forward]
Beginning balance	8
Ending balance	7	8
Contract owner account balance	7	8
1.01% - 1.50% Above GMIR | 2.01% - 3.00%
Policyholder Account Balance [Roll Forward]
Beginning balance	108
Ending balance	60	108
Contract owner account balance	60	108
1.01% - 1.50% Above GMIR | 3.01% - 4.00%
Policyholder Account Balance [Roll Forward]
Beginning balance	6
Ending balance	1	6
Contract owner account balance	1	6
1.01% - 1.50% Above GMIR | 4.01% and Above
Policyholder Account Balance [Roll Forward]
Beginning balance	0
Ending balance	0	0
Contract owner account balance	0	0
1.01% - 1.50% Above GMIR | Renewable beyond 12 months (MYGA)
Policyholder Account Balance [Roll Forward]
Beginning balance	0
Ending balance	0	0
Contract owner account balance	0	0
1.51% - 2.00% Above GMIR
Policyholder Account Balance [Roll Forward]
Beginning balance	869
Ending balance	1,549	869
Contract owner account balance	1,549	869
1.51% - 2.00% Above GMIR | Up to 1.00%
Policyholder Account Balance [Roll Forward]
Beginning balance	863
Ending balance	1,545	863
Contract owner account balance	1,545	863
1.51% - 2.00% Above GMIR | 1.01% - 2.00%
Policyholder Account Balance [Roll Forward]
Beginning balance	3
Ending balance	2	3
Contract owner account balance	2	3
1.51% - 2.00% Above GMIR | 2.01% - 3.00%
Policyholder Account Balance [Roll Forward]
Beginning balance	0
Ending balance	0	0
Contract owner account balance	0	0
1.51% - 2.00% Above GMIR | 3.01% - 4.00%
Policyholder Account Balance [Roll Forward]
Beginning balance	0
Ending balance		0
Contract owner account balance		0
1.51% - 2.00% Above GMIR | 4.01% and Above
Policyholder Account Balance [Roll Forward]
Beginning balance	0
Ending balance	0	0
Contract owner account balance	0	0
1.51% - 2.00% Above GMIR | Renewable beyond 12 months (MYGA)
Policyholder Account Balance [Roll Forward]
Beginning balance	3
Ending balance	2	3
Contract owner account balance	2	3
More than 2.00% Above GMIR
Policyholder Account Balance [Roll Forward]
Beginning balance	809
Ending balance	938	809
Contract owner account balance	938	809
More than 2.00% Above GMIR | Up to 1.00%
Policyholder Account Balance [Roll Forward]
Beginning balance	800
Ending balance	928	800
Contract owner account balance	928	800
More than 2.00% Above GMIR | 1.01% - 2.00%
Policyholder Account Balance [Roll Forward]
Beginning balance	6
Ending balance	6	6
Contract owner account balance	6	6
More than 2.00% Above GMIR | 2.01% - 3.00%
Policyholder Account Balance [Roll Forward]
Beginning balance	3
Ending balance	4	3
Contract owner account balance	4	3
More than 2.00% Above GMIR | 3.01% - 4.00%
Policyholder Account Balance [Roll Forward]
Beginning balance	0
Ending balance	0	0
Contract owner account balance	0	0
More than 2.00% Above GMIR | 4.01% and Above
Policyholder Account Balance [Roll Forward]
Beginning balance	0
Ending balance	0	0
Contract owner account balance	0	0
More than 2.00% Above GMIR | Renewable beyond 12 months (MYGA)
Policyholder Account Balance [Roll Forward]
Beginning balance	0
Ending balance	0	0
Contract owner account balance	0	0
Wealth Solutions
Policyholder Account Balance [Roll Forward]
Beginning balance	31,139	33,622
Deposits	2,505	2,309
Fee income	(50)	(9)
Surrenders, withdrawals and benefits	(5,127)	(5,663)
Net transfers (from) to the general account	312	(5)
Interest credited	845	885
Ending balance	$ 29,624	$ 31,139	33,622
Weighted-average crediting rate	2.80%	2.80%
Net amount at risk	$ 90	$ 123
Cash surrender value	29,169	30,676
Contract owner account balance	29,624	31,139	33,622
Net transfers (from) to the separate account	(1,461)	(518)
Businesses Exited
Policyholder Account Balance [Roll Forward]
Beginning balance	4,635	5,146
Deposits	287	288
Fee income	(371)	(373)
Surrenders, withdrawals and benefits	(544)	(577)
Net transfers (from) to the general account	4	10
Interest credited	171	141
Ending balance	$ 4,182	$ 4,635	5,146
Weighted-average crediting rate	3.90%	2.50%
Net amount at risk	$ 676	$ 734
Cash surrender value	1,236	1,491
Contract owner account balance	4,182	4,635	$ 5,146
Other
Policyholder Account Balance [Roll Forward]
Beginning balance	950
Ending balance	891	950
Contract owner account balance	891	950
Non-puttable funding agreement
Policyholder Account Balance [Roll Forward]
Beginning balance	1,175
Ending balance	1,249	1,175
Contract owner account balance	1,249	1,175
Business Exited Excluded
Policyholder Account Balance [Roll Forward]
Beginning balance	1,275
Ending balance	1,158	1,275
Contract owner account balance	$ 1,158	$ 1,275

Reserves for Future Policy Be_5

Reserves for Future Policy Benefits and Contract Owner Account Balances (Details) $ in Millions	12 Months Ended
	Dec. 31, 2024 USD ($) professional	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]
Liability for Unpaid Claims and Claims Adjustment Expense, Net	$ 590	$ 385	$ 392
Current Year Claims and Claims Adjustment Expense	1,538	1,042
Prior Year Claims and Claims Adjustment Expense	(143)	(8)
Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims	1,681	1,034
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year	(964)	(665)
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years	512	376
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid	(1,476)	(1,041)
Reinsurance Recoverable for Unpaid Claims and Claims Adjustments	(5)	(16)	(6)
Liability for Claims and Claims Adjustment Expense	595	401	398
Short-Duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items]
Short-Duration Insurance Contracts, Incurred Claims and Allocated Claim Adjustment Expense, Net	3,599
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years	512	376
Short-Duration Insurance Contracts, Liability for Unpaid Claims and Allocated Claim Adjustment Expense, Net	590
Short-Duration Insurance Contracts, Cumulative Paid Claims and Allocated Claim Adjustment Expense, Net	(3,009)
Short-Duration Insurance Contract, Accident Year 2022
Short-Duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items]
Short-Duration Insurance Contracts, Incurred Claims and Allocated Claim Adjustment Expense, Net	870	872	859
Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net	$ 2
Short-Duration Insurance Contract, Cumulative Number of Reported Claims | professional	26,060,000,000
Short-Duration Insurance Contracts, Cumulative Paid Claims and Allocated Claim Adjustment Expense, Net	$ (868)	(862)	$ (496)
Short-Duration Insurance Contract, Accident Year 2023
Short-Duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items]
Short-Duration Insurance Contracts, Incurred Claims and Allocated Claim Adjustment Expense, Net	1,191	1,042
Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net	$ 14
Short-Duration Insurance Contract, Cumulative Number of Reported Claims | professional	32,515,000,000
Short-Duration Insurance Contracts, Cumulative Paid Claims and Allocated Claim Adjustment Expense, Net	$ (1,177)	$ (665)
Short-Duration Insurance Contract, Accident Year 2024
Short-Duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items]
Short-Duration Insurance Contracts, Incurred Claims and Allocated Claim Adjustment Expense, Net	1,538
Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net	$ 574
Short-Duration Insurance Contract, Cumulative Number of Reported Claims | professional	24,560,000,000
Short-Duration Insurance Contracts, Cumulative Paid Claims and Allocated Claim Adjustment Expense, Net	$ (964)

Reinsurance - Assets and Liabil

Reinsurance - Assets and Liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Assets
Premiums receivable, direct	$ 205	$ 193
Premiums Receivable, assumed	10	9
Premiums receivable, ceded	(238)	(219)
Premiums receivable, Net of reinsurance	(23)	(17)
Reinsurance recoverable, net of allowance for credit losses, ceded	11,307	11,999
Reinsurance recoverable, net of allowance for credit losses, net	11,307	11,999
Total assets, direct	205	193
Total assets, assumed	10	9
Total assets, ceded	11,069	11,780
Premium receivable and reinsurance recoverable (net of allowance for credit losses of $16 and $28 as of 2024 and 2023, respectively)	11,284	11,982
Liabilities
Future policy benefits and contract owner account balances, direct	45,540	47,781
Future policy benefits and contract owner account balances, assumed	896	953
Future policy benefits and contract owner account balances, net	46,436	48,734
Liability for funds withheld under reinsurance agreements, direct	103	103
Liability for funds withheld under reinsurance agreements, net	103	103
Total liabilities, direct	45,643	47,884
Total liabilities, assumed	896	953
Total liabilities, net	$ 46,539	$ 48,837

Reinsurance - Effect of Reinsur

Reinsurance - Effect of Reinsurance (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Premiums:
Direct premiums	$ 4,084	$ 3,599	$ 3,257
Reinsurance assumed	21	26	25
Reinsurance ceded	(929)	(908)	(859)
Net premiums	3,176	2,717	2,423
Fee income:
Gross fee income	2,494	2,303	2,137
Reinsurance assumed	16	17	18
Reinsurance ceded	(397)	(404)	(413)
Net fee income	2,113	1,916	1,742
Interest credited and other benefits to contract owners / policyholders:
Direct interest credited and other benefits to contract owners / policyholders	4,931	4,322	4,448
Reinsurance assumed	60	64	50
Reinsurance ceded	(1,372)	(1,350)	(1,970)
Net interest credited and other benefits to contract owners / policyholders	$ 3,619	$ 3,036	$ 2,528

Reinsurance - Narrative (Detail

Reinsurance - Narrative (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Effects of Reinsurance [Line Items]
Deposit assets	$ 1,100	$ 1,200
Security Life of Denver Insurance Company (CO)
Effects of Reinsurance [Line Items]
Reinsurance recoverable	8,600	9,200
Lincoln National Corporation
Effects of Reinsurance [Line Items]
Reinsurance recoverable	$ 900	$ 1,000

Separate Accounts (Details)

Separate Accounts (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Separate Account, Liability [Roll Forward]
Beginning balance	$ 93,133
Net transfers (from) to the separate account	(1,149)	$ (523)
Ending balance	101,676	93,133
Assets held in separate accounts	101,676	93,133
U.S. Government agencies and authorities
Separate Account, Liability [Roll Forward]
Assets held in separate accounts	913	1,015
Corporate and foreign debt securities
Separate Account, Liability [Roll Forward]
Assets held in separate accounts	2,493	2,528
Mortgage-backed securities | Mortgage-Backed Securities, Issued by Private Enterprises
Separate Account, Liability [Roll Forward]
Assets held in separate accounts	3,087	3,231
Equity securities (including mutual funds)
Separate Account, Liability [Roll Forward]
Assets held in separate accounts	94,685	85,916
Cash, cash equivalents and short-term investments
Separate Account, Liability [Roll Forward]
Assets held in separate accounts	437	399
Receivable for securities and accruals
Separate Account, Liability [Roll Forward]
Assets held in separate accounts	61	44
Wealth Solutions
Separate Account, Liability [Roll Forward]
Beginning balance	89,485	76,348
Premiums and deposits	10,861	10,992
Fee income	(520)	(460)
Surrenders, withdrawals and benefits	(13,915)	(10,973)
Net transfers (from) to the separate account	(1,461)	(518)
Investment performance	13,207	14,096
Ending balance	97,657	89,485
Cash surrender value	90,734	82,286
Other
Separate Account, Liability [Roll Forward]
Beginning balance	3,648
Ending balance	4,019	3,648
Wealth Solutions Stabilizer | Wealth Solutions
Separate Account, Liability [Roll Forward]
Beginning balance	7,175	7,196
Premiums and deposits	891	940
Fee income	(33)	(34)
Net transfers (from) to the separate account	0	0
Investment performance	244	415
Ending balance	6,901	7,175
Separate Account, Liability, Surrender	1,376	1,342
Wealth Solutions Deferred Annuity | Wealth Solutions
Separate Account, Liability [Roll Forward]
Beginning balance	82,310	69,152
Premiums and deposits	9,970	10,052
Fee income	(487)	(426)
Net transfers (from) to the separate account	(1,461)	(518)
Investment performance	12,963	13,681
Ending balance	90,756	82,310
Separate Account, Liability, Surrender	$ 12,539	$ 9,631

Segments - Narrative (Details)

Segments - Narrative (Details)	12 Months Ended
	Dec. 31, 2024 segment
Segment Reporting [Abstract]
Number of operating segments	3

Segment - Operating Revenues Re

Segment - Operating Revenues Reconciliation (Details) - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Income (loss) related to CIEs	$ 291,000,000	$ 301,000,000	$ 22,000,000
Total revenues	8,050,000,000	7,348,000,000	5,930,000,000
Other corporate	28,000,000	10,000,000	9,000,000
Income (loss) attributable to noncontrolling interests	75,000,000	104,000,000	(77,000,000)
Dividend payments made to preferred shareholders	41,000,000	36,000,000	36,000,000
Income (loss) before income taxes	799,000,000	678,000,000	428,000,000
Operating Segments and Corporate Nonsegment
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
External customer revenue	5,712,000,000	4,960,000,000	4,313,000,000
Net investment income and Net gains (losses)	2,047,000,000	2,087,000,000	1,595,000,000
Income (loss) related to CIEs	291,000,000	301,000,000	22,000,000
Adjustments	(563,000,000)	(526,000,000)	250,000,000
Adjusted operating revenues	7,487,000,000	6,822,000,000	6,183,000,000
Interest credited and other benefits to contract owners/policyholders	3,451,000,000	2,790,000,000	2,566,000,000
Administrative expenses	2,125,000,000	2,127,000,000	1,713,000,000
Premium taxes, fees and assessments	186,000,000	147,000,000	126,000,000
Net commissions	443,000,000	415,000,000	399,000,000
DAC/VOBA and other intangibles amortization	120,000,000	123,000,000	124,000,000
Financing costs and preferred dividends	162,000,000	161,000,000	177,000,000
Other corporate	66,000,000	96,000,000	142,000,000
Adjusted operating earnings before income taxes including Allianz noncontrolling interest	933,000,000	964,000,000	934,000,000
Less: Earnings (loss) attributable to Allianz noncontrolling interest	63,000,000	48,000,000	26,000,000
Adjusted operating earnings before income taxes	870,000,000	916,000,000	908,000,000
Net investment gains (losses)	50,000,000	(15,000,000)	(190,000,000)
Income (loss) related to businesses exited or to be exited through reinsurance or divestment	(142,000,000)	(182,000,000)	(138,000,000)
Income (loss) attributable to noncontrolling interests		104,000,000	(77,000,000)
Dividend payments made to preferred shareholders		36,000,000	36,000,000
Other adjustments	(95,000,000)	(180,000,000)	(111,000,000)
Operating Segments | Wealth Solutions
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
External customer revenue	1,332,000,000	1,121,000,000	1,100,000,000
Net investment income and Net gains (losses)	1,711,000,000	1,663,000,000	1,566,000,000
Income (loss) related to CIEs	0	0	0
Adjustments	(138,000,000)	(8,000,000)	111,000,000
Adjusted operating revenues	2,905,000,000	2,776,000,000	2,778,000,000
Interest credited and other benefits to contract owners/policyholders	849,000,000	895,000,000	886,000,000
Administrative expenses	897,000,000	931,000,000	867,000,000
Premium taxes, fees and assessments	0	0	0
Net commissions	255,000,000	229,000,000	232,000,000
DAC/VOBA and other intangibles amortization	84,000,000	90,000,000	95,000,000
Financing costs and preferred dividends	0	0	0
Other corporate	0	0	0
Adjusted operating earnings before income taxes including Allianz noncontrolling interest		632,000,000	697,000,000
Less: Earnings (loss) attributable to Allianz noncontrolling interest	0	0	0
Adjusted operating earnings before income taxes	820,000,000	632,000,000	697,000,000
Operating Segments | Health Solutions
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
External customer revenue	3,438,000,000	2,948,000,000	2,448,000,000
Net investment income and Net gains (losses)	138,000,000	130,000,000	135,000,000
Income (loss) related to CIEs	0	0	0
Adjustments	1,000,000	4,000,000	(1,000,000)
Adjusted operating revenues	3,577,000,000	3,082,000,000	2,582,000,000
Interest credited and other benefits to contract owners/policyholders	2,602,000,000	1,896,000,000	1,680,000,000
Administrative expenses	525,000,000	506,000,000	276,000,000
Premium taxes, fees and assessments	186,000,000	147,000,000	126,000,000
Net commissions	188,000,000	186,000,000	167,000,000
DAC/VOBA and other intangibles amortization	36,000,000	33,000,000	29,000,000
Financing costs and preferred dividends	0	0	0
Other corporate	0	0	0
Adjusted operating earnings before income taxes including Allianz noncontrolling interest		315,000,000	304,000,000
Less: Earnings (loss) attributable to Allianz noncontrolling interest	0	0	0
Adjusted operating earnings before income taxes	40,000,000	315,000,000	304,000,000
Operating Segments | Investment Management
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
External customer revenue	920,000,000	831,000,000	663,000,000
Net investment income and Net gains (losses)	20,000,000	26,000,000	14,000,000
Income (loss) related to CIEs	288,000,000	301,000,000	22,000,000
Intersegment Fee income and elimination	79,000,000	85,000,000	91,000,000
Adjustments	(325,000,000)	(327,000,000)	(35,000,000)
Adjusted operating revenues	982,000,000	916,000,000	756,000,000
Interest credited and other benefits to contract owners/policyholders	0	0	0
Administrative expenses	703,000,000	690,000,000	570,000,000
Premium taxes, fees and assessments	0	0	0
Net commissions	0	0	0
DAC/VOBA and other intangibles amortization	0	0	0
Financing costs and preferred dividends	0	0	0
Other corporate	0	0	0
Adjusted operating earnings before income taxes including Allianz noncontrolling interest	278,000,000	225,000,000	186,000,000
Less: Earnings (loss) attributable to Allianz noncontrolling interest	65,000,000	49,000,000	27,000,000
Adjusted operating earnings before income taxes	213,000,000	177,000,000	158,000,000
Corporate
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
External customer revenue	22,000,000	60,000,000	102,000,000
Net investment income and Net gains (losses)	178,000,000	268,000,000	(120,000,000)
Income (loss) related to CIEs	3,000,000	0	0
Intersegment Fee income and elimination	(79,000,000)	(85,000,000)	(91,000,000)
Adjustments	(101,000,000)	(195,000,000)	175,000,000
Adjusted operating revenues	23,000,000	48,000,000	67,000,000
Interest credited and other benefits to contract owners/policyholders	0	0	0
Administrative expenses	0	0	0
Premium taxes, fees and assessments	0	0	0
Net commissions	0	0	0
DAC/VOBA and other intangibles amortization	0	0	0
Financing costs and preferred dividends	162,000,000	161,000,000	177,000,000
Other corporate	66,000,000	96,000,000	142,000,000
Adjusted operating earnings before income taxes including Allianz noncontrolling interest	(205,000,000)	(208,000,000)	(253,000,000)
Less: Earnings (loss) attributable to Allianz noncontrolling interest	(2,000,000)	(1,000,000)	(1,000,000)
Adjusted operating earnings before income taxes	(203,000,000)	(207,000,000)	(251,000,000)
Excluding Corporate Nonsegment
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Investment gains (losses) and other related adjustments	22,000,000	(44,000,000)	(215,000,000)
Revenues related to business exited through reinsurance or divestment	102,000,000	113,000,000	(123,000,000)
Revenues Attributable to Noncontrolling Interest	243,000,000	247,000,000	(33,000,000)
Other Operating Income	$ 196,000,000	$ 210,000,000	$ 121,000,000

Segments - Total Assets (Detail

Segments - Total Assets (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Segment Reporting Information [Line Items]
Total assets	$ 163,889	$ 157,085
Operating Segments and Corporate Nonsegment
Segment Reporting Information [Line Items]
Total assets	159,361	152,781
Operating Segments | Wealth Solutions
Segment Reporting Information [Line Items]
Total assets	129,058	122,318
Operating Segments | Health Solutions
Segment Reporting Information [Line Items]
Total assets	3,490	3,336
Operating Segments | Investment Management
Segment Reporting Information [Line Items]
Total assets	1,873	1,600
Corporate
Segment Reporting Information [Line Items]
Total assets	24,940	25,527
Consolidation of investment entities
Segment Reporting Information [Line Items]
Total assets	$ 4,528	$ 4,304

Goodwill and Other Intangible_3

Goodwill and Other Intangible Assets - Goodwill (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Goodwill [Roll Forward]
Goodwill, Beginning Balance	$ 748	$ 327
Additions from business combinations	0	421
Goodwill, Ending Balance	748	748
Accumulated impairment of goodwill	0
Goodwill, gross	0	0
Operating Segments | Wealth Solutions
Goodwill [Roll Forward]
Goodwill, Beginning Balance	17	17
Additions from business combinations	0	0
Goodwill, Ending Balance	17	17
Operating Segments | Health Solutions
Goodwill [Roll Forward]
Goodwill, Beginning Balance	343	24
Additions from business combinations	0	319
Goodwill, Ending Balance	343	343
Operating Segments | Investment Management
Goodwill [Roll Forward]
Goodwill, Beginning Balance	286	286
Additions from business combinations	0	0
Goodwill, Ending Balance	286	286
Corporate
Goodwill [Roll Forward]
Goodwill, Beginning Balance	102	0
Additions from business combinations	0	102
Goodwill, Ending Balance	102	$ 102
Corporate | Wealth Solutions
Goodwill [Roll Forward]
Goodwill, Ending Balance	72
Corporate | Health Solutions
Goodwill [Roll Forward]
Goodwill, Ending Balance	20
Corporate | Investment Management
Goodwill [Roll Forward]
Goodwill, Ending Balance	$ 10

Goodwill and Other Intangible_4

Goodwill and Other Intangible Assets - Other Intangible Assets (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Finite-Lived Intangible Assets [Line Items]
Intangible assets impairment loss		$ 33
Impairment, Intangible Asset, Statement of Income or Comprehensive Income [Extensible Enumeration]		Operating expenses
Indefinite-lived intangible assets, Gross Carrying Amount	$ 350	$ 350
Finite-life intangibles, Gross Carrying Amount	1,253	1,344
Finite-life intangibles, Accumulated Amortization	421	487
Finite-life intangibles, Net Carrying Amount	$ 832	857
Management contract rights
Finite-Lived Intangible Assets [Line Items]
Weighted Average Amortization Lives	17 years
Finite-life intangibles, Gross Carrying Amount	$ 131	153
Finite-life intangibles, Accumulated Amortization	19	11
Finite-life intangibles, Net Carrying Amount	112	142
Finite-lived intangible assets, net, write off	$ 18
Customer relationship lists
Finite-Lived Intangible Assets [Line Items]
Weighted Average Amortization Lives	17 years
Finite-life intangibles, Gross Carrying Amount	$ 325	325
Finite-life intangibles, Accumulated Amortization	145	128
Finite-life intangibles, Net Carrying Amount	$ 180	197
Trademarks
Finite-Lived Intangible Assets [Line Items]
Weighted Average Amortization Lives	8 years
Finite-life intangibles, Gross Carrying Amount	$ 15	15
Finite-life intangibles, Accumulated Amortization	4	2
Finite-life intangibles, Net Carrying Amount	$ 11	13
Computer software
Finite-Lived Intangible Assets [Line Items]
Weighted Average Amortization Lives	5 years
Finite-life intangibles, Gross Carrying Amount	$ 432	501
Finite-life intangibles, Accumulated Amortization	253	346
Finite-life intangibles, Net Carrying Amount	179	155
Management contract rights
Finite-Lived Intangible Assets [Line Items]
Indefinite-lived intangible assets, Gross Carrying Amount	350	$ 350
Computer software
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, accumulated amortization, write off	$ 156

Goodwill and Other Intangible_5

Goodwill and Other Intangible Assets - Amortization Expense of Other Intangible Assets (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization expense related to intangible assets	$ 96	$ 85	$ 36
Estimated Future Amortization Expense Related to Intangible Assets, Fiscal Year Maturity [Abstract]
2025	92
2026	78
2027	57
2028	34
2029	$ 31

Share-based Incentive Compens_3

Share-based Incentive Compensation Plans - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	May 23, 2024
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for issuance (in shares)	7,169,274
Reserved and available for issuance (in shares)				8,000,000
Expiration period of stock options	10 years
Weighted average volatility rate used	70%
Expected volatility of stock price	30%
Vested	$ 104	$ 118	$ 104
Aggregate intrinsic value	$ 13	$ 16	$ 5
PSU awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted	$ 59.21	$ 66.10	$ 56.67
PSU awards | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based payment award, vesting percentage	0%	0%	0%
Award vesting period	1 year	1 year	1 year
PSU awards | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based payment award, vesting percentage	150%	150%	150%
Award vesting period	3 years	3 years	3 years
Restricted Share Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted	$ 67.70	$ 70.51	$ 65.33
Restricted Share Units (RSUs) | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	1 year	1 year	1 year
Restricted Share Units (RSUs) | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	3 years	3 years	3 years
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Aggregate intrinsic value	$ 19	$ 34.3

Share-based Incentive Compens_4

Share-based Incentive Compensation Plans - Fair Value Assumptions (Details) - $ / shares	9 Months Ended	12 Months Ended
	Sep. 30, 2020	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2019
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility	28.60%		26.50%
Expected term (in years)	6 years 7 days		5 years 11 months 26 days
Strike price (usd per share)			$ 50.03		$ 37.60
Risk-free interest rate	2.10%		2.70%
Expected dividend yield	0.11%		1%
Weighted average estimated fair value (usd per share)	$ 11.89		$ 13.78
Total Shareholder Return
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility		27.76%	30.43%	34.37%
Average expected volatility of peer companies		34%	41.53%	49.41%
Expected term (in years)		2 years 10 months 9 days	2 years 10 months 6 days	2 years 10 months 6 days
Risk-free interest rate		4.41%	4.42%	1.71%
Expected dividend yield		0%	0%	0%
Average correlation coefficient of peer companies		61.10%	65.80%	71.50%

Share-based Incentive Compens_5

Share-based Incentive Compensation Plans - Compensation Cost (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Payment Arrangement, Expense	$ 99	$ 129	$ 90
Income tax benefit	25	31	24
Share-based compensation expense	74	98	66
Restricted Share Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Payment Arrangement, Expense	60	81	45
Unrecognized compensation cost	$ 28
Expected remaining weighted-average period of expense recognition (in years)	9 months 29 days
PSU awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Payment Arrangement, Expense	$ 39	$ 48	$ 45
Unrecognized compensation cost	$ 32
Expected remaining weighted-average period of expense recognition (in years)	1 year 2 months 8 days

Share-based Incentive Compens_6

Share-based Incentive Compensation Plans - Awards Outstanding under Stock Option Plans by Award Type (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Outstanding, aggregate intrinsic value	$ 13	$ 16	$ 5
Restricted Share Units (RSUs)
Number of Awards
Outstanding, beginning balance	2,000,000
Adjusted for PSU performance factor	0
Granted	900,000
Vested	(900,000)
Forfeited	(100,000)
Outstanding, ending balance	1,900,000	2,000,000
Awards expected to vest	1,900,000
Weighted Average Grant Date Fair Value (usd per award)
Outstanding, beginning balance	$ 67.06
Adjusted for PSU performance factor	0
Granted	67.70	$ 70.51	$ 65.33
Vested	65.14
Forfeited	69.87
Outstanding, ending balance	67.95	$ 67.06
Awards expected to vest	$ 67.95
PSU awards
Number of Awards
Outstanding, beginning balance	2,200,000
Adjusted for PSU performance factor	(100,000)
Granted	700,000
Vested	(600,000)
Forfeited	0
Outstanding, ending balance	2,200,000	2,200,000
Awards expected to vest	2,200,000
Weighted Average Grant Date Fair Value (usd per award)
Outstanding, beginning balance	$ 61.17
Adjusted for PSU performance factor	46.94
Granted	59.21	$ 66.10	$ 56.67
Vested	53.73
Forfeited	68.42
Outstanding, ending balance	63.48	$ 61.17
Awards expected to vest	$ 63.48
Stock options
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Outstanding, beginning balance	1,200,000
Granted	0
Exercised	(400,000)
Forfeited	0
Outstanding, ending balance	800,000	1,200,000
Vested, exercisable	800,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Outstanding, beginning balance	$ 44.79
Granted	0
Exercised	42.86
Forfeited	0
Outstanding, ending balance	45.71	$ 44.79
Vested exercisable, weighted average exercise price	$ 45.71
Outstanding,weighted average remaining contractual term (years)	2 years 8 months 12 days	3 years 1 month 6 days
Vested, exercisable, weighted average remaining contractual term (years)	2 years 8 months 12 days
Outstanding, aggregate intrinsic value	$ 19	$ 34.3
Vested, aggregate intrinsic value	$ 19

Shareholders' Equity - Common S

Shareholders' Equity - Common Share Rollforward (Details) - USD ($) $ in Millions								12 Months Ended
	Nov. 05, 2024	Sep. 12, 2024	Sep. 20, 2022	Jun. 21, 2022	May 11, 2022	Mar. 17, 2022	Sep. 12, 2018	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Sep. 15, 2023	May 07, 2013
Increase (Decrease) in Stockholders' Equity
Common stock, shares issued, beginning balance (in shares)								103,584,699
Common stock, shares held in treasury, beginning balance (in shares)								730,130
Common stock, shares outstanding, beginning balance (in shares)								102,854,569	97,200,000	107,800,000
Common stock, shares issued (in shares)										100,000
Common stock, shares acquired under share repurchase (in shares)	(222,007)	(1,061,853)	(819,566)	(3,382,950)	(890,112)	(3,305,786)		(8,600,000)	(5,400,000)	(11,700,000)
Common stock, shares issued for share-based compensation programs (in shares)								1,100,000	1,400,000	1,000,000
Treasury Stock retirement (in shares)									0	0
Common stock, shares issued, ending balance (in shares)								105,592,281	103,584,699
Common stock, shares held in treasury, ending balance (in shares)								10,095,016	730,130
Common stock, shares outstanding, ending balance (in shares)								95,497,265	102,854,569	97,200,000
Less: Valuation allowance								$ 96	$ 95
Number of warrants issued and outstanding								0				26,050,846
Preferred Stock, Dividend Rate, Applicable Period											5 years
Series A Preferred Stock
Increase (Decrease) in Stockholders' Equity
Preferred stock, shares issued (in shares)							325,000	325,000	325,000
Preferred stock, shares outstanding (in shares)								325,000	325,000
Preferred stock, dividend rate, percentage							6.125%	7.758%	612.50%
Common Stock
Increase (Decrease) in Stockholders' Equity
Common stock, shares issued, beginning balance (in shares)								103,600,000	97,800,000	109,000,000
Common stock, shares issued (in shares)								100,000	9,700,000	100,000
Common stock, shares acquired under share repurchase (in shares)								0	0	0
Common stock, shares issued for share-based compensation programs (in shares)								1,900,000	2,100,000	1,700,000
Treasury Stock retirement (in shares)									(6,000,000)	(13,000,000)
Common stock, shares issued, ending balance (in shares)								105,600,000	103,600,000	97,800,000
Treasury stock
Increase (Decrease) in Stockholders' Equity
Common stock, shares held in treasury, beginning balance (in shares)								(700,000)	(600,000)	1,200,000
Common stock, shares issued (in shares)								0	0	0
Common stock, shares acquired under share repurchase (in shares)								(8,600,000)	(5,400,000)	(11,700,000)
Common stock, shares issued for share-based compensation programs (in shares)								800,000	700,000	700,000
Treasury Stock retirement (in shares)									(6,000,000)	(13,000,000)
Common stock, shares held in treasury, ending balance (in shares)								10,100,000	(700,000)	(600,000)

Shareholders' Equity - Common_2

Shareholders' Equity - Common Stock Dividends Declared (Details) - $ / shares	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Equity [Abstract]
Dividends declared per share of Common Stock (in dollars per share)	$ 1.70	$ 1.20	$ 0.80

Shareholders' Equity - Narrativ

Shareholders' Equity - Narrative (Details) - USD ($)									12 Months Ended
	Nov. 05, 2024	Sep. 12, 2024	Sep. 20, 2022	Jun. 21, 2022	May 11, 2022	Mar. 17, 2022	Jun. 11, 2019	Sep. 12, 2018	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	May 10, 2023	Oct. 28, 2021	May 07, 2013
Class of stock [Line Items]
Amount authorized for repurchase													$ 761,000,000
Number of shares repurchased and placed in treasury	222,007	1,061,853	819,566	3,382,950	890,112	3,305,786			8,600,000	5,400,000	11,700,000
Common stock acquired - Share repurchase		$ (100,000,000)		$ (250,000,000)		$ (275,000,000)			$ (640,000,000)	$ (374,000,000)	$ (750,000,000)
Number of warrants issued and outstanding									0					26,050,846
Percentage of issued warrants to total shares issued and outstanding														9.99%
Preferred stock, par value									$ 0.01	$ 0.01
Issuer's redemption option, period to redeem after a redemption event									90 days
Preferred stock, shares authorized (in shares)									100,000,000	100,000,000
Preferred stock dividends in arrears									$ 0
Number of shares of common stock for each warrant												9,600,000
Rating Agency Event
Class of stock [Line Items]
Redemption price (in dollars per share)									$ 1,020
Regulatory Capital Event
Class of stock [Line Items]
Redemption price (in dollars per share)									$ 1,000
Open market repurchase
Class of stock [Line Items]
Number of shares repurchased and placed in treasury									7,295,206	5,365,303	3,295,800
Common stock acquired - Share repurchase									$ (535,000,000)	$ (374,000,000)	$ (225,000,000)
Series B Preferred Stock
Class of stock [Line Items]
Preferred stock, shares issued (in shares)							300,000		300,000	300,000
Preferred stock, dividend rate, percentage							5.35%		5.35%
Preferred stock, par value							$ 0.01
Liquidation preference (in dollars per share)							$ 1,000
Proceeds from issuance of preferred stock, net							$ 293,000,000
Series A Preferred Stock
Class of stock [Line Items]
Preferred stock, shares issued (in shares)								325,000	325,000	325,000
Preferred stock, dividend rate, percentage								6.125%	7.758%	612.50%
Preferred stock, par value								$ 0.01
Liquidation preference (in dollars per share)								$ 1,000
Proceeds from issuance of preferred stock, net								$ 319,000,000
Depositary Shares | Rating Agency Event
Class of stock [Line Items]
Redemption price (in dollars per share)									$ 25.50
Depositary Shares | Regulatory Capital Event
Class of stock [Line Items]
Redemption price (in dollars per share)									$ 25

Shareholders' Equity - Repurcha

Shareholders' Equity - Repurchases of Common Stock (Details) - USD ($) $ in Millions							12 Months Ended
	Nov. 05, 2024	Sep. 12, 2024	Sep. 20, 2022	Jun. 21, 2022	May 11, 2022	Mar. 17, 2022	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Equity, Class of Treasury Stock [Line Items]
Payment		$ 100		$ 250		$ 275	$ 640	$ 374	$ 750
Number of shares repurchased and placed in treasury	222,007	1,061,853	819,566	3,382,950	890,112	3,305,786	8,600,000	5,400,000	11,700,000
Total Shares Repurchased (in shares)	1,283,860		4,202,516		4,195,898
Less: Valuation allowance							$ 96	$ 95
Open market repurchase
Equity, Class of Treasury Stock [Line Items]
Payment							$ 535	$ 374	$ 225
Number of shares repurchased and placed in treasury							7,295,206	5,365,303	3,295,800

Shareholders' Equity - Preferre

Shareholders' Equity - Preferred Stock (Details) - shares			12 Months Ended
	Jun. 11, 2019	Sep. 12, 2018	Dec. 31, 2024	Dec. 31, 2023
Preferred Stock
Class of Stock [Line Items]
Preferred stock, shares issued (in shares)			625,000	625,000
Preferred stock, shares outstanding (in shares)			625,000	625,000
Series A Preferred Stock
Class of Stock [Line Items]
Preferred stock, dividend rate, percentage		6.125%	7.758%	612.50%
Preferred stock, shares issued (in shares)		325,000	325,000	325,000
Preferred stock, shares outstanding (in shares)			325,000	325,000
Series B Preferred Stock
Class of Stock [Line Items]
Preferred stock, dividend rate, percentage	5.35%		5.35%
Preferred stock, shares issued (in shares)	300,000		300,000	300,000
Preferred stock, shares outstanding (in shares)			300,000	300,000

Shareholders' Equity - Prefer_2

Shareholders' Equity - Preferred Stock Dividends Declared (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Class of Stock [Line Items]
Dividends on preferred stock	$ 41	$ 36	$ 36
Series A Preferred Stock
Class of Stock [Line Items]
Preferred stock, dividends paid (in dollars per share)	$ 77.58	$ 61.25	$ 61.25
Dividends on preferred stock	$ 25	$ 20	$ 20
Series B Preferred Stock
Class of Stock [Line Items]
Preferred stock, dividends paid (in dollars per share)	$ 53.50	$ 53.50	$ 53.50
Dividends on preferred stock	$ 16	$ 16	$ 16

Earnings per Common Share Ear_2

Earnings per Common Share Earnings per Common Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Class of Stock [Line Items]
Income (Loss) from continuing operations	$ 742	$ 729	$ 433
Preferred Stock Dividends, Income Statement Impact	41	36	36
Income (loss) attributable to noncontrolling interests	75	104	(77)
Net income available to Voya Financial, Inc.'s common shareholders	$ 626	$ 589	$ 474
Basic (shares)	99.2	102.7	100.7
Diluted (shares)	101.4	108.8	110.2
Basic	$ 6.31	$ 5.74	$ 4.70
Diluted	$ 6.17	$ 5.42	$ 4.30
Warrants
Class of Stock [Line Items]
Dilutive Effects (shares)	0	3.3	7.2
Restricted Share Units (RSUs)
Class of Stock [Line Items]
Dilutive Effects (shares)	1.1	1.2	0.9
PSU awards
Class of Stock [Line Items]
Dilutive Effects (shares)	0.7	1.1	0.8
Stock options
Class of Stock [Line Items]
Dilutive Effects (shares)	0.4	0.5	0.6

Insurance Subsidiaries - Statut

Insurance Subsidiaries - Statutory Equity and Income (Details) $ in Millions	12 Months Ended
	Dec. 31, 2024 USD ($) subsidiary	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)
Insurance [Abstract]
Number of insurance subsidiaries | subsidiary	2
Voya Retirement Insurance and Annuity Company ("VRIAC") (CT) | Connecticut
Statutory Accounting Practices [Line Items]
Statutory Net Income (Loss)	$ 640	$ 577	$ 549
Statutory Capital and Surplus	2,033	1,955
ReliaStar Life Insurance Company ("RLI") (MN) | Minnesota
Statutory Accounting Practices [Line Items]
Statutory Net Income (Loss)	163	401	$ 418
Statutory Capital and Surplus	$ 1,098	$ 1,447

Insurance Subsidiaries - Divide

Insurance Subsidiaries - Dividends Restrictions and Approved Distributions (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2025
Statutory Accounting Practices [Line Items]
Dividends Paid	$ 168	$ 125	$ 80
Insurance Laws Applicable to Insurance Subsidiaries in Connecticut, Iowa, and Minnesota [Member]
Statutory Accounting Practices [Line Items]
Percentage Threshold of Dividends Paid in Previous Twelve Months to Earned Statutory Surplus of Prior Year End, Requiring Approval of Payment of Dividends if Exceeded	10%
Subsidiaries | Voya Retirement Insurance and Annuity Company ("VRIAC") (CT) | Connecticut
Statutory Accounting Practices [Line Items]
Dividends Permitted without Approval	$ 473
Dividends Paid	473	310
Extraordinary Distributions Paid	0	0
Subsidiaries | Voya Retirement Insurance and Annuity Company ("VRIAC") (CT) | Connecticut | Forecast
Statutory Accounting Practices [Line Items]
Dividends Permitted without Approval				$ 562
Subsidiaries | ReliaStar Life Insurance Company ("RLI") (MN) | Minnesota
Statutory Accounting Practices [Line Items]
Dividends Permitted without Approval	403
Dividends Paid	402	0
Extraordinary Distributions Paid	$ 0	$ 747
Subsidiaries | ReliaStar Life Insurance Company ("RLI") (MN) | Minnesota | Forecast
Statutory Accounting Practices [Line Items]
Dividends Permitted without Approval				$ 177

Employee Benefit Arrangements -

Employee Benefit Arrangements - Pension, Other Postretirement Benefit Plans and Other Benefit Plans (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Defined Benefit Plan Disclosure [Line Items]
Annual credit earned by participants, percentage of eligible compensation	4%
Deferred compensation commitment	$ 330	$ 302
Pension Plan
Defined Benefit Plan Disclosure [Line Items]
Projected benefit obligation	1,912	1,999	$ 1,943
Defined Benefit Plan, Net Periodic Benefit Cost (Credit)	(1)	23	(14)
Other Postretirement Benefits
Defined Benefit Plan Disclosure [Line Items]
Projected benefit obligation	8	9
Defined Benefit Plan, Net Periodic Benefit Cost (Credit)	$ 1	$ (1)	$ (2)

Employee Benefit Arrangements_2

Employee Benefit Arrangements - Obligations and Funded Status (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Change in plan assets:
Fair value of plan assets, beginning balance	$ 1,831
Fair value of plan assets, ending balance	1,773	$ 1,831
Pension Plan
Change in benefit obligation:
Benefits obligations, beginning balance	1,999	1,943
Service cost	30	24	$ 28
Interest cost	102	103	72
Net actuarial (gains) losses	(98)	44
Benefits paid	(121)	(115)
Benefits obligations, ending balance	$ 1,912	$ 1,999	1,943
Discount rate, benefit obligation	5.88%	5.28%
Interest credit rate	3.75%	3.75%
Change in plan assets:
Fair value of plan assets, beginning balance	$ 1,831	$ 1,770
Actual return on plan assets	36	149
Employer contributions	28	27
Benefits paid	(122)	(115)
Fair value of plan assets, ending balance	1,773	1,831	$ 1,770
Funded status at end of the year	(139)	(168)
Actuarial gain (loss) due to discount rate	$ 110	$ (37)
Increase in discount rate	0.60%
decrease in discount rate		0.19%
Amounts recognized in the Consolidated Balance Sheets consist of:
Prepaid benefit cost	$ 192	$ 182
Accrued benefit cost	(331)	(350)
Net amount recognized	(139)	(168)
Pension Plan | Qualified Plan
Change in benefit obligation:
Benefits obligations, beginning balance	1,649
Benefits obligations, ending balance	1,581	1,649
Pension Plan | Nonqualified pension plan
Change in benefit obligation:
Benefits obligations, beginning balance	350
Benefits obligations, ending balance	$ 331	$ 350

Employee Benefit Arrangements_3

Employee Benefit Arrangements - Obligations in Excess of Plan Assets (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	$ 1,773	$ 1,831
Pension Plan
Defined Benefit Plan Disclosure [Line Items]
Projected benefit obligation	1,912	1,999	$ 1,943
Fair value of plan assets	$ 1,773	$ 1,831	$ 1,770

Employee Benefit Arrangements_4

Employee Benefit Arrangements - Net Periodic Benefit Costs and Other Changes in Plan Assets and Future Amortizaion of Prior Service Costs (Details) - Pension Plan - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Net Periodic (Benefit) Costs Recognized in Consolidated Statements of Operations:
Service cost	$ 30	$ 24	$ 28
Interest cost	102	103	72
Expected return on plan assets	(107)	(100)	(108)
(Gain) loss recognized due to curtailment	0	0	0
Net (gain) loss recognition	(26)	(4)	(6)
Net periodic (benefit) costs	$ (1)	$ 23	$ (14)
Discount rate, net benefit cost	5.28%	5.47%	3%
Expected rate of return on plan assets, net benefit cost	6%	5.82%	4.85%
Interest credit rate	3.75%	3%	2.80%

Employee Benefit Arrangements_5

Employee Benefit Arrangements - Plan Assets, Allocation (Details) - Pension Plan	Dec. 31, 2024	Dec. 31, 2023
Defined Benefit Plan Disclosure [Line Items]
Actual allocation	100%	100%
Equity securities
Defined Benefit Plan Disclosure [Line Items]
Actual allocation	8.20%	8.20%
Equity securities | Minimum
Defined Benefit Plan Disclosure [Line Items]
Target allocation range, minimum	5%	7%
Equity securities | Maximum
Defined Benefit Plan Disclosure [Line Items]
Target allocation range, minimum	13%	12%
Large-cap domestic
Defined Benefit Plan Disclosure [Line Items]
Actual allocation	4.30%	3.70%
Small/Mid-cap domestic
Defined Benefit Plan Disclosure [Line Items]
Actual allocation	0.90%	0.80%
International Commingled Funds
Defined Benefit Plan Disclosure [Line Items]
Actual allocation	2.90%	3.20%
Other
Defined Benefit Plan Disclosure [Line Items]
Actual allocation	0.10%	0.50%
Debt securities
Defined Benefit Plan Disclosure [Line Items]
Actual allocation	85.80%	84.40%
Debt securities | Minimum
Defined Benefit Plan Disclosure [Line Items]
Target allocation range, minimum	83%	83%
Debt securities | Maximum
Defined Benefit Plan Disclosure [Line Items]
Target allocation range, minimum	87%	87%
U.S. Treasuries, short term investments, cash and futures
Defined Benefit Plan Disclosure [Line Items]
Actual allocation	2%	3%
U.S. government agencies and authorities
Defined Benefit Plan Disclosure [Line Items]
Actual allocation	4.70%	0.30%
U.S. corporate, state and municipalities
Defined Benefit Plan Disclosure [Line Items]
Actual allocation	66.80%	71.30%
Other investments, including securities pledged
Defined Benefit Plan Disclosure [Line Items]
Actual allocation	6%	7.40%
Other investments, including securities pledged | Minimum
Defined Benefit Plan Disclosure [Line Items]
Target allocation range, minimum	2%	4%
Other investments, including securities pledged | Maximum
Defined Benefit Plan Disclosure [Line Items]
Target allocation range, minimum	10%	8%
Hedge funds
Defined Benefit Plan Disclosure [Line Items]
Actual allocation	2.90%	4.10%
Real estate
Defined Benefit Plan Disclosure [Line Items]
Actual allocation	3.10%	3.30%
Foreign securities
Defined Benefit Plan Disclosure [Line Items]
Actual allocation	12.30%	9.80%

Employee Benefit Arrangements_6

Employee Benefit Arrangements - Fair Value of Plan Assets (Details)	12 Months Ended
	Dec. 31, 2024 USD ($) fund_asset	Dec. 31, 2023 USD ($) fund_asset	Dec. 31, 2022 USD ($)
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net, total pension assets, fair value	$ 1,773,000,000	$ 1,831,000,000
Redemption of investor's units, period of required notice	60 days
Cash and cash equivalents
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net, total pension assets, net asset value	$ 0	0
U.S. Government securities
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net, total pension assets, net asset value	0	0
U.S. corporate, state and municipalities
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net, total pension assets, net asset value	0	0
Foreign securities
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net, total pension assets, net asset value	0	0
Level 1
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net, total pension assets, fair value	120,000,000	161,000,000
Level 2
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net, total pension assets, fair value	1,384,000,000	1,360,000,000
Level 3
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net, total pension assets, fair value	92,000,000	85,000,000
Pension Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net, total pension assets, fair value	1,773,000,000	1,831,000,000	$ 1,770,000,000
Net, total pension assets, net asset value	177,000,000	225,000,000
Projected benefit obligation	1,912,000,000	1,999,000,000	$ 1,943,000,000
Accrued benefit cost	(331,000,000)	(350,000,000)
Prepaid benefit cost	192,000,000	182,000,000
Pension Plan | Debt securities
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net, total pension assets, fair value	1,521,000,000	1,544,000,000
Net, total pension assets, net asset value	19,000,000	21,000,000
Pension Plan | Cash and cash equivalents
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net, total pension assets, fair value	18,000,000	9,000,000
Pension Plan | Hedge Funds, Equity
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net, total pension assets, fair value	19,000,000
Net, total pension assets, net asset value	19,000,000	21,000,000
Pension Plan | U.S. Government securities
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net, total pension assets, fair value	82,000,000	128,000,000
Pension Plan | U.S. corporate, state and municipalities
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net, total pension assets, fair value	1,184,000,000	1,196,000,000
Pension Plan | Equity securities
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net, total pension assets, fair value	152,000,000	151,000,000
Net, total pension assets, net asset value	$ 58,000,000	$ 68,000,000
Pension Plan | International Commingled Funds
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Number of assets In fund | fund_asset	2	2
Pension Plan | International Commingled Funds | Baillie Gifford Funds
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net, total pension assets, fair value	$ 26,000,000	$ 25,000,000
Unfunded commitments	0
Pension Plan | International Commingled Funds | Silchester
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net, total pension assets, fair value	$ 26,000,000	33,000,000
Number of business days prior to month-end clients must submit redemption request	6 days
Unfunded commitments	$ 0
Pension Plan | Other investments, including securities pledged
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net, total pension assets, fair value	100,000,000	136,000,000
Net, total pension assets, net asset value	100,000,000	136,000,000
Pension Plan | Real estate | UBS Trumbull Property Fund
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net, total pension assets, fair value	$ 52,000,000	61,000,000
Real return performance objective, rate of return	5%
Pension Plan | Real estate | UBS Trumbull Property Fund | Minimum
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Real return performance objective, rate of return, determination period	3 years
Pension Plan | Real estate | UBS Trumbull Property Fund | Maximum
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Real return performance objective, rate of return, determination period	5 years
Pension Plan | Limited partnerships | Magnitude Institutional, Ltd.
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net, total pension assets, fair value	$ 48,000,000	75,000,000
Pension Plan | Foreign securities
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net, total pension assets, fair value	218,000,000	190,000,000
Pension Plan | Hedge Funds, Equity Long (Short)
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net, total pension assets, fair value		21,000,000
Pension Plan | Level 1 | Debt securities
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net, total pension assets, fair value	103,000,000	146,000,000
Pension Plan | Level 1 | Cash and cash equivalents
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net, total pension assets, fair value	11,000,000	8,000,000
Pension Plan | Level 1 | Hedge Funds, Equity
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net, total pension assets, fair value	0	0
Pension Plan | Level 1 | U.S. Government securities
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net, total pension assets, fair value	82,000,000	128,000,000
Pension Plan | Level 1 | U.S. corporate, state and municipalities
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net, total pension assets, fair value	10,000,000	10,000,000
Pension Plan | Level 1 | Equity securities
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net, total pension assets, fair value	17,000,000	15,000,000
Pension Plan | Level 1 | Other investments, including securities pledged
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net, total pension assets, fair value	0	0
Pension Plan | Level 1 | Foreign securities
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net, total pension assets, fair value	0	0
Pension Plan | Level 2 | Debt securities
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net, total pension assets, fair value	1,307,000,000	1,292,000,000
Pension Plan | Level 2 | Cash and cash equivalents
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net, total pension assets, fair value	7,000,000	1,000,000
Pension Plan | Level 2 | Hedge Funds, Equity
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net, total pension assets, fair value	0	0
Pension Plan | Level 2 | U.S. Government securities
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net, total pension assets, fair value	0	0
Pension Plan | Level 2 | U.S. corporate, state and municipalities
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net, total pension assets, fair value	1,102,000,000	1,121,000,000
Pension Plan | Level 2 | Equity securities
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net, total pension assets, fair value	77,000,000	68,000,000
Pension Plan | Level 2 | Other investments, including securities pledged
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net, total pension assets, fair value	0	0
Pension Plan | Level 2 | Foreign securities
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net, total pension assets, fair value	198,000,000	170,000,000
Pension Plan | Level 3 | Debt securities
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net, total pension assets, fair value	92,000,000	85,000,000
Pension Plan | Level 3 | Cash and cash equivalents
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net, total pension assets, fair value	0	0
Pension Plan | Level 3 | Hedge Funds, Equity
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net, total pension assets, fair value	0	0
Pension Plan | Level 3 | U.S. Government securities
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net, total pension assets, fair value	0	0
Pension Plan | Level 3 | U.S. corporate, state and municipalities
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net, total pension assets, fair value	72,000,000	65,000,000
Pension Plan | Level 3 | Equity securities
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net, total pension assets, fair value	0	0
Pension Plan | Level 3 | Other investments, including securities pledged
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net, total pension assets, fair value	0	0
Pension Plan | Level 3 | Foreign securities
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net, total pension assets, fair value	20,000,000	20,000,000
Nonqualified pension plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net, total pension assets, fair value	0	0
Projected benefit obligation	331,000,000	350,000,000
Accumulated benefit obligation	$ 328,000,000	$ 348,000,000

Employee Benefit Arrangements_7

Employee Benefit Arrangements - Expected Future Contributions and Benefit Payments (Details) - Pension Plan $ in Millions	Dec. 31, 2024 USD ($)
Defined Benefit Plan Disclosure [Line Items]
2025	$ 135
2026	136
2027	139
2030-2034	775
Estimated future employer contributions next year	28
2028	143
2029	$ 146

Employee Benefit Arrangements_8

Employee Benefit Arrangements - Defined Contribution Plans (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Retirement Benefits [Abstract]
Company match, percentage	6%
Matching contributions, graded vesting schedule, period	4 years
Cost recognized for defined contribution pension plans	$ 51	$ 44	$ 36
Pension Plan
Retirement Benefits [Abstract]
Defined Benefit Plan, Amounts Recognized in Accumulated Other Comprehensive Income (Loss)	0
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined Benefit Plan, Amounts Recognized in Accumulated Other Comprehensive Income (Loss)	$ 0

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Income (Loss) - Components of AOCI (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Components Of Accumulated Other Comprehensive Income Loss [Line Items]
Fixed maturities, net of impairment	$ (2,553)	$ (2,370)	$ (3,294)
DAC/VOBA adjustment on available-for-sale securities(2)		64	125
AOCI, Liability for Future Policy Benefit, before Tax	(787)	(890)	(858)
Deferred income tax asset (liability)(2)	810	794	969
Total	(2,464)	(2,402)	(3,058)
Pension and other postretirement benefits liability, net of tax	2	2	3
Accumulated other comprehensive income (loss)	(2,462)	$ (2,400)	$ (3,055)
Accumulated Other Comprehensive Income (Loss), Derivative, before Tax	66
Other Contract
Components Of Accumulated Other Comprehensive Income Loss [Line Items]
Portion of AOCI expected to be reclassified into earnings within the next 12 months	$ 10

Accumulated Other Comprehensi_4

Accumulated Other Comprehensive Income (Loss) - Changes in AOCI, including Reclassification Adjustments (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Before-Tax Amount
Available-for-sale securities, fixed maturities	$ (208)	$ 899	$ (6,569)
Adjustments for amounts recognized in Net gains (losses) in the Consolidated Statements of Operations	26	25	78
Change in unrealized gains/losses on available-for-sale securities	(182)	924	(6,491)
Derivatives	18	(43)	66
Adjustments for amounts recognized in Net investment income in the Condensed Consolidated Statements of Operations	(16)	(18)	(20)
Change in unrealized gains (losses) on derivatives	2	(61)	46
Change in current discount rate	103	(33)	290
Amortization of prior service cost recognized in Operating expenses in the Consolidated Statements of Operations	(1)	(1)
Change in pension and other postretirement benefits liability	(1)	(1)	0
Other comprehensive income (loss), before tax	(78)	829	(6,155)
Income Tax (Benefit)
Available-for-sale securities, fixed maturities	44	(189)	1,380
Adjustments for amounts recognized in Net realized capital gains (losses) in the Condensed Consolidated Statements of Operations	(5)	(5)	(16)
Change in unrealized gains/losses on available-for-sale securities	39	(194)	1,364
Derivatives	(4)	9	(14)
Adjustments related to effective cash flow hedges for amounts recognized in Net investment income in the Consolidated Statements of Operations	3	4	4
Change in unrealized gains (losses) on derivatives	(1)	13	(10)
Change in current discount rate	(22)	7	(61)
Amortization of prior service cost recognized in Operating expenses in the Condensed Consolidated Statements of Operations	0	0
Change in pension and other postretirement benefits liability	0	0
Change in Other comprehensive income (loss)	16	(174)	1,293
After-Tax Amount
Available-for-sale securities, fixed maturities	(164)	710	(5,189)
Adjustments for amounts recognized in Net realized capital gains (losses) in the Condensed Consolidated Statements of Operations	21	20	62
Change in unrealized gains/losses on available-for-sale securities	(143)	730	(5,127)
Derivatives	14	(34)	52
Adjustments related to effective cash flow hedges for amounts recognized in Net investment income in the Consolidated Statements of Operations	(13)	(14)	(16)
Change in unrealized gains (losses) on derivatives	1	(48)	36
Change in current discount rate	81	(26)	229
Amortization of prior service cost recognized in Operating expenses in the Condensed Consolidated Statements of Operations	(1)	(1)
Change in pension and other postretirement benefits liability	(1)	(1)
Other comprehensive income (loss), after tax	$ (62)	$ 655	$ (4,862)

Revenue from Contracts with C_3

Revenue from Contracts with Customers (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Disaggregation of Revenue [Line Items]
Revenue	$ 2,150	$ 1,939	$ 1,691
Revenue from other sources (non-financial services revenue)	386	304	199
Total fee income and other revenue	2,536	2,243	1,890
Receivables	361	339
Operating Segments | Wealth Solutions
Disaggregation of Revenue [Line Items]
Revenue	625	497	525
Operating Segments | Wealth Solutions | Distribution and shareholder servicing
Disaggregation of Revenue [Line Items]
Revenue	133	121	116
Operating Segments | Investment Management
Disaggregation of Revenue [Line Items]
Revenue	1,004	924	826
Operating Segments | Investment Management | Distribution and shareholder servicing
Disaggregation of Revenue [Line Items]
Revenue	153	146	145
Operating Segments | Health Solutions
Disaggregation of Revenue [Line Items]
Revenue	26	18	17
Operating Segments | Health Solutions | Software subscriptions and services
Disaggregation of Revenue [Line Items]
Revenue	206	205	0
Corporate
Disaggregation of Revenue [Line Items]
Revenue	$ 3	$ 28	$ 62

Income Taxes - Components of In

Income Taxes - Components of Income Tax Expense (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Current tax expense (benefit):
Federal	$ 1	$ 2	$ (6)
Foreign	9	4	1
State	5	5	(3)
Total current tax expense (benefit)	15	11	(8)
Deferred tax expense (benefit):
Federal	38	(50)	8
State	4	(12)	(5)
Total deferred tax expense (benefit)	42	(62)	3
Total income tax expense (benefit)	$ 57	$ (51)	$ (5)

Income Taxes - Income Tax Recon

Income Taxes - Income Tax Reconciliation (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Income before income taxes	$ 799	$ 678	$ 428
Tax Rate	21%	21%	21%
Income tax expense (benefit) at federal statutory rate	$ 168	$ 142	$ 90
Valuation allowance	1	(1)	7
Dividends received deduction	(49)	(38)	(44)
State tax expense (benefit)	8	(6)	(16)
Noncontrolling interest	(16)	(22)	16
Tax credits	(19)	(17)	(63)
Nondeductible expenses	3	6	7
Security Life of Denver Company capital loss carryback	(38)	(92)	0
Non-taxable Voya India gain	0	(10)	0
Other	(1)	(13)	(2)
Total income tax expense (benefit)	$ 57	$ (51)	$ (5)
Effective tax rate	7.10%	(7.50%)	(1.20%)

Income Taxes - Narrative (Detai

Income Taxes - Narrative (Details) - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Valuation Allowance [Line Items]
Current income tax receivable	$ 12,000,000
Net operating loss carryforwards	62,000,000
Valuation allowance	96,000,000	$ 95,000,000
Valuation allowance allocated to continuing operations	219,000,000	218,000,000
Valuation allowance allocated to Other comprehensive income (losses) related to realized and unrealized capital losses	(123,000,000)	(123,000,000)
Unrealized gains (losses) on securities	(180,000,000)	863,000,000	$ (6,445,000,000)
Unrecognized tax benefits that would affect effective rate	1,000,000
Gross interest (benefit) related to unrecognized tax	0
Income tax expense (benefit)	57,000,000	(51,000,000)	(5,000,000)
Net gains (losses)	(27,000,000)	(72,000,000)	(686,000,000)
Income tax expense (benefit)	57,000,000	(51,000,000)	(5,000,000)
Net gains (losses)	(27,000,000)	(72,000,000)	$ (686,000,000)
Voya India
Valuation Allowance [Line Items]
Net gains (losses)	45,000,000	45,000,000
Net gains (losses)	45,000,000	$ 45,000,000
SLD
Valuation Allowance [Line Items]
Income tax expense (benefit)	92,000,000
Income tax expense (benefit)	$ 92,000,000

Income Taxes - Temporary Differ

Income Taxes - Temporary Differences (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Deferred tax assets
Federal and state loss carryforwards	$ 1,421	$ 1,489
Net unrealized investment losses	522	484
Compensation and benefits	161	190
Current discount rate	165	187
Tax credits	154	131
Insurance Reserves	0	9
Investments	47	5
Other assets	175	165
Total gross assets before valuation allowance	2,645	2,660
Less: Valuation allowance	96	95
Assets, net of valuation allowance	2,549	2,565
Deferred tax liabilities
Deferred policy acquisition costs	(324)	(358)
Insurance reserves	(24)	0
Other liabilities	(67)	(47)
Total gross liabilities	(415)	(405)
Net deferred income tax asset (liability)	2,134	2,160
Business Acquisition [Line Items]
Net Deferred tax assets	2,134	2,160
Valuation allowance	96	95
Accumulated other comprehensive income (loss)	(2,462)	(2,400)	$ (3,055)
Accumulated other comprehensive income (loss)	(2,462)	(2,400)	$ (3,055)
Fixed maturities
Business Acquisition [Line Items]
Accumulated other comprehensive income (loss)	(2,500)	(2,300)
Accumulated other comprehensive income (loss)	$ (2,500)	$ (2,300)

Income Taxes - Tax Credit and L

Income Taxes - Tax Credit and Loss Carryforwards (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Tax Credit Carryforward [Line Items]
Net operating loss carryforwards	$ 62
Tax capital loss/credit carryforward	154	$ 131
Internal Revenue Service (IRS)
Tax Credit Carryforward [Line Items]
Net operating loss carryforwards	6,335	6,667
NOL carryforwards not subject to expiration	3,320
NOLs subject to expiration	3,015
State and Local Jurisdiction
Tax Credit Carryforward [Line Items]
Net operating loss carryforwards	2,412	$ 2,454
NOL carryforwards not subject to expiration	390
NOLs subject to expiration	$ 2,022

Income Taxes - Unrecognized Tax

Income Taxes - Unrecognized Tax Benefits (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Unrecognized Tax Benefits [Roll Forward]
Unrecognized tax benefits, beginning balance	$ 27	$ 33	$ 33
Additions for tax positions related to current year	0	0	0
(Reductions) for tax positions related to prior years	(3)	(6)	0
Unrecognized tax benefits, ending balance	$ 24	$ 27	$ 33

Financing Agreements - Short-te

Financing Agreements - Short-term Debt (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Debt Disclosure [Abstract]
Current portion of long-term debt	$ 399	$ 1

Financing Agreements - Long-ter

Financing Agreements - Long-term Debt (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023	Jan. 23, 2018	Mar. 17, 2015
Debt Instrument [Line Items]
Total	$ 2,502	$ 2,098
Current portion of long-term debt	399	1
Long-term debt	$ 2,103	2,097
Senior Notes
Debt Instrument [Line Items]
Annual interest rate on loan				1.875%
3.976% Senior Notes, due 2025 | Senior Notes
Debt Instrument [Line Items]
Annual interest rate on loan	3.976%
Total	$ 399	$ 390
3.65% Senior Notes, due 2026 | Senior Notes
Debt Instrument [Line Items]
Annual interest rate on loan	3.65%	3.65%
Total	$ 446	$ 446
5.0% Senior Notes, due 2034 | Senior Notes
Debt Instrument [Line Items]
Annual interest rate on loan	5%
Total	$ 395	$ 0
5.7% Senior Notes, due 2043 | Senior Notes
Debt Instrument [Line Items]
Annual interest rate on loan	5.70%	5.70%
Total	$ 396	$ 396
4.8% Senior Notes, due 2046 | Senior Notes
Debt Instrument [Line Items]
Annual interest rate on loan	4.80%	4.80%
Total	$ 297	$ 297
4.7% Fixed-to-Floating Rate Junior Subordinated Notes, due 2048 | Junior Subordinated Notes
Debt Instrument [Line Items]
Annual interest rate on loan	4.70%	4.70%	4.70%
Total	$ 336	$ 336
7.63% Voya Holdings Inc. debentures, due 2026 | Debentures
Debt Instrument [Line Items]
Annual interest rate on loan	7.625%	7.625%
Total	$ 139	$ 139
6.97% Voya Holdings Inc. debentures, due 2036 | Debentures
Debt Instrument [Line Items]
Annual interest rate on loan	6.97%	6.97%
Total	$ 79	$ 79
8.42% Equitable of Iowa Companies Capital Trust II Notes, due 2027 | Notes Payable
Debt Instrument [Line Items]
Annual interest rate on loan	8.42%	8.42%
Total	$ 13	$ 13
1.00% Windsor Property Loan | Property Loan
Debt Instrument [Line Items]
Annual interest rate on loan	1%	1%
Total	$ 2	$ 2

Financing Agreements - Future P

Financing Agreements - Future Principal Payments (Details) $ in Millions	Dec. 31, 2024 USD ($)
Debt Instrument [Line Items]
2025	$ 401
2026	587
2027	13
2028	0
2029	0
Thereafter	1,518
Parent
Debt Instrument [Line Items]
2025	400
2026	447
2027	0
2028	0
2029	0
Thereafter	$ 1,440

Financing Agreements - Addition

Financing Agreements - Additional Information (Details) - USD ($) $ in Millions		12 Months Ended
	Mar. 17, 2015	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	May 03, 2023	May 01, 2023	Jan. 23, 2018	May 16, 2013
Debt Instrument [Line Items]
Long-term debt		$ 2,502	$ 2,098
Business agreement, term of agreement	10 years
Put option agreement, face amount	$ 500	100
Capacity		512
Utilization		12
Revolving Credit Agreement
Debt Instrument [Line Items]
Utilization		0
Aetna Notes
Debt Instrument [Line Items]
Amounts of LOCs outstanding		12
Revolving Credit Agreement
Debt Instrument [Line Items]
Capacity		$ 500
Minimum net worth required for compliance						$ 4,998
Voya Holdings Debentures | Aetna Notes
Debt Instrument [Line Items]
Minimum principal outstanding in year one			0
Quarterly fee to guarantor of notes if minimum principal balance is not met		1.25%
Collateral amount		$ 227
Cash collateral deposited for debt		215
Voya Holdings Debentures | Aetna Notes | Minimum
Debt Instrument [Line Items]
Collateral amount		218	218
U.S. Treasuries
Debt Instrument [Line Items]
Amount of unsecured notes issued					$ 400
Five Point Six Five Percentage Fixed-to-Floating Rate Junior Subordinated Note Due 2053
Debt Instrument [Line Items]
Annual interest rate on loan								5.65%
Short-Term Debt | Revolving Credit Agreement
Debt Instrument [Line Items]
Capacity						$ 25
Senior Notes
Debt Instrument [Line Items]
Annual interest rate on loan	1.875%
Senior Notes | 5.0% Senior Notes, due 2034
Debt Instrument [Line Items]
Amount of unsecured notes issued		$ 400
Annual interest rate on loan		5%
Proceeds from debt		$ 397
Long-term debt		395	0
Senior Notes | 3.976% Senior Notes, due 2025
Debt Instrument [Line Items]
Amount of unsecured notes issued		$ 400
Annual interest rate on loan		3.976%
Long-term debt		$ 399	$ 390
Senior Notes | Pre-Capitalized Trust
Debt Instrument [Line Items]
Amount of unsecured notes issued					$ 400
Annual interest rate on loan	3.976%
Junior Subordinated Notes
Debt Instrument [Line Items]
Maximum deferral period for one or more consecutive interest payments		5 years
Junior Subordinated Notes | 5.65% Fixed-to-Floating Rate Junior Subordinated Notes, due 2053
Debt Instrument [Line Items]
Amount of unsecured notes issued		$ 357
Annual interest rate on loan								5.65%
Junior Subordinated Notes | 4.7% Fixed-to-Floating Rate Junior Subordinated Notes, due 2048
Debt Instrument [Line Items]
Amount of unsecured notes issued		$ 10					$ 340
Annual interest rate on loan		4.70%	4.70%				4.70%
Long-term debt		$ 336	$ 336
Debentures | 7.63% Voya Holdings Inc. debentures, due 2026
Debt Instrument [Line Items]
Annual interest rate on loan		7.625%	7.625%
Long-term debt		$ 139	$ 139
Debentures | 6.97% Voya Holdings Inc. debentures, due 2036
Debt Instrument [Line Items]
Annual interest rate on loan		6.97%	6.97%
Long-term debt		$ 79	$ 79
Debentures | Voya Holdings Debentures
Debt Instrument [Line Items]
Long-term debt		218	218
Revolving Credit Agreement
Debt Instrument [Line Items]
Amounts of LOCs outstanding		0
Utilization		$ 0
Interest expense | Debt securities
Debt Instrument [Line Items]
Loss on extinguishment of debt			$ 5	$ 3

Financing Agreements - Junior S

Financing Agreements - Junior Subordinated Notes (Details) - 4.7% Fixed-to-Floating Rate Junior Subordinated Notes, due 2048 - Junior Subordinated Notes - USD ($) $ in Millions	Jan. 23, 2018	Dec. 31, 2024	Dec. 31, 2023
Debt Instrument [Line Items]
Annual interest rate on loan	4.70%	4.70%	4.70%
Basis spread	2.084%
Amount of unsecured notes issued	$ 340	$ 10

Financing Agreements - Credit F

Financing Agreements - Credit Facilities (Details) - USD ($) $ in Millions	Dec. 31, 2024	Jun. 30, 2024	Dec. 31, 2023
Line of Credit Facility [Line Items]
Capacity	$ 512
Utilization	12
Unused Commitment	500
Unsecured and Committed | Voya Financial, Inc.
Line of Credit Facility [Line Items]
Capacity	500
Utilization	0
Unused Commitment	500
Unsecured and Committed | Voya Financial, Inc.
Line of Credit Facility [Line Items]
Capacity	12	$ 12	$ 200
Utilization	12
Unused Commitment	$ 0

Commitments and Contingencies -

Commitments and Contingencies - Leases (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Operating Lease, Liability, Statement of Financial Position [Extensible List]	Other liabilities
Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]	Other liabilities
Operating lease, impairment loss	$ 0	$ 14
Lease, Cost [Abstract]
Operating lease costs	26	22	$ 21
Finance lease costs	11	9	19
Amortization of the right of use assets	7	5	19
Payments for finance lease liabilities	10	20	21
Payments for operating lease liabilities	28	$ 26	$ 18
Operating Leases
2025	23
2026	20
2027	18
2028	16
2029	12
Thereafter	51
Total undiscounted lease payments	140
Less: Imputed interest	28
Total Lease liabilities	112
Finance Leases
2025	12
2026	12
2027	12
2028	13
2029	13
Thereafter	27
Total undiscounted lease payments	89
Less: Imputed interest	15
Total Lease liabilities	$ 74

Commitments and Contingencies_2

Commitments and Contingencies - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Loss Contingencies [Line Items]
Undiscounted liability of future guaranty fund assessments	$ 3	$ 1
Future credits to premium taxes	21	10
Possible losses in excess of amounts accrued	25
Amount of previously accrued interest subject to full or partial reversal if cumulative fund performance is not maintained	93
Federal Home Loan Bank Borrowings | Line of Credit
Loss Contingencies [Line Items]
Non-putable funding agreements	1,249	$ 1,175
Purchase of mortgage loans
Loss Contingencies [Line Items]
Amount of purchase commitments	221
Investment purchase commitment
Loss Contingencies [Line Items]
Amount of purchase commitments	1,617
Investment purchase commitment | VOEs
Loss Contingencies [Line Items]
Amount of purchase commitments	$ 415

Commitments and Contingencies_3

Commitments and Contingencies - Restricted Assets (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Loss Contingencies [Line Items]
Pledged Collateral	$ 2,007	$ 1,956
FHLB restricted stock	65	64
Trading securities	35	37
Cash and cash equivalents	21	25
Total restricted assets	3,651	3,242
Securities pledged
Loss Contingencies [Line Items]
Securities loaned to lending agent	1,083	842
Securities pledged/obligations under repurchase agreements	281	117
Securities Loaned
Loss Contingencies [Line Items]
Securities Owned and Pledged as Collateral	159	201
Collateral pledged
Loss Contingencies [Line Items]
Securities pledged	$ 1,523	$ 1,160

Consolidated and Nonconsolida_3

Consolidated and Nonconsolidated Investment Entities - Narrative (Details) $ in Millions	12 Months Ended
	Dec. 31, 2024 USD ($) entity fund CLO	Dec. 31, 2023 USD ($) fund entity CLO
Variable Interest Entity [Line Items]
Consolidated collateral loan obligations | CLO	4	5
LPs life	10 years
Consolidated funds | fund	13	11
Noncontrolling interest	$ 1,783	$ 1,685
Capacity	512
Utilization	12
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net	$ 0
Number of deconsolidated investment entities | entity	4	2
Consolidated Investment Entities
Variable Interest Entity [Line Items]
Maximum exposure to loss	$ 366	$ 316
VIE, Corporate Loan Investments | Senior secured corporate loans
Variable Interest Entity [Line Items]
Unpaid principal exceeds fair value, amount	$ 17	$ 46
Default of collateral assets, percentage	1%	1%
VIE, Corporate Loan Investments | Maximum | Senior secured corporate loans | SOFR, EURIBOR Or PRIME [Member]
Variable Interest Entity [Line Items]
Basis spread	8%
VIEs
Variable Interest Entity [Line Items]
Investment in subsidiaries	$ 3,067	$ 2,861
VIE, CLO Notes | Senior secured corporate loans
Variable Interest Entity [Line Items]
Weighted average maturity on debt	11 years
VIE, CLO Notes | Maximum | Senior secured corporate loans | EURIBOR Or SOFR [Member]
Variable Interest Entity [Line Items]
Basis spread	8.80%
VIE, CLO Notes | Minimum | Senior secured corporate loans | EURIBOR Or SOFR [Member]
Variable Interest Entity [Line Items]
Basis spread	1%
VIE, Private Equity Funds
Variable Interest Entity [Line Items]
Capacity	$ 1,308	1,330
Renewal period for term loan	3 years
Utilization	$ 1,153	1,198
VIE, Private Equity Funds | Maximum | EURIBOR Or SOFR [Member]
Variable Interest Entity [Line Items]
Basis spread	2.40%
VIE, Private Equity Funds | Minimum | EURIBOR Or SOFR [Member]
Variable Interest Entity [Line Items]
Basis spread	1.40%
Nonconsolidated VIEs
Variable Interest Entity [Line Items]
Net Assets	$ 466	383
Excluding consolidated VIEs
Variable Interest Entity [Line Items]
Investment in subsidiaries	$ 1,836	$ 1,621

Consolidated and Nonconsolida_4

Consolidated and Nonconsolidated Investment Entities - Fair Value Hierarchy (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Collateralized loan obligations notes, at fair value using the fair value option	$ 1,101	$ 1,332
Assets measured on recurring basis
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	4,719	4,446
Liabilities	1,101	1,332
Assets measured on recurring basis | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	113	181
Loans Receivable, Fair Value Disclosure	1,434	1,404
NAV		2,861
Other Investments, Fair Value Disclosure	53
Collateralized loan obligations notes, at fair value using the fair value option	1,101	1,332
Assets measured on recurring basis | VIEs | Limited Partnerships/Corporations, at fair value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
NAV	3,067
Assets measured on recurring basis | VOEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	2
Assets measured on recurring basis | VOEs | Cash and cash equivalents
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Other Investments, Fair Value Disclosure	50
Assets measured on recurring basis | Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	115	181
Assets measured on recurring basis | Level 1 | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	113	181
Assets measured on recurring basis | Level 1 | VOEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	2
Assets measured on recurring basis | Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	1,434	1,404
Liabilities	1,101	1,332
Assets measured on recurring basis | Level 2 | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Loans Receivable, Fair Value Disclosure	1,434	1,404
Collateralized loan obligations notes, at fair value using the fair value option	1,101	1,332
Assets measured on recurring basis | Level 2 | VIEs | Limited Partnerships/Corporations, at fair value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets		0
Assets measured on recurring basis | Level 3
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	53
Assets measured on recurring basis | Level 3 | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Other Investments, Fair Value Disclosure	53
Assets measured on recurring basis | Fair Value Measured at Net Asset Value Per Share [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	3,117	2,861
Assets measured on recurring basis | Fair Value Measured at Net Asset Value Per Share [Member] | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
NAV	$ 3,067	$ 2,861

Schedule I - Summary of Inves_2

Schedule I - Summary of Investments Other than Investments in Affiliates (Details) $ in Millions	Dec. 31, 2024 USD ($)
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost	$ (37,337)
Fair Value	34,808
Amount Shown on Consolidated Balance Sheet	35,024
Fixed maturities
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost	(30,050)
Fair Value	27,454
Amount Shown on Consolidated Balance Sheet	27,454
U.S. Treasuries
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost	(524)
Fair Value	472
Amount Shown on Consolidated Balance Sheet	472
U.S. Government agencies and authorities
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost	(29)
Fair Value	30
Amount Shown on Consolidated Balance Sheet	30
State, municipalities, and political subdivisions
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost	(697)
Fair Value	580
Amount Shown on Consolidated Balance Sheet	580
U.S. corporate public securities
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost	(7,938)
Fair Value	7,008
Amount Shown on Consolidated Balance Sheet	7,008
U.S. corporate private securities
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost	(5,275)
Fair Value	4,983
Amount Shown on Consolidated Balance Sheet	4,983
Foreign Corporate Public Securities and Foreign Governments [Member]
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost	(2,729)
Fair Value	2,472
Amount Shown on Consolidated Balance Sheet	2,472
Foreign corporate private securities(1)
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost	(2,693)
Fair Value	2,537
Amount Shown on Consolidated Balance Sheet	2,537
Residential mortgage-backed securities
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost	(3,709)
Fair Value	3,471
Amount Shown on Consolidated Balance Sheet	3,471
Commercial mortgage-backed securities
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost	(3,677)
Fair Value	3,132
Amount Shown on Consolidated Balance Sheet	3,132
Other asset-backed securities
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost	(2,779)
Fair Value	2,769
Amount Shown on Consolidated Balance Sheet	2,769
Equity securities
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost	(246)
Fair Value	246
Amount Shown on Consolidated Balance Sheet	246
Short-term investments
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost	(94)
Fair Value	94
Amount Shown on Consolidated Balance Sheet	94
Mortgage loans on real estate
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost	(4,699)
Fair Value	4,459
Amount Shown on Consolidated Balance Sheet	4,675
Policy loans
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost	(342)
Fair Value	342
Amount Shown on Consolidated Balance Sheet	342
Limited partnerships/corporations
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost	(1,836)
Fair Value	1,836
Amount Shown on Consolidated Balance Sheet	1,836
Derivatives
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost	(4)
Fair Value	303
Amount Shown on Consolidated Balance Sheet	303
Other investments, including securities pledged
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost	(74)
Fair Value	74
Amount Shown on Consolidated Balance Sheet	$ 74

Schedule II - Condensed Finan_2

Schedule II - Condensed Financial Information of Parent - Balance Sheets (Details) - USD ($) $ / shares in Units, $ in Millions	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Investments:
Short-term investments under securities loan agreements, including collateral delivered	$ 1,042	$ 1,015
Deferred income taxes	2,134	2,160
Total assets	163,889	157,085
Liabilities:
Payables under securities loan and repurchase agreements, including collateral held	1,309	1,121
Short-term debt	399	1
Long-term debt	2,502	2,098
Derivatives	332	371
Shareholders' equity:
Preferred stock ($0.01 par value per share; $625 aggregate liquidation preference as of 2024 and 2023)	0	0
Common stock ($0.01 par value per share; 900,000,000 shares authorized; 105,592,281 and 103,584,699 shares issued as of 2024 and 2023, respectively; 95,497,265 and 102,854,569 shares outstanding as of 2024 and 2023, respectively)	1	1
Treasury stock (at cost; 10,095,016 and 730,130 shares as of 2024 and 2023, respectively)	(754)	(56)
Additional paid-in capital	6,266	6,143
Accumulated other comprehensive income (loss)	(2,462)	(2,400)	$ (3,055)
Retained earnings:
Unappropriated	954	505
Total shareholders' equity	5,788	5,878	$ 4,831	$ 9,668
Fixed maturities, amortized cost	$ 26,536	$ 27,690
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, aggregate liquidation preference	$ 625	$ 625
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	900,000,000	900,000,000
Common stock, shares issued	105,592,281	103,584,699
Common stock, shares outstanding	95,497,265	102,854,569	97,200,000	107,800,000
Treasury Stock, shares	10,095,016	730,130
Parent
Investments:
Fixed maturities, available-for-sale	$ 0	$ 6
Equity securities, at fair value	3	3
Short-term investments	20	13
Investment in subsidiaries	6	0
Derivatives	14	10
Investments In Subsidiaries	5,116	5,250
Total investments	5,159	5,282
Cash and cash equivalents	217	206
Short-term investments under securities loan agreements, including collateral delivered	1	1
Loans and Leases Receivable, Loans in Process	392	293
DueFromAffiliates	0	8
Deferred income taxes	819	856
Other assets	6	7
Total assets	6,594	6,653
Liabilities:
Payables under securities loan and repurchase agreements, including collateral held	0	10
Short-term debt	575	445
Long-term debt	1,871	1,865
Derivatives	22	9
Due to subsidiaries and affiliates	2	0
Other liabilities	119	131
Total liabilities	2,589	2,460
Retained earnings:
Unappropriated		505
Total shareholders' equity	4,005	4,193
Total liabilities and shareholders' equity	6,594	6,653
Fixed maturities, amortized cost	$ 0
Fixed maturities, including securities pledged, Amortized Cost Basis		$ 6

Schedule II - Condensed Finan_3

Schedule II - Condensed Financial Information of Parent - Statements of Operations (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Revenues:
Net investment income	$ 2,074	$ 2,159	$ 2,281
Net gains (losses)	(27)	(72)	(686)
Other Income	423	327	148
Total revenues	8,050	7,348	5,930
Expenses:
Total benefits and expenses	7,251	6,670	5,502
Income tax expense (benefit)	57	(51)	(5)
Net income available to Voya Financial, Inc.	667	625	510
Less: Preferred stock dividends	41	36	36
Net income available to Voya Financial, Inc.'s common shareholders	626	589	474
Parent
Revenues:
Net investment income	36	38	12
Net gains (losses)	20	65	(52)
Other Income	1	27	18
Total revenues	57	130	(22)
Expenses:
Interest expense	130	130	114
Other expense	5	35	30
Total benefits and expenses	135	165	144
Income (loss) before income taxes and equity in earnings (losses) of subsidiaries	(78)	(35)	(166)
Income tax expense (benefit)	(18)	(18)	(86)
Less: Net income (loss) attributable to noncontrolling interest and redeemable noncontrolling interest	(60)	(17)	(80)
Equity in earnings (losses) of subsidiaries, net of tax	727	642	590
Net income available to Voya Financial, Inc.	667	625	510
Less: Preferred stock dividends	41	36	36
Net income available to Voya Financial, Inc.'s common shareholders	$ 626	$ 589	$ 474

Schedule II - Condensed Finan_4

Schedule II - Condensed Financial Information of Parent - Statements of Comprehensive Income (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Condensed Financial Statements, Captions [Line Items]
Net income (loss) available to Voya Financial, Inc.	$ 667	$ 625	$ 510
Other comprehensive income (loss), after tax	(62)	655	(4,862)
Comprehensive income (loss) attributable to Voya Financial, Inc.	605	1,280	(4,352)
Parent
Condensed Financial Statements, Captions [Line Items]
Net income (loss) available to Voya Financial, Inc.	667	625	510
Other comprehensive income (loss), after tax	(62)	655	(4,862)
Comprehensive income (loss) attributable to Voya Financial, Inc.	$ 605	$ 1,280	$ (4,352)

Schedule II - Condensed Finan_5

Schedule II - Condensed Financial Information of Parent - Statements of Cash Flow (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Cash Flows from Operating Activities:
Net income (loss) available to Voya Financial, Inc.	$ 667	$ 625	$ 510
Deferred income tax expense (benefit)	42	(62)	3
Net (gains) losses	27	72	686
Changes in operating assets and liabilities:
Other receivables and asset accruals	(153)	31	(211)
Other, net	152	209	143
Net cash (used in) provided by operating activities	1,345	1,638	1,352
Cash Flows from Investing Activities:
Limited partnerships/corporations	292	470	256
Fixed maturities	6,239	6,980	7,900
Fixed maturities	(5,511)	(4,439)	(8,518)
Equity securities	36	139	5
Short-term investments, net	119	144	(260)
Payments for business acquisitions, net of cash acquired	0	(584)	(2)
Collateral received (delivered), net	167	(19)	54
Other, net	(132)	(87)	(65)
Net cash provided by (used in) investing activities	481	2,532	(1,946)
Net cash provided (used in) financing activities
Repayment of debt with maturities of more than three months	(1)	(541)	(366)
Proceeds from issuance of common stock, net	6	0	7
Dividends paid on common stock	(171)	(127)	(83)
Dividends paid on preferred stock	(41)	(36)	(36)
Net cash provided by (used in) financing activities	(1,430)	(4,059)	28
Net increase (decrease) in cash and cash equivalents, including cash in CIEs	396	111	(566)
Cash and cash equivalents, beginning of period	1,118
Cash and cash equivalents, end of period	1,514	1,118
Supplemental cash flow information:
Income taxes paid	9	11	14
Interest paid	103	113	131
Parent
Cash Flows from Operating Activities:
Net income (loss) available to Voya Financial, Inc.	667	625	510
Equity in earnings (losses) of subsidiaries, net of tax	(727)	(642)	(590)
Dividends from subsidiaries	861	1,057	502
Deferred income tax expense (benefit)	37	54	(35)
Net (gains) losses	(20)	(65)	52
Changes in operating assets and liabilities:
Other receivables and asset accruals	1	5	(21)
Due from subsidiaries and affiliates	106	108	46
Other payables and accruals	(12)	0	(10)
Other, net	(2)	(7)	29
Net cash (used in) provided by operating activities	911	1,135	483
Cash Flows from Investing Activities:
Limited partnerships/corporations	0	53	0
Fixed maturities	6	0	22
Fixed maturities	0	0	(16)
Equity securities	0	(3)	0
Short-term investments, net	(7)	(13)	18
Payments for Derivative Instrument, Investing Activities	29	19	(37)
Maturity (issuance) of short-term intercompany loans, net	(99)	(203)	34
Return of capital contributions and dividends from subsidiaries	0	0	708
Capital contributions to subsidiaries	(60)	(8)	0
Payments for business acquisitions, net of cash acquired	0	(584)	0
Collateral received (delivered), net	(10)	15	(5)
Other, net	0	(94)	0
Net cash provided by (used in) investing activities	(141)	(818)	724
Net cash provided (used in) financing activities
Proceeds from issuance of debt with maturities of more than three months	397	400	0
Repayment of debt with maturities of more than three months	0	(393)	(366)
Repayments of Debt	(269)	250	65
Proceeds from issuance of common stock, net	6	0	7
Share-based compensation	(44)	(47)	(40)
Proceeds from (Repurchase of) Equity	(640)	(369)	(750)
Dividends paid on common stock	(168)	(125)	(80)
Dividends paid on preferred stock	(41)	(36)	(36)
Net cash provided by (used in) financing activities	(759)	(320)	(1,200)
Net increase (decrease) in cash and cash equivalents, including cash in CIEs	11	(3)	7
Cash and cash equivalents, beginning of period	206	209	202
Cash and cash equivalents, end of period	217	206	209
Supplemental cash flow information:
Income taxes paid	5	4	14
Interest paid	$ 110	$ 111	$ 111

Schedule II - Condensed Finan_6

Schedule II - Condensed Financial Information of Parent - Loans to Subsidiaries (Details) - Parent - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans to subsidiaries	$ 392,000,000	$ 293,000,000
Interest income, operating	$ 24,000,000	18,000,000	$ 5,000,000
Voya Institutional Plan Services, LLC | Subsidiary Loan, Due January 3, 2023, 3.83 percent
Accounts, Notes, Loans and Financing Receivable [Line Items]
Rate	4.50%
Loans to subsidiaries	$ 43,000,000	0
Voya Institutional Plan Services, LLC | Subsidiary Loan, Due January 2, 2024, 5.44 percent
Accounts, Notes, Loans and Financing Receivable [Line Items]
Rate	5.44%
Loans to subsidiaries	$ 0	$ 31,000,000
Voya Investment Management, LLC | Subsidiary Loan, Due January 13, 2023, 4.46 Percent
Accounts, Notes, Loans and Financing Receivable [Line Items]
Rate		4.57%
Loans to subsidiaries	50,000,000	$ 0
Voya Services Company | Subsidiary Loan, Due January 3, 2023, 3.83 percent
Accounts, Notes, Loans and Financing Receivable [Line Items]
Rate		4.50%
Loans to subsidiaries	$ 224,000,000	$ 0
Voya Services Company | Subsidiary Loan, Due January 2, 2024, 5.44 percent
Accounts, Notes, Loans and Financing Receivable [Line Items]
Rate	5.44%
Loans to subsidiaries	$ 0	185,000,000
Voya Payroll Management, Inc. | Subsidiary Loan, Due January 2, 2024, 5.44 percent
Accounts, Notes, Loans and Financing Receivable [Line Items]
Rate	5.44%
Loans to subsidiaries	$ 0	11,000,000
Voya Payroll Management, Inc. | Subsidiary Loan, Due January 2, 2025, 4.50 percent
Accounts, Notes, Loans and Financing Receivable [Line Items]
Rate	4.50%
Loans to subsidiaries	$ 2,000,000
Voya Holdings Inc. | Subsidiary Loan, Due January 18, 2024, 5.53 Percent
Accounts, Notes, Loans and Financing Receivable [Line Items]
Rate	5.53%
Loans to subsidiaries	$ 0	44,000,000
Voya Holdings Inc. | Subsidiary Loan, Due January 12, 2024, 5.51 Percent
Accounts, Notes, Loans and Financing Receivable [Line Items]
Rate	5.51%
Loans to subsidiaries	$ 0	$ 22,000,000
Voya Holdings Inc. | Subsidiary Loan, Due January 30, 2025, 4.57 Percent
Accounts, Notes, Loans and Financing Receivable [Line Items]
Rate	4.57%
Loans to subsidiaries	$ 5,000,000
ReliaStar Life Insurance Company [Member] | Subsidiary Loan, Due January 2, 2025, 4.50 percent
Accounts, Notes, Loans and Financing Receivable [Line Items]
Rate	4.50%
Loans to subsidiaries	$ 68,000,000

Schedule II - Condensed Finan_7

Schedule II - Condensed Financial Information of Parent - Financing Agreements (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Debt Instrument [Line Items]
Total	$ 399	$ 1
Revolving lines of credit, capacity	512
Outstanding borrowings	12
Payments of financing costs	1	1	$ 2
Long-term debt	2,502	2,098
Current portion of long-term debt	399	1
Notes Payable | 8.42% Equitable of Iowa Companies Capital Trust II Notes, due 2027
Debt Instrument [Line Items]
Long-term debt	$ 13	$ 13
Annual interest rate on loan	8.42%	8.42%
Debentures | Voya Holdings Debentures
Debt Instrument [Line Items]
Long-term debt	$ 218	$ 218
Parent
Debt Instrument [Line Items]
Intercompany financing - Subsidiaries	176	445
Total	575	445
Revolving lines of credit, capacity	512
Outstanding borrowings	12
Payments of financing costs	1	1	$ 2
Long-term debt	1,871	$ 1,865
Parent | Unsecured and Committed
Debt Instrument [Line Items]
Revolving lines of credit, capacity	512
Parent | Notes Payable | Voya Holdings Inc. | 8.42% Equitable of Iowa Companies Capital Trust II Notes, due 2027 | Financial Guarantee
Debt Instrument [Line Items]
Long-term debt	$ 13

Schedule II - Condensed Finan_8

Schedule II - Condensed Financial Information of Parent - Returns of Capital and Dividends (Details) - Parent - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Condensed Financial Statements, Captions [Line Items]
Return of capital contributions and dividends from subsidiaries	$ 861	$ 1,057	$ 1,210
Voya Holdings Inc.
Condensed Financial Statements, Captions [Line Items]
Return of capital contributions and dividends from subsidiaries	$ 861	$ 1,057	$ 1,210

Schedule II - Condensed Finan_9

Schedule II - Condensed Financial Information of Parent - Income Taxes (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Schedule of Deferred Tax Assets and Liabilities [Line Items]
Deferred income taxes	$ 2,134	$ 2,160
Current income tax receivable	12
Parent
Schedule of Deferred Tax Assets and Liabilities [Line Items]
Deferred income taxes	819	856
Current income tax receivable	$ 4	$ 5

Schedule III - Supplementary _2

Schedule III - Supplementary Insurance Information (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items]
DAC and VOBA	$ 2,148	$ 2,250
Future Policy Benefits and Contract Owner Account Balances	46,436	48,734
Unearned Premiums	0	0
Net Investment Income	2,074	2,159	$ 2,281
Premiums and Fee Income	5,289	4,633	4,165
Interest Credited and Other Benefits to Contract Owners	3,619	3,036	2,528
Amortization of DAC and VOBA	223	230	240
Other Operating Expenses	3,082	3,096	2,542
Premiums Written (Excluding Life)	2,462	2,120	1,849
Operating Segments | Wealth Solutions
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items]
DAC and VOBA	1,044	1,064
Future Policy Benefits and Contract Owner Account Balances	30,090	31,653
Unearned Premiums	0	0
Net Investment Income	1,735	1,807	2,006
Premiums and Fee Income	1,151	1,007	992
Interest Credited and Other Benefits to Contract Owners	834	872	868
Amortization of DAC and VOBA	83	88	93
Other Operating Expenses	1,261	1,242	1,192
Premiums Written (Excluding Life)	0	0	0
Operating Segments | Health Solutions
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items]
DAC and VOBA	234	211
Future Policy Benefits and Contract Owner Account Balances	2,444	2,268
Unearned Premiums	0	0
Net Investment Income	145	135	134
Premiums and Fee Income	3,225	2,748	2,454
Interest Credited and Other Benefits to Contract Owners	2,602	1,895	1,680
Amortization of DAC and VOBA	36	33	29
Other Operating Expenses	951	903	577
Premiums Written (Excluding Life)	2,462	2,120	1,849
Operating Segments | Investment Management
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items]
DAC and VOBA	0	0
Future Policy Benefits and Contract Owner Account Balances	0	0
Unearned Premiums	0	0
Net Investment Income	20	26	9
Premiums and Fee Income	953	903	745
Interest Credited and Other Benefits to Contract Owners	0	0	0
Amortization of DAC and VOBA	0	0	0
Other Operating Expenses	865	855	689
Premiums Written (Excluding Life)	0	0	0
Corporate
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items]
DAC and VOBA	870	975
Future Policy Benefits and Contract Owner Account Balances	13,902	14,813
Unearned Premiums	0	0
Net Investment Income	174	191	132
Premiums and Fee Income	(40)	(25)	(26)
Interest Credited and Other Benefits to Contract Owners	183	269	(20)
Amortization of DAC and VOBA	104	109	118
Other Operating Expenses	5	96	84
Premiums Written (Excluding Life)	$ 0	$ 0	$ 0

Schedule IV - Reinsurance (Deta

Schedule IV - Reinsurance (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Life insurance in force, Gross	$ 583,218	$ 596,806	$ 610,227
Life insurance in force, Ceded	328,594	346,714	368,598
Life insurance in force, Assumed	4,671	4,963	5,644
Life insurance in force, Net	$ 259,295	$ 255,055	$ 247,273
Percentage of Assumed to Net, Life insurance in force	1.80%	1.90%	2.30%
Direct premiums	$ 4,084	$ 3,599	$ 3,257
Ceded Premiums	929	908	859
Assumed premiums	21	26	25
Net premiums	$ 3,176	$ 2,717	$ 2,423
Percentage Assumed to Net, Premiums	0.70%	1%	1%
Life Insurance Product Line
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Direct premiums	$ 1,209	$ 1,188	$ 1,198
Ceded Premiums	530	571	589
Assumed premiums	21	25	24
Net premiums	$ 700	$ 642	$ 633
Percentage Assumed to Net, Premiums	3%	3.90%	3.80%
Accident and Health Insurance Product Line
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Direct premiums	$ 2,847	$ 2,359	$ 2,018
Ceded Premiums	388	323	255
Assumed premiums	0	0	0
Net premiums	$ 2,459	$ 2,036	$ 1,763
Percentage Assumed to Net, Premiums	0%	0%	0%
Annuity Contracts
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Direct premiums	$ 28	$ 52	$ 41
Ceded Premiums	11	14	15
Assumed premiums	0	1	1
Net premiums	$ 17	$ 39	$ 27
Percentage Assumed to Net, Premiums	0%	2.60%	3.70%

Schedule V - Valuation and Qu_2

Schedule V - Valuation and Qualifying Accounts (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Allowance for losses for commercial mortgage loans, beginning balance	$ 26
Allowance for losses for commercial mortgage loans, Charged to Costs and Expenses	1	$ 11	$ 3
Allowance for losses for commercial mortgage loans, ending balance	24	26
Allowance for credit losses on available-for-sale fixed maturity securities, beginning balance	17	12	58
Credit losses on securities for which credit losses were not previously recorded	22	10	11
Write-offs/Payments/Other	(1)	(5)	(57)
Allowance for credit losses on available-for-sale fixed maturity securities, ending balance	38	17	12
Allowance for credit losses on reinsurance recoverable, beginning balance	28	32	24
Reinsurance Recoverable, Credit Loss Expense (Reversal)	(12)	(4)	8
Reinsurance Recoverable, Allowance for Credit Loss, Period Increase (Decrease)	0	0	0
Allowance for credit losses on reinsurance recoverable, ending balance	16	28	32
Allowance for credit losses on deposit asset, Beginning balance	1	1	0
Charged to cost and expenses	0	0	1
Reinsurance, Loss on Uncollectible Accounts in Period, Amount	0	0	0
Allowance for credit losses on deposit asset, Ending balance	1	1	1
Commercial Portfolio Segment
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Allowance for losses for commercial mortgage loans, beginning balance	26	18	15
Allowance for losses for commercial mortgage loans, Write-offs	(3)	(3)	0
Allowance for losses for commercial mortgage loans, ending balance	24	26	18
Valuation allowance on deferred tax assets
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Valuation allowance on deferred tax assets, beginning balance	95	70	63
Charged to Costs and Expenses	1	(1)	(7)
Write-offs/Payments/Other	0	26	0
Valuation allowance on deferred tax assets, ending balance	$ 96	$ 95	$ 70